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Major structural or genetic congenital anomalies affect approximately 3% of births in 
Europe.1 Since the introduction of prenatal screening methods such as the 20-week 
fetal anomaly scan (the Netherlands, 2007), 40% of major structural congenital 
anomalies are detected prenatally.2 This offers the possibility of early parental 
counseling and of optimizing postnatal care, provided that sufficient information is 
available on the implications of the fetal anomaly on survival, hospital outcome, and 
long-term consequences. 
 
As of yet, limited data are available on the long-term outcome of children with either 
an abdominal wall defect (AWD; i.e. gastroschisis or omphalocele) or a congenital lung 
malformation (CLM). The prenatal detection rates of these anomalies are high; 
approximately 90% of AWD are diagnosed prenatally,2 and previous research reported 
a three-fold increase in prenatally detected CLM between 1994 and 2012.3-5 In the past, 
the follow-up of these children after birth was characterized by a monodisciplinary 
approach, and research focused on survival rates and surgical outcome. As medical 
possibilities and survival rates have improved, the focus of research is shifting towards 
the long-term implications.  
 
Twenty years ago, a longitudinal multidisciplinary follow-up program was initiated at the 
Erasmus MC-Sophia Children's Hospital as standard of care for children with structural 
congenital anomalies; in particular for those with any of the surgical index diagnoses as 
described by Ravitch.6, 7 Data from this prospective follow-up program have been 
collected, and analyzed in numerous papers published by our group.6, 8-15 The long-term 
outcomes of children with AWD or CLM have not yet been described. 
 
When counseling expectant parents, it is important to know how to interpret certain 
prenatal characteristics. Adequate parental counseling should also include expectations 
of the child’s long-term outcome. Many surviving infants with AWD or CLM experience 
feeding difficulties, respiratory problems and infections, which put them at risk for long-
term impairments.  
 
 
General key questions  
• Can we identify prenatal characteristics that contribute to the prediction 
of postnatal morbidity? 
• What kind of long-term morbidity is seen in these children?  
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Gastroschisis  
The term gastroschisis was introduced by the Italian pathologist 
Cesare Taruffi in 1894 to describe all types of congenital 
AWD.16 The currently used classifications of gastroschisis and 
omphalocele were established by Thomas Moore and George 
Stokes in 1953, on the basis of the location of the umbilical cord, 
the presence or absence of a covering membrane, and the 
appearance of eviscerated intestines.17  
 
Gastroschisis is a congenital AWD, usually located on the right side of the umbilical 
cord. Abdominal organs herniate through the defect, and are – in contrast with 
omphalocele – not covered by a membrane (figure 1). Gastroschisis occurs in 
approximately 2.6 per 10 000 births.1 It is associated with accumulation of a variety of 
maternal stressor exposures, including young maternal age, smoking, alcohol use, illicit 
drug use, infections, and use of several medications.18 The mothers typically have a 
lower body mass index,19 and are more likely to be nulliparous.20 
 
Infants with gastroschisis require surgery shortly after birth, by means of primary 
closure if possible, or by secondary closure (e.g. by placing a silastic silo to allow gradual 
reduction into the abdominal cavity prior to definite closure).21 Although survival rates 
are now over 90%,22 children with gastroschisis are at high risk of morbidity – especially 
when additional intestinal defects are diagnosed. Gastroschisis complicated by intestinal 
atresia, necrosis, perforation or volvulus is therefore called ‘complex gastroschisis’; this 
occurs in approximately 17% of cases.23, 24 It often takes longer than usual to establish 
full enteral feeding in these children, they are more likely to develop complications such 
as sepsis, intestinal failure and parenteral nutrition-related cholestasis, and need to stay 
longer in hospital.23-25 
 
Prenatal prediction of complex gastroschisis 
If the presence of complex gastroschisis could be predicted prenatally, parental 
counselling would be more complete. Unfortunately, it is difficult to distinguish simple 
from complex gastroschisis on prenatal ultrasound. The association between two-
dimensional (2D) prenatal ultrasound findings (such as bowel and stomach dilatation) 
and complex gastroschisis has been investigated in a number of retrospective studies, 
which showed conflicting results.26 Three-dimensional (3D) ultrasound has been 
proposed to be superior to 2D ultrasound in fetal imaging.27, 28 The fetal stomach 
volume could perhaps be measured more accurately using 3D ultrasound, and thus 
facilitate predicting complex gastroschisis. To date there are no studies, however, to 
support this hypothesis.  
Figure 1 Gastroschisis 
 
Long-term outcome 
In addition to the high risk of morbidity in early life, many neonates with gastroschisis 
are born small for gestational age29, 30 or preterm.22 These characteristics give reason 
for concern regarding these children’s long-term outcome, such as physical growth, 
mental development, and motor function. Unfortunately, relevant information in the 
literature is scarce.  
 
The two studies on physical growth that took into account the type of gastroschisis (i.e. 
simple or complex) found that children with complex gastroschisis had lower weight 
than those with simple gastroschisis at the ages of 12 months31 and 5-17 years.32 Studies 
comparing mental development and motor function between infants with simple and 
complex gastroschisis are still lacking. 
 
Outcomes of children born with gastroschisis at school age (i.e. 4-17 years) vary 
between studies. Most studies reported normal health status.33-35 Other results were 
contradictory: some studies showed normal intelligence,36-38 motor function39, 40 or 
behavior,38, 41 whereas others found intellectual delay,41 problems regarding motor 
skills,41 or behavioral problems.36, 37  
 
 
 
Omphalocele  
Omphalocele is a midline congenital AWD; abdominal organs 
protrude through the opening into the umbilical cord, and are 
covered by a membrane (figure 2). Omphalocele occurs in 
approximately 3.4 per 10 000 births.1 It is associated with either 
young or advanced maternal age (i.e. <20 or >34 years),42 and 
several maternal stressor exposures, including smoking,43 use of 
Specific key questions  
• Can we identify prenatal 2D or 3D ultrasound markers of complex 
gastroschisis? (chapters 2 and 3) 
• How do infants with either simple or complex gastroschisis grow up in 
terms of physical growth, mental development, and motor development? 
(chapter 3) 
• How do parents rate their child’s motor function, cognition, health status, 
quality of life and behavior at school age? (chapter 4) 
Figure 2 Omphalocele 
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alcohol,43 and use of several medications.44, 45 Other than in the case of gastroschisis, 
women who are pregnant with a fetus with omphalocele are more likely to be obese,19, 
46 and to be pregnant with multiple fetuses.42, 47   
Prenatal and postnatal frames of reference 
Survival rates up to 90% have been reported for live-born infants with isolated 
omphalocele.42 However, approximately 75-80% of fetuses with omphalocele present 
with chromosomal abnormalities and/or additional congenital anomalies.42, 48 This leads 
to a high prevalence of termination of pregnancy and intrauterine death. The frame of 
reference of prenatal specialists could therefore be different from that of pediatric 
surgeons and pediatricians.  
 
Prenatal prediction of the type of surgical closure  
After birth, an omphalocele is usually defined as giant if the defect is ≥5cm at primary 
evaluation, with the liver (partly) protruding.49 Otherwise, it is called minor 
omphalocele. Minor omphaloceles can usually be closed primarily, within 48 hours after 
birth. In contrast, closure of giant omphaloceles is usually delayed in view of the 
visceroabdominal disproportion. In the Erasmus MC-Sophia Children's hospital, most 
children with a giant omphalocele are treated conservatively; this implies that after 
epithelialization of the omphalocele, the abdominal wall is reconstructed using the 
component separation technique by Ramirez.50, 51 This is usually planned before 12 
months postnatal age.50  
 
Several prenatal ultrasound parameters have shown to be predictive of the type of 
surgical closure (i.e. primary or delayed); these include the ratio between omphalocele 
diameter (OD) and abdominal circumference (AC; OD/AC-ratio),52, 53 and the ratio 
between omphalocele circumference (OC) and AC (OC/AC-ratio).54, 55 Three of these 
studies found an optimal cut-off of 0.26 (when calculating OD/AC)52, 53 or 0.82 (0.26*π; 
when calculating OC/AC).54 These studies had only one measurement per fetus 
available,53 however, or included only fetuses with an isolated omphalocele.52, 54 It is yet 
unclear whether the OC/AC-ratio throughout gestation is a valid predictor of type of 
surgical closure in all fetuses with an omphalocele, including non-isolated ones.  
 
Long-term outcome 
In addition to the need for surgery in early life, complications such as respiratory failure 
or feeding difficulties could negatively affect the long-term outcomes.56 Previous 
research on outcome in infants with omphalocele mainly focused on those with giant 
omphalocele,56-58 or did not distinguish between different types of non-cardiac 
structural anomalies.59-61 Information on outcomes beyond the age of five years is 
limited.40, 57, 62 
 
 
Congenital lung malformations 
CLM are a heterogeneous group of malformations, including 
congenital pulmonary airway malformation (CPAM; figure 3), 
bronchopulmonary sequestration (BPS), congenital lobar 
emphysema (CLE), bronchogenic cysts (BC), and hybrid forms of 
these lesions.63  
 
As a result of routine fetal anomaly scanning and improved 
ultrasound technology, CLM are increasingly being detected 
prenatally.3 The current estimated incidence is 4.2 per 10 000 
births.3 
 
Prenatal ultrasound evaluation of CLM focuses on the location, 
size, appearance of the cysts (i.e. microcystic, macrocystic, or 
mixed), and on the presence or absence of systemic blood supply, hydrops, and 
mediastinal shift. Correctly diagnosing the specific type of CLM is challenging, as fetal 
lungs are not aerated yet, and because different CLM can look similar on prenatal 
ultrasound. In addition, the postnatal classification of CLM differs from the prenatal 
classification; after birth, CPAMs are classified into Stocker type 0 to 4,64 rather than 
being grouped into microcystic, macrocystic or mixed. Only few studies have recently 
studied the concordance between prenatal appearance and postnatal type of CLM.65-67 
 
 
 
Specific key questions 
• How does the prenatal frame of reference differ from that after birth? 
(chapter 6) 
• Can we prenatally predict the type of surgical closure in fetuses with 
either isolated or non-isolated omphalocele? (chapter 5) 
• How do infants with either minor or giant omphalocele grow up in 
terms of physical growth, mental development, and motor 
development? (chapter 6) 
• How do parents rate their child’s motor function, cognition, health 
status, quality of life and behavior at school age? (chapter 7) 
Figure 3 Congenital 
pulmonary airway 
malformation 
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Prenatal prediction of adverse postnatal outcome 
Prenatal prediction of the need for respiratory support and the need for surgery would 
not only be useful in parental counseling, but also for delivery planning and appropriate 
follow-up. After birth, the majority of neonates with CLM remain asymptomatic, 
whereas some require immediate respiratory support and intensive care admission. 
Others present with recurrent lower respiratory tract infections later in childhood. 
Those children who develop symptoms, either directly after birth or later in life, 
undergo surgical resection.  
 
Previous studies have sought to identify prenatal predictors of adverse postnatal 
outcome, including the CPAM volume ratio (CVR). The volume of the CLM is calculated 
using the formula for the volume of an ellipse (length x weight x height x 0.52); to 
normalize for gestational age, the calculated volume is divided by the head 
circumference: length x weight x height x 0.52 / head circumference = CVR.68 The CVR, 
which was originally developed to predict fetal hydrops,68 has proven to be predictive 
of several adverse perinatal outcomes, including respiratory distress,69 need for 
intensive care admission,70 and need for early surgical resection.71, 72 Most studies 
calculated a cut-off for the maximum CVR measured at any time during pregnancy,69, 71, 
72 or for the CVR at initial evaluation with a large range in gestational age.72, 73 Neither 
of these cut-offs is helpful in the parental counseling at the 20-week fetal anomaly scan. 
The study that calculated multiple cut-offs during pregnancy for predicting the need for 
intensive care admission, suggested a cut-off of 0.5 for a CVR measured before 24 
weeks' gestation.70 Optimal cut-offs for the CVR measured around 20 weeks' gestation, 
for predicting respiratory distress or the need for surgical resection, are not well 
established yet. 
 
Controversies and long-term outcome 
Although the management of children with symptomatic CLM is straightforward, there 
is ongoing debate regarding the need for and the most accurate timing of surgery in 
asymptomatic children.74 Those who support elective surgical resection of 
asymptomatic CLM worry mostly about pulmonary infections and malignant 
development. Others advocate observational management, considering that the 
possible benefits of elective surgical resection may not outweigh the risk of 
postoperative complications and the adverse effects of anesthesia on children's brain 
development.74, 75  
 
The literature on pulmonary outcome in children with CLM is scarce. A previous study 
at our center showed that approximately one third of them suffered from airflow 
obstruction in the first year after birth, with no significant difference between those 
 
managed surgically or observationally.76 Data on long-term outcome are also scarce, 
especially in those with asymptomatic CLM.77-79  
 
 
 
Aims and outline of this thesis 
 
The studies presented in this thesis were performed with the aim to improve the 
knowledge on prenatal characteristics and long-term outcome of gastroschisis, 
omphalocele, and CLM, with the ultimate goal to optimize parental counselling and 
postnatal follow-up.  
 
In chapter 10, the study results are discussed and put into perspective, and suggestions 
for future research are described. The results of all studies are summarized in English 
(chapter 11) and in Dutch (chapter 12).   
  
Specific key questions 
• How does the prenatal appearance of CLM correspond with that after 
birth? (chapter 8) 
• Can we prenatally predict the need for postnatal respiratory support 
and/or surgical intervention? (chapter 8) 
• How do these children, either managed observationally or surgically, 
grow up in terms of physical growth, lung function, and exercise 
tolerance? (chapter 9) 
Chapter 1
16
Prenatal prediction of adverse postnatal outcome 
Prenatal prediction of the need for respiratory support and the need for surgery would 
not only be useful in parental counseling, but also for delivery planning and appropriate 
follow-up. After birth, the majority of neonates with CLM remain asymptomatic, 
whereas some require immediate respiratory support and intensive care admission. 
Others present with recurrent lower respiratory tract infections later in childhood. 
Those children who develop symptoms, either directly after birth or later in life, 
undergo surgical resection.  
 
Previous studies have sought to identify prenatal predictors of adverse postnatal 
outcome, including the CPAM volume ratio (CVR). The volume of the CLM is calculated 
using the formula for the volume of an ellipse (length x weight x height x 0.52); to 
normalize for gestational age, the calculated volume is divided by the head 
circumference: length x weight x height x 0.52 / head circumference = CVR.68 The CVR, 
which was originally developed to predict fetal hydrops,68 has proven to be predictive 
of several adverse perinatal outcomes, including respiratory distress,69 need for 
intensive care admission,70 and need for early surgical resection.71, 72 Most studies 
calculated a cut-off for the maximum CVR measured at any time during pregnancy,69, 71, 
72 or for the CVR at initial evaluation with a large range in gestational age.72, 73 Neither 
of these cut-offs is helpful in the parental counseling at the 20-week fetal anomaly scan. 
The study that calculated multiple cut-offs during pregnancy for predicting the need for 
intensive care admission, suggested a cut-off of 0.5 for a CVR measured before 24 
weeks' gestation.70 Optimal cut-offs for the CVR measured around 20 weeks' gestation, 
for predicting respiratory distress or the need for surgical resection, are not well 
established yet. 
 
Controversies and long-term outcome 
Although the management of children with symptomatic CLM is straightforward, there 
is ongoing debate regarding the need for and the most accurate timing of surgery in 
asymptomatic children.74 Those who support elective surgical resection of 
asymptomatic CLM worry mostly about pulmonary infections and malignant 
development. Others advocate observational management, considering that the 
possible benefits of elective surgical resection may not outweigh the risk of 
postoperative complications and the adverse effects of anesthesia on children's brain 
development.74, 75  
 
The literature on pulmonary outcome in children with CLM is scarce. A previous study 
at our center showed that approximately one third of them suffered from airflow 
obstruction in the first year after birth, with no significant difference between those 
 
managed surgically or observationally.76 Data on long-term outcome are also scarce, 
especially in those with asymptomatic CLM.77-79  
 
 
 
Aims and outline of this thesis 
 
The studies presented in this thesis were performed with the aim to improve the 
knowledge on prenatal characteristics and long-term outcome of gastroschisis, 
omphalocele, and CLM, with the ultimate goal to optimize parental counselling and 
postnatal follow-up.  
 
In chapter 10, the study results are discussed and put into perspective, and suggestions 
for future research are described. The results of all studies are summarized in English 
(chapter 11) and in Dutch (chapter 12).   
  
Specific key questions 
• How does the prenatal appearance of CLM correspond with that after 
birth? (chapter 8) 
• Can we prenatally predict the need for postnatal respiratory support 
and/or surgical intervention? (chapter 8) 
• How do these children, either managed observationally or surgically, 
grow up in terms of physical growth, lung function, and exercise 
tolerance? (chapter 9) 
1
Introduction
17
References  
1 EUROCAT Prevalence Data Tables. 
Accessed April 2019. 
2 EUROCAT Prenatal Detection Rates. 
Accessed April 2019. 
3 Stocker LJ, Wellesley DG, Stanton MP, 
et al. The increasing incidence of foetal 
echogenic congenital lung 
malformations: an observational study. 
Prenat Diagn. 2015;35(2):148-153. 
4 Burge D, Wheeler R. Increasing 
incidence of detection of congenital 
lung lesions. Pediatr Pulmonol. 
2010;45(1):103; author reply 104. 
5 Alamo L, Gudinchet F, Reinberg O, et 
al. Prenatal diagnosis of congenital lung 
malformations. Pediatr Radiol. 
2012;42(3):273-283. 
6 Gischler SJ, Mazer P. Children with 
Anatomical Congenital Anomalies; a 
Portrait. Follow-up over five years. 
Rotterdam: Erasmus University 
Rotterdam; 2008. 
7 Ravitch MM, Barton BA. The need for 
pediatric surgeons as determined by 
the volume of work and the mode of 
delivery of surgical care. Surgery. 
1974;76(5):754-763. 
8 Snoek KG. A dive into the wondrous 
world of congenital diaphragmatic 
hernia. Rotterdam: Erasmus University 
Rotterdam; 2016. 
9 Leeuwen L. From the first breath of life: 
congenital diaphragmatic hernia, the 
child at risk. Rotterdam: Erasmus 
University Rotterdam; 2017. 
10 Van der Cammen-van Zijp MH. In a 
gentle breeze. Pulmonary morbidity in 
children with anatomical congenital 
anomalies; long-term effects on 
exercise capacity and motor function. 
Rotterdam: Erasmus University 
Rotterdam; 2010. 
11 Schiller R. The vulnerable brain. 
Neurodevelopment after neonatal 
critical illness. Rotterdam: Erasmus 
University Rotterdam; 2018. 
12 Van den Hondel D. Anorectal 
malformations. A multidisciplinary 
approach. Rotterdam: Erasmus 
University Rotterdam; 2015. 
13 Versteegh H. Cloacal malformations. 
When all ends meet. Rotterdam: 
Erasmus University Rotterdam; 2015. 
14 Spoel M. The air that we breathe. 
Respiratory morbidity in children with 
congenital pulmonary malformations. 
Rotterdam: Erasmus University 
Rotterdam; 2012. 
15 Madderom M. Long-term follow-up of 
children treated with neonatal 
extracorporeal membrane 
oxygenation: neuropsychologiscal 
outcome. Rotterdam: Erasmus 
University Rotterdam; 2013. 
16 Taruffi C. Storia della teratologia. Vol VII. 
Bologna, Italy: Regia Tipografia; 1894. 
17 Moore TC, Stokes GE. Gastroschisis; 
report of two cases treated by a 
modification of the gross operation for 
omphalocele. Surgery. 1953;33(1):112-
120. 
18 Werler MM, Guery E, Waller DK, et al. 
Gastroschisis and Cumulative Stressor 
Exposures. Epidemiology. 
2018;29(5):721-728. 
19 Waller DK, Shaw GM, Rasmussen SA, 
et al. Prepregnancy obesity as a risk 
factor for structural birth defects. Arch 
Pediatr Adolesc Med. 2007;161(8):745-
750. 
20 Duong HT, Hoyt AT, Carmichael SL, et 
al. Is maternal parity an independent 
risk factor for birth defects? Birth 
Defects Res A Clin Mol Teratol. 
2012;94(4):230-236. 
21 Chesley PM, Ledbetter DJ, Meehan JJ, et 
al. Contemporary trends in the use of 
primary repair for gastroschisis in 
surgical infants. Am J Surg. 
2015;209(5):901-905; discussion 905-
906. 
22 Corey KM, Hornik CP, Laughon MM, et 
al. Frequency of anomalies and hospital 
 
outcomes in infants with gastroschisis 
and omphalocele. Early Hum Dev. 
2014;90(8):421-424. 
23 Molik KA, Gingalewski CA, West KW, 
et al. Gastroschisis: a plea for risk 
categorization. J Pediatr Surg. 
2001;36(1):51-55. 
24 Bergholz R, Boettcher M, Reinshagen K, 
et al. Complex gastroschisis is a 
different entity to simple gastroschisis 
affecting morbidity and mortality-a 
systematic review and meta-analysis. J 
Pediatr Surg. 2014;49(10):1527-1532. 
25 Arnold MA, Chang DC, Nabaweesi R, 
et al. Risk stratification of 4344 patients 
with gastroschisis into simple and 
complex categories. J Pediatr Surg. 
2007;42(9):1520-1525. 
26 D'Antonio F, Virgone C, Rizzo G, et al. 
Prenatal Risk Factors and Outcomes in 
Gastroschisis: A Meta-Analysis. 
Pediatrics. 2015;136(1):e159-169. 
27 Hata T, Tanaka H, Noguchi J, et al. 
Three-dimensional sonographic volume 
measurement of the fetal stomach. 
Ultrasound Med Biol. 2010;36(11):1808-
1812. 
28 Goncalves LF, Lee W, Espinoza J, et al. 
Three- and 4-dimensional ultrasound in 
obstetric practice: does it help? J 
Ultrasound Med. 2005;24(12):1599-
1624. 
29 Girsen AI, Do S, Davis AS, et al. 
Peripartum and neonatal outcomes of 
small-for-gestational-age infants with 
gastroschisis. Prenat Diagn. 
2015;35(5):477-482. 
30 Payne NR, Simonton SC, Olsen S, et al. 
Growth restriction in gastroschisis: 
quantification of its severity and 
exploration of a placental cause. BMC 
Pediatr. 2011;11:90. 
31 Minutillo C, Rao SC, Pirie S, et al. 
Growth and developmental outcomes 
of infants with gastroschisis at one year 
of age: a retrospective study. J Pediatr 
Surg. 2013;48(8):1688-1696. 
32 Harris EL, Minutillo C, Hart S, et al. The 
long term physical consequences of 
gastroschisis. J Pediatr Surg. 
2014;49(10):1466-1470. 
33 Rankin J, Glinianaia SV, Jardine J, et al. 
Measuring self-reported quality of life in 
8- to 11-year-old children born with 
gastroschisis: Is the KIDSCREEN 
questionnaire acceptable? Birth Defects 
Res A Clin Mol Teratol. 2016;106(4):250-
256. 
34 Carpenter JL, Wiebe TL, Cass DL, et al. 
Assessing quality of life in pediatric 
gastroschisis patients using the 
Pediatric Quality of Life Inventory 
survey: An institutional study. J Pediatr 
Surg. 2016;51(5):726-729. 
35 Arnold HE, Baxter KJ, Short HL, et al. 
Short-term and family-reported long-
term outcomes of simple versus 
complicated gastroschisis. J Surg Res. 
2018;224:79-88. 
36 Harris EL, Hart SJ, Minutillo C, et al. 
The long-term neurodevelopmental 
and psychological outcomes of 
gastroschisis: A cohort study. J Pediatr 
Surg. 2016;51(4):549-553. 
37 Burnett AC, Gunn JK, Hutchinson EA, 
et al. Cognition and behaviour in 
children with congenital abdominal wall 
defects. Early Hum Dev. 2018;116:47-52. 
38 Ginn-Pease ME, King DR, Tarnowski KJ, 
et al. Psychosocial adjustment and 
physical growth in children with 
imperforate anus or abdominal wall 
defects. J Pediatr Surg. 1991;26(9):1129-
1135. 
39 van der Cammen-van Zijp MH, Gischler 
SJ, Mazer P, et al. Motor-function and 
exercise capacity in children with major 
anatomical congenital anomalies: an 
evaluation at 5 years of age. Early Hum 
Dev. 2010;86(8):523-528. 
40 Henrich K, Huemmer HP, Reingruber 
B, et al. Gastroschisis and omphalocele: 
treatments and long-term outcomes. 
Pediatr Surg Int. 2008;24(2):167-173. 
Chapter 1
18
References  
1 EUROCAT Prevalence Data Tables. 
Accessed April 2019. 
2 EUROCAT Prenatal Detection Rates. 
Accessed April 2019. 
3 Stocker LJ, Wellesley DG, Stanton MP, 
et al. The increasing incidence of foetal 
echogenic congenital lung 
malformations: an observational study. 
Prenat Diagn. 2015;35(2):148-153. 
4 Burge D, Wheeler R. Increasing 
incidence of detection of congenital 
lung lesions. Pediatr Pulmonol. 
2010;45(1):103; author reply 104. 
5 Alamo L, Gudinchet F, Reinberg O, et 
al. Prenatal diagnosis of congenital lung 
malformations. Pediatr Radiol. 
2012;42(3):273-283. 
6 Gischler SJ, Mazer P. Children with 
Anatomical Congenital Anomalies; a 
Portrait. Follow-up over five years. 
Rotterdam: Erasmus University 
Rotterdam; 2008. 
7 Ravitch MM, Barton BA. The need for 
pediatric surgeons as determined by 
the volume of work and the mode of 
delivery of surgical care. Surgery. 
1974;76(5):754-763. 
8 Snoek KG. A dive into the wondrous 
world of congenital diaphragmatic 
hernia. Rotterdam: Erasmus University 
Rotterdam; 2016. 
9 Leeuwen L. From the first breath of life: 
congenital diaphragmatic hernia, the 
child at risk. Rotterdam: Erasmus 
University Rotterdam; 2017. 
10 Van der Cammen-van Zijp MH. In a 
gentle breeze. Pulmonary morbidity in 
children with anatomical congenital 
anomalies; long-term effects on 
exercise capacity and motor function. 
Rotterdam: Erasmus University 
Rotterdam; 2010. 
11 Schiller R. The vulnerable brain. 
Neurodevelopment after neonatal 
critical illness. Rotterdam: Erasmus 
University Rotterdam; 2018. 
12 Van den Hondel D. Anorectal 
malformations. A multidisciplinary 
approach. Rotterdam: Erasmus 
University Rotterdam; 2015. 
13 Versteegh H. Cloacal malformations. 
When all ends meet. Rotterdam: 
Erasmus University Rotterdam; 2015. 
14 Spoel M. The air that we breathe. 
Respiratory morbidity in children with 
congenital pulmonary malformations. 
Rotterdam: Erasmus University 
Rotterdam; 2012. 
15 Madderom M. Long-term follow-up of 
children treated with neonatal 
extracorporeal membrane 
oxygenation: neuropsychologiscal 
outcome. Rotterdam: Erasmus 
University Rotterdam; 2013. 
16 Taruffi C. Storia della teratologia. Vol VII. 
Bologna, Italy: Regia Tipografia; 1894. 
17 Moore TC, Stokes GE. Gastroschisis; 
report of two cases treated by a 
modification of the gross operation for 
omphalocele. Surgery. 1953;33(1):112-
120. 
18 Werler MM, Guery E, Waller DK, et al. 
Gastroschisis and Cumulative Stressor 
Exposures. Epidemiology. 
2018;29(5):721-728. 
19 Waller DK, Shaw GM, Rasmussen SA, 
et al. Prepregnancy obesity as a risk 
factor for structural birth defects. Arch 
Pediatr Adolesc Med. 2007;161(8):745-
750. 
20 Duong HT, Hoyt AT, Carmichael SL, et 
al. Is maternal parity an independent 
risk factor for birth defects? Birth 
Defects Res A Clin Mol Teratol. 
2012;94(4):230-236. 
21 Chesley PM, Ledbetter DJ, Meehan JJ, et 
al. Contemporary trends in the use of 
primary repair for gastroschisis in 
surgical infants. Am J Surg. 
2015;209(5):901-905; discussion 905-
906. 
22 Corey KM, Hornik CP, Laughon MM, et 
al. Frequency of anomalies and hospital 
 
outcomes in infants with gastroschisis 
and omphalocele. Early Hum Dev. 
2014;90(8):421-424. 
23 Molik KA, Gingalewski CA, West KW, 
et al. Gastroschisis: a plea for risk 
categorization. J Pediatr Surg. 
2001;36(1):51-55. 
24 Bergholz R, Boettcher M, Reinshagen K, 
et al. Complex gastroschisis is a 
different entity to simple gastroschisis 
affecting morbidity and mortality-a 
systematic review and meta-analysis. J 
Pediatr Surg. 2014;49(10):1527-1532. 
25 Arnold MA, Chang DC, Nabaweesi R, 
et al. Risk stratification of 4344 patients 
with gastroschisis into simple and 
complex categories. J Pediatr Surg. 
2007;42(9):1520-1525. 
26 D'Antonio F, Virgone C, Rizzo G, et al. 
Prenatal Risk Factors and Outcomes in 
Gastroschisis: A Meta-Analysis. 
Pediatrics. 2015;136(1):e159-169. 
27 Hata T, Tanaka H, Noguchi J, et al. 
Three-dimensional sonographic volume 
measurement of the fetal stomach. 
Ultrasound Med Biol. 2010;36(11):1808-
1812. 
28 Goncalves LF, Lee W, Espinoza J, et al. 
Three- and 4-dimensional ultrasound in 
obstetric practice: does it help? J 
Ultrasound Med. 2005;24(12):1599-
1624. 
29 Girsen AI, Do S, Davis AS, et al. 
Peripartum and neonatal outcomes of 
small-for-gestational-age infants with 
gastroschisis. Prenat Diagn. 
2015;35(5):477-482. 
30 Payne NR, Simonton SC, Olsen S, et al. 
Growth restriction in gastroschisis: 
quantification of its severity and 
exploration of a placental cause. BMC 
Pediatr. 2011;11:90. 
31 Minutillo C, Rao SC, Pirie S, et al. 
Growth and developmental outcomes 
of infants with gastroschisis at one year 
of age: a retrospective study. J Pediatr 
Surg. 2013;48(8):1688-1696. 
32 Harris EL, Minutillo C, Hart S, et al. The 
long term physical consequences of 
gastroschisis. J Pediatr Surg. 
2014;49(10):1466-1470. 
33 Rankin J, Glinianaia SV, Jardine J, et al. 
Measuring self-reported quality of life in 
8- to 11-year-old children born with 
gastroschisis: Is the KIDSCREEN 
questionnaire acceptable? Birth Defects 
Res A Clin Mol Teratol. 2016;106(4):250-
256. 
34 Carpenter JL, Wiebe TL, Cass DL, et al. 
Assessing quality of life in pediatric 
gastroschisis patients using the 
Pediatric Quality of Life Inventory 
survey: An institutional study. J Pediatr 
Surg. 2016;51(5):726-729. 
35 Arnold HE, Baxter KJ, Short HL, et al. 
Short-term and family-reported long-
term outcomes of simple versus 
complicated gastroschisis. J Surg Res. 
2018;224:79-88. 
36 Harris EL, Hart SJ, Minutillo C, et al. 
The long-term neurodevelopmental 
and psychological outcomes of 
gastroschisis: A cohort study. J Pediatr 
Surg. 2016;51(4):549-553. 
37 Burnett AC, Gunn JK, Hutchinson EA, 
et al. Cognition and behaviour in 
children with congenital abdominal wall 
defects. Early Hum Dev. 2018;116:47-52. 
38 Ginn-Pease ME, King DR, Tarnowski KJ, 
et al. Psychosocial adjustment and 
physical growth in children with 
imperforate anus or abdominal wall 
defects. J Pediatr Surg. 1991;26(9):1129-
1135. 
39 van der Cammen-van Zijp MH, Gischler 
SJ, Mazer P, et al. Motor-function and 
exercise capacity in children with major 
anatomical congenital anomalies: an 
evaluation at 5 years of age. Early Hum 
Dev. 2010;86(8):523-528. 
40 Henrich K, Huemmer HP, Reingruber 
B, et al. Gastroschisis and omphalocele: 
treatments and long-term outcomes. 
Pediatr Surg Int. 2008;24(2):167-173. 
1
Introduction
19
41 Lap CC, Bolhuis SW, Van Braeckel KN, 
et al. Functional outcome at school age 
of children born with gastroschisis. 
Early Hum Dev. 2017;106-107:47-52. 
42 Marshall J, Salemi JL, Tanner JP, et al. 
Prevalence, Correlates, and Outcomes 
of Omphalocele in the United States, 
1995-2005. Obstet Gynecol. 
2015;126(2):284-293. 
43 Mac Bird T, Robbins JM, Druschel C, et 
al. Demographic and environmental risk 
factors for gastroschisis and 
omphalocele in the National Birth 
Defects Prevention Study. J Pediatr Surg. 
2009;44(8):1546-1551. 
44 Anderson KN, Dutton AC, Broussard 
CS, et al. ADHD Medication Use 
During Pregnancy and Risk for Selected 
Birth Defects: National Birth Defects 
Prevention Study, 1998-2011. J Atten 
Disord. 2018:1087054718759753. 
45 Reefhuis J, Devine O, Friedman JM, et 
al. Specific SSRIs and birth defects: 
Bayesian analysis to interpret new data 
in the context of previous reports. Bmj. 
2015;351:h3190. 
46 Blomberg MI, Kallen B. Maternal 
obesity and morbid obesity: the risk for 
birth defects in the offspring. Birth 
Defects Res A Clin Mol Teratol. 
2010;88(1):35-40. 
47 Dawson AL, Tinker SC, Jamieson DJ, et 
al. Twinning and major birth defects, 
National Birth Defects Prevention 
Study, 1997-2007. J Epidemiol 
Community Health. 2016;70(11):1114-
1121. 
48 Benjamin B, Wilson GN. Anomalies 
associated with gastroschisis and 
omphalocele: analysis of 2825 cases 
from the Texas Birth Defects Registry. 
J Pediatr Surg. 2014;49(4):514-519. 
49 Bauman B, Stephens D, Gershone H, et 
al. Management of giant omphaloceles: 
A systematic review of methods of 
staged surgical vs. nonoperative delayed 
closure. J Pediatr Surg. 
2016;51(10):1725-1730. 
50 van Eijck FC, de Blaauw I, Bleichrodt 
RP, et al. Closure of giant omphaloceles 
by the abdominal wall component 
separation technique in infants. J Pediatr 
Surg. 2008;43(1):246-250. 
51 Wijnen RM, van Eijck F, van der Staak 
FH, et al. Secondary closure of a giant 
omphalocele by translation of the 
muscular layers: a new method. Pediatr 
Surg Int. 2005;21(5):373-376. 
52 Kiyohara MY, Brizot ML, Liao AW, et 
al. Should we measure fetal 
omphalocele diameter for prediction of 
perinatal outcome? Fetal Diagn Ther. 
2014;35(1):44-50. 
53 Fawley JA, Peterson EL, Christensen 
MA, et al. Can omphalocele ratio 
predict postnatal outcomes? J Pediatr 
Surg. 2016;51(1):62-66. 
54 Peters NC, Hooft ME, Ursem NT, et al. 
The relation between viscero-
abdominal disproportion and type of 
omphalocele closure. Eur J Obstet 
Gynecol Reprod Biol. 2014;181:294-299. 
55 Kleinrouweler CE, Kuijper CF, van 
Zalen-Sprock MM, et al. Characteristics 
and outcome and the omphalocele 
circumference/abdominal 
circumference ratio in prenatally 
diagnosed fetal omphalocele. Fetal Diagn 
Ther. 2011;30(1):60-69. 
56 Danzer E, Gerdes M, D'Agostino JA, et 
al. Patient characteristics are important 
determinants of neurodevelopmental 
outcome during infancy in giant 
omphalocele. Early Hum Dev. 
2015;91(3):187-193. 
57 van Eijck FC, van Vlimmeren LA, 
Wijnen RM, et al. Functional, motor 
developmental, and long-term outcome 
after the component separation 
technique in children with giant 
omphalocele: a case control study. J 
Pediatr Surg. 2013;48(3):525-532. 
58 Danzer E, Gerdes M, D'Agostino JA, et 
al. Prospective, interdisciplinary follow-
up of children with prenatally diagnosed 
giant omphalocele: short-term 
 
neurodevelopmental outcome. J Pediatr 
Surg. 2010;45(4):718-723. 
59 Mazer P, Gischler SJ, MH VDC-VZ, et 
al. Early developmental assessment of 
children with major non-cardiac 
congenital anomalies predicts 
development at the age of 5 years. Dev 
Med Child Neurol. 2010;52(12):1154-
1159. 
60 Laing S, Walker K, Ungerer J, et al. Early 
development of children with major 
birth defects requiring newborn 
surgery. J Paediatr Child Health. 
2011;47(3):140-147. 
61 Walker K, Loughran-Fowlds A, Halliday 
R, et al. Developmental outcomes at 3 
years of age following major non-
cardiac and cardiac surgery in term 
infants: A population-based study. J 
Paediatr Child Health. 2015;51(12):1221-
1225. 
62 van Eijck FC, Hoogeveen YL, van Weel 
C, et al. Minor and giant omphalocele: 
long-term outcomes and quality of life. 
J Pediatr Surg. 2009;44(7):1355-1359. 
63 Puligandla PS, Laberge JM. Congenital 
lung lesions. Clin Perinatol. 
2012;39(2):331-347. 
64 Stocker JT. Congenital pulmonary 
airway malformation: A new name for 
and an expanded classification of 
congenital cystic adenomatoid 
malformation of the lung. 
Histopathology. 2002;41(Suppl 2):424-
430. 
65 Walker L, Cohen K, Rankin J, et al. 
Outcome of prenatally diagnosed 
congenital lung anomalies in the North 
of England: a review of 228 cases to aid 
in prenatal counselling. Prenat Diagn. 
2017;37(10):1001-1007. 
66 Mon RA, Johnson KN, Ladino-Torres 
M, et al. Diagnostic accuracy of imaging 
studies in congenital lung 
malformations. Arch Dis Child Fetal 
Neonatal Ed. 2018. 
67 Hardee S, Tuzovic L, Silva CT, et al. 
Congenital Cystic Lung Lesions: 
Evolution From In-utero Detection to 
Pathology Diagnosis-A Multidisciplinary 
Approach. Pediatr Dev Pathol. 
2017;20(5):403-410. 
68 Crombleholme TM, Coleman B, 
Hedrick H, et al. Cystic adenomatoid 
malformation volume ratio predicts 
outcome in prenatally diagnosed cystic 
adenomatoid malformation of the lung. 
J Pediatr Surg. 2002;37(3):331-338. 
69 Ruchonnet-Metrailler I, Leroy-
Terquem E, Stirnemann J, et al. 
Neonatal outcomes of prenatally 
diagnosed congenital pulmonary 
malformations. Pediatrics. 
2014;133(5):e1285-1291. 
70 Feghali M, Jean KM, Emery SP. 
Ultrasound assessment of congenital 
fetal lung masses and neonatal 
respiratory outcomes. Prenat Diagn. 
2015;35(12):1208-1212. 
71 Fuchimoto Y, Watanabe T, Fujino A, et 
al. Predictors of early lobectomy after 
birth in prenatally diagnosed congenital 
pulmonary airway malformation. J 
Pediatr Surg. 2018;53(12):2386-2389. 
72 Ehrenberg-Buchner S, Stapf AM, 
Berman DR, et al. Fetal lung lesions: can 
we start to breathe easier? Am J Obstet 
Gynecol. 2013;208(2):151 e151-157. 
73 Yong PJ, Von Dadelszen P, Carpara D, 
et al. Prediction of pediatric outcome 
after prenatal diagnosis and expectant 
antenatal management of congenital 
cystic adenomatoid malformation. Fetal 
Diagn Ther. 2012;31(2):94-102. 
74 Wong KKY, Flake AW, Tibboel D, et al. 
Congenital pulmonary airway 
malformation: advances and 
controversies. Lancet Child Adolesc 
Health. 2018;2(4):290-297. 
75 Stanton M, Njere I, Ade-Ajayi N, et al. 
Systematic review and meta-analysis of 
the postnatal management of congenital 
cystic lung lesions. J Pediatr Surg. 
2009;44(5):1027-1033. 
76 Spoel M, van de Ven KP, Tiddens HA, 
et al. Lung function of infants with 
Chapter 1
20
41 Lap CC, Bolhuis SW, Van Braeckel KN, 
et al. Functional outcome at school age 
of children born with gastroschisis. 
Early Hum Dev. 2017;106-107:47-52. 
42 Marshall J, Salemi JL, Tanner JP, et al. 
Prevalence, Correlates, and Outcomes 
of Omphalocele in the United States, 
1995-2005. Obstet Gynecol. 
2015;126(2):284-293. 
43 Mac Bird T, Robbins JM, Druschel C, et 
al. Demographic and environmental risk 
factors for gastroschisis and 
omphalocele in the National Birth 
Defects Prevention Study. J Pediatr Surg. 
2009;44(8):1546-1551. 
44 Anderson KN, Dutton AC, Broussard 
CS, et al. ADHD Medication Use 
During Pregnancy and Risk for Selected 
Birth Defects: National Birth Defects 
Prevention Study, 1998-2011. J Atten 
Disord. 2018:1087054718759753. 
45 Reefhuis J, Devine O, Friedman JM, et 
al. Specific SSRIs and birth defects: 
Bayesian analysis to interpret new data 
in the context of previous reports. Bmj. 
2015;351:h3190. 
46 Blomberg MI, Kallen B. Maternal 
obesity and morbid obesity: the risk for 
birth defects in the offspring. Birth 
Defects Res A Clin Mol Teratol. 
2010;88(1):35-40. 
47 Dawson AL, Tinker SC, Jamieson DJ, et 
al. Twinning and major birth defects, 
National Birth Defects Prevention 
Study, 1997-2007. J Epidemiol 
Community Health. 2016;70(11):1114-
1121. 
48 Benjamin B, Wilson GN. Anomalies 
associated with gastroschisis and 
omphalocele: analysis of 2825 cases 
from the Texas Birth Defects Registry. 
J Pediatr Surg. 2014;49(4):514-519. 
49 Bauman B, Stephens D, Gershone H, et 
al. Management of giant omphaloceles: 
A systematic review of methods of 
staged surgical vs. nonoperative delayed 
closure. J Pediatr Surg. 
2016;51(10):1725-1730. 
50 van Eijck FC, de Blaauw I, Bleichrodt 
RP, et al. Closure of giant omphaloceles 
by the abdominal wall component 
separation technique in infants. J Pediatr 
Surg. 2008;43(1):246-250. 
51 Wijnen RM, van Eijck F, van der Staak 
FH, et al. Secondary closure of a giant 
omphalocele by translation of the 
muscular layers: a new method. Pediatr 
Surg Int. 2005;21(5):373-376. 
52 Kiyohara MY, Brizot ML, Liao AW, et 
al. Should we measure fetal 
omphalocele diameter for prediction of 
perinatal outcome? Fetal Diagn Ther. 
2014;35(1):44-50. 
53 Fawley JA, Peterson EL, Christensen 
MA, et al. Can omphalocele ratio 
predict postnatal outcomes? J Pediatr 
Surg. 2016;51(1):62-66. 
54 Peters NC, Hooft ME, Ursem NT, et al. 
The relation between viscero-
abdominal disproportion and type of 
omphalocele closure. Eur J Obstet 
Gynecol Reprod Biol. 2014;181:294-299. 
55 Kleinrouweler CE, Kuijper CF, van 
Zalen-Sprock MM, et al. Characteristics 
and outcome and the omphalocele 
circumference/abdominal 
circumference ratio in prenatally 
diagnosed fetal omphalocele. Fetal Diagn 
Ther. 2011;30(1):60-69. 
56 Danzer E, Gerdes M, D'Agostino JA, et 
al. Patient characteristics are important 
determinants of neurodevelopmental 
outcome during infancy in giant 
omphalocele. Early Hum Dev. 
2015;91(3):187-193. 
57 van Eijck FC, van Vlimmeren LA, 
Wijnen RM, et al. Functional, motor 
developmental, and long-term outcome 
after the component separation 
technique in children with giant 
omphalocele: a case control study. J 
Pediatr Surg. 2013;48(3):525-532. 
58 Danzer E, Gerdes M, D'Agostino JA, et 
al. Prospective, interdisciplinary follow-
up of children with prenatally diagnosed 
giant omphalocele: short-term 
 
neurodevelopmental outcome. J Pediatr 
Surg. 2010;45(4):718-723. 
59 Mazer P, Gischler SJ, MH VDC-VZ, et 
al. Early developmental assessment of 
children with major non-cardiac 
congenital anomalies predicts 
development at the age of 5 years. Dev 
Med Child Neurol. 2010;52(12):1154-
1159. 
60 Laing S, Walker K, Ungerer J, et al. Early 
development of children with major 
birth defects requiring newborn 
surgery. J Paediatr Child Health. 
2011;47(3):140-147. 
61 Walker K, Loughran-Fowlds A, Halliday 
R, et al. Developmental outcomes at 3 
years of age following major non-
cardiac and cardiac surgery in term 
infants: A population-based study. J 
Paediatr Child Health. 2015;51(12):1221-
1225. 
62 van Eijck FC, Hoogeveen YL, van Weel 
C, et al. Minor and giant omphalocele: 
long-term outcomes and quality of life. 
J Pediatr Surg. 2009;44(7):1355-1359. 
63 Puligandla PS, Laberge JM. Congenital 
lung lesions. Clin Perinatol. 
2012;39(2):331-347. 
64 Stocker JT. Congenital pulmonary 
airway malformation: A new name for 
and an expanded classification of 
congenital cystic adenomatoid 
malformation of the lung. 
Histopathology. 2002;41(Suppl 2):424-
430. 
65 Walker L, Cohen K, Rankin J, et al. 
Outcome of prenatally diagnosed 
congenital lung anomalies in the North 
of England: a review of 228 cases to aid 
in prenatal counselling. Prenat Diagn. 
2017;37(10):1001-1007. 
66 Mon RA, Johnson KN, Ladino-Torres 
M, et al. Diagnostic accuracy of imaging 
studies in congenital lung 
malformations. Arch Dis Child Fetal 
Neonatal Ed. 2018. 
67 Hardee S, Tuzovic L, Silva CT, et al. 
Congenital Cystic Lung Lesions: 
Evolution From In-utero Detection to 
Pathology Diagnosis-A Multidisciplinary 
Approach. Pediatr Dev Pathol. 
2017;20(5):403-410. 
68 Crombleholme TM, Coleman B, 
Hedrick H, et al. Cystic adenomatoid 
malformation volume ratio predicts 
outcome in prenatally diagnosed cystic 
adenomatoid malformation of the lung. 
J Pediatr Surg. 2002;37(3):331-338. 
69 Ruchonnet-Metrailler I, Leroy-
Terquem E, Stirnemann J, et al. 
Neonatal outcomes of prenatally 
diagnosed congenital pulmonary 
malformations. Pediatrics. 
2014;133(5):e1285-1291. 
70 Feghali M, Jean KM, Emery SP. 
Ultrasound assessment of congenital 
fetal lung masses and neonatal 
respiratory outcomes. Prenat Diagn. 
2015;35(12):1208-1212. 
71 Fuchimoto Y, Watanabe T, Fujino A, et 
al. Predictors of early lobectomy after 
birth in prenatally diagnosed congenital 
pulmonary airway malformation. J 
Pediatr Surg. 2018;53(12):2386-2389. 
72 Ehrenberg-Buchner S, Stapf AM, 
Berman DR, et al. Fetal lung lesions: can 
we start to breathe easier? Am J Obstet 
Gynecol. 2013;208(2):151 e151-157. 
73 Yong PJ, Von Dadelszen P, Carpara D, 
et al. Prediction of pediatric outcome 
after prenatal diagnosis and expectant 
antenatal management of congenital 
cystic adenomatoid malformation. Fetal 
Diagn Ther. 2012;31(2):94-102. 
74 Wong KKY, Flake AW, Tibboel D, et al. 
Congenital pulmonary airway 
malformation: advances and 
controversies. Lancet Child Adolesc 
Health. 2018;2(4):290-297. 
75 Stanton M, Njere I, Ade-Ajayi N, et al. 
Systematic review and meta-analysis of 
the postnatal management of congenital 
cystic lung lesions. J Pediatr Surg. 
2009;44(5):1027-1033. 
76 Spoel M, van de Ven KP, Tiddens HA, 
et al. Lung function of infants with 
1
Introduction
21
congenital lung lesions in the first year 
of life. Neonatology. 2013;103(1):60-66. 
77 Cook J, Chitty LS, De Coppi P, et al. 
The natural history of prenatally 
diagnosed congenital cystic lung lesions: 
long-term follow-up of 119 cases. Arch 
Dis Child. 2017;102(9):798-803. 
78 Delestrain C, Khen-Dunlop N, 
Hadchouel A, et al. Respiratory 
Morbidity in Infants Born With a 
Congenital Lung Malformation. 
Pediatrics. 2017;139(3). 
79 Criss CN, Musili N, Matusko N, et al. 
Asymptomatic congenital lung 
malformations: Is nonoperative 
management a viable alternative? J 
Pediatr Surg. 2018;53(6):1092-1097.
 
 
 
 
  
Chapter 1
22
congenital lung lesions in the first year 
of life. Neonatology. 2013;103(1):60-66. 
77 Cook J, Chitty LS, De Coppi P, et al. 
The natural history of prenatally 
diagnosed congenital cystic lung lesions: 
long-term follow-up of 119 cases. Arch 
Dis Child. 2017;102(9):798-803. 
78 Delestrain C, Khen-Dunlop N, 
Hadchouel A, et al. Respiratory 
Morbidity in Infants Born With a 
Congenital Lung Malformation. 
Pediatrics. 2017;139(3). 
79 Criss CN, Musili N, Matusko N, et al. 
Asymptomatic congenital lung 
malformations: Is nonoperative 
management a viable alternative? J 
Pediatr Surg. 2018;53(6):1092-1097.
 
 
 
 
  
1
Introduction
23
 
 
 
 
 
 
  
 
 
 
 
 
 
GASTROSCHISIS 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
GASTROSCHISIS 
  
  
 
2 
Using three-dimensional ultrasound in predicting 
complex gastroschisis: a longitudinal, 
prospective, multicenter cohort study 
 
Annelieke Hijkoop* 
Chiara CMM Lap* 
Moska Aliasi 
Eduard JH Mulder 
William LM Kramer 
Hens AA Brouwers 
Robertine van Baren 
Eva Pajkrt 
Anton H van Kaam 
Caterina M Bilardo 
Lourens R Pistorius 
Gerard HA Visser 
René MH Wijnen 
Dick Tibboel 
Gwendolyn TR Manten 
Titia E Cohen-Overbeek 
 
* both authors contributed equally 
 
Prenatal Diagnosis 2019; DOI 10.1002/pd.5568 
 
  
  
 
2 
Using three-dimensional ultrasound in predicting 
complex gastroschisis: a longitudinal, 
prospective, multicenter cohort study 
 
Annelieke Hijkoop* 
Chiara CMM Lap* 
Moska Aliasi 
Eduard JH Mulder 
William LM Kramer 
Hens AA Brouwers 
Robertine van Baren 
Eva Pajkrt 
Anton H van Kaam 
Caterina M Bilardo 
Lourens R Pistorius 
Gerard HA Visser 
René MH Wijnen 
Dick Tibboel 
Gwendolyn TR Manten 
Titia E Cohen-Overbeek 
 
* both authors contributed equally 
 
Prenatal Diagnosis 2019; DOI 10.1002/pd.5568 
 
  
Abstract 
 
Objective 
To determine whether complex gastroschisis (i.e. intestinal atresia, perforation, 
necrosis or volvulus) can prenatally be distinguished from simple gastroschisis by fetal 
stomach volume and stomach-bladder distance, using three-dimensional (3D) 
ultrasound. 
 
Methods 
This multicenter prospective cohort study was conducted in the Netherlands between 
2010-2015. Of seven university medical centers, we included the four centers that 
performed longitudinal 3D ultrasound measurements at a regular basis. We calculated 
stomach volumes (n=223) using Sonography-based Automated Volume Count. The 
shortest stomach-bladder distance (n=241) was determined using multiplanar 
visualization of the volume datasets. We used linear mixed modelling to evaluate the 
effect of gestational age and type of gastroschisis (simple or complex) on fetal stomach 
volume and stomach-bladder distance. 
 
Results 
We included 79 affected fetuses. Sixty-six (84%) had been assessed with 3D ultrasound 
at least once; 64 of these 66 were live-born, nine (14%) had complex gastroschisis. With 
advancing gestational age, stomach volume significantly increased, and stomach-bladder 
distance decreased (both p<0.001). The developmental changes did not differ 
significantly between fetuses with simple and complex gastroschisis, neither for fetal 
stomach volume (p=0.85), nor for stomach bladder distance (p=0.78). 
 
Conclusion 
Fetal stomach volume and stomach-bladder distance, measured during pregnancy 
using 3D ultrasonography, do not predict complex gastroschisis.  
 
Introduction 
Gastroschisis is an abdominal wall defect that is diagnosed prenatally in over 90% of the 
cases, usually before 23 weeks' gestation.1 In countries that offer routine ultrasound 
scans at 11-14 weeks’ gestation, gastroschisis is usually diagnosed in the first trimester.2 
This allows for early parental counselling and adjustment of obstetric management.  
 
Seventeen percent of all neonates with gastroschisis are diagnosed with additional 
intestinal defects at birth, i.e. intestinal atresia, perforation, necrosis or volvulus (defined 
as complex gastroschisis).3, 4 Infants with complex gastroschisis have a higher risk of 
morbidity than those with simple gastroschisis; they often experience prolonged time 
to full enteral feeding (TFEF), more complications, and prolonged length of hospital stay 
(LOS).3-6  
 
Prenatal detection or prediction of complex gastroschisis would lead to more complete 
parental counselling. The association between two-dimensional (2D) prenatal 
ultrasound findings (e.g. bowel dilatation, stomach dilatation, or amniotic fluid index) 
and complex gastroschisis has been investigated in a number of studies, which showed 
conflicting results.7 Intra-abdominal bowel dilatation has been associated with intestinal 
atresia, but its positive predictive value is debatable.8 Fetal stomach dilatation has been 
associated with neonatal death, but not with complex gastroschisis.8 However, volume 
calculation using 2D ultrasound measurements assumes certain geometric 
characteristics and regular contours of the stomach, which may not be accurate. Three-
dimensional (3D) ultrasound might be more accurate in measuring fetal stomach volume 
and thus predicting complex gastroschisis, but to date there are no studies to support 
this hypothesis. 
 
One study used magnetic resonance imaging (MRI) to describe fetal development in 
case of gastroschisis.9 Extensive contact was seen between the stomach and urinary 
bladder in all but the youngest third trimester fetus who presented with simple 
gastroschisis at birth. In contrast, those fetuses presenting with intestinal stenosis had 
not shown any stomach-bladder contact, as their abdominal cavity was filled with dilated 
bowel loops.9 Therefore, stomach-bladder distance might be a reflection of intra-
abdominal bowel dilatation (IABD), and may predict complex gastroschisis. 
 
The primary aim of this study was to define whether fetal stomach volume, measured 
longitudinally using 3D ultrasound, can predict complex gastroschisis. In addition, we 
aimed to evaluate the value of stomach-bladder distance in predicting complex 
gastroschisis in 3D ultrasound volumes. 
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Seventeen percent of all neonates with gastroschisis are diagnosed with additional 
intestinal defects at birth, i.e. intestinal atresia, perforation, necrosis or volvulus (defined 
as complex gastroschisis).3, 4 Infants with complex gastroschisis have a higher risk of 
morbidity than those with simple gastroschisis; they often experience prolonged time 
to full enteral feeding (TFEF), more complications, and prolonged length of hospital stay 
(LOS).3-6  
 
Prenatal detection or prediction of complex gastroschisis would lead to more complete 
parental counselling. The association between two-dimensional (2D) prenatal 
ultrasound findings (e.g. bowel dilatation, stomach dilatation, or amniotic fluid index) 
and complex gastroschisis has been investigated in a number of studies, which showed 
conflicting results.7 Intra-abdominal bowel dilatation has been associated with intestinal 
atresia, but its positive predictive value is debatable.8 Fetal stomach dilatation has been 
associated with neonatal death, but not with complex gastroschisis.8 However, volume 
calculation using 2D ultrasound measurements assumes certain geometric 
characteristics and regular contours of the stomach, which may not be accurate. Three-
dimensional (3D) ultrasound might be more accurate in measuring fetal stomach volume 
and thus predicting complex gastroschisis, but to date there are no studies to support 
this hypothesis. 
 
One study used magnetic resonance imaging (MRI) to describe fetal development in 
case of gastroschisis.9 Extensive contact was seen between the stomach and urinary 
bladder in all but the youngest third trimester fetus who presented with simple 
gastroschisis at birth. In contrast, those fetuses presenting with intestinal stenosis had 
not shown any stomach-bladder contact, as their abdominal cavity was filled with dilated 
bowel loops.9 Therefore, stomach-bladder distance might be a reflection of intra-
abdominal bowel dilatation (IABD), and may predict complex gastroschisis. 
 
The primary aim of this study was to define whether fetal stomach volume, measured 
longitudinally using 3D ultrasound, can predict complex gastroschisis. In addition, we 
aimed to evaluate the value of stomach-bladder distance in predicting complex 
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Methods 
Between June, 2010 and April, 2015, we performed a prospective, longitudinal, 
multicenter cohort study at seven university medical centers with a prenatal and a 
pediatric surgery department in The Netherlands. The centers that performed 
longitudinal 3D ultrasound measurements on fetuses with gastroschisis at a regular basis 
(i.e. if  ≥50% of included fetuses had ≥1 assessment) were included. Fetuses were eligible 
for inclusion if gastroschisis without any extra-gastrointestinal anomaly was confirmed 
by prenatal ultrasound. Neonates who presented with unexpected additional extra-
gastrointestinal anomalies at birth were excluded post-hoc. This study was approved by 
the Medical Ethical Review Board of University Medical Center Utrecht. Parents gave 
written informed consent. 
 
Ultrasound examinations 
Advanced ultrasound examinations were planned at 20, 24, 28, 30, 32, 34, 35 and 36 
weeks' gestation for longitudinal measurements. 2D ultrasound measures are described 
elsewhere (i.e. fetal biometry, amniotic fluid index, pulsatility indices of the umbilical 
and superior mesenteric artery, and bowel diameter measurements.10 3D volumes of 
the fetal abdomen were obtained if logistically possible (settings: coronal or sagittal 
plane; sectional planes with speckle reduction imaging (SRI) and X-beam activated; 
quality: high). The volume sample box was adjusted to include the entire fetal abdomen, 
but as narrow as possible to shorten the acquisition time. The acquisition of the volume 
was repeated if movement artifacts were detected. All examinations were performed 
by three to five trained ultrasonographers per center, using a General Electric Voluson 
730 or E8 (General Electric Healthcare, London) ultrasound machine, with a 4-8 MHz 
transabdominal transducer.  
 
To calculate fetal stomach volumes, we used the Sonography-based Automated Volume 
Count (SonoAVC) method.11 Each volume was analyzed using 4D View V14 Ext. 4. 
After uploading the volume dataset, we used multiplanar visualization and positioned 
the reference point in the center of the stomach in all three planes. We started volume 
analysis and selected the smallest box possible (figure 1). After activating SonoAVC 
general, stomach volumes were calculated by right clicking inside the stomach walls 
(figure 1). If necessary, we used the edit mode to cut or merge contours. Volume 
datasets were excluded if they did not include the stomach, or if insufficient image 
quality or presence of debris hampered SonoAVC to calculate a volume.    
 
To measure the shortest stomach-bladder distance, from outer wall to outer wall, we 
used the multiplanar visualization of the volume datasets (figure 2). Volume datasets 
were excluded from analysis if they did not include the stomach or bladder, or if image 
 
quality was insufficient for stomach-bladder distance calculation. All volumes were 
analyzed by one investigator (AH), who was blinded to the type of gastroschisis. 
 
 
Figure 1 Fetal stomach volume at 21 weeks' gestation, measured using Sonography-
based Automated Volume Count (SonoAVC) 
 
 
Figure 2 Fetal stomach-bladder distance at 24 weeks' gestation (yellow markers and 
line), measured in multiplanar visualization 
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(figure 1). If necessary, we used the edit mode to cut or merge contours. Volume 
datasets were excluded if they did not include the stomach, or if insufficient image 
quality or presence of debris hampered SonoAVC to calculate a volume.    
 
To measure the shortest stomach-bladder distance, from outer wall to outer wall, we 
used the multiplanar visualization of the volume datasets (figure 2). Volume datasets 
were excluded from analysis if they did not include the stomach or bladder, or if image 
 
quality was insufficient for stomach-bladder distance calculation. All volumes were 
analyzed by one investigator (AH), who was blinded to the type of gastroschisis. 
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Figure 2 Fetal stomach-bladder distance at 24 weeks' gestation (yellow markers and 
line), measured in multiplanar visualization 
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Variables and definitions 
We documented maternal, perinatal and postnatal characteristics of infants with simple 
and complex gastroschisis. Complex gastroschisis was defined as gastroschisis 
complicated by intestinal atresia, volvulus, perforation and/or necrosis at primary 
evaluation at birth. Neonates were classified as small for gestational age (SGA) if their 
birth weight was below the 10th percentile according to Dutch reference curves.12 If 
infants needed parenteral nutrition for over 2 years, TFEF was documented as 730 days. 
Data of deceased infants were excluded from TFEF and LOS analyses.  
 
Statistical analysis 
Categorical variables were presented as number (%) and continuous variables as median 
(interquartile range, IQR). We compared maternal, perinatal and postnatal 
characteristics between infants with simple and complex gastroschisis using the chi-
square tests or Fisher's exact tests (in case of expected counts <5) for categorical data, 
and the Mann-Whitney U test for continuous data. A two-sided p value of <0.05 was 
considered statistically significant. Statistical analyses were performed using SPSS V.21.0.  
 
Intra- and inter-observer reliability and agreement  
A random subset of 30 stomach volumes was analyzed twice by one investigator (AH) 
to determine intra-observer agreement. The same subset was analyzed by a second 
independent investigator (MA) to determine inter-observer agreement. A different 
subset, also consisting of 30 volumes, was used to determine intra- and inter-observer 
agreement of stomach-bladder distance measurements. We constructed Bland-Altman 
plots using the absolute difference between measurements against their mean. The 
intra- and inter-observer reliability was estimated by calculating the 95% limits of 
agreement.13 In addition, intra- and inter-observer agreement scores were assessed by 
calculating the intraclass correlation coefficient (ICC) with 95% confidence interval (CI). 
 
Longitudinal 3D ultrasound measurements  
Non-normally distributed data were natural log (ln) transformed. If the fetal stomach 
was adjacent to the bladder (value zero), stomach-bladder distance was registered as 
0.01 cm. We used linear mixed modelling to evaluate the effects of gestational age (GA), 
type of gastroschisis (simple or complex), and their interaction on the developmental 
courses of fetal stomach volume and stomach-bladder distance. Mixed-effects models 
allow for intra-fetal correlation of repeated measurements, make use of the exact age 
at measurement, and account for a dissimilar number of measurements on each fetus. 
Such models also allow for individual variation in growth trajectories, as random effects 
permit variability in intercept and slope between subjects. We explored linear and 
quadratic terms of GA that were included as both fixed and random effects. Type of 
 
gastroschisis was included as a main effect and also as an interaction with the GA terms. 
Model estimates are presented as mean and 95% CI.  
 
Results 
During the study period, 131 fetuses were diagnosed with gastroschisis in The 
Netherlands. Twenty-seven (21%) fetuses were excluded: one pregnancy resulted in 
intra-uterine demise (IUD) before 20 weeks' gestation, 12 couples opted for 
termination of the pregnancy, and 14 couples did not want to participate in this study 
(figure 3). In addition, three out of seven university medical centers did not perform 
longitudinal 3D ultrasound measurements on a regular basis; fetuses from these three 
centers (n=25) were excluded. No statistically significant differences in maternal, 
perinatal or postnatal characteristics were found between infants who were included in 
our study and those who were excluded, apart from the proportion of neonates 
delivered by cesarean section which was almost four times higher in the included 
neonates (p=0.023, supplemental table 1). 
 
The remaining four centers included 79 fetuses, of which 66 (84%) had been assessed 
with 3D ultrasound at least once. Two (3%) of these pregnancies resulted in IUD at 28 
and 33 weeks' gestation, respectively, and 9 of the remaining 64 (14%) live-born 
neonates were diagnosed with complex gastroschisis.  
 
A total of 312 3D ultrasound examinations were performed (figure 3): 275 in 55 fetuses 
with simple gastroschisis (mean (range) per fetus: 5 (1-11)), and 37 in 9 fetuses with 
complex gastroschisis (mean (range) per fetus: 4 (1-7)). Eighty-nine stomach volumes of 
45 fetuses and 71 stomach-bladder distances of 42 fetuses were excluded from analysis 
(e.g. due to insufficient quality). In the 89 volume datasets that were excluded from 
analysis of stomach volume, the proportion of volumes derived from fetuses with 
complex gastroschisis (20/89, 22%) was significantly higher than that in the total number 
of volumes available (37/312, 12%) (p=0.011).  
 
We included a total of 223 stomach volume calculations: 206 of 52 fetuses with simple 
gastroschisis (mean (range) per fetus: 4 (1-9)), and 17 of 8 fetuses with complex 
gastroschisis (mean (range) per fetus: 2 (1-5)). We included a total of 241 stomach-
bladder distances: 216 of 53 fetuses with simple gastroschisis (mean (range) per fetus: 
4 (1-9)), and 25 of 7 fetuses with complex gastroschisis (mean (range) per fetus: 4 (1-
8)). Eight fetuses had only one stomach volume calculation available, and for 3 fetuses 
only one stomach-bladder distance could be calculated.
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Variables and definitions 
We documented maternal, perinatal and postnatal characteristics of infants with simple 
and complex gastroschisis. Complex gastroschisis was defined as gastroschisis 
complicated by intestinal atresia, volvulus, perforation and/or necrosis at primary 
evaluation at birth. Neonates were classified as small for gestational age (SGA) if their 
birth weight was below the 10th percentile according to Dutch reference curves.12 If 
infants needed parenteral nutrition for over 2 years, TFEF was documented as 730 days. 
Data of deceased infants were excluded from TFEF and LOS analyses.  
 
Statistical analysis 
Categorical variables were presented as number (%) and continuous variables as median 
(interquartile range, IQR). We compared maternal, perinatal and postnatal 
characteristics between infants with simple and complex gastroschisis using the chi-
square tests or Fisher's exact tests (in case of expected counts <5) for categorical data, 
and the Mann-Whitney U test for continuous data. A two-sided p value of <0.05 was 
considered statistically significant. Statistical analyses were performed using SPSS V.21.0.  
 
Intra- and inter-observer reliability and agreement  
A random subset of 30 stomach volumes was analyzed twice by one investigator (AH) 
to determine intra-observer agreement. The same subset was analyzed by a second 
independent investigator (MA) to determine inter-observer agreement. A different 
subset, also consisting of 30 volumes, was used to determine intra- and inter-observer 
agreement of stomach-bladder distance measurements. We constructed Bland-Altman 
plots using the absolute difference between measurements against their mean. The 
intra- and inter-observer reliability was estimated by calculating the 95% limits of 
agreement.13 In addition, intra- and inter-observer agreement scores were assessed by 
calculating the intraclass correlation coefficient (ICC) with 95% confidence interval (CI). 
 
Longitudinal 3D ultrasound measurements  
Non-normally distributed data were natural log (ln) transformed. If the fetal stomach 
was adjacent to the bladder (value zero), stomach-bladder distance was registered as 
0.01 cm. We used linear mixed modelling to evaluate the effects of gestational age (GA), 
type of gastroschisis (simple or complex), and their interaction on the developmental 
courses of fetal stomach volume and stomach-bladder distance. Mixed-effects models 
allow for intra-fetal correlation of repeated measurements, make use of the exact age 
at measurement, and account for a dissimilar number of measurements on each fetus. 
Such models also allow for individual variation in growth trajectories, as random effects 
permit variability in intercept and slope between subjects. We explored linear and 
quadratic terms of GA that were included as both fixed and random effects. Type of 
 
gastroschisis was included as a main effect and also as an interaction with the GA terms. 
Model estimates are presented as mean and 95% CI.  
 
Results 
During the study period, 131 fetuses were diagnosed with gastroschisis in The 
Netherlands. Twenty-seven (21%) fetuses were excluded: one pregnancy resulted in 
intra-uterine demise (IUD) before 20 weeks' gestation, 12 couples opted for 
termination of the pregnancy, and 14 couples did not want to participate in this study 
(figure 3). In addition, three out of seven university medical centers did not perform 
longitudinal 3D ultrasound measurements on a regular basis; fetuses from these three 
centers (n=25) were excluded. No statistically significant differences in maternal, 
perinatal or postnatal characteristics were found between infants who were included in 
our study and those who were excluded, apart from the proportion of neonates 
delivered by cesarean section which was almost four times higher in the included 
neonates (p=0.023, supplemental table 1). 
 
The remaining four centers included 79 fetuses, of which 66 (84%) had been assessed 
with 3D ultrasound at least once. Two (3%) of these pregnancies resulted in IUD at 28 
and 33 weeks' gestation, respectively, and 9 of the remaining 64 (14%) live-born 
neonates were diagnosed with complex gastroschisis.  
 
A total of 312 3D ultrasound examinations were performed (figure 3): 275 in 55 fetuses 
with simple gastroschisis (mean (range) per fetus: 5 (1-11)), and 37 in 9 fetuses with 
complex gastroschisis (mean (range) per fetus: 4 (1-7)). Eighty-nine stomach volumes of 
45 fetuses and 71 stomach-bladder distances of 42 fetuses were excluded from analysis 
(e.g. due to insufficient quality). In the 89 volume datasets that were excluded from 
analysis of stomach volume, the proportion of volumes derived from fetuses with 
complex gastroschisis (20/89, 22%) was significantly higher than that in the total number 
of volumes available (37/312, 12%) (p=0.011).  
 
We included a total of 223 stomach volume calculations: 206 of 52 fetuses with simple 
gastroschisis (mean (range) per fetus: 4 (1-9)), and 17 of 8 fetuses with complex 
gastroschisis (mean (range) per fetus: 2 (1-5)). We included a total of 241 stomach-
bladder distances: 216 of 53 fetuses with simple gastroschisis (mean (range) per fetus: 
4 (1-9)), and 25 of 7 fetuses with complex gastroschisis (mean (range) per fetus: 4 (1-
8)). Eight fetuses had only one stomach volume calculation available, and for 3 fetuses 
only one stomach-bladder distance could be calculated.
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Intra- and inter-observer reliability and agreement 
We found a high degree of intra-observer reliability for both stomach volume (ICC: 
0.997, 95% CI: 0.988-0.999) and stomach-bladder distance calculations (ICC: 0.931, 95% 
CI: 0.861-0.966). The same was true for inter-observer reliability (ICC: 0.981, 95% CI: 
0.955-0.991 for stomach volume, and ICC: 0.962, 95% CI: 0.950-0.992 for stomach-
bladder distance calculations). Bland-Altman plots showed good intra- and inter-
observer agreement for both stomach volume and for stomach-bladder distance 
calculations (mean intra-observer and inter-observer differences with 95% limits of 
agreement are shown in supplemental figure 1).  
 
Maternal, perinatal and postnatal characteristics 
Neonates with complex gastroschisis were born 1.5 weeks earlier than those with 
simple gastroschisis, but this difference did not reach statistical significance. Infants with 
complex gastroschisis were over three times more likely to develop cholestatic jaundice 
than those with simple gastroschisis (table 1). In addition, wound infections were over 
six times more prevalent in the complex gastroschisis group. Median TFEF was more 
than six months in infants with complex gastroschisis, compared to less than one month 
in infants with simple gastroschisis. Median LOS was four months in infants with 
complex gastroschisis, and one month in those with simple gastroschisis. One infant 
with complex gastroschisis died of sepsis at 8 months of age.  
 
Table 1 Maternal, perinatal and postnatal characteristics of included live-born infants 
(n=64, from 4 centers) with simple or complex gastroschisis 
 n Simple 
gastroschisis  
n=55 (86%) 
n Complex 
gastroschisis A 
n=9 (14%) 
p 
value 
Number of 3D assessments  55 5 (4-7) 9 4 (2-6) 0.30 
Maternal characteristics     
Age (years)  54 25 (22-30) 9 24 (22-29) 0.54 
Primigravid 55 31 (56%) 9 4 (44%) 0.72 
Smoking 49 17 (35%) 8 3 (38%) 1.00 
Recreational drug use B  50 6 (12%) 8 2 (25%) 0.30 
Perinatal characteristics     
Gestational age at birth (weeks) 55 36.9 (35.7-
37.4) 
9 35.4 (33.5-37.0) 0.06 
Spontaneous onset of delivery 55 13 (24%) 9 4 (44%) 0.23 
Cesarean section 55 16 (29%) 9 4 (44%) 0.44 
Birth weight (grams) 55 2565 (2230-
2775) 
9 2220 (1840-
2800) 
0.23 
Birth weight <p10 55 8 (15%) 9 3 (33%) 0.18 
Male gender 55 25 (45%) 9 5 (56%) 0.72 
Apgar at 5 min <7 54 3 (6%) 9 1 (11%) 0.47 
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Intra- and inter-observer reliability and agreement 
We found a high degree of intra-observer reliability for both stomach volume (ICC: 
0.997, 95% CI: 0.988-0.999) and stomach-bladder distance calculations (ICC: 0.931, 95% 
CI: 0.861-0.966). The same was true for inter-observer reliability (ICC: 0.981, 95% CI: 
0.955-0.991 for stomach volume, and ICC: 0.962, 95% CI: 0.950-0.992 for stomach-
bladder distance calculations). Bland-Altman plots showed good intra- and inter-
observer agreement for both stomach volume and for stomach-bladder distance 
calculations (mean intra-observer and inter-observer differences with 95% limits of 
agreement are shown in supplemental figure 1).  
 
Maternal, perinatal and postnatal characteristics 
Neonates with complex gastroschisis were born 1.5 weeks earlier than those with 
simple gastroschisis, but this difference did not reach statistical significance. Infants with 
complex gastroschisis were over three times more likely to develop cholestatic jaundice 
than those with simple gastroschisis (table 1). In addition, wound infections were over 
six times more prevalent in the complex gastroschisis group. Median TFEF was more 
than six months in infants with complex gastroschisis, compared to less than one month 
in infants with simple gastroschisis. Median LOS was four months in infants with 
complex gastroschisis, and one month in those with simple gastroschisis. One infant 
with complex gastroschisis died of sepsis at 8 months of age.  
 
Table 1 Maternal, perinatal and postnatal characteristics of included live-born infants 
(n=64, from 4 centers) with simple or complex gastroschisis 
 n Simple 
gastroschisis  
n=55 (86%) 
n Complex 
gastroschisis A 
n=9 (14%) 
p 
value 
Number of 3D assessments  55 5 (4-7) 9 4 (2-6) 0.30 
Maternal characteristics     
Age (years)  54 25 (22-30) 9 24 (22-29) 0.54 
Primigravid 55 31 (56%) 9 4 (44%) 0.72 
Smoking 49 17 (35%) 8 3 (38%) 1.00 
Recreational drug use B  50 6 (12%) 8 2 (25%) 0.30 
Perinatal characteristics     
Gestational age at birth (weeks) 55 36.9 (35.7-
37.4) 
9 35.4 (33.5-37.0) 0.06 
Spontaneous onset of delivery 55 13 (24%) 9 4 (44%) 0.23 
Cesarean section 55 16 (29%) 9 4 (44%) 0.44 
Birth weight (grams) 55 2565 (2230-
2775) 
9 2220 (1840-
2800) 
0.23 
Birth weight <p10 55 8 (15%) 9 3 (33%) 0.18 
Male gender 55 25 (45%) 9 5 (56%) 0.72 
Apgar at 5 min <7 54 3 (6%) 9 1 (11%) 0.47 
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Table 1 (continued)      
 n Simple 
gastroschisis  
n=55 (86%) 
n Complex 
gastroschisis A 
n=9 (14%) 
p 
value 
Postnatal characteristics      
Primary closure 55 34 (62%) 9 5 (56%) 0.73 
Complications C 55 28 (51%) 9 8 (89%) 0.07 
- Necrotizing enterocolitis  0 (0%)  1 (11%) 0.14 
- Cholestatic jaundice  13 (24%)  7 (78%) 0.003 
- Line sepsis  18 (33%)  5 (56%) 0.26 
- Wound infection  3 (5%)  3 (33%) 0.03 
Mortality 55 0 (0%) 9 1 (11%) 0.14 
Time to full enteral feeding (days) 54 28 (17-42) 8 201 (98-386) 0.001 
Length of hospital stay (days) D 55 34 (25-63) 8 122 (71-180) 0.001 
Data presented as median (interquartile range) or n (%). A Intestinal atresia (n=6), intestinal 
atresia + perforation (n=1), intestinal atresia +necrosis (n=1), intestinal atresia + necrosis + 
volvulus (n=1). B Simple gastroschisis: cocaine (n=4), marihuana (n=2); complex gastroschisis: 
cocaine (n=1), marihuana (n=1). C Percentages do not necessarily add up to 100, as one 
infant can have multiple problems. One infant with complex gastroschisis died of sepsis at 8 
months of age. D One infant with simple gastroschisis and one with complex gastroschisis 
were transferred to another hospital with an unknown discharge date to home; in these 
infants, length of hospital stay was documented as time to transfer.  
 
Developmental course of stomach volume and stomach-bladder distance 
Linear mixed modelling showed no significant contribution of a GA-squared term; a 
linear model fitted the ln-transformed data best. Fetal stomach volume did not differ 
significantly between fetuses with simple and those with complex gastroschisis at 20 
weeks’ gestation (figure 4, table 2; p=0.397), nor did stomach-bladder distance (figure 
5, table 2; p=0.345). With advancing GA, stomach volume significantly increased, and 
stomach-bladder distance decreased (both p<0.001). The course of these changes did 
not differ significantly between simple and complex gastroschisis (table 2).  
 
The infant who died of sepsis at 8 months of age had shown normal stomach volume at 
24 weeks' gestation, stomach-bladder distance was not assessable; no 3D ultrasound 
measurements were available between 24 and 33 weeks' gestation for this infant. The 
infant was born at 33 weeks' gestation with an appropriate birth weight for GA. 
 
For the two pregnancies resulting in IUD (beyond 20 weeks’ gestation), we found fetal 
stomach volume and stomach-bladder distance comparable to those shown in figures 4 
and 5, respectively. Neither had any other structural malformations at autopsy. The 
autopsy report of one fetus mentioned intestinal malrotation, the report of the other 
fetus stated signs of placental inflammation without specifically addressing intestinal 
malrotation.  
 
 
 
Figure 4 Stomach volumes in fetuses with simple or complex gastroschisis during 
gestational age 
Different colors and symbols represent different fetuses. Location of intestinal atresia in 
complex gastroschisis (n=8): jejunal (pink rhombus, green triangle); jejunal + colonic (pink 
circle); ileal (light blue triangle, dark blue triangle, orange rhombus); unclear (orange square, 
purple circle). 
 
 
 
 
Figure 5 Stomach-bladder distances in fetuses with simple or complex gastroschisis 
during gestational age  
Different colors and symbols represent different fetuses. Location of intestinal atresia in 
complex gastroschisis (n=7): jejunal (pink rhombus, green triangle); jejunal + colonic (pink 
circle); ileal (light blue triangle, dark blue triangle, orange rhombus); unclear (orange square). 
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Table 1 (continued)      
 n Simple 
gastroschisis  
n=55 (86%) 
n Complex 
gastroschisis A 
n=9 (14%) 
p 
value 
Postnatal characteristics      
Primary closure 55 34 (62%) 9 5 (56%) 0.73 
Complications C 55 28 (51%) 9 8 (89%) 0.07 
- Necrotizing enterocolitis  0 (0%)  1 (11%) 0.14 
- Cholestatic jaundice  13 (24%)  7 (78%) 0.003 
- Line sepsis  18 (33%)  5 (56%) 0.26 
- Wound infection  3 (5%)  3 (33%) 0.03 
Mortality 55 0 (0%) 9 1 (11%) 0.14 
Time to full enteral feeding (days) 54 28 (17-42) 8 201 (98-386) 0.001 
Length of hospital stay (days) D 55 34 (25-63) 8 122 (71-180) 0.001 
Data presented as median (interquartile range) or n (%). A Intestinal atresia (n=6), intestinal 
atresia + perforation (n=1), intestinal atresia +necrosis (n=1), intestinal atresia + necrosis + 
volvulus (n=1). B Simple gastroschisis: cocaine (n=4), marihuana (n=2); complex gastroschisis: 
cocaine (n=1), marihuana (n=1). C Percentages do not necessarily add up to 100, as one 
infant can have multiple problems. One infant with complex gastroschisis died of sepsis at 8 
months of age. D One infant with simple gastroschisis and one with complex gastroschisis 
were transferred to another hospital with an unknown discharge date to home; in these 
infants, length of hospital stay was documented as time to transfer.  
 
Developmental course of stomach volume and stomach-bladder distance 
Linear mixed modelling showed no significant contribution of a GA-squared term; a 
linear model fitted the ln-transformed data best. Fetal stomach volume did not differ 
significantly between fetuses with simple and those with complex gastroschisis at 20 
weeks’ gestation (figure 4, table 2; p=0.397), nor did stomach-bladder distance (figure 
5, table 2; p=0.345). With advancing GA, stomach volume significantly increased, and 
stomach-bladder distance decreased (both p<0.001). The course of these changes did 
not differ significantly between simple and complex gastroschisis (table 2).  
 
The infant who died of sepsis at 8 months of age had shown normal stomach volume at 
24 weeks' gestation, stomach-bladder distance was not assessable; no 3D ultrasound 
measurements were available between 24 and 33 weeks' gestation for this infant. The 
infant was born at 33 weeks' gestation with an appropriate birth weight for GA. 
 
For the two pregnancies resulting in IUD (beyond 20 weeks’ gestation), we found fetal 
stomach volume and stomach-bladder distance comparable to those shown in figures 4 
and 5, respectively. Neither had any other structural malformations at autopsy. The 
autopsy report of one fetus mentioned intestinal malrotation, the report of the other 
fetus stated signs of placental inflammation without specifically addressing intestinal 
malrotation.  
 
 
 
Figure 4 Stomach volumes in fetuses with simple or complex gastroschisis during 
gestational age 
Different colors and symbols represent different fetuses. Location of intestinal atresia in 
complex gastroschisis (n=8): jejunal (pink rhombus, green triangle); jejunal + colonic (pink 
circle); ileal (light blue triangle, dark blue triangle, orange rhombus); unclear (orange square, 
purple circle). 
 
 
 
 
Figure 5 Stomach-bladder distances in fetuses with simple or complex gastroschisis 
during gestational age  
Different colors and symbols represent different fetuses. Location of intestinal atresia in 
complex gastroschisis (n=7): jejunal (pink rhombus, green triangle); jejunal + colonic (pink 
circle); ileal (light blue triangle, dark blue triangle, orange rhombus); unclear (orange square). 
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Table 2 Estimates with 95% confidence intervals of linear mixed modelling for stomach 
volume and stomach-bladder distance (natural log transformed) 
Variable Estimate 
(mean) 
95% Confidence 
Interval 
p 
value 
Stomach volume (ln)    
Intercept -0.31 -0.49 to -0.13 0.001 
Type of gastroschisis (complex versus 
simple)  
0.25 -0.33 to 0.83 0.40 
Gestational age (centered at 20 weeks) 0.13 0.11 to 0.15 <0.001 
Gestational age by type of gastroschisis 0.01 -0.07 to 0.08 0.85 
Stomach-bladder distance (ln)    
Intercept 0.06 -0.27 to 0.39 0.71 
Type of gastroschisis (complex versus 
simple)  
0.48 -0.53 to 1.48 0.35 
Gestational age (centered at 20 weeks) -0.26 -0.30 to -0.22 <0.001 
Gestational age by type of gastroschisis -0.02 -0.15 to 0.11 0.78 
 
Discussion 
This longitudinal prospective multicenter study is the first to evaluate the possible 
benefit of the use of 3D ultrasound in fetuses with gastroschisis. Stomach volume and 
stomach-bladder distance during pregnancy did not differ between simple and complex 
gastroschisis. Therefore, we were unable to predict complex gastroschisis using these 
prenatal variables.    
 
Many attempts have been made to prenatally predict complex gastroschisis.8 Fetal 
stomach dilatation has been found to be associated with the postnatal need for bowel 
resection,14 but a recent meta-analysis showed no significant association between 
stomach dilatation and complex gastroschisis.8 However, stomach dilatation in these 
fetuses was always evaluated retrospectively, using 2D ultrasound.8 In addition, the cut-
off values used in these studies were either not mentioned14, 15 or were derived from 
healthy fetuses more than thirty years ago.8, 16, 17 In our group of more than 100 fetuses 
that were evaluated with 2D ultrasound, we found that both intra- and extra-abdominal 
bowel diameters were of limited value in the prediction of complex gastroschisis.10 
Although both parameters were increased in those with complex gastroschisis, the large 
fluctuations over time and the overlap with simple cases made it difficult to identify 
complex gastroschisis prenatally. The best predictor appeared to be intra-abdominal 
bowel diameters ≥p97.7 measured at least three times during gestation, but the positive 
predictive value was low (i.e. 50%). Gastric size was not assessed in the 2D ultrasound 
part of the study. 
 
As 3D ultrasound has been proposed to be superior to 2D ultrasound in evaluating 
fetal stomach volume,18 we hypothesized that this method would be more accurate in 
 
predicting complex gastroschisis. However, fetuses with complex gastroschisis showed 
stomach volumes comparable to those measured in simple gastroschisis fetuses.  
 
Previous studies have reported an association between fetal stomach dilatation and 
death in the neonatal8 or perinatal14 period. In our study, the two cases ending in IUD 
had stomach volumes that were comparable to those who were live-born. No previous 
study has evaluated the association between fetal stomach-bladder distance and 
complex gastroschisis. Brugger and Prayer, however, did report extensive stomach-
bladder contact on magnetic resonance imaging in fetuses who presented with simple 
gastroschisis at birth.9 This was in contrast to the three fetuses with complex 
gastroschisis included in their study, who had shown absence of stomach-bladder 
contact in the third trimester due to IABD.9 As IABD has previously been associated 
with complex gastroschisis,8 we hypothesized that a greater stomach-bladder distance 
–as a reflection of IABD– could also be predictive of complex gastroschisis. Rather than 
measuring the largest bowel loop, stomach-bladder distance would reflect IABD in 
general. However, both in simple and in complex gastroschisis, we observed great 
variations in stomach-bladder distance, probably due to alternate filling and emptying of 
these organs. As no differences were observed between the two types of gastroschisis, 
we conclude that stomach-bladder distance is not helpful in predicting complex 
gastroschisis.  
 
Strengths and limitations 
The major strength of our study is its prospective, longitudinal study design, with a large 
number of measurements per fetus. Investigators were blinded to outcome during 
ultrasonography and during calculations of stomach volume and stomach-bladder 
distance. As we used 3D instead of 2D ultrasonography, we did not depend on certain 
geometric characteristics or regular contours of the stomach to calculate stomach 
volume, and we were able to reliably calculate the shortest stomach-bladder distance.   
 
Several limitations need to be addressed. First, we excluded three centers because of 
low compliance of performing 3D ultrasound measurements. However, we found no 
significant differences in characteristics between cases of included centers and cases of 
excluded centers, apart from the number of cesarean sections. Therefore, we expect 
that selection bias can be considered minimal. Second, the small sample of fetuses with 
complex gastroschisis decreased the power of our tests. Since these fetuses showed 
comparable stomach volume and stomach-bladder distance to those with simple 
gastroschisis, we think this has not affected our conclusion. A third limitation is the 
substantial number of missing data for fetuses from included centers. Especially in the 
complex gastroschisis group, a relatively high number of volume datasets had to be 
excluded from stomach volume analyses, because no stomach was seen intra-
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Table 2 Estimates with 95% confidence intervals of linear mixed modelling for stomach 
volume and stomach-bladder distance (natural log transformed) 
Variable Estimate 
(mean) 
95% Confidence 
Interval 
p 
value 
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simple)  
0.48 -0.53 to 1.48 0.35 
Gestational age (centered at 20 weeks) -0.26 -0.30 to -0.22 <0.001 
Gestational age by type of gastroschisis -0.02 -0.15 to 0.11 0.78 
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abdominally or because volume calculations were not assessable. We speculate that 
fetuses with complex gastroschisis may have an increased incidence of stomach 
evisceration, or increased presence of debris inside the stomach, which hampered 
SonoAVC to calculate stomach volumes. Nonetheless, all fetuses with complex 
gastroschisis included in our analysis showed comparable stomach volumes to those 
with simple gastroschisis. Even if the excluded volume datasets would have shown 
strongly deviating values, it would still be very difficult to predict complex gastroschisis 
using stomach volume. Last, we chose to focus on 3D ultrasound measures only. Future 
research may investigate whether combining 3D with 2D ultrasound measures leads to 
improved prediction of complex gastroschisis.  
 
Conclusion 
We conclude that fetal stomach volume and stomach-bladder distance, measured 
during pregnancy using 3D ultrasonography, cannot predict complex gastroschisis. 
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Supplemental material 
 
Supplemental table 1 Maternal, perinatal and postnatal characteristics of fetuses with 
gastroschisis from included and excluded centers 
 n Included 
centers 
(n=4)  
79 fetuses 
n Excluded 
centers 
(n=3) 
25 fetuses 
p 
value 
≥1 3D ultrasound assessment 79 66 (84%) 25 7 (28%) <0.001 
Maternal characteristics      
Age (years)  78 25 (22 – 31) 25 26 (23 – 31) 0.64 
Primigravid 79 40 (51%) 25 14 (56%) 0.64 
Smoking 68 24 (35%) 25 10 (40%) 0.68 
Recreational drug use  69 13 (19%) 24 2 (8%) 0.34 
Perinatal characteristics      
Live birth 79 75 (95%) 25 25 (100%) 0.57 
Gestational age at birth (weeks) 75 36.7 (35.3 – 
37.3) 
25 36.7 (35.6 – 
37.1) 
0.93 
Spontaneous onset of delivery 75 23 (31%) 25 9 (36%) 0.62 
Cesarean section 75 23 (31%) 25 2 (8%) 0.02 
Birth weight (grams)  75 2490 (2175 – 
2775) 
25 2395 (2165 – 
2770) 
0.82 
Birth weight <p10 75 13 (17%) 25 3 (12%) 0.75 
Male gender 75 38 (51%) 25 15 (60%) 0.42 
Apgar at 5 min <7 74 4 (5%) 25 1 (4%) 1.00 
Postnatal characteristics      
Complex gastroschisis 75 13 (17%) 25 6 (24%) 0.56 
Primary closure 75 44 (59%) 24 19 (79%) 0.07 
Complications A 75 45 (60%) 25 15 (60%) 1.00 
- Necrotizing enterocolitis  1 (1%)  1 (4%) 0.44 
- Cholestatic jaundice  26 (35%)  10 (40%) 0.63 
- Line sepsis  27 (36%)  11 (44%) 0.48 
- Wound infection  10 (13%)  3 (12%) 1.00 
Mortality 75 3 (4%) 25 0 (0%) 0.57 
Time to full enteral feeding (days) 71 29 (19 – 70) 23 36 (23 – 49) 0.79 
Length of hospital stay (days) B 72 43 (26 – 81) 24 44 (27 – 80) 0.81 
Data presented as median (interquartile range) or n (%). A Percentages do not necessarily 
add up to 100, as one infant can have multiple problems. B Three infants in the included 
group and one in the excluded group were transferred to another hospital with an unknown 
discharge date to home; in these infants, length of hospital stay was documented as time to 
transfer. 
 
 
 
Supplemental figure 1 Bland-Altman plots showing intra- and interobserver 
agreement of stomach volume and stomach-bladder distance measurements 
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Abstract 
 
Objective 
We aimed to identify gestational-age corrected prenatal ultrasound markers of complex 
gastroschisis, and to compare physical growth and neurodevelopment between children 
with simple and complex gastroschisis. 
 
Design 
We included prenatally diagnosed gastroschisis patients from 2000 to 2012 who joined 
our longitudinal follow-up program. Associations between complex gastroschisis and 
prenatal ultrasound markers collected at 30 weeks’ gestation and prior to delivery were 
tested using logistic regression. Physical growth (SD scores (SDS)), mental and 
psychomotor developmental index (MDI, PDI; Bayley Scales of Infant Development) 
were recorded at 12 and 24 months. Data were analyzed using general linear models 
and compared with population 
norms. 
 
Results 
Data of 61 children were analyzed (82% of eligible cases). Extra-abdominal bowel 
dilatation at 30 weeks’ gestation was significantly associated with complex gastroschisis 
(OR (95% CI): 5.00 (1.09 to 22.98)), with a high negative (88%) but low positive (40%) 
predictive value. The mean (95% CI) height SDS at 12 months (−0.46 (–0.82 to –0.11)), 
and weight SDS at 12 and 24 months (−0.45 (–0.85 to –0.05), and −0.44 (−0.87 to –
0.01), respectively) fell significantly below 0 SDS. MDI and PDI were significantly below 
100 at 24 months; 93 (88 to 99) and 83 (78 to 87), respectively). Children with complex 
gastroschisis had a significantly lower PDI (76 (68 to 84)) than those with simple 
gastroschisis (94 (90 to 97), p<0.001). 
 
Conclusions 
Prenatal ultrasound markers could not reliably distinguish between simple and complex 
gastroschisis. Children with complex gastroschisis may be at increased risk for delayed 
psychomotor development; they should be monitored more closely, and offered timely 
intervention. 
 
Introduction 
Gastroschisis is a congenital abdominal wall defect with an estimated prevalence of 2.16 
per 10 000 pregnancies.1 Surgery is required shortly after birth, by means of primary 
closure when possible or by placing a silastic silo to allow gradual reduction into the 
abdominal cavity prior to definite closure.2  
 
Gastroschisis patients who have additional intestinal defects, that is, intestinal atresia, 
perforation, necrosis or volvulus (‘complex’ gastroschisis),3 have a higher risk of 
morbidity than children with ‘simple’ gastroschisis (without intestinal defects). This 
includes prolonged time to full enteral feeding (TFEF) and prolonged length of hospital 
stay (LOS).3–5  
 
Over 90% of gastroschisis cases are diagnosed prenatally.6 A recent meta-analysis 
evaluated several prenatal ultrasound markers and showed significant positive 
associations between intra-abdominal bowel dilatation (IABD) and intestinal atresia, 
between polyhydramnios and intestinal atresia, and between gastric dilatation and 
neonatal death.7 These findings should be interpreted with caution, however, given that 
definitions of bowel and gastric dilatation differed between studies and data were not 
always corrected for gestational age (GA).  
 
Additionally, adequate parental counselling should include expectations of the child’s 
physical growth and neurodevelopment. Physical growth in children older than 1 year 
has only been studied in small groups (<40 patients).8–11 No previous study has evaluated 
possible differences in neurodevelopment between children with simple and complex 
gastroschisis. 
The aim of our study was to (1) identify GA-corrected prenatal ultrasound markers of 
complex gastroschisis and (2) to assess physical growth and neurodevelopment up to 2 
years of age of children  with either simple or complex gastroschisis. 
 
Methods 
Study population 
A retrospective analysis was performed of prospectively collected data of all prenatally 
diagnosed gastroschisis cases delivered and treated at the Erasmus Medical Center-
Sophia Children’s Hospital Rotterdam between 2000 and 2012. Following the diagnosis, 
several prenatal characteristics were assessed every 4 weeks. From 2007 onwards, 
additional assessments were scheduled weekly, starting at 30 weeks’ gestation.12 Vaginal 
delivery was planned from 37 weeks onwards, unless obstetric reasons required 
otherwise. Survivors could join a longitudinal prospective follow-up program which 
since 1999 is standard of care for children with anatomical congenital malformations 
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gastroschisis, and to compare physical growth and neurodevelopment between children 
with simple and complex gastroschisis. 
 
Design 
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were recorded at 12 and 24 months. Data were analyzed using general linear models 
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Conclusions 
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Introduction 
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Over 90% of gastroschisis cases are diagnosed prenatally.6 A recent meta-analysis 
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possible differences in neurodevelopment between children with simple and complex 
gastroschisis. 
The aim of our study was to (1) identify GA-corrected prenatal ultrasound markers of 
complex gastroschisis and (2) to assess physical growth and neurodevelopment up to 2 
years of age of children  with either simple or complex gastroschisis. 
 
Methods 
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A retrospective analysis was performed of prospectively collected data of all prenatally 
diagnosed gastroschisis cases delivered and treated at the Erasmus Medical Center-
Sophia Children’s Hospital Rotterdam between 2000 and 2012. Following the diagnosis, 
several prenatal characteristics were assessed every 4 weeks. From 2007 onwards, 
additional assessments were scheduled weekly, starting at 30 weeks’ gestation.12 Vaginal 
delivery was planned from 37 weeks onwards, unless obstetric reasons required 
otherwise. Survivors could join a longitudinal prospective follow-up program which 
since 1999 is standard of care for children with anatomical congenital malformations 
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treated in our hospital.13 The Medical Ethical Review Board waived approval (‘Medical 
Research in Human Subjects Act does not apply to this research proposal’; MEC-2015–
308).  
 
Prenatal and perinatal characteristics of simple and complex gastroschisis  
We obtained the following ultrasound data at 30 weeks’ gestation and at the last 
ultrasound examination prior to delivery: amniotic fluid index, considered abnormal if 
<5 cm (oligohydramnios) or >24 cm (polyhydramnios); intrauterine growth restriction, 
defined as estimated fetal weight ≤10th percentile for GA according to the Hadlock 
formula III14; IABD and extra-abdominal bowel dilatation (EABD) determined using a 
GA-specific nomogram, considering the bowel dilated if ≥13 mm at a GA of 25–30 
weeks, ≥16 mm at 30–35 weeks, and if ≥26 mm at 35–40 weeks15; and intra-abdominal 
gastric dilatation, defined as measurements exceeding two SDs above the mean 
reference value, adjusted for GA.16 Preterm birth was defined as delivery prior to 37 
weeks’ gestation. Small for GA was diagnosed if birth weight was below the 10th centile 
according to Dutch reference curves.17 Socioeconomic status scores (with population 
mean 0 and SD 1) were based on postal codes.18, 19  
 
Postnatal outcome in simple and complex gastroschisis 
Complex gastroschisis was defined as presence of intestinal atresia, necrosis, 
perforation and/or volvulus at primary postnatal evaluation. We recorded duration of 
initial mechanical ventilation, LOS of the initial hospitalization, and additionally during 
follow-up: TFEF; number of procedures under general anesthesia; complications; and 
presence of intestinal failure, defined as TFEF ≥6 weeks.20 If TFEF or LOS was ≥2 years, 
the duration was set at 730 days.  
 
Physical growth and neurodevelopment 
Height and weight were measured at 12 and 24 months (corrected for preterm birth). 
SD scores (SDS) were determined according to Dutch reference norms, with −2 to +2 
SD considered as normal range.21 Neurodevelopment was assessed using the Dutch 
version of the Bayley Developmental Scales (BOS 2–30)22 and from December 2003, 
Bayley Scales of Infant Development-Second Edition (BSID-II-NL).23 These tests are 
interchangeable,23 and provide a mental developmental index (MDI) and psychomotor 
developmental index (PDI) with a mean score of 100 and an SD of 15.22, 23 Scores 70–
84 indicate mildly impaired development, scores 55–69 moderately impaired 
development, and scores <55 (recorded as 55) are indicative of severe developmental 
delay. 
 
  
 
Statistical analysis 
Categorical variables are presented as number (%) and continuous variables as median 
(IQR). Prenatal characteristics and postnatal outcome parameters of children with 
simple or complex gastroschisis were compared using chi-square tests or Fisher’s exact 
tests (in case of expected counts <5) for categorical data, and the Mann-Whitney test 
for continuous data. We used logistic regression to find relevant ultrasound predictors 
of complex gastroschisis. Spearman’s rank correlation coefficient was used to assess the 
association between GA at birth and TFEF. General linear models were used to analyze 
the repeated growth and neurodevelopment measurements over time. These models 
included both the time point (12 or 24 months) and the type of gastroschisis (simple or 
complex) as independent variables. To account for the within-subject correlations, an 
unstructured error covariance matrix for the repeated measurements of each patient 
was used in the general linear models. The results are presented using estimated 
marginal means (i.e. the predicted values of the dependent variable adjusted for 
covariates in the model). Estimated marginal means and their 95% CIs were compared 
with reference norms. A two-sided p value of <0.05 was considered statistically 
significant. Statistical analyses were performed using SPSS V.21.0. 
 
Results 
Of 82 prenatally diagnosed cases of gastroschisis, three (4%) pregnancies were 
terminated. Four (5%) other fetuses died in utero between 20 and 36 weeks’ gestation. 
All four showed intrauterine growth restriction but not bowel or gastric dilatation. Of 
75 live-born children, 12 (16%) were diagnosed with complex gastroschisis. One infant 
with simple gastroschisis died of sepsis at 5 months of age. Of 61 (82 %) children who 
joined the follow-up program, 46 (75%) were seen at both 12 and 24 months (figure 1). 
Prenatal, perinatal and postnatal data did not significantly differ between children who 
joined the follow-up program and children who did not (data not shown).  
 
Prenatal and perinatal characteristics 
Ultrasound examination at 30 weeks’ gestation revealed EABD in 6/51 (12%) fetuses 
postnatally diagnosed with simple gastroschisis, versus 4/10 (40%) fetuses postnatally 
diagnosed with complex gastroschisis (OR (95% CI) 5.00 (1.09 to 22.98)). Thus the 
positive and negative predictive values of EABD for complex gastroschisis were 40% 
and 88%, respectively. These four children with complex gastroschisis all had intestinal 
atresia. No significant associations were found regarding any other assessed prenatal 
parameter at 30 weeks’ gestation or at the last ultrasound examination prior to delivery. 
Perinatal data did not significantly differ between children with simple and children with 
complex gastroschisis (table 1). 
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Prenatally deceased: n=7
- Termination of pregnancy: n=3
- Intrauterine death: n=4
Eligible for follow-up
n=74 
Live-born
n=75 
Prenatally diagnosed 
gastroschisis
n=82
Deceased < 2 years
- Infant death: n=1
In follow-up
n=61 
(Complex: n=10 (16%))
No follow-up at all: n=13
(Complex: n=2 (15%))
- Refusal: n=11
- Organizational: n=1
- Not traceable: n=1
Evaluation
 at 12 months only
n=8 
Evaluation 
at 12 and 24 months 
n=46 
Evaluation 
at 24 months only
n=7 
12 months assessment*
n=54 
(Complex: n=8 (15%))
- Height and weight: n=53
- Mental development: n=52
- Motor development: n=52
24 months assessment*
n=53 
(Complex: n=7 (13%))
- Height and weight: n=53
- Mental development: n=49
- Motor development: n=43
 
 
Figure 1 Inclusion flow chart 
*Reasons for missing neurodevelopmental data at 12 months: non-cooperative n=2 (both 
motor/mental n=1; mental n=1); immobilization of foot n=1 (motor). At 24 months: non-
cooperative n=6 (both motor/mental n=2, motor n=4); organizational n=3 (both 
motor/mental n=1; motor n=2), refusal n=1 (both motor/mental). 
 
  
 
Table 1 Maternal, prenatal and perinatal characteristics of children in follow-up 
(n=61) 
 
Simple 
gastroschisis 
n=51 
Complex 
gastroschisis A 
n=10 
p 
value 
Maternal age (years)  23.2 (19.7 – 28.4) 26.7 (21.1 – 32.7) 0.45 
Socioeconomic status score at 
birth  -0.52 (-1.45 – 0.34) 0.19 (-0.93 – 0.71) 0.18 
- Low status score (< -1) 20 (39%) 2 (20%) 0.31 
Prenatal characteristics    
30 weeks' gestation     
Gestational age (weeks)  30.3 (29.9 – 30.7) 30.1 (29.7 – 31.1) 0.85 
Amniotic fluid volume, normal 51 (100%) 10 (100%) - 
Intrauterine growth restriction 20 (39%) 4 (40%) 1.00 
Intra-abdominal bowel 
dilatation 3 (6%) 0 (0%) 1.00 
Extra-abdominal bowel 
dilatation 6 (12%) 4 (40%) 0.049 
Gastric dilatation 2 (4%) 1 (10%) 0.42 
Last ultrasound examination prior to delivery    
Gestational age (weeks)  35.7 (34.0 – 36.6) 36.1 (35.8 – 36.5) 0.46 
Amniotic fluid volume, normal B 46 (93%) 10 (100%) 1.00 
Intrauterine growth restriction 26 (51%) 8 (80%) 0.16 
Intra-abdominal bowel 
dilatation C 3 (6%) 2 (22%) 0.16 
Extra-abdominal bowel 
dilatation 11 (22%) 4 (40%) 0.24 
Gastric dilatation D 8 (17%) 2 (25%) 0.63 
Perinatal characteristics    
Induced delivery 33 (65%) 8 (80%) 0.47 
Cesarean section 14 (27%) 3 (30%) 1.00 
Gestational age at birth (weeks)  36.9 (34.6 – 37.4) 36.8 (36.4 – 37.4) 0.76 
Preterm birth E 26 (51%) 6 (60%) 0.74 
Birthweight (grams)  2300 (2100 – 2700) 2385 (2228 – 2525) 0.75 
Small for gestational age 8 (16%) 3 (30%) 0.37 
Apgar score < 7 at 5 min  4 (8%) 0 (0%) 1.00 
Umbilical cord pH F 7.30 (7.24 – 7.35) 7.31 (7.24 – 7.40) 0.59 
- pH < 7.00 1 (2%) 0 (0%) 1.00 
Data presented as median (interquartile range) or n (%). A Bowel atresia (n=3), intestinal 
atresia + necrosis (n=2), intestinal atresia + perforation (n=1), necrosis (n=1), necrosis + 
volvulus (n=1), perforation (n=2). B Data unknown in n=2, oligohydramnios in n=3 (all 
simple gastroschisis). C Data unknown in n=1. D Data unknown in n=6. E All preterm born 
babies were born after 32 weeks' gestation. F Data  unknown in n=1.  
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Postnatal outcome 
Children with complex gastroschisis needed over three times as many procedures 
under general anesthesia as those with simple gastroschisis (table 2). Moreover, median 
duration of initial mechanical ventilation was 24 days in infants with complex 
gastroschisis versus 2 days in infants with simple gastroschisis. Median durations of 
parenteral nutrition and hospitalization were less than 2 months in children with simple 
gastroschisis, and close to 6 months in those with complex gastroschisis. There was no 
significant correlation between GA at birth and TFEF (Spearman’s r=−0.086, p=0.47). 
Intestinal failure developed in all children with complex gastroschisis, and in 25% of 
those with simple gastroschisis. Complications were common in both groups, especially 
sepsis and parenteral nutrition-related cholestasis. 
 
Table 2 Postnatal characteristics of children in follow-up (n=61) 
 Simple 
gastroschisis 
n=51 
Complex 
gastroschisis A 
n=10 
p 
value 
Postnatal characteristics    
Eviscerated organs B    
- Intestines only 21 (41%) 3 (30%) 0.73 
- + stomach 25 (49%) 5 (50%) 1.00 
- + bladder 6 (12%) 2 (20%) 0.61 
Multiple congenital anomalies C 7 (13.7%) 2 (20%) 0.63 
Primary closure, directly after 
birth 
35 (69%) 4 (40%) 0.15 
Procedures under general 
anesthesia  
2 (1 – 3) 7 (4 – 14) <0.001 
Duration of initial mechanical 
ventilation (days) D 
2 (1 – 6) 24 (7 – 30) 0.001 
Time to full enteral feeding (days)  27 (20 – 47) 165 (66 – 624) <0.001 
- Intestinal failure 13 (25%) 10 (100%) <0.001 
Length of initial hospital stay 
(days)  
42 (28 – 62) 173 (81 – 426) <0.001 
Complications B 30 (59%) 10 (100%) 0.01 
- Sepsis 25 (49%) 9 (90%) 0.03 
- Parenteral nutrition-related 
cholestasis 
14 (27%) 9 (90%) <0.001 
- Cardiopulmonary 
resuscitation 
5 (10%) 1 (10%) 1.00 
- Central venous line-
thrombosis 
2 (4%) 2 (20%) 0.12 
- Miscellaneous E 13 (25%) 5 (50%) 0.14 
Data presented as median (interquartile range) or n (%). A Bowel atresia (n=3), intestinal 
atresia + necrosis (n=2), intestinal atresia + perforation (n=1), necrosis (n=1), necrosis + 
 
volvulus (n=1), perforation (n=2). B Percentages do not necessarily add up to 100, as one 
patient can have multiple problems. C Polydactyly (n=2); dysmorphic features (n=2: 
retrognathia and short philtrum, frontal bossing and hypertelorism); hydronephrosis and 
atrial septal defect, spontaneous closure (n=1); small ventricular septal defect (n=1); benign 
peripheral hydrocephalus (n=1); hypospadias (n=1); and retrognathia and urethral valves 
(n=1). D Data unknown in n=1. E Surgery-related (n=8); preterm birth-related (n=4); 
infectious, not catheter-related (n=6); neurologic (n=4); catheter-related (n=2); drug-
related (n=1). 
 
Physical growth and neurodevelopment 
Physical growth data of all gastroschisis patients in follow-up is shown in figure 2. The 
general linear model analysis showed significant improvement in height SDS from 12 to 
24 months of +0.16 (95% CI: 0.01 to 0.31). The estimated marginal means (95% CI) of 
height SDS at 12 months (−0.46 (–0.82 to –0.11)), and weight SDS at 12 and 24 months 
(−0.45 (-0.85 to –0.05), and −0.44 (−0.87 to –0.01), respectively) fell significantly below 
0 SD, but within the normal range of −2 to +2 SD. Growth parameters did not differ 
significantly between children with simple and complex gastroschisis. At 24 months, 
4/53 (8%) children scored below −2 SD for weight; all four had simple gastroschisis. 
None of the children had abnormally low height SDS. 
 
 
Figure 2 Physical growth at 12 and 24 months of all gastroschisis patients in follow-
up  
Symbols represent estimated marginal means with 95% confidence intervals. SDS: standard 
deviation score. * indicates a significant improvement in SDS (p<0.05). 
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- Parenteral nutrition-related 
cholestasis 
14 (27%) 9 (90%) <0.001 
- Cardiopulmonary 
resuscitation 
5 (10%) 1 (10%) 1.00 
- Central venous line-
thrombosis 
2 (4%) 2 (20%) 0.12 
- Miscellaneous E 13 (25%) 5 (50%) 0.14 
Data presented as median (interquartile range) or n (%). A Bowel atresia (n=3), intestinal 
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volvulus (n=1), perforation (n=2). B Percentages do not necessarily add up to 100, as one 
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atrial septal defect, spontaneous closure (n=1); small ventricular septal defect (n=1); benign 
peripheral hydrocephalus (n=1); hypospadias (n=1); and retrognathia and urethral valves 
(n=1). D Data unknown in n=1. E Surgery-related (n=8); preterm birth-related (n=4); 
infectious, not catheter-related (n=6); neurologic (n=4); catheter-related (n=2); drug-
related (n=1). 
 
Physical growth and neurodevelopment 
Physical growth data of all gastroschisis patients in follow-up is shown in figure 2. The 
general linear model analysis showed significant improvement in height SDS from 12 to 
24 months of +0.16 (95% CI: 0.01 to 0.31). The estimated marginal means (95% CI) of 
height SDS at 12 months (−0.46 (–0.82 to –0.11)), and weight SDS at 12 and 24 months 
(−0.45 (-0.85 to –0.05), and −0.44 (−0.87 to –0.01), respectively) fell significantly below 
0 SD, but within the normal range of −2 to +2 SD. Growth parameters did not differ 
significantly between children with simple and complex gastroschisis. At 24 months, 
4/53 (8%) children scored below −2 SD for weight; all four had simple gastroschisis. 
None of the children had abnormally low height SDS. 
 
 
Figure 2 Physical growth at 12 and 24 months of all gastroschisis patients in follow-
up  
Symbols represent estimated marginal means with 95% confidence intervals. SDS: standard 
deviation score. * indicates a significant improvement in SDS (p<0.05). 
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Both MDI and PDI significantly declined over time (mean differences (95% CI): −8 (−3 
to –13) and −4 (−1 to –8), respectively). The estimated marginal mean (95% CI) MDI 
at 24 months (93 (88 to 99)) was significantly below 100, but within the normal range 
of 85–115. The estimated marginal mean PDI was significantly below 100 at both 12 and 
24 months, 87 (82 to 92) and 83 (78 to 87), respectively. Children with complex 
gastroschisis scored a significantly lower PDI than those with simple gastroschisis (76 
(68 to 84) vs 94 (90 to 97), respectively, p<0.001), whereas MDI did not significantly 
differ between groups. At 24 months a higher percentage of children with simple 
gastroschisis versus children with complex gastroschisis showed normal mental 
development (86% vs 57%, figure 3), but this difference was not statistically significant 
(p=0.11). The same holds for psychomotor development (81% vs 50%, figure 3; p=0.13). 
One child with complex gastroschisis and dysmorphic features had severe 
neurodevelopmental delay. Re-analysis of our data after exclusion of this child did not 
change the results on development in terms of significance. 
 
 
 
Figure 3 Proportions of children with simple or complex gastroschisis with normal 
or delayed mental (left panel) and motor (right panel) development at 24 months of 
follow-up.  
Mild delay: developmental index 70–84; moderate delay: 55–69; severe delay:<55. 
 
  
 
Discussion 
In this longitudinal follow-up study, we assessed prenatal characteristics, growth and 
development of children born with simple or complex gastroschisis up to 2 years of 
age. We found a significant association between EABD at 30 weeks’ gestation and 
complex gastroschisis. Despite the high morbidity in gastroschisis patients, their height 
and weight SDS at the age of 2 years fell within normal range. Although the differences 
between groups were not statistically significant, both mental and motor development 
were normal in over 80% of children with simple gastroschisis, and in half of those with 
complex gastroschisis.  
 
We hypothesized that a GA-corrected definition of bowel and gastric dilatation would 
improve prediction of complex gastroschisis. The low prevalence of prenatal gastric 
dilatation may explain why this failed. Moreover, gastric dilatation might be physiological 
in gastroschisis, rather than a sign of complexity. Surprisingly, IABD at 30 weeks’ 
gestation only occurred in simple gastroschisis, which suggests that IABD is not a clear 
sign of complex gastroschisis. A recent meta-analysis in contrast showed a significant 
association between IABD and bowel atresia, although the positive predictive value was 
low (22%, derived from table 4 of that paper) and thresholds of bowel dilatation differed 
between studies.7 Furthermore, EABD –with thresholds ranging from 6 to 30 mm—did 
not predict bowel atresia.7 One recent study showed an association between GA-
corrected EABD and complex gastroschisis.24 We showed that EABD at 30 weeks’ 
gestation, but not at the last ultrasound prior to delivery, was significantly associated 
with complex gastroschisis. As evisceration of intra-abdominal organs continues during 
gestation, the colon—with a wider diameter than jejunum or ileum— may have 
eviscerated more frequently at later gestation also in simple gastroschisis. This may 
explain why uncorrected EABD is an unreliable predictor of complex gastroschisis, and 
why the association we found between EABD at 30 weeks’ gestation and complex 
gastroschisis was no longer valid at the last ultrasound prior to delivery. In future 
studies, using up-to-date reference norms for bowel dilatation in healthy fetuses and 
gastroschisis fetuses, corrected for position (intra- or extra-abdominal), small and large 
intestine, and for GA will allow for valid comparison of study results and enable meta-
analyses. 
 
With the ultimate aim to optimize prenatal counselling, we evaluated physical growth 
and neurodevelopment up to 2 years of age, distinguishing between simple and complex 
gastroschisis. Previous studies on physical growth in gastroschisis patients reported 
suboptimal10, 25 or normal growth9 in infancy, and normal growth in childhood.8, 11, 26, 27 
The two studies that took into account the type of gastroschisis (simple or complex) 
found lower weight SDS in complex gastroschisis in infants aged 12 months,25 and in 
children aged 5–17 years.8 In contrast, we found no significant difference between 
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simple and complex gastroschisis; both groups had a height and weight SDS slightly 
below 0 SD, but within Dutch reference norms. 
 
Neurodevelopment in gastroschisis patients has previously been studied in small 
cohorts,9, 10, 28 sometimes combining different types of abdominal wall defects,13, 29–31 or 
limited to simple gastroschisis.32 Studies using formal neurodevelopmental assessment 
instruments reported favorable outcomes in gastroschisis patients aged 6–36 months, 
and a low incidence of adverse developmental outcome.9, 10, 25, 28, 32 While Harris and 
coworkers reported normal intelligence in 39 gastroschisis patients aged 5–17 years,33 
Henrich and coworkers described parent-reported physical or intellectual delay in one-
third of cases aged 1–10 years.11 Giúdici and coworkers reported normal development 
in only half of 34 gastroschisis patients at the age of 3 years, and this proportion was 
even less at the age of 6 years.27 The authors used a specific Argentine screening 
instrument, however, and did not differentiate between mental and motor 
development, which complicates comparison of results. To our knowledge, no previous 
study compared neurodevelopmental outcome between children with simple and 
complex gastroschisis. 
 
We speculate that children with complex gastroschisis were more at risk for 
neurodevelopmental problems because of increased morbidity. We think social reasons 
have contributed less, as the prevalence of low status score was almost twice as low as 
in simple gastroschisis (although not significant). Because medical variables strongly 
correlate it is difficult to pinpoint the exact cause of delayed neurodevelopment. In 
addition, the sample of complex gastroschisis patients was too small to permit 
multivariable regression analysis. 
 
We recommend close monitoring of psychomotor development of these children and 
referral to physical therapy at the earliest signs of disturbed development. 
Strengths of our study are the relatively large sample size for such a rare disease; the 
high proportion of patients that joined the follow-up program with no significant 
differences in characteristics between children who did join and children who did not, 
so that selection bias can be considered to be minimal; and the use of standardized 
assessments both prenatally and postnatally.  
 
Several limitations need to be addressed. First, the cut-off values for bowel dilatation 
were derived from a small cohort of healthy fetuses more than 25 years ago. Ultrasound 
techniques have been improved since then, and new cut-off values should be established 
for small bowel and colon dilatation. Second, the small sample of complex gastroschisis 
patients decreased the power of our tests. We think this has not affected the physical 
growth findings, as only 8% had weight below −2 SD and all of them had simple 
 
gastroschisis. Still, failure to detect a significant difference between the proportions of 
children with normal and abnormal neurodevelopment may have derived from limited 
power. 
 
In conclusion, prenatal ultrasound markers could not reliably distinguish between simple 
and complex gastroschisis. Two-year-old children with gastroschisis included in our 
study showed encouraging physical growth and neurodevelopment. Complex 
gastroschisis was associated with motor function delay within the first 2 years of life. 
Early start of pediatric physical therapy is recommended when motor function delay is 
suspected. 
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Abstract 
 
Children with gastroschisis are at high risk of morbidity in early life, which could affect 
long-term outcomes. We determined parent-reported outcomes in school-aged 
children born in 2000-2012, using paper questionnaires. Parent-perceived child 
vulnerability and motor function were compared with the Dutch reference data; parent-
rated data on cognition, health status, quality of life, and behavior were compared with 
those of controls matched for age, gender, and maternal education level. Of 77 eligible 
participants, 31 (40%) returned the questionnaires. Parent-reported motor function 
was normal in 23 (74%) children. Total scores on health status, quality of life, and 
behavior did not differ significantly from those of matched controls. Children with 
gastroschisis had lower scores on cognition (median (interquartile range); 109 (87-127)) 
than their matched controls (124 (113-140); p = 0.04). Neonatal intestinal failure and 
increased parent-perceived vulnerability were associated with lower scores on 
cognition (β - 25.66 (95% confidence interval - 49.41 to - 1.91); - 2.76 (- 5.27 to - 0.25), 
respectively).  
 
Conclusion 
Parent-reported outcomes of school-aged children with gastroschisis were mainly 
reassuring. Clinicians and parents should be aware of the higher risk of cognitive 
problems, especially in those with neonatal intestinal failure or increased parent-
perceived vulnerability. We recommend multidisciplinary follow-up at school age of 
children with gastroschisis and neonatal intestinal failure. 
  
 
Introduction 
Gastroschisis is a life-threatening congenital abdominal wall defect requiring surgical 
treatment shortly after birth. Nowadays, over 90% of cases are diagnosed prenatally,1 
which allows for early parental counseling. Additional anomalies are relatively rare, and 
survival rates are over 90%.2 However, these infants are at high risk of morbidity, 
especially those with associated intestinal defects (complex gastroschisis3). Morbidities 
include intestinal failure, prolonged length of hospital stay (LOS), and complications such 
as adhesive small bowel obstruction, parenteral nutrition-related cholestasis, and 
sepsis.4, 5, 6, 7 In addition to having undergone surgery in early life, many of these infants 
are born small for gestational age (SGA)8, 9 or preterm,2 which may affect 
neurodevelopmental outcomes.10, 11, 12, 13 Parent-reported outcome measures are 
becoming increasingly relevant, but data on outcomes at school age are scarce and 
conflicting.14, 15, 16, 17, 18 
 
To optimize follow-up and to improve parental counseling, we evaluated parent-
reported motor function, cognition, health status, quality of life, and behavior in school-
aged children (i.e. 4–17 years) with gastroschisis. In addition, we sought to identify 
predictors of cognition and behavior at school age, including parent-perceived child 
vulnerability, infant clinical data, sociodemographic characteristics, and 
neurodevelopmental outcomes that had been evaluated in these children at 2 years of 
age.7 
 
Materials and methods 
Participants 
We sent paper questionnaires with a self-addressed envelope to the caregivers of all 
surviving children born with gastroschisis between 2000 and 2012, and treated at our 
hospital. Questionnaires were sent once. In non-responders, a follow-up phone call was 
made after 2 to 4 weeks to check whether the questionnaires had been received. These 
caregivers had been offered to enter their child in the longitudinal prospective follow-
up program that since 1999 is standard of care for children with anatomical congenital 
anomalies treated at our hospital.19 Based on the favorable outcomes reported 
previously,15, 19 the follow-up duration of children born with gastroschisis was limited 
to 2 years. Those with intestinal failure were invited to join an intestinal rehabilitation 
program. 
 
At 2 years of age, the children’s mental and motor development had been assessed 
using the Bayley Developmental Scales20 or, from December 2003, the Bayley Scales of 
Infant Development-Second edition.21 Both tests provide a psychomotor and mental 
developmental index (mean score 100, SD 15). Neurodevelopmental outcomes at 2 
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years of age in those with prenatally diagnosed gastroschisis have been published 
previously.7 For the purpose of the current study, we excluded four children (figure 1). 
The Medical Ethical Review Board waived approval (‘Medical Research in Human 
Subjects Act does not apply to this research proposal’). 
 
Children with gastroschisis
2000-2012
n=81
Eligible
n=77
Excluded
n=4
 - Emigrated:                          n=2
 - Organizational:            n=1
 - Severe developmental delay:     n=1
Included
n=31 (40%)
 - Child vulnerability (CVS):   n=31
 - Motor function (MABC-2 Checklist): n=31
 - Cognition (PedsPCF):   n=23*
 - Health status (PedsQL): n=30*
 - Quality of life (DUX-25):   n=30*
 - Behavior (SDQ):   n=31
No response
n=46 (60%)
 
 
Figure 1 Inclusion flow chart 
*Reasons for missing data: cognition (n = 8): child aged < 7 years (n = 8); health status 
(n = 1): questionnaire missing (n = 1); quality of life (n = 1): excluded because of > 3 missing 
values (n = 1). 
 
Data collection 
We retrieved infant clinical data from medical records. Preterm birth was defined as 
delivery <37 weeks of gestation. Infants with a birth weight <10th centile for Dutch 
reference curves were classified as SGA.22 Those with additional intestinal defects (i.e. 
atresia, volvulus, necrosis, or perforation) were diagnosed with complex gastroschisis. 
We documented multiple congenital anomalies (MCA) that required surgery or multiple 
follow-up visits. If the time to full enteral feeding (TFEF) exceeded 2 years, the duration 
was set at 730 days. Intestinal failure was defined as TFEF >6 weeks. Socioeconomic 
status (SES) scores (population mean 0, SD 1) were based on postal codes at birth.23, 24 
The child’s living situation, medical data, and educational information were retrieved 
from a background questionnaire (supplemental file 1). Maternal and paternal education 
level were classified according to the International Standard Classification of Education 
(ISCED) 2011, with ISCED 0–2 considered as low, ISCED 3–4 as middle, and ISCED 5–
8 as high.25 
 
Measures 
We assessed the following outcome measures from parent-reported questionnaires 
(Dutch versions). A detailed description of each questionnaire is provided in 
supplemental file 1. For the analyses of cognition, health status, quality of life, and 
behavior, for each child with gastroschisis, we included two controls matched for age 
(maximum difference of 1 year), gender, and maternal education level (low, middle, or 
high25). Matched controls were randomly selected from three recently collected 
datasets for different outcome measures (supplemental file 2). 
Child vulnerability: Child Vulnerability Scale (CVS). 
Motor function: Movement Assessment Battery for Children-Second Edition (MABC-2) 
Checklist. 
Cognition: Parents of children aged ≥ 7 years rated cognitive functioning via the Pediatric 
Perceived Cognitive Function (PedsPCF) questionnaire. 
Health status and quality of life: Pediatric Quality of Life Inventory (PedsQL; health status) 
and DUX-25 (quality of life). As no matched controls were available for DUX-25 scores 
in 4–7 year-olds, these data were analyzed separately. 
Behavior: Strengths and Difficulties Questionnaire (SDQ). 
 
Statistical analysis 
Continuous variables are presented as median (IQR), and categorical variables as 
number (%). Baseline characteristics of responders and non-responders were compared 
using Mann-Whitney tests (continuous variables), and chi-square or Fisher’s exact tests 
(categorical variables). One-sample Wilcoxon signed-rank tests served to compare 
median scores of participants with those reported in the reference population; Mann-
Whitney U tests and chi-square or Fisher’s exact tests served to compare PedsPCF, 
PedsQL, DUX-25, and SDQ scores between participants and their matched controls. 
 
To find possible predictors of cognition and behavior at school age, we used univariable 
linear regression analyses. These included parent-perceived child vulnerability, infant 
clinical data, sociodemographic characteristics, and neurodevelopmental outcomes at 2 
years of age. Results were considered significant at p<0.05. 
 
Results 
Of 77 eligible participants, 31 (40%) caregivers returned the questionnaires (figure 1). 
Children of responders had a significantly higher SES score, were less often born SGA, 
and had shorter LOS than children of non-responders (table 1). 
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Table 1 Infant clinical data and sociodemographic data of responders (n=31) and 
non-responders (n=46) 
 n Responders 
n=31; 40% 
n Non-
responders 
n=46; 60% 
p 
value 
Age at current study (years) 31 9 (6-13) 46 9 (6-11) 0.38 
Infant clinical data      
Prenatal diagnosis 31 27 (87%) 46 44 (96%) 0.21 
Intoxications during pregnancy 24  43   
- Alcohol   -  - n/a 
- Smoking   11 (46%)  17 (40%) 0.62 
- Recreational drugs   3 (13%)  2 (5%) 0.34 
Male sex 31 17 (55%) 46 17 (37%) 0.12 
Gestational age at birth 
(weeks) 
31 37.0 (36.0-
37.4) 
46 36.4 (34.5-
37.5) 
0.39 
Preterm birth 31 14 (45%) 46 27 (59%) 0.24 
Birth weight (grams) 31 2500 (2200-
2910) 
46 2310 (2026-
2663) 
0.09 
Small for gestational age 31 2 (6%) 45 12 (27%) 0.03 
Complex gastroschisis 31 3 (10%) 46 8 (17%) 0.51 
Primary closure 31 23 (74%) 46 31 (67%) 0.52 
Multiple congenital anomalies A 31 4 (13%) 46 1 (2%) 0.15 
Number of procedures under 
general anesthesia 
31 2 (1-3) 46 2 (1-3) 0.24 
Duration of initial mechanical 
ventilation (days) 
29 2 (1-6) 46 2 (1-9) 0.49 
Sepsis 31 10 (32%) 46 28 (61%) 0.02 
Length of hospital stay (days) 31 35 (22-45) 46 50 (30-88) 0.02 
Time to full enteral feeding 
(days) 
31 25 (17-40) 45 36 (21-75) 0.06 
Intestinal failure 31 7 (23%) 45 19 (42%) 0.08 
- Time to full enteral feeding 
(days) 
7 61 (48-67) 19 92 (64-159) 0.14 
Sociodemographic data      
Maternal age at conception 
(years) 
26 26.6 (20.6-
30.9) 
44 22.2 (19.7-
27.4) 
0.10 
Socioeconomic status score 31 0.00 (-0.60 to 
0.43) 
46 -0.41 (-1.86 to 
0.33) 
0.04 
- Low status score (< -1) 31 5 (16%) 46 21 (46%) 0.01 
  
 
Table 1 (continued)      
 n Responders 
n=31; 40% 
n Non-
responders 
n=46; 60% 
p 
value 
Maternal education level 30   n/a  
- Low (ISCED 0-2)  7 (23%)    
- Middle (ISCED 3-4)  15 (50%)    
- High (ISCED 5-8)  8 (27%)    
Paternal education level 24   n/a  
- Low (ISCED 0-2)  8 (33%)    
- Middle (ISCED 3-4)  12 (50%)    
- High (ISCED 5-8)  4 (17%)    
Two caregivers at home 31 23 (74%)  n/a  
Primary language at home: 
Dutch 
31 31 (100%)  n/a  
Neurodevelopmental data at 2 years    
Mental developmental index B  25 101 (94-108) 28 101 (90-112) 0.90 
- Delayed (<85) 25 4 (16%) 28 4 (14%) 1.00 
Psychomotor developmental 
index C 
20 91 (87-97) 27 94 (89-102) 0.37 
- Delayed (<85) 20 4 (20%) 27 6 (22%) 1.00 
Data are presented as median (IQR) or n (%). ISCED International Standard Classification 
of Education. A Responders: polydactyly (n = 2), cryptorchidism (n = 1), hypospadias (n = 1); 
non-responders: urethral valves (n = 1). B Missing data responders: organizational (n = 4), 
non-cooperative child (n = 1), parental refusal (n = 1); missing data non-responders: 
organizational (n = 4), non-cooperative child (n = 1), parental refusal (n = 12), migration 
(n = 1). C Missing data responders: organizational (n = 6), non-cooperative child (n = 4), 
parental refusal (n = 1); missing data non-responders: organizational (n = 5), non-
cooperative child (n = 1), parental refusal (n = 12), migration (n = 1). 
 
Background 
Participating children had a median age of 9 years (IQR 6–13; range 4–16). Twenty-eight 
(90%) were raised by at least one biological parent, and three (10%) lived in a foster 
family. Twenty-three (74%) children had two caregivers at home. The questionnaires 
were answered by either the child’s mother (n = 22), both parents (n = 6), or a foster 
parent (n = 3). Seven (23%) of 30 children required medication; one parent did not 
answer this question. Medication was prescribed for gastro-intestinal problems (n = 5), 
attention deficit hyperactivity disorder (ADHD; n = 1), or ADHD with an anxiety 
disorder (n = 1). Eleven (35%) parents reported that their child had behavioral or 
emotional problems, such as ADHD, autism, anxiety, or aggression. Five (16%) children 
attended special education; all five were reported to have behavioral or emotional 
problems. 
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parental refusal (n = 1); missing data non-responders: organizational (n = 5), non-
cooperative child (n = 1), parental refusal (n = 12), migration (n = 1). 
 
Background 
Participating children had a median age of 9 years (IQR 6–13; range 4–16). Twenty-eight 
(90%) were raised by at least one biological parent, and three (10%) lived in a foster 
family. Twenty-three (74%) children had two caregivers at home. The questionnaires 
were answered by either the child’s mother (n = 22), both parents (n = 6), or a foster 
parent (n = 3). Seven (23%) of 30 children required medication; one parent did not 
answer this question. Medication was prescribed for gastro-intestinal problems (n = 5), 
attention deficit hyperactivity disorder (ADHD; n = 1), or ADHD with an anxiety 
disorder (n = 1). Eleven (35%) parents reported that their child had behavioral or 
emotional problems, such as ADHD, autism, anxiety, or aggression. Five (16%) children 
attended special education; all five were reported to have behavioral or emotional 
problems. 
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Child vulnerability 
The CVS score of children with gastroschisis (median 2 (IQR 0–5)) was significantly 
higher than that of the reference population (i.e. median CVS: 1,26 p=0.004). Three (9%) 
children were perceived as being highly vulnerable; all had simple gastroschisis without 
MCA. 
 
Motor function 
MABC-2 Checklist scores were available for all 31 children (figure 1). Twenty-three 
(74%) scored within the normal range, four (13%) had borderline scores, and four (13%) 
were highly likely to have motor problems. One of these latter eight children had 
complex gastroschisis, none had MCA. Ball skills were particularly problematic. 
 
Cognition 
PedsPCF scores were analyzed in all 23 children aged 7 years or older. Their PedsPCF 
score (median 109 (IQR 87–127)) was significantly lower than that of matched controls 
(124 (113–140), p=0.04; table 2). The proportion of children scoring ≤ − 1 SD was 
significantly higher in the gastroschisis group (10/23, 43%) than in matched controls 
(5/46, 11%, p=0.002). Of the three children with complex gastroschisis, two scored 
≤− 1 SD. 
 
Table 2 Cognition, health status, quality of life and behavior of children with 
gastroschisis compared with control groups 
 Gastroschisis A; 
n=23 
Matched control 
group; n=46 
p 
value 
Cognition (PedsPCF)    
Total score 109 (87-127) 124 (113-140) 0.04 
 Gastroschisis A; 
n=30 
Matched control 
group; n=60 
p 
value 
Health status (PedsQL)    
Total score 86 (72-90) 84 (74-93) 0.82 
- Physical functioning 92 (84-100) 91 (81-99) 0.42 
- Emotional functioning 80 (64-86) 75 (61-89) 0.93 
- Social functioning 85 (74-100) 90 (75-100) 0.50 
- School functioning  78 (59-90) 80 (70-99) 0.04 
Quality of life (DUX-25)    
Total score (4-7 year old); n=12 85 (76-97) n/a n/a 
- Physical functioning 88 (72-99)   
- Emotional functioning 88 (76-100)   
- Social functioning 80 (71-96)   
- Home functioning 90 (76-100)   
    
    
 
Table 2 (continued)    
 Gastroschisis A; 
n=30 
Matched control 
group; n=60 
p 
value 
Total score (8-17 year old); n=18 74 (64-95) 85 (75-93) 0.12 
- Physical functioning 67 (58-94) 88 (75-96) 0.03 
- Emotional functioning 73 (56-88) 82 (71-93) 0.19 
- Social functioning 79 (67-90) 84 (69-93) 0.36 
- Home functioning 78 (64-100) 93 (80-100) 0.04 
 Gastroschisis A; 
n=31 
Matched control 
group; n=62 
p 
value 
Behavior (SDQ)    
Total difficulties score 10 (4-14) 6 (3-10) 0.15 
- Emotional problems 2 (0-3) 1 (0-3) 0.39 
- Conduct problems 2 (0-3) 1 (0-2) 0.31 
- Hyperactivity-inattention 4 (1-6) 3 (1-6) 0.42 
- Peer problems 1 (0-2) 1 (0-1) 0.07 
- Prosocial behavior 9 (7-10) 9 (8-10) 0.71 
Data presented as median (IQR). P-values were derived from Mann-Whitney U tests. A For 
one child, maternal education level was unknown. This child was matched to a control with 
middle maternal education level. PedsPCF: Pediatric Perceived Cognitive Function 
questionnaire; PedsQL: Pediatric Quality of Life Inventory; SDQ: Strengths and Difficulties 
Questionnaire. 
 
Health status 
PedsQL scores were available for 30 children. Their total score (median 86 (IQR 72–
90)) was similar to that of matched controls (84 (74–93), p=0.82), as well as subscale 
scores for physical, emotional, and social functioning (table 2). The subscale score for 
school functioning was significantly lower in children with gastroschisis (median 78 (59–
90) versus 80 (70–99), p=0.04; table 2). 
 
Quality of life 
DUX-25 total scores were available for 30 children, of whom 18 were 8–17 years old. 
In this latter group, the difference in median DUX-25 total score between children with 
gastroschisis (74 (IQR 64–95)) and matched controls (85 (75–93)) did not reach 
statistical significance (p=0.12; table 2). Children with gastroschisis had significantly 
lower subscale scores for physical functioning (67 (58–94)) and home functioning (78 
(64–100)) than their matched controls (88 (75–96), p=0.03, and 93 (80–100), p=0.04, 
respectively). In the 4- to 7-year-olds, the median DUX-25 total score was 85 (76–97). 
 
Behavior 
SDQ scores were analyzed in all 31 children. Their total difficulties score (median 10 
(IQR 4–14)) did not significantly differ from that of matched controls (6 (3–10), p=0.15; 
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The CVS score of children with gastroschisis (median 2 (IQR 0–5)) was significantly 
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children were perceived as being highly vulnerable; all had simple gastroschisis without 
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Motor function 
MABC-2 Checklist scores were available for all 31 children (figure 1). Twenty-three 
(74%) scored within the normal range, four (13%) had borderline scores, and four (13%) 
were highly likely to have motor problems. One of these latter eight children had 
complex gastroschisis, none had MCA. Ball skills were particularly problematic. 
 
Cognition 
PedsPCF scores were analyzed in all 23 children aged 7 years or older. Their PedsPCF 
score (median 109 (IQR 87–127)) was significantly lower than that of matched controls 
(124 (113–140), p=0.04; table 2). The proportion of children scoring ≤ − 1 SD was 
significantly higher in the gastroschisis group (10/23, 43%) than in matched controls 
(5/46, 11%, p=0.002). Of the three children with complex gastroschisis, two scored 
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Total score 86 (72-90) 84 (74-93) 0.82 
- Physical functioning 92 (84-100) 91 (81-99) 0.42 
- Emotional functioning 80 (64-86) 75 (61-89) 0.93 
- Social functioning 85 (74-100) 90 (75-100) 0.50 
- School functioning  78 (59-90) 80 (70-99) 0.04 
Quality of life (DUX-25)    
Total score (4-7 year old); n=12 85 (76-97) n/a n/a 
- Physical functioning 88 (72-99)   
- Emotional functioning 88 (76-100)   
- Social functioning 80 (71-96)   
- Home functioning 90 (76-100)   
    
    
 
Table 2 (continued)    
 Gastroschisis A; 
n=30 
Matched control 
group; n=60 
p 
value 
Total score (8-17 year old); n=18 74 (64-95) 85 (75-93) 0.12 
- Physical functioning 67 (58-94) 88 (75-96) 0.03 
- Emotional functioning 73 (56-88) 82 (71-93) 0.19 
- Social functioning 79 (67-90) 84 (69-93) 0.36 
- Home functioning 78 (64-100) 93 (80-100) 0.04 
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Matched control 
group; n=62 
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value 
Behavior (SDQ)    
Total difficulties score 10 (4-14) 6 (3-10) 0.15 
- Emotional problems 2 (0-3) 1 (0-3) 0.39 
- Conduct problems 2 (0-3) 1 (0-2) 0.31 
- Hyperactivity-inattention 4 (1-6) 3 (1-6) 0.42 
- Peer problems 1 (0-2) 1 (0-1) 0.07 
- Prosocial behavior 9 (7-10) 9 (8-10) 0.71 
Data presented as median (IQR). P-values were derived from Mann-Whitney U tests. A For 
one child, maternal education level was unknown. This child was matched to a control with 
middle maternal education level. PedsPCF: Pediatric Perceived Cognitive Function 
questionnaire; PedsQL: Pediatric Quality of Life Inventory; SDQ: Strengths and Difficulties 
Questionnaire. 
 
Health status 
PedsQL scores were available for 30 children. Their total score (median 86 (IQR 72–
90)) was similar to that of matched controls (84 (74–93), p=0.82), as well as subscale 
scores for physical, emotional, and social functioning (table 2). The subscale score for 
school functioning was significantly lower in children with gastroschisis (median 78 (59–
90) versus 80 (70–99), p=0.04; table 2). 
 
Quality of life 
DUX-25 total scores were available for 30 children, of whom 18 were 8–17 years old. 
In this latter group, the difference in median DUX-25 total score between children with 
gastroschisis (74 (IQR 64–95)) and matched controls (85 (75–93)) did not reach 
statistical significance (p=0.12; table 2). Children with gastroschisis had significantly 
lower subscale scores for physical functioning (67 (58–94)) and home functioning (78 
(64–100)) than their matched controls (88 (75–96), p=0.03, and 93 (80–100), p=0.04, 
respectively). In the 4- to 7-year-olds, the median DUX-25 total score was 85 (76–97). 
 
Behavior 
SDQ scores were analyzed in all 31 children. Their total difficulties score (median 10 
(IQR 4–14)) did not significantly differ from that of matched controls (6 (3–10), p=0.15; 
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table 2), and neither did the subscale scores. The total difficulty score was abnormally 
high in four (13%) children with gastroschisis, compared with seven (11%) matched 
controls (p=1.00). 
 
Predictors of cognition and behavior 
For cognition, univariable regression analysis revealed that both neonatal intestinal 
failure and increased parent-perceived child vulnerability were significantly associated 
with a lower PedsPCF total score (neonatal intestinal failure β −25.66 (−49.41 to −1.91); 
CVS score β −2.76 (95% CI −5.27 to −0.25); supplemental table 1). 
 
For behavior, both older age and SGA were significantly associated with a lower SDS 
of the SDQ total difficulties score (older age, in years −0.13 (−0.24 to −0.02); SGA 
−2.18 (−3.79 to −0.57); supplemental table 2). 
 
Discussion 
We analyzed parent-reported daily functioning and developmental outcome of children 
with gastroschisis at school age. Scores on motor function, health status, overall quality 
of life, and behavior were comparable with those of healthy children. Cognitive 
problems were reported more frequently in children with gastroschisis, especially in 
those with neonatal intestinal failure or higher parent-perceived vulnerability. 
 
Previous similar studies have shown contradicting results. Some have reported normal 
intelligence, motor function, or behavior, whereas others reported intellectual delay, 
problems regarding motor skills, or behavioral problems (supplemental table 3). 
 
The studies that reported normal motor function either included children with 
omphalocele in their analyses15 or used a non-standardized questionnaire,16 which 
complicates comparison of results. A previous study in 16 children with gastroschisis 
showed normal motor function in only 7 on evaluation with the MABC-2 Test.17 The 
difference with our finding of normal scores in 74% may be ascribed to the lower 
proportion of children born SGA in our study (6% vs. 44%), or to parents 
overestimating their child’s motor function, or it might imply that the MABC-2 Checklist 
is less sensitive in diagnosing motor function delay than the MABC-2 Test itself. Our 
conclusion of normal motor function in children with gastroschisis should, therefore, 
be regarded with caution. 
 
Children with gastroschisis appeared to be at risk for cognitive problems; PedsPCF 
scores were lower than those of matched controls, and 16% attended special education, 
which proportion is higher than in the Dutch reference population (i.e. approximately 
5%).27 A previous Dutch study in 16 children with gastroschisis found a lower total IQ 
 
at school age, and three (19%) attended special education.17 Two other studies, 
however, reported normal total IQ in 20 children with gastroschisis at 5 years of age18 
and in 39 children at school age.14 Remarkably, both studies reported significant 
problems in working memory.14, 18 Neonatal critical illness may well have contributed 
to cognitive problems; exposure to anesthetics, possible hypoxia, inflammation, and 
stress in early life increase the risk of hippocampal alterations, which may eventually 
lead to learning problems.11 
 
Lower PedsPCF scores were associated with increased parent-perceived child 
vulnerability, which could have several causes. First, parents who perceive their child as 
highly vulnerable may report more problems, despite normal outcomes at medical 
evaluation. Early parental counseling and support may positively affect the child’s 
outcomes as perceived by parents. Second, medical or sociodemographic factors such 
as intestinal failure or SES could act as confounders, by influencing both child 
vulnerability and cognitive functioning. Children with intestinal failure scored 
approximately 26 points (≈1 SD) less on the PedsPCF total score than those without 
intestinal failure. As the prevalence of intestinal failure in the non-responder group was 
almost twice that in the responder group, we may have underestimated the prevalence 
of cognitive problems. 
 
In comparison with our study, previous literature showed overall health status in line 
with normative expectations.5, 28, 29, 30 Our study showed that children with gastroschisis 
had slightly lower scores on the school functioning subscale of the PedsQL than their 
matched controls. As median scores differed with only 2 points on a scale of 0–100, we 
expect this difference not to be clinically relevant. 
 
Although overall quality of life was reported as normal, the DUX-25 subscale scores of 
physical functioning and home functioning were significantly lower in the gastroschisis 
group. Negative feelings about physical appearance might be caused by poor physical 
growth, or by the scar. Home functioning might be impaired by factors associated with 
the risk of gastroschisis itself, such as teenage pregnancy or maternal mental disorders.31 
However, we acknowledge that these hypotheses are speculative. 
 
Of all children eligible for our study, 18% had been born SGA versus only 6% in the 
group of parents who returned the questionnaires. Although we should note the very 
small sample size, being born SGA was significantly associated with behavioral problems. 
Consequently, the prevalence of behavioral problems in the total gastroschisis 
population may well be higher. In a previous study including 20 children with 
gastroschisis, of whom 40% were born SGA, one-third of parents reported behavioral 
executive problems at 5 years of age.18 This might still be an underestimation, as we 
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table 2), and neither did the subscale scores. The total difficulty score was abnormally 
high in four (13%) children with gastroschisis, compared with seven (11%) matched 
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failure and increased parent-perceived child vulnerability were significantly associated 
with a lower PedsPCF total score (neonatal intestinal failure β −25.66 (−49.41 to −1.91); 
CVS score β −2.76 (95% CI −5.27 to −0.25); supplemental table 1). 
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of the SDQ total difficulties score (older age, in years −0.13 (−0.24 to −0.02); SGA 
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The studies that reported normal motor function either included children with 
omphalocele in their analyses15 or used a non-standardized questionnaire,16 which 
complicates comparison of results. A previous study in 16 children with gastroschisis 
showed normal motor function in only 7 on evaluation with the MABC-2 Test.17 The 
difference with our finding of normal scores in 74% may be ascribed to the lower 
proportion of children born SGA in our study (6% vs. 44%), or to parents 
overestimating their child’s motor function, or it might imply that the MABC-2 Checklist 
is less sensitive in diagnosing motor function delay than the MABC-2 Test itself. Our 
conclusion of normal motor function in children with gastroschisis should, therefore, 
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scores were lower than those of matched controls, and 16% attended special education, 
which proportion is higher than in the Dutch reference population (i.e. approximately 
5%).27 A previous Dutch study in 16 children with gastroschisis found a lower total IQ 
 
at school age, and three (19%) attended special education.17 Two other studies, 
however, reported normal total IQ in 20 children with gastroschisis at 5 years of age18 
and in 39 children at school age.14 Remarkably, both studies reported significant 
problems in working memory.14, 18 Neonatal critical illness may well have contributed 
to cognitive problems; exposure to anesthetics, possible hypoxia, inflammation, and 
stress in early life increase the risk of hippocampal alterations, which may eventually 
lead to learning problems.11 
 
Lower PedsPCF scores were associated with increased parent-perceived child 
vulnerability, which could have several causes. First, parents who perceive their child as 
highly vulnerable may report more problems, despite normal outcomes at medical 
evaluation. Early parental counseling and support may positively affect the child’s 
outcomes as perceived by parents. Second, medical or sociodemographic factors such 
as intestinal failure or SES could act as confounders, by influencing both child 
vulnerability and cognitive functioning. Children with intestinal failure scored 
approximately 26 points (≈1 SD) less on the PedsPCF total score than those without 
intestinal failure. As the prevalence of intestinal failure in the non-responder group was 
almost twice that in the responder group, we may have underestimated the prevalence 
of cognitive problems. 
 
In comparison with our study, previous literature showed overall health status in line 
with normative expectations.5, 28, 29, 30 Our study showed that children with gastroschisis 
had slightly lower scores on the school functioning subscale of the PedsQL than their 
matched controls. As median scores differed with only 2 points on a scale of 0–100, we 
expect this difference not to be clinically relevant. 
 
Although overall quality of life was reported as normal, the DUX-25 subscale scores of 
physical functioning and home functioning were significantly lower in the gastroschisis 
group. Negative feelings about physical appearance might be caused by poor physical 
growth, or by the scar. Home functioning might be impaired by factors associated with 
the risk of gastroschisis itself, such as teenage pregnancy or maternal mental disorders.31 
However, we acknowledge that these hypotheses are speculative. 
 
Of all children eligible for our study, 18% had been born SGA versus only 6% in the 
group of parents who returned the questionnaires. Although we should note the very 
small sample size, being born SGA was significantly associated with behavioral problems. 
Consequently, the prevalence of behavioral problems in the total gastroschisis 
population may well be higher. In a previous study including 20 children with 
gastroschisis, of whom 40% were born SGA, one-third of parents reported behavioral 
executive problems at 5 years of age.18 This might still be an underestimation, as we 
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found that older age was significantly associated with behavioral problems, despite the 
fact that SDS had already been corrected for age. 
 
Strengths of our study include the assessment of outcomes in children beyond the age 
of 5 years rather than at pre-school age, the comparison of outcomes with those of 
matched controls, and the availability of neurodevelopmental data at 2 years of age. We 
used parent-reported outcome measures; since parents are largely responsible for 
seeking help for their children, we expect our results to be a relevant representation 
of the need for care in this group. Several limitations need to be addressed. First, while 
45% of children with gastroschisis in our cohort were born preterm, we were unable 
to match controls on GA at birth. A second limitation is the low response rate of 40% 
and the positive selection bias. Low response rates are a common problem 
(supplemental table 3). As children in the responder group had higher SES, and had 
experienced less morbidity than non-responders, we may have underestimated the 
frequency and severity of problems regarding daily functioning. To improve response 
rates, future studies may limit the number and the length of questionnaires. Based on 
our outcomes, we would suggest to focus on cognitive functioning and on parent-
perceived vulnerability. Additionally, home visits and computerized adaptive testing may 
help to encourage participation in follow-up studies. 
 
In conclusion, parent-reported outcomes of children with gastroschisis at school age 
were mainly reassuring. Clinicians and parents should be aware of the higher risk of 
cognitive problems, especially in those with neonatal intestinal failure or increased 
parent-perceived vulnerability. We recommend multidisciplinary follow-up at school 
age of children with neonatal intestinal failure. Early parental counseling and support 
may positively affect the child’s outcomes as perceived by parents. 
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found that older age was significantly associated with behavioral problems, despite the 
fact that SDS had already been corrected for age. 
 
Strengths of our study include the assessment of outcomes in children beyond the age 
of 5 years rather than at pre-school age, the comparison of outcomes with those of 
matched controls, and the availability of neurodevelopmental data at 2 years of age. We 
used parent-reported outcome measures; since parents are largely responsible for 
seeking help for their children, we expect our results to be a relevant representation 
of the need for care in this group. Several limitations need to be addressed. First, while 
45% of children with gastroschisis in our cohort were born preterm, we were unable 
to match controls on GA at birth. A second limitation is the low response rate of 40% 
and the positive selection bias. Low response rates are a common problem 
(supplemental table 3). As children in the responder group had higher SES, and had 
experienced less morbidity than non-responders, we may have underestimated the 
frequency and severity of problems regarding daily functioning. To improve response 
rates, future studies may limit the number and the length of questionnaires. Based on 
our outcomes, we would suggest to focus on cognitive functioning and on parent-
perceived vulnerability. Additionally, home visits and computerized adaptive testing may 
help to encourage participation in follow-up studies. 
 
In conclusion, parent-reported outcomes of children with gastroschisis at school age 
were mainly reassuring. Clinicians and parents should be aware of the higher risk of 
cognitive problems, especially in those with neonatal intestinal failure or increased 
parent-perceived vulnerability. We recommend multidisciplinary follow-up at school 
age of children with neonatal intestinal failure. Early parental counseling and support 
may positively affect the child’s outcomes as perceived by parents. 
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Supplemental material 
 
Supplemental file 1 Description of questionnaires 
 
We used Dutch versions of all questionnaires. All questionnaires were parent-reported. 
If two answers were selected for one question, we documented the most unfavorable 
score. 
 
Background 
Description: We asked caregivers to report the following background information: child's 
living situation (e.g. with biological parents or in a foster family, presence of two 
caregivers, number of children), maternal and paternal education levels (based on the 
International Standard Classification of Education 2011),1 medical (use of medication, 
hospital admissions, use of medical aids such as a wheelchair or parenteral nutrition), 
educational  (e.g. regular or special, grade repetition, learning difficulties, need of extra 
help at school), social-emotional functioning (presence of behavioral or emotional 
problems), and main language spoken at home.  
 
Child vulnerability 
Child Vulnerability Scale (CVS) 2, 3 
Description: The CVS is an 8-item questionnaire on parental perceptions of their child's 
vulnerability. Each item states a problem, for example 'my child gets more colds than 
other children I know'. Answers vary from strongly disagree (=0) to strongly agree (=3) 
on a 4-point Likert scale. Total scores range from 0-24; higher scores reflect higher 
perceived vulnerability. We used a cut-off of ≥10 for high perception of vulnerability.  
Validated: This questionnaire has been validated for Dutch children aged 5-18 years.2 
 
Motor function 
Movement Assessment Battery for Children - Second Edition (MABC-2) Checklist 4-6 
Description: The M-ABC 2 Checklist is aimed at evaluating motor problems in daily life. 
Section A measures movement in a static (or predictable) environment; section B 
measures movement in a dynamic (or unpredictable) environment. Both sections 
consist of 15 items. Each of the 30 items states a skill, for example 'rides a bicycle 
without stabilizers'. The parent indicates to what extent the child is able to do this, 
varying from very well (=0) to not close (=3). Scores are reported using a Traffic Light 
color system, corrected for age, with high scores representing poor performance. 
'Green zone' indicates a score within the normal range (< 85th centile); 'amber zone' 
means that the child is at risk for motor problems (85th-94th centile), and a score in the 
'red zone' indicates a high possibility of serious motor problems (≥ 95th centile).  
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educational  (e.g. regular or special, grade repetition, learning difficulties, need of extra 
help at school), social-emotional functioning (presence of behavioral or emotional 
problems), and main language spoken at home.  
 
Child vulnerability 
Child Vulnerability Scale (CVS) 2, 3 
Description: The CVS is an 8-item questionnaire on parental perceptions of their child's 
vulnerability. Each item states a problem, for example 'my child gets more colds than 
other children I know'. Answers vary from strongly disagree (=0) to strongly agree (=3) 
on a 4-point Likert scale. Total scores range from 0-24; higher scores reflect higher 
perceived vulnerability. We used a cut-off of ≥10 for high perception of vulnerability.  
Validated: This questionnaire has been validated for Dutch children aged 5-18 years.2 
 
Motor function 
Movement Assessment Battery for Children - Second Edition (MABC-2) Checklist 4-6 
Description: The M-ABC 2 Checklist is aimed at evaluating motor problems in daily life. 
Section A measures movement in a static (or predictable) environment; section B 
measures movement in a dynamic (or unpredictable) environment. Both sections 
consist of 15 items. Each of the 30 items states a skill, for example 'rides a bicycle 
without stabilizers'. The parent indicates to what extent the child is able to do this, 
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'red zone' indicates a high possibility of serious motor problems (≥ 95th centile).  
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Validated: This questionnaire has been validated for Dutch children aged 3-16 years.6 As 
no Dutch reference norms exist for 17-year old children, these children were scored 
according to reference norms for 16-year olds.  
 
Cognition 
Pediatric Perceived Cognitive Function (PedsPCF) questionnaire 7 
Description: The PedsPCF assesses the child's cognitive functioning as perceived by the 
parent, referring to the past four weeks. Each item reflects a problem, for example 
'forgets things easily'. Answers vary from very much/all of the time (=1) to not at 
all/none of the time (=5) on a 5-point Likert scale. Based on preliminary results of the 
collection of Dutch reference data, we used only the first 30 items of the PedsPCF 
rather than the full-length PedsPCF (which counts 43 items), and we used the following 
cut-offs of ≤-1 standard deviation (SD): 102 (7-12 years), 104 (13-18 years). Total scores 
range from 30-150; higher scores reflect better cognitive functioning.  
Validated: This questionnaire has been validated for Dutch children aged 7-18 years.8 
 
Health status 
Pediatric Quality of Life Inventory (PedsQL) 9 
Description: The PedsQL is an instrument for measuring health status in children and 
adolescents. It consists of four subscales: physical (8 items), emotional (5 items), social 
(5 items) and school functioning (5 items). Each item reflects a problem, for example 
'problems with running'. Answers vary from never (=0) to almost always (=4) on a 5-
point Likert scale. Each answer is reversed scored and rescaled to a 0-100 scale (0=100, 
4=0). Total scores range from 0-100; higher scores reflect better quality of life. We 
used the version that referred to the past month.  
Validated: This questionnaire has been validated for Dutch children aged 5-18 years.10 
 
Quality of life 
DUX-25 
Description: The DUX-25 is a visual health-related quality of life questionnaire. Each 
question evaluates the child's feelings in daily life, for example 'your child often feels …'. 
It consists of four subscales: physical (6 items), emotional (7 items), social (7 items) and 
home functioning (5 items). Answers are scored on a happy-to-sad faces scale by use 
of smileys. These smileys visualize a 5-point Likert scale, ranging from sad (=0) to happy 
(=100). Total scores range from 0-100; higher scores reflect better quality of life.  
Validated: Dutch reference data are currently being analyzed (age 8-17 years).  
 
  
 
Behavior 
Strengths and Difficulties Questionnaire (SDQ) 11 
Description: The SDQ covers the most important domains of child psychopathology and 
personal strengths. It consists of five subscales: emotional symptoms, conduct problems, 
hyperactivity-inattention, peer problems, and prosocial behavior. Each item is scored 
on a 3-point Likert scale; answer vary from not true (=0) to certainly true (=2). Higher 
scores reflect more difficulties, except for the prosocial scale where higher scores 
reflect strengths. All but the prosocial behavior subscale scores are summed to generate 
a total difficulties score. Total scores range from 0-40. The total difficulties score was 
categorized into 'normal' or 'abnormal' using age-dependent cut-off values.11 
Validated: This questionnaire has been validated for Dutch children aged 2-18 years.11 In 
children aged <6 years, no SD scores or cut-off values were available for 'conduct 
problems' and 'peer problems' due to insufficient internal consistency of these subscales 
in this age group. 
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Validated: This questionnaire has been validated for Dutch children aged 3-16 years.6 As 
no Dutch reference norms exist for 17-year old children, these children were scored 
according to reference norms for 16-year olds.  
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'forgets things easily'. Answers vary from very much/all of the time (=1) to not at 
all/none of the time (=5) on a 5-point Likert scale. Based on preliminary results of the 
collection of Dutch reference data, we used only the first 30 items of the PedsPCF 
rather than the full-length PedsPCF (which counts 43 items), and we used the following 
cut-offs of ≤-1 standard deviation (SD): 102 (7-12 years), 104 (13-18 years). Total scores 
range from 30-150; higher scores reflect better cognitive functioning.  
Validated: This questionnaire has been validated for Dutch children aged 7-18 years.8 
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4=0). Total scores range from 0-100; higher scores reflect better quality of life. We 
used the version that referred to the past month.  
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Description: The DUX-25 is a visual health-related quality of life questionnaire. Each 
question evaluates the child's feelings in daily life, for example 'your child often feels …'. 
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home functioning (5 items). Answers are scored on a happy-to-sad faces scale by use 
of smileys. These smileys visualize a 5-point Likert scale, ranging from sad (=0) to happy 
(=100). Total scores range from 0-100; higher scores reflect better quality of life.  
Validated: Dutch reference data are currently being analyzed (age 8-17 years).  
 
  
 
Behavior 
Strengths and Difficulties Questionnaire (SDQ) 11 
Description: The SDQ covers the most important domains of child psychopathology and 
personal strengths. It consists of five subscales: emotional symptoms, conduct problems, 
hyperactivity-inattention, peer problems, and prosocial behavior. Each item is scored 
on a 3-point Likert scale; answer vary from not true (=0) to certainly true (=2). Higher 
scores reflect more difficulties, except for the prosocial scale where higher scores 
reflect strengths. All but the prosocial behavior subscale scores are summed to generate 
a total difficulties score. Total scores range from 0-40. The total difficulties score was 
categorized into 'normal' or 'abnormal' using age-dependent cut-off values.11 
Validated: This questionnaire has been validated for Dutch children aged 2-18 years.11 In 
children aged <6 years, no SD scores or cut-off values were available for 'conduct 
problems' and 'peer problems' due to insufficient internal consistency of these subscales 
in this age group. 
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Supplemental file 2 Description of matched controls 
 
We obtained matched controls from three different datasets, as described below. 
Controls were matched for age (maximum difference of one year), gender, and 
maternal education level (low, middle, or high; based on the International Standard 
Classification of Education 20111). Controls were selected randomly using an online 
randomizer. If the maternal education level of a case was unknown, this case was 
matched with two controls with middle maternal education level.  
 
Cognition  
Pediatric Perceived Cognitive Function (PedsPCF) questionnaire 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsPCF.2 A general population sample of parents and their children had been 
approached through research agency Kantar TNS in January 2016. This study included 
children with a chronic health condition, such as asthma or diabetes mellitus. This study 
used online questionnaires. We used the parent-reported data. 
 
Health status and quality of life  
Pediatric Quality of Life Inventory (PedsQL) and DUX-25 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsQL (4-17 years) and the DUX-25 (8-17 years) (publications in preparation). 
Children with a chronic health condition had been excluded from this study; those with 
attention deficit hyperactivity disorder had been included. Online questionnaires had 
been sent to caregivers and their children, who were recruited via primary and 
secondary schools in the Netherlands from April 2015 till March 2016. We used the 
parent-reported data.  
 
Behavior  
Strengths and Difficulties Questionnaire (SDQ) 
Matched controls were obtained from the database of Maurice-Stam and coworkers.3 
A general population sample of parents had been approached through research agency 
Kantar TNS in November and December 2014. 
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Supplemental file 2 Description of matched controls 
 
We obtained matched controls from three different datasets, as described below. 
Controls were matched for age (maximum difference of one year), gender, and 
maternal education level (low, middle, or high; based on the International Standard 
Classification of Education 20111). Controls were selected randomly using an online 
randomizer. If the maternal education level of a case was unknown, this case was 
matched with two controls with middle maternal education level.  
 
Cognition  
Pediatric Perceived Cognitive Function (PedsPCF) questionnaire 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsPCF.2 A general population sample of parents and their children had been 
approached through research agency Kantar TNS in January 2016. This study included 
children with a chronic health condition, such as asthma or diabetes mellitus. This study 
used online questionnaires. We used the parent-reported data. 
 
Health status and quality of life  
Pediatric Quality of Life Inventory (PedsQL) and DUX-25 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsQL (4-17 years) and the DUX-25 (8-17 years) (publications in preparation). 
Children with a chronic health condition had been excluded from this study; those with 
attention deficit hyperactivity disorder had been included. Online questionnaires had 
been sent to caregivers and their children, who were recruited via primary and 
secondary schools in the Netherlands from April 2015 till March 2016. We used the 
parent-reported data.  
 
Behavior  
Strengths and Difficulties Questionnaire (SDQ) 
Matched controls were obtained from the database of Maurice-Stam and coworkers.3 
A general population sample of parents had been approached through research agency 
Kantar TNS in November and December 2014. 
 
References
1 International Standard Classification of 
Education ISCED 2011. Montreal, 
Canada: UNESCO Institute for 
Statistics; 2012. 
2 Marchal JP, de Vries M, Conijn J, et al. 
Pediatric Perceived Cognitive 
Functioning: Psychometric Properties 
and Normative Data of the Dutch Item 
Bank and Short Form. J Int Neuropsychol 
Soc. 2019:1-12. 
3 Maurice-Stam H, Haverman L, Splinter 
A, et al. Dutch norms for the Strengths 
and Difficulties Questionnaire (SDQ) - 
parent form for children aged 2-18 
years. Health Qual Life Outcomes. 
2018;16(1):123.
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Abstract 
 
Objective 
To determine the predictive value of the fetal omphalocele circumference/abdominal 
circumference (OC/AC)-ratio for type of surgical closure and survival, and to describe 
the trajectory of OC/AC-ratio throughout gestation. 
 
Methods 
This cohort study included all live-born infants prenatally diagnosed with an 
omphalocele in our tertiary center (2000-2017) with an intention to treat. The OC/AC-
ratio and liver position were determined using 2D-ultrasound at three periods during 
gestation (11-16, 17-26 and/or 30-38 weeks). Primary outcome was type of closure; 
secondary outcome was survival. In the secondary analyses the predictive value of the 
OC/AC-ratio trend for type of closure and survival was assessed. 
 
Results 
Primary closure was performed in 37/63 (59%) infants and 54/63 (86%) survived. The 
OC/AC-ratio was predictive for type of closure and survival in all periods. Optimal cut-
off values for predicting closure decreased throughout gestation from 0.69 (11-16 
weeks) to 0.63 (30-38 weeks). Repeated OC/AC-ratio measurements were available in 
33 (73%) fetuses. The trend of the OC/AC-ratio throughout gestation was not 
significantly associated with type of closure. All infants without liver herniation 
underwent primary closure. 
 
Conclusion 
Type of omphalocele surgical closure and survival can be predicted prenatally on the 
basis of the OC/AC-ratio and liver herniation, independent of associated anomalies. 
 
Introduction 
An omphalocele is a congenital anomaly characterized by herniation of the abdominal 
viscera through the abdominal wall at the umbilicus covered by a membrane.1 It is 
reported to occur in 1-2 per 10 000 live births.2 Multiple congenital anomalies (MCA) 
are observed in 30-70% of fetuses with an omphalocele, and chromosomal 
abnormalities are present in 10-30%.1, 3, 4 Infants with MCA or chromosomal 
abnormalities carry a significantly higher risk of co-morbidity than those with an isolated 
omphalocele.1, 3-6 In the Netherlands, in up to 74% of cases, depending on the presence 
of associated anomalies and gestational age at diagnosis, the pregnancy is terminated.7 
A small (or minor) omphalocele can be closed primarily, i.e. within 48 hours after birth. 
If the postnatal defect size equals or is larger than 5 cm, with liver (partly) protruding,8 
closure is usually delayed in view of the viscero-abdominal disproportion.9 These infants 
with a ‘giant’ omphalocele are at risk for chronic lung disease (CLD), feeding problems, 
prolonged hospital stay and a lower chance of survival, besides the difficulty of closure 
of the abdominal wall defect.10-13   
Today,  around 90% of omphaloceles and most of the additional anomalies are detected 
by prenatal ultrasound from 11 weeks' gestation onwards.2, 14 Previous studies have 
shown that ultrasound parameters can predict postnatal outcome in fetuses with an 
omphalocele.15-19 More recent studies showed that the ratio between the omphalocele 
circumference (OC) and the abdominal circumference (AC) – the OC/AC-ratio – 
predicts the method of postnatal surgical closure.17, 20 These studies were mostly limited 
to single measurements and infants whose omphalocele was assumed to be isolated at 
prenatal ultrasound. Still, in approximately one third of such cases, additional anomalies 
are detected after birth.4, 21 These additional anomalies may influence postnatal 
outcome, including type of closure.  
The primary aim of this study was to evaluate the predictive value of the OC/AC-ratio 
as either cross-sectional or a repeated measurement in all fetuses with an omphalocele 
(isolated and non-isolated) and a postnatal intention to treat. Secondarily, we examined 
the predictive value of the OC/AC-ratio for survival before and after birth.  
 
Methods 
Study population 
We analyzed prospectively stored data of live-born infants who were prenatally 
diagnosed with an omphalocele in our tertiary referral center from January 2000 up to 
and including December 2017. On a postnatal intention-to-treat basis, those infants 
were included for whom at least one prenatal ultrasound image was available. Fetuses 
with a rare abdominal wall defect (e.g. body stalk anomaly, pentalogy of Cantrell or 
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amniotic band syndrome), and infants lost to follow-up were excluded. Data of 
pregnancies resulting in intra-uterine fetal death (IUFD) or neonatal death (NND; 
defined as death during the first 28 days) were stored in a separate database. Fourteen 
of the included isolated cases have previously been studied to validate the OC/AC-ratio 
measured prior to 24 weeks’ gestation.4, 17  The Medical Ethical Review Board waived 
approval because data obtained during routine care were retrospectively analyzed 
(MEC-2015-308). 
 
Prenatal measurements and parameters 
The OC and AC were measured, if possible, at three time periods during gestation: at 
the beginning of the second trimester (11-16 weeks' gestation; US1), mid second 
trimester (17-26 weeks' gestation; US2) and in the third trimester (30-38 weeks' 
gestation; US3). Based on availability of data, the OC/AC-ratios were calculated 
according to a previously described method.17 We included three examples of third 
trimester measurements of the OC/AC-ratio as supplemental figure 1. All 
measurements were performed in retrospect by two experienced physicians (TECO 
and NCJP), who were unaware of postnatal outcome. We retrieved data on content of 
the omphalocele, presence of fetal growth restriction, polyhydramnios (defined as an 
amniotic fluid index (AFI) of >24 cm), presence of chromosomal abnormalities and 
MCA. Those MCA that required surgery or multiple follow-up visits were regarded as 
major. 
 
Postnatal parameters 
We retrieved data on delivery mode, gestational age (GA) at delivery, birth weight and 
Apgar score at 5 minutes. Preterm birth was defined as delivery prior to 37 weeks' 
gestation. The method of closure was recorded as either primary or delayed. Delayed 
treatment included both initial epithelization and later surgical closure.9, 10 Additional 
data retrieved were the durations of parenteral feeding, length of hospital stay (LOS) 
and supplemental oxygen dependency during the initial hospital stay after birth as well 
as the presence of CLD, defined as oxygen supplementation for at least 28 days.10, 22 A 
giant omphalocele was defined as a postnatal defect size of at least 5 cm, with liver 
(partly) protruding. Survival was defined as survival until at least 1 year of age. Infant 
death is defined as a death >28 days after birth. 
 
Statistical analysis 
Patient characteristics are described as number (%) for categorical data and median 
(interquartile range, IQR) for continuous data. Prenatal and postnatal parameters were 
compared between neonates with primary and delayed closure and between survivors 
and non-survivors using chi-square or Fisher exact tests (nominal or ordinal variables) 
or Mann-Whitney tests (continuous variables). The mean OC/AC-ratios at the three 
 
time periods were compared using a general linear model that accounts for the within-
subject correlations. The association between OC/AC-ratio at these three time periods 
and type of closure, survival or presence of CLD was evaluated using univariable logistic 
regression analysis. The association between OC/AC-ratio at these three time periods 
and LOS was evaluated using Spearman’s rank correlation coefficient. 
 
The intraclass correlation coefficient (ICC) was used to quantify the interobserver 
agreement. TECO and NCJP both measured the OC/AC-ratio in 20 randomly selected 
cases, where they were blinded to each other’s result. For good agreement, the ICC 
has to be 0.75 and for excellent agreement the ICC has to be higher than 0.90. The 
ICC was calculated in a two-way mixed model, with absolute agreement and reported 
as single measures. 
 
To calculate the predictive value of the OC/AC-ratio for type of postnatal closure and 
for survival, a receiver-operating-characteristic (ROC) curve was made for each time 
period separately. Data are presented as area under the curve (AUC) with a 95% 
confidence interval (95% CI). The cut-off with the highest value of the Youden index 
(sensitivity plus specificity minus 1) was regarded as the most suitable.  
 
To examine the trend in the OC/AC-ratio throughout gestation, we performed a linear 
regression of the OC/AC-ratio at the three time periods for each patient separately, 
with GA (coded as a continuous variable) as the only independent variable. To 
summarize the longitudinal data of the OC/AC-ratio we used an estimated level 
(intercept in the linear regression) and time trend (slope in the linear regression). This 
analysis concerned only fetuses for whom 2 or 3 OC/AC-ratios were available. The 
resulting estimates of the intercept and slope in the linear regressions served as 
independent variables in logistic regressions for type of closure. The slope is calculated 
per one day difference in gestation. Logistic regressions were performed to predict type 
of closure and survival rate only in fetuses with liver herniation with the OC/AC-ratio 
as independent variable, for the time periods US2 and US3 separately.  
 
For the purpose of the secondary aim, i.e. to examine the predictive value of the 
OC/AC-ratio for survival before birth, we included data of fetuses with an IUFD or 
NND – referred to as ‘fetuses without intention to treat’. Those who were live-born 
and survived past 1 month (i.e. not an IUFD or NND) are referred to as ‘fetuses with 
an intention to treat’ for this analysis. 
 
All odds ratios are related to the occurrence of either a delayed closure when the 
outcome is type of postnatal surgical closure or mortality when the outcome is survival. 
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All calculations were performed using SPSS version 21.0 for Windows and Windows 
Excel 2010. A two-sided p value of <0.05 was considered statistically significant. 
 
Omphaloceles without a lethal karyotype 
or part of a syndrome
n=147
Ongoing pregnancies 
n=101
Live-born infants in our tertiary center with 
an omphalocele 
n=78
Infants with a postnatal intention to treat 
n=69
TOP 
n=46
IUFD
n=14
NND <28 days and/or 
no intention to treat
n=9
Included cases
n=63
No ultrasound image 
n=6
Prenatally diagnosed omphaloceles 
between 2000 and 2017
n=235
Lethal karyotype 
n=59
Part of a severe syndrome 
i.e. OEIS complex, Pentalogy of 
Cantrell, siamese twin pregnancy, 
amniotic band syndrome
n=29
Omphaloceles without a lethal karyotype
n=176
Delivery elsewere
n=9
Live-born infants with an omphalocele
n=87
 
Figure 1 Inclusion flow chart of fetuses diagnosed prenatally with an omphalocele 
OEIS: omphalocele-exstrophy-imperforate anus-spinal defects; TOP: termination of 
pregnancy; IUFD: intrauterine fetal death; NND: neonatal death 
 
 
Results 
Study population 
Sixty-three live-born infants with an intention to treat were eligible for analyses (figure 
1). Primary closure had been performed in 37 (59%) infants. Fifty-four (86%) infants 
survived. The OC/AC-ratio could be calculated for 22 fetuses at US1, for 50 at US2 and 
for 58 at US3. Two or three OC/AC-ratios were available for 48 (76%) fetuses. The 
required image for measurement of the OC/AC-ratio was not available for 2 fetuses at 
US1 and 2 fetuses at US3. There were no differences between the assessments of liver 
location (extra-abdominal versus intra-abdominal) at the different time periods per 
fetus. Interobserver agreement calculations resulted in an ICC of 0.97 (95% CI: 0.92–
0.99), representing excellent agreement. Patient characteristics are summarized in table 
1.  
 
Table 1 Patient characteristics 
  
Primary closure 
n=37 
Delayed closure 
n=26 
p 
value 
Prenatal parameters       
11-16 weeks’ gestation       
  Gestational age (w+d) 13+1 (12+4 -15+4) 16+1 (13+5-16+6) 0.02 
  OC/AC-ratio (n=22;P=9/D=13) 0.51 (0.44-0.68) 0.94 (0.79-1.00) <0.001 
  Liver herniation (n=21;P=8/D=13) 2 (25%) 13 (100%) 0.001 
18-26 weeks’ gestation       
  Gestational age (w+d) 20+4 (20+0-21+5) 20+5 (19+5-21+2) 0.63 
  OC/AC-ratio (n=50; P=28/D=22) 0.46 (0.30-0.56) 0.84 (0.76-0.92) <0.001 
  Liver herniation (n=51;P=28/D=23) 5 (18%) 23 (100%) <0.001 
30-38 weeks’ gestation       
  Gestational age (w+d) 31+4 (30+4 -32+1) 31+1 (30+1-32+0) 0.58 
  OC/AC-ratio (n=58; P=36/D=22) 0.40 (0.32-0.46) 0.77 (0.72-0.88) <0.001 
  Liver herniation (n=58;P=35/D=23) 5 (14%) 23 (100%) <0.001 
Liver herniation 5 (14%) 26 (100%) <0.001 
Isolated 23 (62%) 23 (89%) 0.02 
Postnatal parameters       
GA at delivery (w+d) 38+1 (36+3-38+6) 38+3 (35+6-38+6) 0.93 
Delivery <32 weeks GA 3 (8%) 3 (12%) 0.65 
Spontaneous vaginal delivery 25 (68%) 15 (58%) 0.42 
Apgar score at 5 minutes 9 (8-10) 8 (6-9) 0.002 
Birth weight (grams) 2960 (2433-3330) 2815 (1994-3378) 0.40 
Gender female 21 (57%) 12 (46%) 0.41 
Isolated 19 (51%) 17 (66%) 0.19 
Giant omphalocele 2 (5%) 24 (92%) <0.001 
Survival (until 1 year of age) 36 (97%) 18 (69%) 0.002 
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All calculations were performed using SPSS version 21.0 for Windows and Windows 
Excel 2010. A two-sided p value of <0.05 was considered statistically significant. 
 
Omphaloceles without a lethal karyotype 
or part of a syndrome
n=147
Ongoing pregnancies 
n=101
Live-born infants in our tertiary center with 
an omphalocele 
n=78
Infants with a postnatal intention to treat 
n=69
TOP 
n=46
IUFD
n=14
NND <28 days and/or 
no intention to treat
n=9
Included cases
n=63
No ultrasound image 
n=6
Prenatally diagnosed omphaloceles 
between 2000 and 2017
n=235
Lethal karyotype 
n=59
Part of a severe syndrome 
i.e. OEIS complex, Pentalogy of 
Cantrell, siamese twin pregnancy, 
amniotic band syndrome
n=29
Omphaloceles without a lethal karyotype
n=176
Delivery elsewere
n=9
Live-born infants with an omphalocele
n=87
 
Figure 1 Inclusion flow chart of fetuses diagnosed prenatally with an omphalocele 
OEIS: omphalocele-exstrophy-imperforate anus-spinal defects; TOP: termination of 
pregnancy; IUFD: intrauterine fetal death; NND: neonatal death 
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required image for measurement of the OC/AC-ratio was not available for 2 fetuses at 
US1 and 2 fetuses at US3. There were no differences between the assessments of liver 
location (extra-abdominal versus intra-abdominal) at the different time periods per 
fetus. Interobserver agreement calculations resulted in an ICC of 0.97 (95% CI: 0.92–
0.99), representing excellent agreement. Patient characteristics are summarized in table 
1.  
 
Table 1 Patient characteristics 
  
Primary closure 
n=37 
Delayed closure 
n=26 
p 
value 
Prenatal parameters       
11-16 weeks’ gestation       
  Gestational age (w+d) 13+1 (12+4 -15+4) 16+1 (13+5-16+6) 0.02 
  OC/AC-ratio (n=22;P=9/D=13) 0.51 (0.44-0.68) 0.94 (0.79-1.00) <0.001 
  Liver herniation (n=21;P=8/D=13) 2 (25%) 13 (100%) 0.001 
18-26 weeks’ gestation       
  Gestational age (w+d) 20+4 (20+0-21+5) 20+5 (19+5-21+2) 0.63 
  OC/AC-ratio (n=50; P=28/D=22) 0.46 (0.30-0.56) 0.84 (0.76-0.92) <0.001 
  Liver herniation (n=51;P=28/D=23) 5 (18%) 23 (100%) <0.001 
30-38 weeks’ gestation       
  Gestational age (w+d) 31+4 (30+4 -32+1) 31+1 (30+1-32+0) 0.58 
  OC/AC-ratio (n=58; P=36/D=22) 0.40 (0.32-0.46) 0.77 (0.72-0.88) <0.001 
  Liver herniation (n=58;P=35/D=23) 5 (14%) 23 (100%) <0.001 
Liver herniation 5 (14%) 26 (100%) <0.001 
Isolated 23 (62%) 23 (89%) 0.02 
Postnatal parameters       
GA at delivery (w+d) 38+1 (36+3-38+6) 38+3 (35+6-38+6) 0.93 
Delivery <32 weeks GA 3 (8%) 3 (12%) 0.65 
Spontaneous vaginal delivery 25 (68%) 15 (58%) 0.42 
Apgar score at 5 minutes 9 (8-10) 8 (6-9) 0.002 
Birth weight (grams) 2960 (2433-3330) 2815 (1994-3378) 0.40 
Gender female 21 (57%) 12 (46%) 0.41 
Isolated 19 (51%) 17 (66%) 0.19 
Giant omphalocele 2 (5%) 24 (92%) <0.001 
Survival (until 1 year of age) 36 (97%) 18 (69%) 0.002 
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Table 1 (continued)    
 
Primary closure 
n=37 
Delayed closure 
n=26 
p 
value 
Chronic lung disease 7 (19%) 15 (58%) 0.002 
Length of initial hospital stay (days) 10 (7-35) 52 (19-107) <0.001 
Data are presented as median (IQR) or number (%). Per ultrasound time period the number 
of cases (n) are described per analysis for the total group and per type of closure, where P 
represents primary closure, and D represents delayed closure. w+d: weeks+days; OC/AC: 
omphalocele circumference / abdominal circumference. 
 
Additional anomalies were diagnosed in 19/63 (30%) of fetuses in the prenatal period. 
In 9/44 (20%) cases where the omphalocele was assumed isolated, additional anomalies 
were detected after birth. In 6 of these cases the anomalies were major (table 2). Eleven 
fetuses were diagnosed with a clinically significant syndrome and/or chromosomal 
abnormality, 9 of them had Beckwith Wiedemann syndrome (BWS). The OC/AC-ratio 
in these fetuses ranged from 0.20 to 0.63 at US2 or US3. In 10 (91%) cases there was 
no herniation of the liver through the defect (p=0.006 compared with fetuses without 
a syndrome or chromosomal abnormality). In the case with liver herniation only a very 
small slip of liver was present in the omphalocele. In all cases with a syndrome or 
chromosomal abnormality a primary closure was performed (p=0.002, compared to 
fetuses without a syndrome or chromosomal abnormality). Three (33%) of the nine 
fetuses with BWS had shown polyhydramnios. 
 
Type of surgical closure 
At all three time periods, the OC/AC-ratio was significantly positively associated with 
the probability of requiring a delayed closure (figure 2, supplemental table 1 for logistic 
regression). Based on ROC curve analysis, type of closure was predicted correctly by 
the OC/AC-ratio with optimal cut-off values of 0.69 at US1 (sensitivity 0.93 and 
specificity 0.90, AUC 0.96 (0.88-1.00), p<0.001), 0.66 at US2 (sensitivity 0.88 and 
specificity 0.93, AUC 0.98 (0.95-1.00), p<0.001), and 0.63 at US3 (sensitivity 0.95 and 
specificity 0.94, AUC 0.98 (0.95-1.00), p<0.001) (figure 3). 
 
The mean OC/AC-ratio differed significantly between the three time periods (p=0.002), 
showing a decreasing trend throughout gestation. On the basis of the different optimal 
cut-offs per time period, prediction of the type of closure at the first time period did 
not change for 43/48 (90%) fetuses for whom multiple OC/AC-ratios were available. 
The type of closure would have been predicted correctly at all time periods for 42/48 
(88%) fetuses, but incorrectly for one fetus (primary closure predicted; delayed closure 
performed). In the remaining five fetuses the predicted method of closure differed 
between the time periods, in 4/5 a primary closure was performed.
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Table 1 (continued)    
 
Primary closure 
n=37 
Delayed closure 
n=26 
p 
value 
Chronic lung disease 7 (19%) 15 (58%) 0.002 
Length of initial hospital stay (days) 10 (7-35) 52 (19-107) <0.001 
Data are presented as median (IQR) or number (%). Per ultrasound time period the number 
of cases (n) are described per analysis for the total group and per type of closure, where P 
represents primary closure, and D represents delayed closure. w+d: weeks+days; OC/AC: 
omphalocele circumference / abdominal circumference. 
 
Additional anomalies were diagnosed in 19/63 (30%) of fetuses in the prenatal period. 
In 9/44 (20%) cases where the omphalocele was assumed isolated, additional anomalies 
were detected after birth. In 6 of these cases the anomalies were major (table 2). Eleven 
fetuses were diagnosed with a clinically significant syndrome and/or chromosomal 
abnormality, 9 of them had Beckwith Wiedemann syndrome (BWS). The OC/AC-ratio 
in these fetuses ranged from 0.20 to 0.63 at US2 or US3. In 10 (91%) cases there was 
no herniation of the liver through the defect (p=0.006 compared with fetuses without 
a syndrome or chromosomal abnormality). In the case with liver herniation only a very 
small slip of liver was present in the omphalocele. In all cases with a syndrome or 
chromosomal abnormality a primary closure was performed (p=0.002, compared to 
fetuses without a syndrome or chromosomal abnormality). Three (33%) of the nine 
fetuses with BWS had shown polyhydramnios. 
 
Type of surgical closure 
At all three time periods, the OC/AC-ratio was significantly positively associated with 
the probability of requiring a delayed closure (figure 2, supplemental table 1 for logistic 
regression). Based on ROC curve analysis, type of closure was predicted correctly by 
the OC/AC-ratio with optimal cut-off values of 0.69 at US1 (sensitivity 0.93 and 
specificity 0.90, AUC 0.96 (0.88-1.00), p<0.001), 0.66 at US2 (sensitivity 0.88 and 
specificity 0.93, AUC 0.98 (0.95-1.00), p<0.001), and 0.63 at US3 (sensitivity 0.95 and 
specificity 0.94, AUC 0.98 (0.95-1.00), p<0.001) (figure 3). 
 
The mean OC/AC-ratio differed significantly between the three time periods (p=0.002), 
showing a decreasing trend throughout gestation. On the basis of the different optimal 
cut-offs per time period, prediction of the type of closure at the first time period did 
not change for 43/48 (90%) fetuses for whom multiple OC/AC-ratios were available. 
The type of closure would have been predicted correctly at all time periods for 42/48 
(88%) fetuses, but incorrectly for one fetus (primary closure predicted; delayed closure 
performed). In the remaining five fetuses the predicted method of closure differed 
between the time periods, in 4/5 a primary closure was performed.
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Figure 2 The OC/AC-ratio throughout gestation per type of postnatal closure 
Data are presented as median OC/AC-ratio with 95% confidence interval, per ultrasound 
time period and stratified for type of closure. The dashed line represents cases with delayed 
closure. The solid line represents cases with primary closure. OC/AC: omphalocele 
circumference/abdominal circumference. 
 
 
 
 
Figure 3 ROC analysis of the OC/AC-ratio at different time periods for type of closure 
ROC for delayed closure according to cut-off values of the OC/AC-ratio. ROC: receiver 
operating characteristic; OC/AC: omphalocele circumference/abdominal circumference; 
AUC: area under the curve; US1: first ultrasound time period (11-16 weeks’ gestation); US2: 
second ultrasound time period (17-26 weeks’ gestation); US3: third ultrasound time period 
(30-38 weeks’ gestation). 
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Figure 2 The OC/AC-ratio throughout gestation per type of postnatal closure 
Data are presented as median OC/AC-ratio with 95% confidence interval, per ultrasound 
time period and stratified for type of closure. The dashed line represents cases with delayed 
closure. The solid line represents cases with primary closure. OC/AC: omphalocele 
circumference/abdominal circumference. 
 
 
 
 
Figure 3 ROC analysis of the OC/AC-ratio at different time periods for type of closure 
ROC for delayed closure according to cut-off values of the OC/AC-ratio. ROC: receiver 
operating characteristic; OC/AC: omphalocele circumference/abdominal circumference; 
AUC: area under the curve; US1: first ultrasound time period (11-16 weeks’ gestation); US2: 
second ultrasound time period (17-26 weeks’ gestation); US3: third ultrasound time period 
(30-38 weeks’ gestation). 
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Using multivariable logistic regression analyses we found a significant association 
between the intercept of the OC/AC-ratio and type of closure (OR 1.31; p=0.01), but 
not for the slope (OR: 0.82; p=0.79), i.e. no association was found between the trend 
in OC/AC-ratio throughout gestation and type of postnatal closure (supplemental figure 
2).  
 
The presence of MCA prenatally was found predictive of type of surgical closure 
(p=0.02), the presence of MCA postnatally was not significantly predictive of type of 
surgical closure (p=0.18). In the group of infants with delayed closure, we found a 
significantly lower median Apgar score at 5 minutes, longer length of initial hospital stay 
(LOS), more frequently CLD, more often a giant omphalocele and worse survival rates 
compared with infants who underwent primary closure (table 1). Using logistic 
regression analysis, we found a significant association between the OC/AC-ratio at US2 
and US3 and presence of CLD (p=0.01 and p=0.003, respectively). Using Spearman’s 
rank correlation, we also found a significant correlation between the OC/AC-ratio at 
US2 and US3 and  LOS (p<0.001 and p<0.001, respectively).  
 
Liver herniation 
The omphalocele was closed primarily in all 32 infants without liver herniation, and 31 
infants survived. Not having liver herniation, independent of the OC/AC-ratio, was a 
perfect predictor for primary closure. We selected only fetuses with liver herniation 
(n=31) for the logistic regression analysis. The OC/AC-ratio was available for 15 fetuses 
at US1, for 27 at US2 and for 27 at US3. Two or three measurements were available 
for 26/31. We found a statistically significant difference between the OC/AC-ratio and 
type of surgical closure at both US2 (p=0.001) and US3 (p=0.04). The number of cases 
at US1 was too small for a meaningful statistical analysis. Since the parental counselling 
period coincides with US2, we designed a flow chart for prediction of type of closure 
and survival based on OC/AC-ratio at US2 (n=59). In 5/27 (21%) infants with an available 
OC/AC-ratio at US2 and herniated liver the defect was closed primarily; they all 
survived. All of these infants had an OC/AC-ratio <0.76 at US2 and a relatively large 
defect diameter which enabled an uncomplicated return of the abdominal organs back 
into the abdominal cavity. The other 22 all required delayed closure, and 17 (77%) 
survived (figure 4).  
 
Survival 
Separate ROC analyses (data not shown) for each of the three measurement time 
periods revealed a statistically significant negative association between the OC/AC-ratio 
and survival at US2 and US3. The ROC at US1 had an AUC of 0.72 (with a 95% CI of 
(0.48-0.96), p=0.15), at US2 an AUC of 0.81 (with a 95% CI of (0.61-1.00), p=0.01), and 
at US3 an AUC of 0.89 (with a 95% CI of (0.79-0.98), p=0.001).  
 
 
Omphaloceles with an intention to treat at US2
n=50
Liver herniation
Primary closure
100%
(n=27/27)
24 without liver 
herniation, 3 with liver 
herniation
Survival
97%
(n=28/29)
Yes
No
<0.61
Delayed closure
100%
(n=17/17)
Delayed closure
71%
(n=5/7)
Survival 
77%
(n=17/22)
>0.76
Primary closure
29%
(n=2/7)
0.62-0.76
OC/AC-ratio
at US2
(n=27)
 
 
Figure 4 Counseling flow chart for type of surgical closure and survival rate according 
to prenatal liver position and the OC/AC-ratio in fetuses with an omphalocele and an 
intention to treat 
OC/AC: omphalocele circumference/abdominal circumference; US2: second ultrasound 
time period (17-26 weeks’ gestation). 
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Using multivariable logistic regression analyses we found a significant association 
between the intercept of the OC/AC-ratio and type of closure (OR 1.31; p=0.01), but 
not for the slope (OR: 0.82; p=0.79), i.e. no association was found between the trend 
in OC/AC-ratio throughout gestation and type of postnatal closure (supplemental figure 
2).  
 
The presence of MCA prenatally was found predictive of type of surgical closure 
(p=0.02), the presence of MCA postnatally was not significantly predictive of type of 
surgical closure (p=0.18). In the group of infants with delayed closure, we found a 
significantly lower median Apgar score at 5 minutes, longer length of initial hospital stay 
(LOS), more frequently CLD, more often a giant omphalocele and worse survival rates 
compared with infants who underwent primary closure (table 1). Using logistic 
regression analysis, we found a significant association between the OC/AC-ratio at US2 
and US3 and presence of CLD (p=0.01 and p=0.003, respectively). Using Spearman’s 
rank correlation, we also found a significant correlation between the OC/AC-ratio at 
US2 and US3 and  LOS (p<0.001 and p<0.001, respectively).  
 
Liver herniation 
The omphalocele was closed primarily in all 32 infants without liver herniation, and 31 
infants survived. Not having liver herniation, independent of the OC/AC-ratio, was a 
perfect predictor for primary closure. We selected only fetuses with liver herniation 
(n=31) for the logistic regression analysis. The OC/AC-ratio was available for 15 fetuses 
at US1, for 27 at US2 and for 27 at US3. Two or three measurements were available 
for 26/31. We found a statistically significant difference between the OC/AC-ratio and 
type of surgical closure at both US2 (p=0.001) and US3 (p=0.04). The number of cases 
at US1 was too small for a meaningful statistical analysis. Since the parental counselling 
period coincides with US2, we designed a flow chart for prediction of type of closure 
and survival based on OC/AC-ratio at US2 (n=59). In 5/27 (21%) infants with an available 
OC/AC-ratio at US2 and herniated liver the defect was closed primarily; they all 
survived. All of these infants had an OC/AC-ratio <0.76 at US2 and a relatively large 
defect diameter which enabled an uncomplicated return of the abdominal organs back 
into the abdominal cavity. The other 22 all required delayed closure, and 17 (77%) 
survived (figure 4).  
 
Survival 
Separate ROC analyses (data not shown) for each of the three measurement time 
periods revealed a statistically significant negative association between the OC/AC-ratio 
and survival at US2 and US3. The ROC at US1 had an AUC of 0.72 (with a 95% CI of 
(0.48-0.96), p=0.15), at US2 an AUC of 0.81 (with a 95% CI of (0.61-1.00), p=0.01), and 
at US3 an AUC of 0.89 (with a 95% CI of (0.79-0.98), p=0.001).  
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Figure 4 Counseling flow chart for type of surgical closure and survival rate according 
to prenatal liver position and the OC/AC-ratio in fetuses with an omphalocele and an 
intention to treat 
OC/AC: omphalocele circumference/abdominal circumference; US2: second ultrasound 
time period (17-26 weeks’ gestation). 
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Thirty-six (97%) of the 37 infants who underwent primary closure of the defect 
survived. One infant who did not survive had multiple congenital anomalies, including a 
congenital heart defect with a total abnormal pulmonary venous return and severe 
insufficiencies over the atrioventricular valves. All non-survivors (n=9) had CLD and 8 
(89%) of them showed herniation of the liver.  
 
In univariable logistic regression analyses, we found a significant association between 
the slope (OR 13.9 with a 95% CI of (2.13-91.18); p=0.01) of the OC/AC-ratio for 
survival, as well as for the intercept (OR 1.07 with a 95% CI of (1.01-1.13); p=0.02). 
Patient numbers were insufficient for multivariable analysis. In fetuses who survived, the 
decline in OC/AC-ratio throughout gestation was steeper than in fetuses who did not 
survive, especially between US1 and US2 (supplemental figure 3).  
 
IUFD and NND  
In a secondary analysis of data of 11 fetuses, we evaluated whether the OC/AC ratio of 
IUFD (n=9) or NND (n=2) differed from that of live-born fetuses who survived at least 
28 days, i.e. fetuses with an intention to treat (supplemental figure 4). For 4/9 IUFD 
cases no cause for the intrauterine demise was found other than the presence of an 
omphalocele. For the remaining 5 cases, other factors next to the omphalocele 
contributed to the cause of death (supplemental table 2). The median (IQR) OC/AC-
ratio at US1 was 0.74 (0.50-0.91) and at US2 0.55 (0.48-0.73). Five of 11 (46%) fetuses 
had liver herniation. The 2 NND cases were born at 27 and 28 weeks’ gestation. The 
median OC/AC-ratios of the IUFD or NND cases at US1 or US2 were not statistically 
different from those of fetuses with an intention to treat, p=0.76 and p=0.75, 
respectively.  
 
Discussion 
In this cohort of fetuses with an omphalocele, the OC/AC-ratio throughout the second 
and third trimesters of pregnancy proved an important determining factor for the 
prediction of both type of postnatal surgical closure and survival. The OC/AC-ratio 
decreased significantly throughout gestation, resulting in different cut-offs during 
gestation for prediction of type of surgical closure. The most reliable period for this 
prediction was the third trimester. The OC/AC-ratio time trend was not significantly 
associated with type of surgical closure. Fetuses without liver herniation underwent 
primary closure. In infants with a syndrome or chromosomal abnormality more often a 
small omphalocele was present and primary closure was possible. 
 
In previous studies, a number of ratios have been investigated,15, 16, 18-20 including the 
OC/AC-ratio.17, 20 Differing outcome parameters and study population inclusion criteria 
hamper comparison. The cut-offs we found in the current study are lower than 
 
previously reported17 in a group of 24 isolated omphalocele cases, but comparable to 
those reported by Kleinrouweler et al.20 In the latter cross-sectional study the 
predictive value of the OC/AC-ratio for type of closure was examined in all (isolated 
and non-isolated) omphalocele cases. Since the cut-offs are comparable in these two 
separate patient populations, we expect a good clinical applicability. In line with our 
finding, Kleinrouweler et al. also found a decreasing OC/AC-ratio with increasing GA, 
which resulted in different cut-offs per GA.20 Kiyora et al.18 and Montero et al,15 
however, found no difference in ratios per GA. The latter study15 used fetal growth 
parameters (abdominal circumference, femur length and head circumference), which 
remained relatively constant throughout gestation. The suggested ratios resulted in a 
lower predictive value for the prediction of postnatal closure (AUC 0.67-0.72) than the 
OC/AC-ratio in our study (AUC 0.96-0.98), as did all ratios including omphalocele 
diameter instead of circumference.16, 18, 19 Additional research should make clear 
whether correction for gestational age could result in a constant cut-off throughout 
gestation, without negatively affecting the predictive value.  
 
An omphalocele is usually diagnosed prior to 24 weeks’ gestational age and parents 
prefer counselling shortly thereafter.23-25 At US1 the result of the invasive prenatal 
testing is not immediately available, which influences prenatal counselling of future 
parents. In addition, we found that type of closure and survival can be more accurately 
predicted by the OC/AC measurements in the late second (US2) and third trimester 
(US3). The latter especially in cases where around 24 weeks’ gestation the OC/AC-
ratio is measured between 0.62 and 0.76 and the liver is herniated. Parents should be 
informed about this early in pregnancy. Although the predictive value of the OC/AC-
ratio at US3 is limited for counselling purposes as referred to in the previous article,17 
it is beneficial for both perinatal planning and preparing parents for the period after 
birth. When a case predicts delayed closure, both physicians and patients can prepare 
for a higher mortality and neonatal morbidity (e.g. longer hospital stay, increased risk 
of feeding problems, increased risk of respiratory problems). To our knowledge, there 
are no previous studies evaluating the value of repeated measurements throughout 
gestation per case. Although we did not find a significant association between the trend 
of the OC/AC-ratio and type of surgical closure, we did find an association between 
the intercept of the OC/AC-ratio and type of closure. Since the intercept describes the 
average OC/AC-ratio throughout gestation, it is more precise than a single 
measurement. Therefore we do advise repeated measurements to improve prenatal 
counselling. 
 
The occurrence of an omphalocele is not seldomly (80%) associated with additional 
anatomical and/or chromosomal abnormalities that may influence the postnatal 
outcome.1, 3-7, 21, 26, 27 We also know from previous studies4, 17  that in approximately 20% 
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Thirty-six (97%) of the 37 infants who underwent primary closure of the defect 
survived. One infant who did not survive had multiple congenital anomalies, including a 
congenital heart defect with a total abnormal pulmonary venous return and severe 
insufficiencies over the atrioventricular valves. All non-survivors (n=9) had CLD and 8 
(89%) of them showed herniation of the liver.  
 
In univariable logistic regression analyses, we found a significant association between 
the slope (OR 13.9 with a 95% CI of (2.13-91.18); p=0.01) of the OC/AC-ratio for 
survival, as well as for the intercept (OR 1.07 with a 95% CI of (1.01-1.13); p=0.02). 
Patient numbers were insufficient for multivariable analysis. In fetuses who survived, the 
decline in OC/AC-ratio throughout gestation was steeper than in fetuses who did not 
survive, especially between US1 and US2 (supplemental figure 3).  
 
IUFD and NND  
In a secondary analysis of data of 11 fetuses, we evaluated whether the OC/AC ratio of 
IUFD (n=9) or NND (n=2) differed from that of live-born fetuses who survived at least 
28 days, i.e. fetuses with an intention to treat (supplemental figure 4). For 4/9 IUFD 
cases no cause for the intrauterine demise was found other than the presence of an 
omphalocele. For the remaining 5 cases, other factors next to the omphalocele 
contributed to the cause of death (supplemental table 2). The median (IQR) OC/AC-
ratio at US1 was 0.74 (0.50-0.91) and at US2 0.55 (0.48-0.73). Five of 11 (46%) fetuses 
had liver herniation. The 2 NND cases were born at 27 and 28 weeks’ gestation. The 
median OC/AC-ratios of the IUFD or NND cases at US1 or US2 were not statistically 
different from those of fetuses with an intention to treat, p=0.76 and p=0.75, 
respectively.  
 
Discussion 
In this cohort of fetuses with an omphalocele, the OC/AC-ratio throughout the second 
and third trimesters of pregnancy proved an important determining factor for the 
prediction of both type of postnatal surgical closure and survival. The OC/AC-ratio 
decreased significantly throughout gestation, resulting in different cut-offs during 
gestation for prediction of type of surgical closure. The most reliable period for this 
prediction was the third trimester. The OC/AC-ratio time trend was not significantly 
associated with type of surgical closure. Fetuses without liver herniation underwent 
primary closure. In infants with a syndrome or chromosomal abnormality more often a 
small omphalocele was present and primary closure was possible. 
 
In previous studies, a number of ratios have been investigated,15, 16, 18-20 including the 
OC/AC-ratio.17, 20 Differing outcome parameters and study population inclusion criteria 
hamper comparison. The cut-offs we found in the current study are lower than 
 
previously reported17 in a group of 24 isolated omphalocele cases, but comparable to 
those reported by Kleinrouweler et al.20 In the latter cross-sectional study the 
predictive value of the OC/AC-ratio for type of closure was examined in all (isolated 
and non-isolated) omphalocele cases. Since the cut-offs are comparable in these two 
separate patient populations, we expect a good clinical applicability. In line with our 
finding, Kleinrouweler et al. also found a decreasing OC/AC-ratio with increasing GA, 
which resulted in different cut-offs per GA.20 Kiyora et al.18 and Montero et al,15 
however, found no difference in ratios per GA. The latter study15 used fetal growth 
parameters (abdominal circumference, femur length and head circumference), which 
remained relatively constant throughout gestation. The suggested ratios resulted in a 
lower predictive value for the prediction of postnatal closure (AUC 0.67-0.72) than the 
OC/AC-ratio in our study (AUC 0.96-0.98), as did all ratios including omphalocele 
diameter instead of circumference.16, 18, 19 Additional research should make clear 
whether correction for gestational age could result in a constant cut-off throughout 
gestation, without negatively affecting the predictive value.  
 
An omphalocele is usually diagnosed prior to 24 weeks’ gestational age and parents 
prefer counselling shortly thereafter.23-25 At US1 the result of the invasive prenatal 
testing is not immediately available, which influences prenatal counselling of future 
parents. In addition, we found that type of closure and survival can be more accurately 
predicted by the OC/AC measurements in the late second (US2) and third trimester 
(US3). The latter especially in cases where around 24 weeks’ gestation the OC/AC-
ratio is measured between 0.62 and 0.76 and the liver is herniated. Parents should be 
informed about this early in pregnancy. Although the predictive value of the OC/AC-
ratio at US3 is limited for counselling purposes as referred to in the previous article,17 
it is beneficial for both perinatal planning and preparing parents for the period after 
birth. When a case predicts delayed closure, both physicians and patients can prepare 
for a higher mortality and neonatal morbidity (e.g. longer hospital stay, increased risk 
of feeding problems, increased risk of respiratory problems). To our knowledge, there 
are no previous studies evaluating the value of repeated measurements throughout 
gestation per case. Although we did not find a significant association between the trend 
of the OC/AC-ratio and type of surgical closure, we did find an association between 
the intercept of the OC/AC-ratio and type of closure. Since the intercept describes the 
average OC/AC-ratio throughout gestation, it is more precise than a single 
measurement. Therefore we do advise repeated measurements to improve prenatal 
counselling. 
 
The occurrence of an omphalocele is not seldomly (80%) associated with additional 
anatomical and/or chromosomal abnormalities that may influence the postnatal 
outcome.1, 3-7, 21, 26, 27 We also know from previous studies4, 17  that in approximately 20% 
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of prenatally assumed isolated cases, postnatally associated anomalies are detected. 
Although we found a statistically significant association between type of surgical closure 
and MCA prenatally, this was not confirmed postnatally. The presence of associated 
anomalies in a neonate may therefore not influence type of surgery, which should be 
considered when counselling future parents. In our study, based on the OC/AC-ratio 
and liver position, delayed closure and a lower chance of survival would have been 
predicted for all but one fetus with major MCA, thus irrespective of the presence of 
these additional anomalies. This is in contrast to fetuses with a syndrome or 
chromosomal abnormality, who showed a relatively smaller OC/AC-ratio, less liver 
herniation and primary closure.  
 
Like Kleinrouweler et al., we were unable to identify prenatal parameters predictive for 
the occurrence of IUFD or NND.20 It is highly likely that the sample sizes were too 
small (13 and 11 cases, respectively), especially since in only 4/11 cases in our study 
there was no apparent cause found for the occurrence of an IUFD and/or NND. Further 
multicenter studies in larger cohorts are needed to verify this outcome.  
 
In all cases without liver herniation, the defect was closed primarily, irrespective of the 
OC/AC-ratio. Previous studies17, 20, 27, 28 confirm our findings of lower survival and a 
higher occurrence of delayed closure in fetuses with liver herniation. Still, our findings 
show that predicting type of closure and survival in fetuses with liver herniation and an 
OC/AC-ratio between 0.62 and 0.76 around 24 weeks’ gestation remains challenging; 
in our study 29% of these neonates underwent a primary closure. The group of patients 
with an OC/AC-ratio between 0.62 and 0.76 around 24 weeks’ gestation warrants 
further investigation. 
 
Conclusion 
In fetuses with an omphalocele, the OC/AC-ratio determined from ultrasound 
measurements in the late second and third trimesters, combined with position of the 
liver predicts type of postnatal surgical closure and survival. The predictive value 
increases with increasing GA, and can be used throughout pregnancy with different cut-
offs for different time periods in pregnancy. The OC/AC-ratio can be a valuable 
predictive tool in the counselling of parents. 
 
Acknowledgements 
Ko Hagoort provided editorial advice. 
  
 
References
1 Barisic I, Clementi M, Hausler M, et al. 
Evaluation of prenatal ultrasound 
diagnosis of fetal abdominal wall defects 
by 19 European registries. Ultrasound 
Obstet Gynecol. 2001;18(4):309-16. 
2 European Surveillance of congenital 
anomalies (EUROCAT) Guide 1.4 
Section 3.3 2014. Available from: 
www.eurocat-network.eu. 
3 Khalil A, Arnaoutoglou C, Pacilli M, et 
al. Outcome of fetal exomphalos 
diagnosed at 11-14 weeks of gestation. 
Ultrasound Obstet Gynecol. 
2012;39(4):401-6. 
4 Cohen-Overbeek TE, Tong WH, 
Hatzmann TR, et al. Omphalocele: 
comparison of outcome following 
prenatal or postnatal diagnosis. 
Ultrasound Obstet Gynecol. 
2010;36(6):687-92. 
5 Brantberg A, Blaas HG, Haugen SE, et 
al. Characteristics and outcome of 90 
cases of fetal omphalocele. Ultrasound 
Obstet Gynecol. 2005;26(5):527-37. 
6 Lakasing L, Cicero S, Davenport M, et 
al. Current outcome of antenatally 
diagnosed exomphalos: an 11 year 
review. J Pediatr Surg. 2006;41(8):1403-
6. 
7 Fleurke-Rozema H, van de Kamp K, 
Bakker M, et al. Prevalence, timing of 
diagnosis and pregnancy outcome of 
abdominal wall defects after the 
introduction of a national prenatal 
screening program. Prenat Diagn. 
2017;37(4):383-8. 
8 Bauman B, Stephens D, Gershone H, et 
al. Management of giant omphaloceles: 
A systematic review of methods of 
staged surgical vs. nonoperative delayed 
closure. J Pediatr Surg. 
2016;51(10):1725-30. 
9 van Eijck FC, de Blaauw I, Bleichrodt 
RP, et al. Closure of giant omphaloceles 
by the abdominal wall component 
separation technique in infants. J Pediatr 
Surg. 2008;43(1):246-50. 
10 van Eijck FC, Aronson DA, Hoogeveen 
YL, et al. Past and current surgical 
treatment of giant omphalocele: 
outcome of a questionnaire sent to 
authors. J Pediatr Surg. 2011;46(3):482-
8. 
11 Rijhwani A, Davenport M, Dawrant M, 
et al. Definitive surgical management of 
antenatally diagnosed exomphalos. J 
Pediatr Surg. 2005;40(3):516-22. 
12 Hijkoop A, Peters NCJ, Lechner RL, et 
al. Omphalocele: from diagnosis to 
growth and development at 2 years of 
age. Arch Dis Child Fetal Neonatal Ed. 
2019;104(1):F18-F23. 
13 Partridge EA, Hanna BD, Panitch HB, et 
al. Pulmonary hypertension in giant 
omphalocele infants. J Pediatr Surg. 
2014;49(12):1767-70. 
14 Kelly KB, Ponsky TA. Pediatric 
abdominal wall defects. Surg Clin North 
Am. 2013;93(5):1255-67. 
15 Montero FJ, Simpson LL, Brady PC, et 
al. Fetal omphalocele ratios predict 
outcomes in prenatally diagnosed 
omphalocele. Am J Obstet Gynecol. 
2011;205(3):284 e1-7. 
16 Tassin M, Descriaud C, Elie C, et al. 
Omphalocele in the first trimester: 
prediction of perinatal outcome. Prenat 
Diagn. 2013;33(5):497-501. 
17 Peters NC, Hooft ME, Ursem NT, et al. 
The relation between viscero-
abdominal disproportion and type of 
omphalocele closure. Eur J Obstet 
Gynecol Reprod Biol. 2014;181:294-9. 
18 Kiyohara MY, Brizot ML, Liao AW, et 
al. Should we measure fetal 
omphalocele diameter for prediction of 
perinatal outcome? Fetal Diagn Ther. 
2014;35(1):44-50. 
19 Diemon N, Funke K, Mollers M, et al. 
Thorax-to-head ratio and defect 
diameter-to-head ratio in giant 
omphaloceles as predictor for fetal 
outcome. Arch Gynecol Obstet. 
2017;295(2):325-30. 
Chapter 5
108
of prenatally assumed isolated cases, postnatally associated anomalies are detected. 
Although we found a statistically significant association between type of surgical closure 
and MCA prenatally, this was not confirmed postnatally. The presence of associated 
anomalies in a neonate may therefore not influence type of surgery, which should be 
considered when counselling future parents. In our study, based on the OC/AC-ratio 
and liver position, delayed closure and a lower chance of survival would have been 
predicted for all but one fetus with major MCA, thus irrespective of the presence of 
these additional anomalies. This is in contrast to fetuses with a syndrome or 
chromosomal abnormality, who showed a relatively smaller OC/AC-ratio, less liver 
herniation and primary closure.  
 
Like Kleinrouweler et al., we were unable to identify prenatal parameters predictive for 
the occurrence of IUFD or NND.20 It is highly likely that the sample sizes were too 
small (13 and 11 cases, respectively), especially since in only 4/11 cases in our study 
there was no apparent cause found for the occurrence of an IUFD and/or NND. Further 
multicenter studies in larger cohorts are needed to verify this outcome.  
 
In all cases without liver herniation, the defect was closed primarily, irrespective of the 
OC/AC-ratio. Previous studies17, 20, 27, 28 confirm our findings of lower survival and a 
higher occurrence of delayed closure in fetuses with liver herniation. Still, our findings 
show that predicting type of closure and survival in fetuses with liver herniation and an 
OC/AC-ratio between 0.62 and 0.76 around 24 weeks’ gestation remains challenging; 
in our study 29% of these neonates underwent a primary closure. The group of patients 
with an OC/AC-ratio between 0.62 and 0.76 around 24 weeks’ gestation warrants 
further investigation. 
 
Conclusion 
In fetuses with an omphalocele, the OC/AC-ratio determined from ultrasound 
measurements in the late second and third trimesters, combined with position of the 
liver predicts type of postnatal surgical closure and survival. The predictive value 
increases with increasing GA, and can be used throughout pregnancy with different cut-
offs for different time periods in pregnancy. The OC/AC-ratio can be a valuable 
predictive tool in the counselling of parents. 
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 Outcome 
Variable OR 95% CI p value 
 Type of closure 
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gestational age 
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Supplemental figure 1 Examples of measurement of the OC/AC-ratio at US3 
Figure showing three examples of measurement of the OC/AC-ratio at ultrasound 
examination between 30-38 weeks’ gestation. The circle on the left is the measurement of 
the abdominal circumference (AC), the circle on the right is the measurement of the 
omphalocele circumference (OC).  
 
 
 
 
Supplemental figure 2 The OC/AC-ratio throughout gestation per type of postnatal 
closure and per case 
Figure showing the trend of the OC/AC-ratio per case throughout gestation per type of 
postnatal surgical closure. The open dots are cases with postnatal primary closure, the solid 
black dots represent cases with delayed closure. The grey lines represent the trend of the 
OC/AC-ratio throughout gestation for cases with ≥2 measurements. Cases with liver 
herniation are marked with the number 1. OC/AC: omphalocele circumference / abdominal 
circumference.  
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Supplemental figure 2 The OC/AC-ratio throughout gestation per type of postnatal 
closure and per case 
Figure showing the trend of the OC/AC-ratio per case throughout gestation per type of 
postnatal surgical closure. The open dots are cases with postnatal primary closure, the solid 
black dots represent cases with delayed closure. The grey lines represent the trend of the 
OC/AC-ratio throughout gestation for cases with ≥2 measurements. Cases with liver 
herniation are marked with the number 1. OC/AC: omphalocele circumference / abdominal 
circumference.  
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Supplemental figure 3 The slope of the mean OC/AC-ratio throughout gestation 
for type of closure and survival 
Data are presented as mean OC/AC-ratio, per ultrasound time period and stratified for 
type of closure (figure on the left) and survival (figure on the right). The dashed line 
represents cases with primary closure (figure on the left) or survivors (figure on the right). 
The solid line represents cases with delayed closure (figure on the left) or non-survivors 
(figure on the right). OC/AC: omphalocele circumference / abdominal circumference.  
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Supplemental figure 4 Inclusion flow chart of fetuses diagnosed with an omphalocele 
and occurrence of IUFD or NND  
IUFD: intrauterine fetal death; NND: neonatal death; MCA: multiple congenital anomalies 
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Supplemental figure 4 Inclusion flow chart of fetuses diagnosed with an omphalocele 
and occurrence of IUFD or NND  
IUFD: intrauterine fetal death; NND: neonatal death; MCA: multiple congenital anomalies 
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Abstract 
 
Objective 
To compare the prenatal frame of reference of omphalocele (i.e. survival of fetuses) 
with that after birth (i.e. survival of live-born neonates), and to assess physical growth 
and neurodevelopment in children with minor or giant omphalocele up to 2 years of 
age. 
 
Design 
We included fetuses and neonates diagnosed 2000-2012. Physical growth (SD scores, 
SDS) and mental and motor development at 12 and 24 months were analyzed using 
general linear models, and outcomes were compared with reference norms. Giant 
omphalocele was defined as defect ≥5cm, with liver protruding. 
 
Results 
We included 145 fetuses and neonates. Of 126 (87%) who were diagnosed prenatally, 
50 (40%) were live-born, and 35 (28%) survived at least 2 years. Nineteen (13%) 
neonates were diagnosed after birth. Of the 69 live-born neonates, 52 (75%) survived 
and 42 children (81% of survivors) were followed longitudinally. At 24 months, mean 
(95% CI) height and weight SDS were significantly below 0 in both minor (height: -0.57 
(-1.05 to -0.09; weight: -0.86 (-1.35 to -0.37)) and giant omphalocele (height: -1.32 (-
2.10 to -0.54); weight: -1.58 (-2.37 to -0.79)). Mental development was comparable with 
reference norms in both groups. Motor function delay was found significantly more 
often in children with giant omphalocele (82%) than in those with minor omphalocele 
(21%, p=0.002). 
 
Conclusions 
The prenatal and postnatal frames of reference of omphalocele differ considerably; a 
multidisciplinary approach in parental counselling is recommended. As many children 
with giant omphalocele had delayed motor development, we recommend close 
monitoring of these children and early referral to physical therapy. 
  
 
Introduction 
Omphalocele is a midline congenital abdominal wall defect (AWD) with an estimated 
prevalence of 3.38 per 10 000 pregnancies.1 It is usually defined as 'giant' if the defect is 
≥5 cm at birth, with the liver (partly) protruding.2 Otherwise, it is called 'minor'.   
 
Nowadays, over 90% of omphaloceles are diagnosed prenatally.3 Isolated omphalocele, 
which presents approximately 20%, usually has a high survival rate of 90%.4 Other 
fetuses, however, present with chromosomal abnormalities and/or associated 
congenital anomalies (non-isolated omphalocele),4 which lead to a high prevalence of 
termination of pregnancy (TOP) and intra-uterine death (IUD). Therefore, we 
hypothesize a striking difference between the frame of reference of prenatal specialists 
and that of pediatric surgeons and pediatricians.  
 
Previous research on long-term outcome mainly focused on children with giant 
omphalocele,5-7 or surprisingly did not differentiate between gastroschisis and 
omphalocele.8-10 We expect normal growth and development in non-syndromic children 
with minor omphalocele, and delayed growth and motor development in those with 
giant omphalocele. 
 
The aims of our study were to (1) compare the prenatal frame of reference of 
omphalocele with that after birth, and (2) assess physical growth and neurodevelopment 
in children with minor or giant omphalocele up to 2 years of age. 
 
Methods 
Study population 
We retrospectively analyzed data of all fetuses and neonates diagnosed with 
omphalocele between 1 January 2000 and 31 December 2012 at the Erasmus Medical 
Center-Sophia Children's Hospital, Rotterdam. All parents of survivors were offered to 
enter their child in the longitudinal prospective follow-up program for children with 
anatomical congenital anomalies treated at our hospital.11 
 
Variables and definitions 
Following prenatal detection of omphalocele, a prenatal specialist further examined the 
fetus to identify possible additional structural anomalies; karyotyping was offered in all 
fetuses. We classified additional anomalies by prognosis as follows: lethal (e.g. trisomy 
18; anencephaly), very poor (e.g. congenital diaphragmatic hernia; large encephalocele) 
or uncertain (e.g. suspected intestinal atresia; congenital heart defect). Fetuses with 
isolated omphalocele were categorized according to the ratio of omphalocele 
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circumference to abdominal circumference (OC/AC-ratio (<0.82 or ≥0.82) at their first 
prenatal ultrasound.12 
 
All fetuses were delivered vaginally, unless obstetric reasons required otherwise. 
Neonates with a birth weight <10th centile of Dutch references curves were 
considered small for gestational age.13 Neonates born <37 weeks' gestation were 
considered preterm. Socioeconomic status scores (population mean 0, SD 1) were 
based on postal codes.14, 15 
 
After birth, the omphalocele was defined as ‘giant’ if the defect diameter was ≥5cm, 
with liver protruding. All neonates were screened for multiple congenital anomalies 
(MCA); we documented those requiring surgery or multiple follow-up visits. Chronic 
lung disease was diagnosed in neonates who required supplemental oxygen for at least 
28 days.16  
 
We documented duration of initial mechanical ventilation, time to full enteral feeding 
(TFEF), presence of intestinal failure (i.e. TFEF ≥6 weeks), and length of initial hospital 
stay. If these exceeded 2 years, data were documented as 730 days. 
Neonatal death was defined as death during the first 28 days of life, and infant death as 
death between 28 days and 1 year.   
 
Physical growth and neurodevelopment 
Height and weight had been measured at 12 and 24 months of age (corrected for 
preterm birth), and head circumference at 12 months of age. We calculated SD scores 
(SDS) according to Dutch reference norms; -2 to +2 SD was considered normal range.17 
Mental and motor development had been assessed at 12 and 24 months using the Bayley 
Developmental Scales (BOS 2-30, Dutch version)18 and, from December 2003, Bayley 
Scales of Infant Development-Second Edition.19 These scales are interchangeable19 and 
provide a mental developmental index (MDI) and psychomotor developmental index 
(PDI) with a mean of 100 and SD of 15.18, 19 Scores <55 are indicative of severe 
developmental delay; those were documented as 55. We excluded children with a 
confirmed syndrome influencing physical growth, neurodevelopment or both from the 
respective analyses. 
 
Statistical analysis 
Categorical variables are presented as number (%) and continuous variables as median 
(IQR). Prenatal, perinatal and postnatal characteristics of children with minor or giant 
omphalocele were compared using Fisher's exact tests for categorical data and Mann-
Whitney tests for continuous data. We used general linear models to analyze the course 
of height, weight and neurodevelopment over time. These models included type of 
 
defect (minor or giant), the time point (12 or 24 months) and their interaction term as 
independent variables. We used an unstructured error covariance matrix for the 
repeated measurements of each child to account for the within-subject correlations. 
The results are presented as estimated marginal means (i.e. the predicted values of the 
dependent variable, adjusted for covariates in the model) with their 95% CIs. A two-
sided p value of <0.05 was considered statistically significant. Statistical analyses were 
performed using SPSS V.21.0. 
 
Results 
We included 145 fetuses and neonates; 126 (87%) were diagnosed prenatally, 50 (40%) 
of them were live-born. Nineteen (13%) neonates were diagnosed postnatally. Of all 69 
live-born neonates, 52 (75%) survived at least 2 years (figure 1). Follow-up data of 42 
(81%) children were analyzed; all but three were seen at both time points (figure 2). 
Prenatal, perinatal and postnatal characteristics of children who entered our follow-up 
program did not significantly differ from those who did not (data not shown).  
 
Prenatal frame of reference 
Overall, 50/126 (40%) fetuses diagnosed with omphalocele were live-born, and 35 (28%) 
survived ≥2 years. Additional structural or chromosomal anomalies were found in 
71/126 (56%) fetuses. Most of these anomalies were lethal (42/71 (59%); figure 1). Two 
fetuses classified as having a lethal prognosis were live born but died shortly after birth. 
Thirteen fetuses had a very poor prognosis; 6/13 (46%) couples continued the 
pregnancy, which resulted in four live births of whom one child survived. Sixteen fetuses 
had an uncertain prognosis; 8/16 (50%) couples decided to continue the pregnancy; 2 
fetuses died in utero and 5/6 live-born neonates survived.  
 
Isolated omphalocele was diagnosed in 55/126 (44%) fetuses. Thirty of them (55%) had 
OC/AC <0.82 and 26/30 (87%) were live-born, compared to 12/25 (48%) fetuses with 
OC/AC ≥0.82 (p=0.003). With TOPs excluded, 93% versus 71% of continuing 
pregnancies resulted in live birth, respectively (p=0.09). Of 38 live-born neonates with 
an isolated omphalocele, 29 (76%) survived. 
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Figure 1 Flow chart of survival in all fetuses and neonates with omphalocele 
IUD: intrauterine death; MCA: multiple congenital anomalies; NND: neonatal death; 
OC/AC: omphalocele circumference/abdominal circumference; TOP: termination of 
pregnancy. 12/126 were diagnosed late in pregnancy (1 at day of birth: MCA (suspected 
intestinal atresia); 1 at 34 weeks’ gestation: isolated, but limited imaging due to severe 
polyhydramnios and maternal obesity); 21/19 prenatally diagnosed with gastroschisis instead 
of ruptured omphalocele; 3including one ruptured giant omphalocele, liver was included in 
22/24 fetuses (1 unknown).  
 
  
 
Postnatal frame of reference 
Including the nineteen (13%) neonates diagnosed after birth, 69 neonates were live-
born. Eight died within 1 week after birth, nine during infancy. Fifty-two (75%) children 
survived at least 2 years, and 42 children participated in our follow-up (figure 2). One 
child with minor omphalocele died at 3 years due to volvulus. All children with minor 
omphalocele underwent primary closure (table 1). 
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Figure 2 Flow chart of children with omphalocele included in follow-up analyses of 
physical growth and neurodevelopment 
*Reasons for missing data on growth at 12 months: excluded because of Beckwith-
Wiedemann syndrome (n=5) and organizational (n=1); and at 24 months: excluded because 
of Beckwith-Wiedemann syndrome (n=5). Reasons for missing data on development at 12 
months: refusal n=1 (both mental/motor); non-cooperative n=1 (motor); immobilization of 
legs n=1 (motor); organizational n=1 (motor); and at 24 months: refusal n=1 (both 
mental/motor); non-cooperative n=10 (both mental/motor n=3; mental n=1; motor n=6). 
 
Of 11 children with giant omphalocele, 1 underwent primary closure and 10 had 
definitive closure at a median age of 19 months (range: 13-95). Children with giant 
omphalocele needed three times as many procedures under general anesthesia as those 
with minor omphalocele. While more than half of the children with giant omphalocele 
developed chronic lung disease, none of those with minor omphalocele did. Three 
children with giant omphalocele needed mechanical ventilation for over 100 days; all 
got a tracheostomy cannula. The others breathed spontaneously within 1 week. Median 
TFEF was less than 1 week in neonates with minor omphalocele. TFEF was three times 
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longer in those with giant omphalocele; almost one-third developed intestinal failure. 
Children with giant omphalocele stayed seven times longer in hospital than those with 
minor omphalocele (table 1).  
 
Table 1 Prenatal, perinatal and postnatal characteristics of children in follow-up 
(n=42) 
 
Minor 
omphalocele 
n=31 
Giant 
omphalocele 
n=11 
p 
value 
Maternal age (years) A 31 (28-35) 31 (29-33) 0.89 
Male sex 15 (48%) 4 (36%) 0.73 
Multiple pregnancy 3 (10%) 0 (0%) 0.55 
Socio-economic status score at 
birth 0.08 (-0.53-0.88) 0.06 (-0.95-0.53) 0.46 
- Low status score (<-1) 8 (26%) 2 (18%) 1.00 
Prenatal characteristics    
Prenatal diagnosis 18 (58%) 10 (91%) 0.07 
- Gestational age (weeks) at 
diagnosis 22.9 (19.5-30.4) 21.2 (15.6-33.4) 0.65 
- OC/AC ≥0.82 at diagnosis 0 (0%) B 8 (73%) <0.001 
- Liver protruding at diagnosis 4 (22%)  9 (90%) 0.001 
Perinatal characteristics    
Cesarean section 8 (26%) 6 (55%) 0.14 
Gestational age at birth (weeks)  38.9 (38.0-39.9) 38.4 (37.0-38.9) 0.16 
Preterm birth  3 (10%) 2 (18%) 0.59 
Birth weight (grams)  3180 (2500-3640) 2750 (2140-3430) 0.12 
Small for gestational age 6 (19%) 3 (27%) 0.68 
Apgar score at 5 min A 10 (9-10) 9 (8-9) 0.04 
- Apgar score <7 at 5 min A 0 (0%) 1 (9%) 0.28 
Postnatal characteristics    
Ruptured omphalocele 5 (16%) 3 (27%) 0.41 
Content of omphalocele C     
- Liver  5 (16%) 11 (100%) <0.001 
- Stomach  0 (0%) 3 (27%) 0.01 
- Bladder  0 (0%) 1 (9%) 0.26 
Multiple congenital anomalies D 11 (35%) 3 (27%) 0.72 
Primary closure 31 (100%) 1 (9%) E <0.001 
Number of procedures under 
general anesthesia F 
1 (1-2) 3 (2-5) 0.003 
Duration of initial mechanical 
ventilation 
0 (0-1) 3 (0-119) 0.06 
Chronic lung disease 0 (0%) 6 (55%) <0.001 
Time to full enteral feeding (days) 6 (3-9) 20 (13-49) <0.001 
- Intestinal failure G 2 (6%) 3 (27%) 0.10 
Length of initial hospital stay (days)  7 (5-13) 50 (23-108) <0.001 
    
 
Table 1 (continued)    
 Minor 
omphalocele 
n=31 
Giant 
omphalocele 
n=11 
p 
value 
Pediatric physiotherapy    
- At 12 months of age 4 (13%) H 6 (55%) 0.01 
- At 24 months of age 2 (7%) I 2 (18%) 0.30 
Data presented as n (%) or median (interquartile range). OC/AC: omphalocele 
circumference/abdominal circumference. A Unknown in n=3 minor omphalocele; B unknown 
in n=4 prenatally diagnosed minor omphalocele; C Percentages do not necessarily add up to 
100, as multiple organs can be herniated; D Minor omphalocele: cryptorchidism (n=1); 
cryptorchidism + ren arcuatus (n=1); Beckwith-Wiedemann Syndrome (n=4); enlarged 
monokidney (n=1); intestinal atresia (n=2); intestinal atresia + microcolon (n=1); ileal cyst 
(n=1); Giant omphalocele: Beckwith-Wiedemann Syndrome (n=1); aortic stenosis (n=1); 
cryptorchidism + epiglottic dysfunction (n=1); E ruptured omphalocele; F unknown in n=1 
minor omphalocele. G Time to full enteral feeding: 49->730 days. Minor omphalocele: 
intestinal atresia (n=1); intestinal atresia + microcolon (n=1); Giant omphalocele: 
respiratory insufficiency due to sepsis, therefore nil per os (n=1); intestinal passage problems 
(n=2). H unknown in n=1 (no follow-up at 12 months); I unknown in n=2 (no follow-up at 
24 months). 
 
Physical growth and neurodevelopment 
Height and weight SDS are shown in figure 3. The general linear model analysis showed 
no significant differences over time. At 12 months, the estimated marginal mean height 
SDS was significantly below 0 in children with giant omphalocele (-1.24 (95% CI: -2.01 
to -0.46)); weight SDS fell significantly below 0 both in children with minor (-0.61 (-1.04 
to -0.18)) and in those with giant omphalocele (-1.49 (-2.20 to -0.78)). At 24 months, 
height and weight SDS were significantly below 0 in both children with minor 
omphalocele (height: -0.57 (-1.05 to -0.09); weight: -0.86 (-1.35 to -0.37)) and in those 
with giant omphalocele (height: -1.32 (-2.10 to -0.54); weight: -1.58 [-2.37 to -0.79)). 
 
Head circumference SDS was measured in 23 children with minor omphalocele (median 
(IQR): -0.56 (-0.89 to 0.42)), and in six with giant omphalocele (-0.22 (-1.18 to -0.05)), 
with no statistically significant difference between those groups (p=0.85).  
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longer in those with giant omphalocele; almost one-third developed intestinal failure. 
Children with giant omphalocele stayed seven times longer in hospital than those with 
minor omphalocele (table 1).  
 
Table 1 Prenatal, perinatal and postnatal characteristics of children in follow-up 
(n=42) 
 
Minor 
omphalocele 
n=31 
Giant 
omphalocele 
n=11 
p 
value 
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- OC/AC ≥0.82 at diagnosis 0 (0%) B 8 (73%) <0.001 
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Number of procedures under 
general anesthesia F 
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Duration of initial mechanical 
ventilation 
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Time to full enteral feeding (days) 6 (3-9) 20 (13-49) <0.001 
- Intestinal failure G 2 (6%) 3 (27%) 0.10 
Length of initial hospital stay (days)  7 (5-13) 50 (23-108) <0.001 
    
 
Table 1 (continued)    
 Minor 
omphalocele 
n=31 
Giant 
omphalocele 
n=11 
p 
value 
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in n=4 prenatally diagnosed minor omphalocele; C Percentages do not necessarily add up to 
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(n=2). H unknown in n=1 (no follow-up at 12 months); I unknown in n=2 (no follow-up at 
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Physical growth and neurodevelopment 
Height and weight SDS are shown in figure 3. The general linear model analysis showed 
no significant differences over time. At 12 months, the estimated marginal mean height 
SDS was significantly below 0 in children with giant omphalocele (-1.24 (95% CI: -2.01 
to -0.46)); weight SDS fell significantly below 0 both in children with minor (-0.61 (-1.04 
to -0.18)) and in those with giant omphalocele (-1.49 (-2.20 to -0.78)). At 24 months, 
height and weight SDS were significantly below 0 in both children with minor 
omphalocele (height: -0.57 (-1.05 to -0.09); weight: -0.86 (-1.35 to -0.37)) and in those 
with giant omphalocele (height: -1.32 (-2.10 to -0.54); weight: -1.58 [-2.37 to -0.79)). 
 
Head circumference SDS was measured in 23 children with minor omphalocele (median 
(IQR): -0.56 (-0.89 to 0.42)), and in six with giant omphalocele (-0.22 (-1.18 to -0.05)), 
with no statistically significant difference between those groups (p=0.85).  
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Figure 3 Height and weight standard deviation scores (SDS) of children with minor or 
giant omphalocele 
Symbols represent estimated marginal means with 95% CIs, based on a general linear model 
that includes age, type of omphalocele and their interaction term as explanatory variables. 
At 12 months, height SDS was <−2 in 1/26 (4%) children with minor and in 2/9 (22%) 
children with giant omphalocele. Weight SDS was <−2 in 3/26 (12%) children with minor 
and in 4/9 (44%) children with giant omphalocele. At 24 months, height SDS was <−2 in 
2/25 (8%) children with minor and in 3/10 (30%) children with giant omphalocele. Weight 
SDS was <−2 in 4/25 (16%) children with minor and in 4/10 (40%) children with giant 
omphalocele. 
 
The estimated marginal mean MDI was comparable with reference norms at both time 
points in children with minor omphalocele (12 months: 106 (100-112); 24 months: 100 
(93-108)) and in those with giant omphalocele (12 months: 97 (87-107); 24 months: 98 
(86-110)) and did not differ between these groups. The mean PDI in children with minor 
omphalocele was significantly below 100 but within the normal range of 85-115, both 
at 12 months (89 (82-95)) and 24 months (93 (87-99)). PDI in those with giant 
omphalocele was significantly below normal at both time points (12 months: 75 (65-
86); 24 months: 77 (69-86)); overall, children with giant omphalocele scored 15 (5-26) 
points less than those with minor omphalocele. At 24 months, motor developmental 
 
delay occurred significantly more often in children with giant omphalocele (82%) than 
in those with minor omphalocele (21%, p=0.002); figure 4. At 12 months, four (13%) 
children with minor and six (55%) with giant omphalocele received physiotherapy at 
home. This was continued up to at least 24 months in two (7%) children with minor 
and two (18%) with giant omphalocele. 
 
 
 
Figure 4 Proportions of children with minor or giant omphalocele with normal or 
delayed mental (left panel) and motor (right panel) at 12 and 24 months of follow-up. 
Mild delay: developmental index: 70–84; moderate delay: 55–69; severe delay: <55. 
Numbers of children are shown in brackets. 
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Discussion 
We evaluated the course of omphalocele from diagnosis to growth and development 
at 2 years of age. As we hypothesized, the prenatal frame of reference was considerably 
worse than that after birth; additional structural or chromosomal anomalies–mainly 
lethal–were found in more than half of the fetuses. Physical growth at 2 years mainly 
fell within normal range. Mental development was generally normal. Motor 
development was delayed in over 80% of children with giant omphalocele.  
 
The 2-year survival rate in live-born neonates was 75%, which is in concordance with 
previous literature.4, 20 The 2-year survival rate in prenatally diagnosed omphalocele was 
almost three times as low, causing a considerable difference between prenatal and 
postnatal frames of reference of this anomaly. The low survival rate in prenatally 
diagnosed omphalocele was mainly determined by the high prevalence of additional 
anomalies and concomitantly high rate of TOP. In addition, IUD and neonatal death 
occurred frequently in this group, which confirms previous literature.21-23 
 
The OC/AC-ratio is intended to provide individualized counselling by predicting type 
of closure.12 In our study, many parents of fetuses with an isolated omphalocele and 
OC/AC ≥0.82 opted for TOP. In the continuing pregnancies, IUD occurred in 29%. In 
fetuses with OC/AC <0.82, the rates of TOP and IUD were much lower. Earlier studies 
on omphalocele ratios only included live-born neonates (12, 24-26) or were unable to 
distinguish between isolated and non-isolated omphalocele due to small sample sizes.27 
Our finding that the OC/AC-ratio may predict survival requires further research.  
 
This study emphasizes the importance of a multidisciplinary approach in parental 
counselling; pediatric surgeons and pediatricians may be more optimistic about survival 
rates than obstetricians and prenatal specialists. Moreover, inclusion criteria in studies 
on survival rates in omphalocele should be considered accurately: those including only 
prenatally diagnosed children are more likely to report lower survival rates than those 
including all children with omphalocele.  
 
Previous studies on physical growth in children with AWD–not distinguishing between 
gastroschisis and omphalocele–reported suboptimal growth in infancy10, 11, and normal28 
or suboptimal9 growth in childhood. Henrich and coworkers reported weight <p3 in 
3/15 (20%) children with omphalocele aged 1-10 years, and height <p3 in two (13%) 
children.29 These proportions are similar to our results in 2-year-olds, and higher than 
those in the reference population (i.e. 2.3%, based on a standard normal distribution). 
Although their height and weight fell within the normal range at both time points, 
children with omphalocele seem to be at greater risk of failure to thrive. Our data did 
not allow for conclusions regarding determinants of poor growth. We assume that 
 
several aspects play a role, including neonatal surgery, work of breathing, prolonged 
hospitalization and impaired mother-child interaction. We recommend close 
monitoring of growth, and early nutritional intervention if necessary.  
 
Neurodevelopment has previously been studied in cohorts combining different types of 
non-cardiac anatomical anomalies8, 30, 31 or AWD,9-11 and in cohorts limited to giant 
omphalocele.5-7 Similar to our results, Burnett and coworkers reported motor function 
delay in 2-year-old children with omphalocele.32 Studies that did not differentiate 
between non-cardiac anatomical anomalies reported high prevalence of 
neurodevelopmental problems.8, 30, 31 In contrast, studies that evaluated children with 
AWD showed normal neurodevelopment in infancy,10, 11 and normal motor 
development in childhood.9 Note, however, that gastroschisis and omphalocele are two 
different entities; the prenatal and postnatal outcomes of children with omphalocele 
included in the present study differ much from those in children with gastroschisis in 
our previous study.33  
 
Parental counselling should stress the importance of the difference between giant and 
minor omphalocele, as we found that giant omphalocele carried a greater risk of motor 
developmental delay. A previous study reported both mental and motor developmental 
delay in more than half of 31 children with giant omphalocele aged 6-35 months.6 We 
suspect the higher proportion of mental developmental delay could be explained by the 
inclusion of children with major MCA and rare syndromes in that study.6 
 
We assume that in many children with giant omphalocele, the ventral hernia and altered 
trunk stability—due to abnormal development of the anterior abdominal muscles—
contribute to impaired motor development in infancy, with a catch-up effect in 
childhood. A previous study reported normal motor function in children with giant 
omphalocele aged 3.5-12 years.5 Nevertheless, monitoring of motor development in 
children with giant omphalocele with timely interventions if needed may be helpful. 
Moreover, parents should be encouraged to stimulate physical activity and should be 
counselled on leisure and sport participation of their children. 
 
Strengths of our study are the data collection from a longitudinal prospective follow-up 
program of mostly prenatally diagnosed children; the high proportion (81%) of children 
that entered this program; the relatively large sample size for such a rare disease; and 
the use of standardized assessments both prenatally and during follow-up. Several 
limitations need to be addressed. First, the sample size was too small to study 
determinants of neurodevelopmental delay. Second, we compared height SDS with 
reference norms rather than with target height SDS, as parental height was often 
missing.  
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Strengths of our study are the data collection from a longitudinal prospective follow-up 
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missing.  
6
Follow-up of minor and giant omphalocele
131
In conclusion, the prenatal frame of reference of omphalocele differs considerably from 
the frame of reference after birth, and a multidisciplinary approach in parental 
counselling is recommended. As 2-year-old children with giant omphalocele often had 
delayed motor development, we recommend timely referral to a pediatric physical 
therapist and prolonged follow-up, at least until these children have reached school age. 
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In conclusion, the prenatal frame of reference of omphalocele differs considerably from 
the frame of reference after birth, and a multidisciplinary approach in parental 
counselling is recommended. As 2-year-old children with giant omphalocele often had 
delayed motor development, we recommend timely referral to a pediatric physical 
therapist and prolonged follow-up, at least until these children have reached school age. 
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Abstract 
 
Objective 
Many children with omphalocele experience morbidity in early life, which could affect 
long-term outcomes. We determined parent-reported outcomes in school-aged 
children treated for minor or giant omphalocele. 
 
Methods 
We sent paper questionnaires to the parents of all children treated for omphalocele in 
2000 – 2012. Giant omphalocele was defined as defect diameter ≥ 5 cm with liver 
protruding. Motor function (MABC-2 Checklist) was compared with Dutch reference 
data; cognition (PedsPCF), health status (PedsQL), quality of life (DUX-25) and behavior 
(Strengths and Difficulties Questionnaire; SDQ) were compared with those of controls 
(two per child) matched for age, gender and maternal education level. Possible 
predictors of cognition and behavior were evaluated using linear regression analyses. 
 
Results 
Of 54 eligible participants, 31 (57%) returned the questionnaires. MABC-2 Checklist 
scores were normal for 21/26 (81%) children. Cognition, health status, quality of life 
and behavior were similar to scores of matched controls. One quarter (26%) of children 
with omphalocele scored ≤ -1 standard deviation on the PedsPCF, compared with 9% 
of matched controls (p=0.07). Giant omphalocele and presence of multiple congenital 
anomalies (MCA) were most prominently associated with lower PedsPCF scores (giant 
omphalocele: β -22.11 (95% CI: -43.65 to -0.57); MCA -23.58 (-40.02 to -7.13)), 
although not significantly after correction for multiple testing. 
 
Conclusion 
Parent-reported outcomes of children with omphalocele at school age are reassuring. 
Children with an isolated, minor omphalocele do not need extensive long-term follow-
up of daily functioning. Those with a giant omphalocele or MCA might be at risk for 
delayed cognitive functioning at school age; we recommend long-term follow-up to 
offer timely intervention.  
 
Introduction 
Omphalocele is a congenital abdominal wall defect with an estimated prevalence of 3.5 
per 10 000 births.1 Almost 90% of omphalocele cases are diagnosed prenatally,2 which 
allows for early parental counseling. Approximately 50-80% of fetuses have multiple 
congenital anomalies (MCA), leading to high rates of termination of pregnancy and 
intrauterine death.3, 4 Of live-born neonates with omphalocele, approximately 35% 
present with MCA (i.e. non-isolated omphalocele).5 For infants with an isolated 
omphalocele, survival rates up to 90% have been reported.3  
 
As medical options and survival rates have improved during the last decades,6 the focus 
of outcome research is shifting towards the long term, and parent-reported outcome 
measures are becoming increasingly relevant.7, 8 Many infants with omphalocele, 
especially those with giant omphalocele or MCA, have experienced morbidity in early 
life.4, 9 This morbidity includes respiratory failure, feeding difficulties, and having 
undergone surgery and other procedures under general anesthesia. Although these 
factors could negatively affect long-term outcomes,9, 10 information on outcomes 
beyond the age of five years is limited.11-13  
 
To optimize follow-up and to improve parental counseling, we evaluated parent-
reported motor function, cognition, health status, quality of life and behavior in school-
aged children (i.e. 4-17 years) treated for omphalocele. We hypothesized that these 
children would have more problems in daily life than healthy children; especially those 
with either giant omphalocele or MCA, considering the increased morbidity in early life. 
Secondarily, we sought to identify predictors of cognition and behavior at school age, 
including parent-perceived child vulnerability, infant clinical data, sociodemographic 
characteristics, and neurodevelopmental outcomes that had been evaluated at 2 years 
of age.4 
 
Methods 
Participants 
We sent paper questionnaires with a self-addressed envelope to the parents of all 
surviving children born with omphalocele between 2000 and 2012 and treated at our 
hospital. After birth, the parents had been offered to enter their child in the longitudinal 
prospective follow-up program that since 1999 is the standard of care for children with 
anatomical congenital anomalies treated at our hospital.14 Based on the favorable 
outcomes reported in 2009 and 2010,14, 15 the follow-up duration of children born with 
a minor omphalocele was limited to 2 years. 
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and behavior were similar to scores of matched controls. One quarter (26%) of children 
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although not significantly after correction for multiple testing. 
 
Conclusion 
Parent-reported outcomes of children with omphalocele at school age are reassuring. 
Children with an isolated, minor omphalocele do not need extensive long-term follow-
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especially those with giant omphalocele or MCA, have experienced morbidity in early 
life.4, 9 This morbidity includes respiratory failure, feeding difficulties, and having 
undergone surgery and other procedures under general anesthesia. Although these 
factors could negatively affect long-term outcomes,9, 10 information on outcomes 
beyond the age of five years is limited.11-13  
 
To optimize follow-up and to improve parental counseling, we evaluated parent-
reported motor function, cognition, health status, quality of life and behavior in school-
aged children (i.e. 4-17 years) treated for omphalocele. We hypothesized that these 
children would have more problems in daily life than healthy children; especially those 
with either giant omphalocele or MCA, considering the increased morbidity in early life. 
Secondarily, we sought to identify predictors of cognition and behavior at school age, 
including parent-perceived child vulnerability, infant clinical data, sociodemographic 
characteristics, and neurodevelopmental outcomes that had been evaluated at 2 years 
of age.4 
 
Methods 
Participants 
We sent paper questionnaires with a self-addressed envelope to the parents of all 
surviving children born with omphalocele between 2000 and 2012 and treated at our 
hospital. After birth, the parents had been offered to enter their child in the longitudinal 
prospective follow-up program that since 1999 is the standard of care for children with 
anatomical congenital anomalies treated at our hospital.14 Based on the favorable 
outcomes reported in 2009 and 2010,14, 15 the follow-up duration of children born with 
a minor omphalocele was limited to 2 years. 
 
7
Omphalocele at school age
139
At 2 years of age, the children's mental and motor development had been assessed using 
the Dutch version of the Bayley Developmental Scales16 or, from December 2003, the 
Bayley Scales of Infant Development-Second edition.17 Both tests provide a 
psychomotor and mental developmental index (mean score 100, SD 15). 
Neurodevelopmental outcomes at 2 years of age have been published previously.4 For 
the purpose of the current study, four children were excluded (figure 1). The Medical 
Ethical Review Board waived approval (‘Medical Research in Human Subjects Act does 
not apply to this research proposal’). 
 
Data collection  
Infant clinical data were retrieved from medical records. Infants born <37 weeks' 
gestation were considered preterm. Those with a birth weight <10th centile for Dutch 
reference curves were classified as small for gestational age.18 The omphalocele was 
labeled ‘giant’ if the defect diameter was ≥5 cm with liver protruding.19 We documented 
MCA that required surgery or multiple follow-up visits. Infants with time to full enteral 
feeding (TFEF) >6 weeks were diagnosed with intestinal failure. In one infant, TFEF 
exceeded 2 years, and data were documented as 730 days. Chronic lung disease was 
diagnosed in neonates who required supplemental oxygen for at least 28 days.20 
 
Socioeconomic status scores (population mean 0, SD 1) were based on postal codes at 
birth.21, 22 In addition, data on the child's living situation, medical information, and 
education were retrieved from a background questionnaire (supplemental file 1). 
Maternal and paternal education levels were based on the International Standard 
Classification of Education (ISCED) 2011, with ISCED 0-2 considered as low, ISCED 3-
4 as middle, and ISCED 5-8 as high level of education.23  
 
Measures 
We assessed the following outcome measures from parent-reported questionnaires 
(Dutch versions). A detailed description of each questionnaire is provided in 
supplemental file 1. Motor function was compared with Dutch reference data.24 For the 
analyses of cognition, health status, quality of life and behavior, for each child with 
omphalocele we included two healthy controls matched for age (maximum difference 
of one year), gender, and maternal education level (low, middle, or high; based on 
ISCED 2011).23 Matched controls were randomly selected from three recently collected 
datasets for different outcome measures (supplemental file 2). 
Child vulnerability: Child Vulnerability Scale (CVS).25, 26  
Motor function: Movement Assessment Battery for Children- Second Edition (MABC-2) 
Checklist.24, 27, 28 
Cognition: Parents of children aged ≥7 years rated cognitive functioning via the Pediatric 
Perceived Cognitive Function (PedsPCF) questionnaire.29 
 
Health status and quality of life: Pediatric Quality of Life Inventory (PedsQL; health 
status)30 and DUX-25 (quality of life). As no matched controls were available for DUX-
25 scores in 4 – 7 year-olds, these data were excluded. 
Behavior: Strengths and Difficulties Questionnaire (SDQ).31 
 
Statistical analysis 
Continuous variables are presented as median (IQR), and categorical variables as 
number (%). Baseline characteristics of responders and non-responders were compared 
using Mann-Whitney tests (continuous variables), and chi-square tests or Fisher's exact 
tests (categorical variables). One-sample Wilcoxon signed rank tests served to compare 
median scores of participants with those reported in the reference population; Mann-
Whitney U tests and Fisher's exact tests served to compare PedsPCF, PedsQL, DUX-
25 and SDQ scores between children with omphalocele and their matched controls. 
 
In this exploratory study, we used univariable linear regression analysis to find possible 
predictors of cognition and behavior at school age. These included parent-perceived 
child vulnerability, infant clinical data, sociodemographic characteristics, and 
neurodevelopmental outcomes at 2 years. A Bonferroni-adjusted significance level of 
0.05/18=0.003 was used in the linear regression analyses to correct for multiple testing 
of 18 possible predictors. Other results were considered significant at p<0.05. Statistical 
analyses were performed using SPSS V.24.0. 
 
Results 
Of 76 children treated for omphalocele, 58 (76%) survived. Four of them were excluded 
because of morbidities or diagnoses that influenced their development (figure 1). Of 54 
eligible participants, 31 (57%) returned the questionnaires (figure 1). The clinical or 
demographic characteristics did not differ significantly between responders and non-
responders (table 1); the difference in median socioeconomic status score between 
responders (0.36 (IQR: -0.31 to 0.90)) and non-responders (-0.68 (-1.06 to 0.35)) did 
not reach statistical significance (p=0.06).  
 
Background  
Participating children had a median age of 9 (IQR: 6 – 13; range: 5 – 17) years. All were 
raised by at least one biological parent; 27 (87%) children had two caregivers at home. 
Either the child's mother (n=23, 74%) or father (n=1, 3%), or both parents (n=7, 23%) 
completed the questionnaires. Eleven (35%) children used medication, because of 
gastrointestinal problems such as reflux or obstipation (n=5), attention deficit 
hyperactivity disorder (ADHD; n=2), sleeping problems (n=2), asthma (n=1), or eczema 
(n=1). Eight (26%) parents reported that their child had behavioral or emotional 
problems (ADHD and autism spectrum disorder: n=2; ADHD: n=1; dysfunctional 
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status)30 and DUX-25 (quality of life). As no matched controls were available for DUX-
25 scores in 4 – 7 year-olds, these data were excluded. 
Behavior: Strengths and Difficulties Questionnaire (SDQ).31 
 
Statistical analysis 
Continuous variables are presented as median (IQR), and categorical variables as 
number (%). Baseline characteristics of responders and non-responders were compared 
using Mann-Whitney tests (continuous variables), and chi-square tests or Fisher's exact 
tests (categorical variables). One-sample Wilcoxon signed rank tests served to compare 
median scores of participants with those reported in the reference population; Mann-
Whitney U tests and Fisher's exact tests served to compare PedsPCF, PedsQL, DUX-
25 and SDQ scores between children with omphalocele and their matched controls. 
 
In this exploratory study, we used univariable linear regression analysis to find possible 
predictors of cognition and behavior at school age. These included parent-perceived 
child vulnerability, infant clinical data, sociodemographic characteristics, and 
neurodevelopmental outcomes at 2 years. A Bonferroni-adjusted significance level of 
0.05/18=0.003 was used in the linear regression analyses to correct for multiple testing 
of 18 possible predictors. Other results were considered significant at p<0.05. Statistical 
analyses were performed using SPSS V.24.0. 
 
Results 
Of 76 children treated for omphalocele, 58 (76%) survived. Four of them were excluded 
because of morbidities or diagnoses that influenced their development (figure 1). Of 54 
eligible participants, 31 (57%) returned the questionnaires (figure 1). The clinical or 
demographic characteristics did not differ significantly between responders and non-
responders (table 1); the difference in median socioeconomic status score between 
responders (0.36 (IQR: -0.31 to 0.90)) and non-responders (-0.68 (-1.06 to 0.35)) did 
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Background  
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raised by at least one biological parent; 27 (87%) children had two caregivers at home. 
Either the child's mother (n=23, 74%) or father (n=1, 3%), or both parents (n=7, 23%) 
completed the questionnaires. Eleven (35%) children used medication, because of 
gastrointestinal problems such as reflux or obstipation (n=5), attention deficit 
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emotion regulation: n=3; tics: n=1; 'possible attachment disorder': n=1); three of these 
attended special education. In total, six (19%) children attended special education.  
 
Children with omphalocele
2000-2012
n=76
Deceased A
n=18 (24%)
Survived
n=58 Excluded
n=4
 - Inversion duplication chr3p:       n=1
 - Perinatal asphyxia:          n=1
 - Spastic quadriplegia:          n=1
 - Turner syndrome:          n=1
Eligible
n=54
Included B
n=31 (57%)
 - Child vulnerability (CVS): n=31
 - Motor function (MABC-2 Checklist): n=26*
 - Cognition (PedsPCF): n=23*
 - Health status (PedsQL): n=30*
 - Quality of life (DUX-25): n=23*
 - Behaviour (SDQ): n=31
No response
n=23 (43%)
 
 
Figure 1 Inclusion flow chart  
A Cause of death: pulmonary hypertension (n=5), chromosomal abnormality (n=4), multiple 
congenital anomalies (n=4), very large omphalocele with no treatment options (n=3), 
circulatory failure (n=1), midgut volvulus (n=1). B One parent with Dutch as a second 
language received also the English versions of the following questionnaires: CVS, MABC-2 
Checklist, PedsPCF, PedsQL, and SDQ. * Reasons for missing data: motor function (n=5): 
excluded because of >3 missing answers (n=4), questionnaire missing (n=1); cognition (n=8): 
child aged <7 years (n=8); health status (n=1): questionnaire missing (n=1); quality of life 
(n=8): child aged <8 years (n=8). CVS: Child Vulnerability Scale; MABC-2 Checklist: 
Movement Assessment Battery for Children- Second Edition Checklist; PedsPCF: Pediatric 
Perceived Cognitive Function questionnaire; PedsQL: Pediatric Quality of Life Inventory; 
SDQ: Strengths and Difficulties Questionnaire. 
 
  
 
Table 1 Infant clinical data and sociodemographic data of responders (n=31) and non-
responders (n=23) 
 n Responders 
n=31 (57%) 
n Non-
responders 
n=23 (43%) 
p 
value 
Age at current study (years) 31 9 (6-13) 23 10 (7-13) 0.92 
Infant clinical data      
Prenatal diagnosis 31 19 (61%) 23 16 (70%) 0.53 
Male sex 31 13 (42%) 23 15 (65%) 0.09 
Gestational age at birth 
(weeks) 
31 38.7 (37.0-
39.6) 
23 38.3 (37.7-39.6) 0.97 
Preterm birth 31 7 (23%) 23 2 (9%) 0.27 
Birth weight (grams) 31 3180 (2435-
3900) 
23 3180 (2730-
3550) 
0.94 
Small for gestational age 31 4 (13%) 23 5 (22%) 0.47 
Giant omphalocele 31 10 (32%) 23 7 (30%) 0.89 
Primary closure 31 22 (71%) 23 17 (74%) 0.81 
Multiple congenital anomalies A 31 11 (37%) 23 6 (26%) 0.46 
Number of procedures under 
general anesthesia 
29 2 (1-3) 23 2 (1-3) 0.93 
Duration of initial mechanical 
ventilation 
29 0 (0-1) 23 1 (0-3) 0.35 
Chronic lung disease 29 6 (21%) 23 2 (9%) 0.28 
Length of hospital stay (days) 29 13 (6-42) 23 11 (6-50) 0.73 
Time to full enteral feeding 
(days) 
28 7 (3-15) 22 8 (4-14) 0.78 
Intestinal failure 28 2 (7%) 22 3 (14%) 0.64 
Sociodemographic data      
Socio-economic status score  31 0.36 (-0.31 to 
0.90) 
23 -0.68 (-1.06 to 
0.35) 
0.06 
- Low status score (< -1)  6 (19%)  8 (35%) 0.20 
Maternal education level 30   n/a  
- Low (ISCED 0-2)  5 (17%)    
- Middle (ISCED 3-4)  8 (27%)    
- High (ISCED 5-8)  17 (57%)    
Paternal education level 28   n/a  
- Low (ISCED 0-2)  4 (14%)    
- Middle (ISCED 3-4)  8 (29%)    
- High (ISCED 5-8)  16 (57%)    
Two caregivers at home 31 27 (87%)  n/a  
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emotion regulation: n=3; tics: n=1; 'possible attachment disorder': n=1); three of these 
attended special education. In total, six (19%) children attended special education.  
 
Children with omphalocele
2000-2012
n=76
Deceased A
n=18 (24%)
Survived
n=58 Excluded
n=4
 - Inversion duplication chr3p:       n=1
 - Perinatal asphyxia:          n=1
 - Spastic quadriplegia:          n=1
 - Turner syndrome:          n=1
Eligible
n=54
Included B
n=31 (57%)
 - Child vulnerability (CVS): n=31
 - Motor function (MABC-2 Checklist): n=26*
 - Cognition (PedsPCF): n=23*
 - Health status (PedsQL): n=30*
 - Quality of life (DUX-25): n=23*
 - Behaviour (SDQ): n=31
No response
n=23 (43%)
 
 
Figure 1 Inclusion flow chart  
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child aged <7 years (n=8); health status (n=1): questionnaire missing (n=1); quality of life 
(n=8): child aged <8 years (n=8). CVS: Child Vulnerability Scale; MABC-2 Checklist: 
Movement Assessment Battery for Children- Second Edition Checklist; PedsPCF: Pediatric 
Perceived Cognitive Function questionnaire; PedsQL: Pediatric Quality of Life Inventory; 
SDQ: Strengths and Difficulties Questionnaire. 
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Table 1 (continued)      
 n Responders 
n=31 (57%) 
n Non-
responders 
n=23 (43%) 
p 
value 
Children in the household  
- Single (=patient) 
- Two children 
- More than two children 
31 
 
 
4 (13%) 
16 (52%) 
11 (35%) 
 n/a  
Neurodevelopmental data 
at 2 years 
     
Mental developmental index B 22 105 (96-113) 13 96 (84-108) 0.34 
- Delayed (<85) 22 3 (14%) 13 3 (23%) 0.65 
Psychomotor developmental 
index C 
17 89 (82-99) 11 83 (75-93) 0.24 
- Delayed (<85) 17 6 (35%) 11 6 (55%) 0.44 
Data are presented as median (IQR) or n (%). ISCED: International Standard Classification 
of Education. A Responders: Beckwith-Wiedemann Syndrome (n=3), intestinal atresia + 
microcolon (n=1), ileal cyst (n=1), cryptorchidism (n=1), cryptorchidism + ren arcuatus 
(n=1), aortic stenosis (n=1), patent ductus arteriosus (n=1), annular pancreas (n=1), urachal 
fistula + congenital neuroblastoma (n=1); non-responders: Beckwith-Wiedemann Syndrome 
(n=2), intestinal atresia (n=2), hemifacial microsomia (n=1), enlarged monokidney (n=1). B 
Missing data responders: organizational (n=4), non-cooperative child (n=3), parental refusal 
(n=2); missing data non-responders: organizational (n=2), non-cooperative child (n=1), 
parental refusal (n=6), emigrated (n=1). C Missing data responders: organizational (n=5), 
non-cooperative child (n=7), parental refusal (n=2); missing data non-responders: 
organizational (n=3), non-cooperative child (n=2), parental refusal (n=6), emigrated (n=1). 
 
Child vulnerability 
The CVS score of children with omphalocele (median 2 (IQR: 0-4)) was significantly 
higher than that reported in the reference population (i.e. median CVS: 1,25 p=0.005). 
Four (13%) children were perceived as being highly vulnerable; three had a giant 
omphalocele, and none of them had MCA.  
 
Motor function 
MABC-2 Checklist scores were available for 26 children (figure 1; giant omphalocele 
n=8). Twenty-one (81%) scored within the normal range, two (8%) had borderline 
scores, and three (12%) were highly likely to have motor problems. Most difficulties in 
these five children were reported on ball skills. Two of them had a giant omphalocele; 
two others had MCA. 
 
  
 
Cognition 
We analyzed PedsPCF scores for all 23 children aged 7 years or older. The median 
PedsPCF total score of children with omphalocele (122 (IQR: 97-137) was comparable 
with that of matched controls (125 (115-134), p=0.45) (table 2). Six (26%) children with 
omphalocele scored ≤-1 SD, compared with 4/46 (9%) matched controls (p=0.07). All 
six children with omphalocele who scored ≤-1 SD had MCA (of whom three had 
Beckwith-Wiedemann Syndrome); three of them had a giant omphalocele (figure 2). 
  
 
  
Figure 2 Scatter plot showing PedsPCF total scores 
Open symbols represent children with an isolated omphalocele, closed symbols represent 
children with multiple congenital anomalies. Dashed lines represent -1 standard deviation 
(102 for age 7-12 years; 104 for age 13-18 years). 
 
Health status 
PedsQL scores were available for 30 children. Their total score (median 88 (IQR: 70-
96)) was comparable to that of matched controls (83 (76-91), p=0.54), and so were the 
subscale scores (table 2). 
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Table 1 (continued)      
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Children in the household  
- Single (=patient) 
- Two children 
- More than two children 
31 
 
 
4 (13%) 
16 (52%) 
11 (35%) 
 n/a  
Neurodevelopmental data 
at 2 years 
     
Mental developmental index B 22 105 (96-113) 13 96 (84-108) 0.34 
- Delayed (<85) 22 3 (14%) 13 3 (23%) 0.65 
Psychomotor developmental 
index C 
17 89 (82-99) 11 83 (75-93) 0.24 
- Delayed (<85) 17 6 (35%) 11 6 (55%) 0.44 
Data are presented as median (IQR) or n (%). ISCED: International Standard Classification 
of Education. A Responders: Beckwith-Wiedemann Syndrome (n=3), intestinal atresia + 
microcolon (n=1), ileal cyst (n=1), cryptorchidism (n=1), cryptorchidism + ren arcuatus 
(n=1), aortic stenosis (n=1), patent ductus arteriosus (n=1), annular pancreas (n=1), urachal 
fistula + congenital neuroblastoma (n=1); non-responders: Beckwith-Wiedemann Syndrome 
(n=2), intestinal atresia (n=2), hemifacial microsomia (n=1), enlarged monokidney (n=1). B 
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higher than that reported in the reference population (i.e. median CVS: 1,25 p=0.005). 
Four (13%) children were perceived as being highly vulnerable; three had a giant 
omphalocele, and none of them had MCA.  
 
Motor function 
MABC-2 Checklist scores were available for 26 children (figure 1; giant omphalocele 
n=8). Twenty-one (81%) scored within the normal range, two (8%) had borderline 
scores, and three (12%) were highly likely to have motor problems. Most difficulties in 
these five children were reported on ball skills. Two of them had a giant omphalocele; 
two others had MCA. 
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PedsPCF total score of children with omphalocele (122 (IQR: 97-137) was comparable 
with that of matched controls (125 (115-134), p=0.45) (table 2). Six (26%) children with 
omphalocele scored ≤-1 SD, compared with 4/46 (9%) matched controls (p=0.07). All 
six children with omphalocele who scored ≤-1 SD had MCA (of whom three had 
Beckwith-Wiedemann Syndrome); three of them had a giant omphalocele (figure 2). 
  
 
  
Figure 2 Scatter plot showing PedsPCF total scores 
Open symbols represent children with an isolated omphalocele, closed symbols represent 
children with multiple congenital anomalies. Dashed lines represent -1 standard deviation 
(102 for age 7-12 years; 104 for age 13-18 years). 
 
Health status 
PedsQL scores were available for 30 children. Their total score (median 88 (IQR: 70-
96)) was comparable to that of matched controls (83 (76-91), p=0.54), and so were the 
subscale scores (table 2). 
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Quality of life 
The DUX-25 total score was analyzed in all 23 children aged 8 years or older. The 
DUX-25 total score of the latter (median 78 (IQR: 63-88) did not differ significantly 
from that of matched controls (82 (70-90), p=0.44), and neither did the subscale scores 
(table 2).  
 
Behavior 
SDQ scores were available for all 31 children. Their total difficulties score (median 8 
(IQR: 3-14)) did not differ significantly from that of matched controls (6 (2-10), p=0.30), 
and neither did the subscale scores (table 2). Two (6%) children with a minor 
omphalocele and MCA had an abnormal total difficulties score, compared with five (8%) 
matched controls (p=1.00).  
 
Predictors of cognition and behavior 
In univariable regression analyses for cognition, the most prominent associations were 
between giant omphalocele and a lower PedsPCF total score (unstandardized β -22.11 
(95% CI: -43.65 to -0.57), and between presence of MCA and a lower PedsPCF total 
score (-23.58 (-40.02 to -7.13); supplemental table 1).  
 
In the analyses for behavior, the most prominent associations were between higher 
parental education level and higher standard deviation score of the SDQ total difficulties 
score (0.56 (0.07 to 1.05)), and between presence of one caregiver at home and a lower 
standard deviation score (-1.29 (-2.39 to -0.20); supplemental table 2). The 
aforementioned associations all had p values <0.05 (i.e. they would be significant without 
adjustment for multiple testing), but were not statistically significant after adjustment 
for multiple testing. 
  
 
Table 2 Cognition, health status, quality of life and behavior of children with 
omphalocele compared with matched controls 
 Omphalocele A 
n=23 
Matched control group 
n=46 
p value 
Cognition (PedsPCF)    
Total score (7-17 year old); 
n=23 
122 (97-137) 125 (115-134) 0.45 
 Omphalocele A 
n=31 
Matched control group 
n=62 
p value 
Health status (PedsQL) B    
Total score (4-17 year old); 
n=30 
88 (70-96) 83 (76-91) 0.56 
- Physical functioning 92 (84-98) 91 (79-94) 0.35 
- Emotional functioning 78 (63-95) 75 (65-89) 0.84 
- Social functioning 93 (64-100) 90 (75-99) 0.88 
- School functioning  83 (60-95) 83 (71-95) 0.49 
Quality of life (DUX-25)    
Total score (8-17 year old); 
n=23 
78 (63-88) 82 (70-90) 0.48 
- Physical functioning 79 (54-92) 83 (70-100) 0.14 
- Emotional functioning 75 (54-96) 73 (63-89) 0.87 
- Social functioning 79 (64-89) 79 (68-89) 0.90 
- Home functioning 85 (65-95) 90 (80-100) 0.15 
 Omphalocele A 
n=31 
Matched control group 
n=62 
p value 
Behavior (SDQ)    
Total difficulties score (4-17 
year old); n=31 
8 (3-14) 6 (2-10) 0.30 
- Emotional problems 2 (0-4) 1 (0-3) 0.55 
- Conduct problems 1 (0-2) 1 (0-2) 0.38 
- Hyperactivity-
inattention 
3 (1-6) 3 (0-5) 0.22 
- Peer problems 1 (0-2) 1 (0-2) 0.24 
- Prosocial behavior 8 (7-9) 9 (8-10) 0.11 
Data are presented as median (IQR). p values were derived from Mann-Whitney U tests. 
A For one child, maternal education level was unknown. This child was matched to a control 
with middle maternal education level. B Complete questionnaire missing in n=1. PedsPCF: 
Pediatric Perceived Cognitive Function questionnaire; PedsQL: Pediatric Quality of Life 
Inventory; SDQ: Strengths and Difficulties Questionnaire. 
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Quality of life 
The DUX-25 total score was analyzed in all 23 children aged 8 years or older. The 
DUX-25 total score of the latter (median 78 (IQR: 63-88) did not differ significantly 
from that of matched controls (82 (70-90), p=0.44), and neither did the subscale scores 
(table 2).  
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omphalocele and MCA had an abnormal total difficulties score, compared with five (8%) 
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(95% CI: -43.65 to -0.57), and between presence of MCA and a lower PedsPCF total 
score (-23.58 (-40.02 to -7.13); supplemental table 1).  
 
In the analyses for behavior, the most prominent associations were between higher 
parental education level and higher standard deviation score of the SDQ total difficulties 
score (0.56 (0.07 to 1.05)), and between presence of one caregiver at home and a lower 
standard deviation score (-1.29 (-2.39 to -0.20); supplemental table 2). The 
aforementioned associations all had p values <0.05 (i.e. they would be significant without 
adjustment for multiple testing), but were not statistically significant after adjustment 
for multiple testing. 
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- Prosocial behavior 8 (7-9) 9 (8-10) 0.11 
Data are presented as median (IQR). p values were derived from Mann-Whitney U tests. 
A For one child, maternal education level was unknown. This child was matched to a control 
with middle maternal education level. B Complete questionnaire missing in n=1. PedsPCF: 
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Discussion 
We analyzed parent-reported motor function, cognition, health status, quality of life, 
and behavior in school-aged children with omphalocele. Most children with a minor, 
isolated omphalocele performed in line with normative expectations. Cognitive 
problems were reported more frequently in those with either a giant omphalocele or 
MCA.  
 
Few follow-up studies have addressed developmental outcomes and daily functioning of 
children with omphalocele at school age (supplemental table 3). Those studies usually 
had smaller sample sizes than our study (i.e. ≤20 children), and – in contrast to our 
study – used non-standardized questionnaires, combined different types of abdominal 
wall defects, or included only children with a giant omphalocele. In accordance with our 
results, these studies concluded that motor function,11, 13, 15 cognition,13, 32, 33 health 
status,34-36 and behavior32 fell within normal range. 
 
Thirteen percent of parents included in this study perceived their child as highly 
vulnerable, which is much higher than reported in previous literature on Dutch children 
(i.e. 2%).25 As developmental outcomes and daily functioning in children with 
omphalocele appeared to be normal, these parents may have heightened perceptions 
of their child's vulnerability. Parental concerns regarding the vulnerability of their child 
with an omphalocele are a natural reaction to an exceptional situation. Early parental 
counseling and support may help to lower the level of perceived vulnerability.  
 
In a previous study, we showed that over 80% of two-year-old children with a giant 
omphalocele had delayed motor development.4 In the current study, the parents of only 
two of eight children with a giant omphalocele reported delayed motor function at 
school age. This finding suggests that impaired motor function may be caught-up later 
in childhood. However, as questionnaires may not be sufficiently sensitive in diagnosing 
motor problems,37 and as these patient numbers are small, further research is 
warranted to draw more definite conclusions. 
 
Nineteen percent of children with omphalocele in our study attended special education. 
This is higher than reported in previous literature,12, 38 and almost four times higher 
than in the Dutch reference population (i.e. approximately 5%).39 Despite this, median 
PedsPCF scores were comparable with those of matched controls. Most likely, referral 
to special education is not mainly based on cognitive functioning, but could also be based 
on behavioral or emotional problems. Another explanation may be that parents 
perceive little discrepancy between the child's cognition and the level of education in 
special education. Linear regression analyses showed that especially children with a giant 
omphalocele and/or MCA may be a vulnerable group regarding cognitive functioning at 
 
school age. These children might benefit from prolonged follow-up and early 
intervention. 
 
Strengths of our study are the assessment of outcomes beyond the age of five years 
rather than at pre-school age, the use of matched controls, the fact that we considered 
omphalocele as a separate entity rather than combining data of all types of abdominal 
wall defects, and the availability of neurodevelopmental data at 2 years of age for most 
children. We used standardized parent-reported outcome measures, i.e. questionnaires 
were psychometrically validated and found to be sufficiently reliable and valid. One 
could say that parents may either over- or underestimate the child’s abilities, which 
would make parent-reported outcome measures less reliable or robust than more 
objective measures, such as IQ. However, despite the fact that global IQ testing can 
give valuable insight into overall cognitive functioning, it does not always identify 
children at risk for academic problems.40 In addition, as parents are largely responsible 
for seeking help for their children, using parent-reported outcomes may better reflect 
the care needs of these children. This also fits well within the family-centered approach 
to care, in which the vision of parents is essential.41 For more detailed evaluation of 
different influences on children’s problems, we assume that future studies could include 
multiple informants.42 
A limitation of our study is the low response rate of 57% and the higher median 
socioeconomic status score of responders compared with that of non-responders. 
Although this difference did not reach statistical significance, we cannot exclude the 
possibility of positive selection bias. Another potential limitation is the use of different 
control populations rather than using a personal control population; future studies may 
include siblings as matched controls to increase homogeneity.  
 
In conclusion, parent-reported outcomes of children with omphalocele at school age 
are reassuring. Children with an isolated, minor omphalocele do not need extensive 
long-term follow-up of daily functioning. Those with a giant omphalocele or multiple 
congenital anomalies might be at risk for delayed cognitive functioning at school age; we 
recommend long-term follow-up to offer timely intervention. 
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Discussion 
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on behavioral or emotional problems. Another explanation may be that parents 
perceive little discrepancy between the child's cognition and the level of education in 
special education. Linear regression analyses showed that especially children with a giant 
omphalocele and/or MCA may be a vulnerable group regarding cognitive functioning at 
 
school age. These children might benefit from prolonged follow-up and early 
intervention. 
 
Strengths of our study are the assessment of outcomes beyond the age of five years 
rather than at pre-school age, the use of matched controls, the fact that we considered 
omphalocele as a separate entity rather than combining data of all types of abdominal 
wall defects, and the availability of neurodevelopmental data at 2 years of age for most 
children. We used standardized parent-reported outcome measures, i.e. questionnaires 
were psychometrically validated and found to be sufficiently reliable and valid. One 
could say that parents may either over- or underestimate the child’s abilities, which 
would make parent-reported outcome measures less reliable or robust than more 
objective measures, such as IQ. However, despite the fact that global IQ testing can 
give valuable insight into overall cognitive functioning, it does not always identify 
children at risk for academic problems.40 In addition, as parents are largely responsible 
for seeking help for their children, using parent-reported outcomes may better reflect 
the care needs of these children. This also fits well within the family-centered approach 
to care, in which the vision of parents is essential.41 For more detailed evaluation of 
different influences on children’s problems, we assume that future studies could include 
multiple informants.42 
A limitation of our study is the low response rate of 57% and the higher median 
socioeconomic status score of responders compared with that of non-responders. 
Although this difference did not reach statistical significance, we cannot exclude the 
possibility of positive selection bias. Another potential limitation is the use of different 
control populations rather than using a personal control population; future studies may 
include siblings as matched controls to increase homogeneity.  
 
In conclusion, parent-reported outcomes of children with omphalocele at school age 
are reassuring. Children with an isolated, minor omphalocele do not need extensive 
long-term follow-up of daily functioning. Those with a giant omphalocele or multiple 
congenital anomalies might be at risk for delayed cognitive functioning at school age; we 
recommend long-term follow-up to offer timely intervention. 
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Supplemental material 
 
Supplemental file 1 Description of questionnaires 
 
We used Dutch versions of all questionnaires. All questionnaires were parent-reported. 
If two answers were selected for one question, we documented the most unfavorable 
score. 
 
Background 
Description: We asked caregivers to report the following background information: child's 
living situation (e.g. with biological parents or in a foster family, presence of two 
caregivers, number of children), maternal and paternal education levels (based on the 
International Standard Classification of Education 2011),1 medical (use of medication, 
hospital admissions, use of medical aids such as a wheelchair or parenteral nutrition), 
educational  (e.g. regular or special, grade repetition, learning difficulties, need of extra 
help at school), social-emotional functioning (presence of behavioral or emotional 
problems), and main language spoken at home.  
 
Child vulnerability 
Child Vulnerability Scale (CVS) 2, 3 
Description: The CVS is an 8-item questionnaire on parental perceptions of their child's 
vulnerability. Each item states a problem, for example 'my child gets more colds than 
other children I know'. Answers vary from strongly disagree (=0) to strongly agree (=3) 
on a 4-point Likert scale. Total scores range from 0-24; higher scores reflect higher 
perceived vulnerability. We used a cut-off of ≥10 for high perception of vulnerability.  
Validated: This questionnaire has been validated for Dutch children aged 5-18 years.2 
 
Motor function 
Movement Assessment Battery for Children - Second Edition (MABC-2) Checklist 4-6 
Description: The M-ABC 2 Checklist is aimed at evaluating motor problems in daily life. 
Section A measures movement in a static (or predictable) environment; section B 
measures movement in a dynamic (or unpredictable) environment. Both sections 
consist of 15 items. Each of the 30 items states a skill, for example 'rides a bicycle 
without stabilizers'. The parent indicates to what extent the child is able to do this, 
varying from very well (=0) to not close (=3). Scores are reported using a Traffic Light 
color system, corrected for age, with high scores representing poor performance. 
'Green zone' indicates a score within the normal range (< 85th centile); 'amber zone' 
means that the child is at risk for motor problems (85th-94th centile), and a score in the 
'red zone' indicates a high possibility of serious motor problems (≥ 95th centile).  
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'Green zone' indicates a score within the normal range (< 85th centile); 'amber zone' 
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Validated: This questionnaire has been validated for Dutch children aged 3-16 years.6 As 
no Dutch reference norms exist for 17-year old children, these children were scored 
according to reference norms for 16-year olds.  
 
Cognition 
Pediatric Perceived Cognitive Function (PedsPCF) questionnaire 7 
Description: The PedsPCF assesses the child's cognitive functioning as perceived by the 
parent, referring to the past four weeks. Each item reflects a problem, for example 
'forgets things easily'. Answers vary from very much/all of the time (=1) to not at 
all/none of the time (=5) on a 5-point Likert scale. Based on preliminary results of the 
collection of Dutch reference data, we used only the first 30 items of the PedsPCF 
rather than the full-length PedsPCF (which counts 43 items), and we used the following 
cut-offs of ≤-1 standard deviation (SD): 102 (7-12 years), 104 (13-18 years). Total scores 
range from 30-150; higher scores reflect better cognitive functioning.  
Validated: This questionnaire has been validated for Dutch children aged 7-18 years.8 
 
Health status 
Pediatric Quality of Life Inventory (PedsQL) 9 
Description: The PedsQL is an instrument for measuring health status in children and 
adolescents. It consists of four subscales: physical (8 items), emotional (5 items), social 
(5 items) and school functioning (5 items). Each item reflects a problem, for example 
'problems with running'. Answers vary from never (=0) to almost always (=4) on a 5-
point Likert scale. Each answer is reversed scored and rescaled to a 0-100 scale (0=100, 
4=0). Total scores range from 0-100; higher scores reflect better quality of life. We 
used the version that referred to the past month.  
Validated: This questionnaire has been validated for Dutch children aged 5-18 years.10 
 
Quality of life 
DUX-25 
Description: The DUX-25 is a visual health-related quality of life questionnaire. Each 
question evaluates the child's feelings in daily life, for example 'your child often feels …'. 
It consists of four subscales: physical (6 items), emotional (7 items), social (7 items) and 
home functioning (5 items). Answers are scored on a happy-to-sad faces scale by use 
of smileys. These smileys visualize a 5-point Likert scale, ranging from sad (=0) to happy 
(=100). Total scores range from 0-100; higher scores reflect better quality of life.  
Validated: Dutch reference data are currently being analyzed (age 8-17 years).  
 
  
 
Behavior 
Strengths and Difficulties Questionnaire (SDQ) 11 
Description: The SDQ covers the most important domains of child psychopathology and 
personal strengths. It consists of five subscales: emotional symptoms, conduct problems, 
hyperactivity-inattention, peer problems, and prosocial behavior. Each item is scored 
on a 3-point Likert scale; answer vary from not true (=0) to certainly true (=2). Higher 
scores reflect more difficulties, except for the prosocial scale where higher scores 
reflect strengths. All but the prosocial behavior subscale scores are summed to generate 
a total difficulties score. Total scores range from 0-40. The total difficulties score was 
categorized into 'normal' or 'abnormal' using age-dependent cut-off values.11 
Validated: This questionnaire has been validated for Dutch children aged 2-18 years.11 In 
children aged <6 years, no SD scores or cut-off values were available for 'conduct 
problems' and 'peer problems' due to insufficient internal consistency of these subscales 
in this age group. 
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Validated: This questionnaire has been validated for Dutch children aged 3-16 years.6 As 
no Dutch reference norms exist for 17-year old children, these children were scored 
according to reference norms for 16-year olds.  
 
Cognition 
Pediatric Perceived Cognitive Function (PedsPCF) questionnaire 7 
Description: The PedsPCF assesses the child's cognitive functioning as perceived by the 
parent, referring to the past four weeks. Each item reflects a problem, for example 
'forgets things easily'. Answers vary from very much/all of the time (=1) to not at 
all/none of the time (=5) on a 5-point Likert scale. Based on preliminary results of the 
collection of Dutch reference data, we used only the first 30 items of the PedsPCF 
rather than the full-length PedsPCF (which counts 43 items), and we used the following 
cut-offs of ≤-1 standard deviation (SD): 102 (7-12 years), 104 (13-18 years). Total scores 
range from 30-150; higher scores reflect better cognitive functioning.  
Validated: This questionnaire has been validated for Dutch children aged 7-18 years.8 
 
Health status 
Pediatric Quality of Life Inventory (PedsQL) 9 
Description: The PedsQL is an instrument for measuring health status in children and 
adolescents. It consists of four subscales: physical (8 items), emotional (5 items), social 
(5 items) and school functioning (5 items). Each item reflects a problem, for example 
'problems with running'. Answers vary from never (=0) to almost always (=4) on a 5-
point Likert scale. Each answer is reversed scored and rescaled to a 0-100 scale (0=100, 
4=0). Total scores range from 0-100; higher scores reflect better quality of life. We 
used the version that referred to the past month.  
Validated: This questionnaire has been validated for Dutch children aged 5-18 years.10 
 
Quality of life 
DUX-25 
Description: The DUX-25 is a visual health-related quality of life questionnaire. Each 
question evaluates the child's feelings in daily life, for example 'your child often feels …'. 
It consists of four subscales: physical (6 items), emotional (7 items), social (7 items) and 
home functioning (5 items). Answers are scored on a happy-to-sad faces scale by use 
of smileys. These smileys visualize a 5-point Likert scale, ranging from sad (=0) to happy 
(=100). Total scores range from 0-100; higher scores reflect better quality of life.  
Validated: Dutch reference data are currently being analyzed (age 8-17 years).  
 
  
 
Behavior 
Strengths and Difficulties Questionnaire (SDQ) 11 
Description: The SDQ covers the most important domains of child psychopathology and 
personal strengths. It consists of five subscales: emotional symptoms, conduct problems, 
hyperactivity-inattention, peer problems, and prosocial behavior. Each item is scored 
on a 3-point Likert scale; answer vary from not true (=0) to certainly true (=2). Higher 
scores reflect more difficulties, except for the prosocial scale where higher scores 
reflect strengths. All but the prosocial behavior subscale scores are summed to generate 
a total difficulties score. Total scores range from 0-40. The total difficulties score was 
categorized into 'normal' or 'abnormal' using age-dependent cut-off values.11 
Validated: This questionnaire has been validated for Dutch children aged 2-18 years.11 In 
children aged <6 years, no SD scores or cut-off values were available for 'conduct 
problems' and 'peer problems' due to insufficient internal consistency of these subscales 
in this age group. 
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Supplemental file 2 Description of matched controls 
 
We obtained matched controls from three different datasets, as described below. 
Controls were matched for age (maximum difference of one year), gender, and 
maternal education level (low, middle, or high; based on the International Standard 
Classification of Education 20111). Controls were selected randomly using an online 
randomizer. If the maternal education level of a case was unknown, this case was 
matched with two controls with middle maternal education level.  
 
Cognition  
Pediatric Perceived Cognitive Function (PedsPCF) questionnaire 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsPCF.2 A general population sample of parents and their children had been 
approached through research agency Kantar TNS in January 2016. This study included 
children with a chronic health condition, such as asthma or diabetes mellitus. This study 
used online questionnaires. We used the parent-reported data. 
 
Health status and quality of life  
Pediatric Quality of Life Inventory (PedsQL) and DUX-25 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsQL (4-17 years) and the DUX-25 (8-17 years) (publications in preparation). 
Children with a chronic health condition had been excluded from this study; those with 
attention deficit hyperactivity disorder had been included. Online questionnaires had 
been sent to caregivers and their children, who were recruited via primary and 
secondary schools in the Netherlands from April 2015 till March 2016. We used the 
parent-reported data.  
 
Behavior  
Strengths and Difficulties Questionnaire (SDQ) 
Matched controls were obtained from the database of Maurice-Stam and coworkers.3 
A general population sample of parents had been approached through research agency 
Kantar TNS in November and December 2014. 
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Supplemental file 2 Description of matched controls 
 
We obtained matched controls from three different datasets, as described below. 
Controls were matched for age (maximum difference of one year), gender, and 
maternal education level (low, middle, or high; based on the International Standard 
Classification of Education 20111). Controls were selected randomly using an online 
randomizer. If the maternal education level of a case was unknown, this case was 
matched with two controls with middle maternal education level.  
 
Cognition  
Pediatric Perceived Cognitive Function (PedsPCF) questionnaire 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsPCF.2 A general population sample of parents and their children had been 
approached through research agency Kantar TNS in January 2016. This study included 
children with a chronic health condition, such as asthma or diabetes mellitus. This study 
used online questionnaires. We used the parent-reported data. 
 
Health status and quality of life  
Pediatric Quality of Life Inventory (PedsQL) and DUX-25 
Matched controls were obtained from a study that collected Dutch normative data for 
the PedsQL (4-17 years) and the DUX-25 (8-17 years) (publications in preparation). 
Children with a chronic health condition had been excluded from this study; those with 
attention deficit hyperactivity disorder had been included. Online questionnaires had 
been sent to caregivers and their children, who were recruited via primary and 
secondary schools in the Netherlands from April 2015 till March 2016. We used the 
parent-reported data.  
 
Behavior  
Strengths and Difficulties Questionnaire (SDQ) 
Matched controls were obtained from the database of Maurice-Stam and coworkers.3 
A general population sample of parents had been approached through research agency 
Kantar TNS in November and December 2014. 
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Abstract 
 
Objective  
To improve counseling on congenital lung malformations (CLM) by describing long-term 
outcomes of children either operated on or managed by observation. 
 
Study design  
We analyzed lung function (spirometry), exercise tolerance (Bruce treadmill), and 
physical growth of 8-year-old children with CLM who participated in our longitudinal 
prospective follow-up program. Data are shown as median SD scores (SDS) with IQR, 
or estimated marginal means (95% CI) on the basis of general linear models. 
 
Results 
Twenty-nine (48%) of the 61 children had required surgery at a median age of 108 (IQR: 
8-828) days, and 32 (52%) were managed by observation. In the surgery group, all lung 
function measurements (except for FVC) were significantly below 0 SDS, with median 
FEV1 -1.07 (IQR: -1.70 to -0.56), FEV1/FVC -1.49 (-2.62 to -0.33), and FEF25-75% -1.95 
(-2.57 to -0.63) (all p<0.001). Children in the observation group had normal FEV1 and 
FVC, whereas FEV1/FVC (-0.81 (-1.65 to -0.14)) and FEF25-75% (-1.14 (-1.71 to -0.22)) 
were significantly below 0 SDS (both p<0.001). Mean exercise tolerance was 
significantly below 0 SDS in both groups (observation: -0.85 (95% CI: -1.30 to -0.41); 
surgery: -1.25 (-1.69 to -0.80)); eight (28%) children in the observation group, and ten 
(40%) in the surgery group scored <-1 SDS. Physical growth was normal in both groups. 
 
Conclusion  
Children with CLM may be at risk for reduced lung function and exercise tolerance, 
especially those who required surgery. As little pulmonary morbidity was found in 
children with asymptomatic CLM, this study supports a watchful waiting approach in 
this group.  
  
 
Introduction 
Congenital lung malformations (CLM) are a heterogeneous group of malformations, 
including congenital pulmonary airway malformation (CPAM), bronchopulmonary 
sequestration, congenital lobar emphysema, bronchogenic cysts, and hybrid forms of 
these lesions.1 CLM are increasingly detected prenatally as a result of routine fetal 
anomaly scanning and improved ultrasound technology. The current estimated 
incidence is 4.15 per 10 000 births.2 Children with CLM who develop symptoms, either 
directly after birth or later in life, undergo surgery. However, the majority of children 
with CLM remain asymptomatic. The best management strategy – i.e. elective surgical 
resection or watchful waiting – in these children remains controversial, because of 
uncertainty about the risk of postoperative complications, the most accurate timing of 
surgical resection, and the risks of infection and malignancy related with watchful 
waiting.3, 4 A previous study at our center showed airflow obstruction in approximately 
one-third of children with CLM at the ages of 6 and 12 months, both in those who had 
required surgery and in those who remained asymptomatic.5 The data on the long-term 
outcome are scarce, especially in children with asymptomatic CLM.6-8  
 
To optimize follow-up and to improve counselling, we primarily aimed to describe 
pulmonary outcomes (i.e. lung function, exercise tolerance and lower respiratory tract 
infections (LRTIs)) and physical growth in 8-year-old children with CLM; both in those 
operated on and those managed by observation. We hypothesized that children with 
asymptomatic CLM have normal growth and no pulmonary morbidity, and that children 
who needed surgery have a more complicated clinical course with growth failure and 
pulmonary morbidity. Secondarily, physical growth, exercise tolerance, and LRTIs were 
evaluated longitudinally in all children. 
 
Materials and methods 
Study population 
We analyzed prospectively collected data of live-born children born with CLM between 
January 1999 and March 2010, and followed in the Erasmus Medical Center-Sophia 
Children's Hospital Rotterdam. These children had been diagnosed either prenatally or 
after birth, due to symptoms or coincidentally. The postnatal diagnosis had been made 
using computed tomography (CT) and/or histology. In our hospital, we advocate a wait-
and-see policy in children with asymptomatic CLM; this group is scheduled for CT-
imaging approximately 6 months after birth. Those who develop symptoms – such as 
respiratory distress after birth or recurrent LRTIs – undergo surgical resection, usually 
after a CT-scan is made. Parents of all surviving children with CLM are invited to enter 
their child in our longitudinal prospective follow-up program. Since 1999, this program 
is the standard of care for children with anatomical congenital malformations treated in 
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our center.9 Follow-up visits are planned at the ages of 1, 2, 5 and 8 years. The Medical 
Ethical Review Board waived approval because data obtained during routine care were 
retrospectively analyzed (MEC-2018-1086). 
 
Variables and definitions 
Neonates born <37 weeks' gestation were considered preterm. Those with a birth 
weight below the 10th centile of Dutch reference curves were considered small for 
gestational age.10 Multiple congenital anomalies (MCA) were only documented if they 
required surgery or multiple follow-up visits. We registered the need for hospitalization 
within 28 days after birth, including the length of stay (LOS) and the need for and 
duration of respiratory support (i.e. supplemental oxygen only, mechanical ventilation 
or extracorporeal membrane oxygenation (ECMO)). Children who had required 
supplemental oxygen for at least 28 days were diagnosed with chronic lung disease.11 
Spinal and thoracic deformities were assessed during a physical examination at 8 years 
of age. 
 
Pulmonary outcomes 
Lung function 
Dynamic lung volumes were measured using spirometry at the age of 8 years. We 
documented the forced expiratory volume in 1 second (FEV1), forced vital capacity 
(FVC), FEV1/FVC, and the forced expiratory flow (FEF) at 25-75% of FVC (FEF25-75%). 
Standard deviation scores (SDS) were calculated according to the Global Lung Initiative 
2012, with -1.64 to +1.64 SDS considered as normal range.12 In addition, bronchodilator 
reversibility was reported. Significant reversibility was defined as an increase in FEV1 of 
>12% compared to the pre-bronchodilator test. Static lung volumes were measured by 
body plethysmography and expressed in residual volume (RV), total lung capacity (TLC), 
and RV/TLC. Diffusion capacity was assessed with carbon monoxide diffusion (DLCO) 
and DLCO corrected for alveolar volume (DLCO/VA). SDS for static lung volumes and 
diffusion capacity were calculated according to the Utrecht data set.13 
 
Exercise tolerance 
Exercise tolerance was determined with the Bruce treadmill protocol14. Time to 
maximal effort was assessed at 5 and 8 years, and converted to SDS according to Dutch 
reference values.15, 16  
 
Occurrence of lower respiratory tract infections 
At each follow-up visit (1, 2, 5 and 8 years), parents reported whether or not their child 
had had suffered from an LRTI in the past year. Only LRTIs treated with antibiotics 
were documented.  
 
 
Additional imaging 
The program does not include routine imaging at 8 years of age yet. Children were, 
however, referred to the pediatric pulmonologist in a low-threshold setting. 
 
Physical growth 
Height and weight were measured at 1, 2, 5 and 8 years of age. We calculated height-
for-age (HFA) and weight-for-height (WFH) SDS according to Dutch reference norms; 
-2 to +2 SDS was considered normal range.17, 18 Target height SDS was calculated from 
parental heights.19 To correct HFA for target height, distance-to-target-height (DTH) 
SDS was calculated as follows: DTH SDS = HFA SDS – target height SDS.  
 
Statistical analysis 
Data are summarized as number (%) or median (interquartile range, IQR), as 
appropriate. Differences in characteristics between the observation group and the 
surgery group were evaluated with chi-square or Fisher's exact tests for categorical 
data, and with Mann-Whitney tests for continuous data. We assessed with Wilcoxon 
signed-rank tests whether median lung function parameters were below 0 SDS. The 
courses of exercise tolerance and physical growth over time were evaluated with 
general linear models. These models included the following independent variables: need 
for surgery (coded as a time-dependent dichotomous variable: negative before and 
positive after surgery), the time point (5 and 8 years in case of exercise tolerance; 1, 2, 
5 and 8 years in case of physical growth), the interaction effect of the need for surgery 
and time point, and presence of MCA. To account for within-subject correlations, we 
used an unstructured error covariance matrix. The results are summarized as estimated 
marginal means (i.e. the predicted values of the dependent variable, adjusted for 
covariates in the model) with their 95% confidence intervals (95% CIs). Statistical 
analyses were performed using IBM SPSS Statistics 24, with a two-sided significance level 
of 0.05.  
 
Results 
Of 79 infants born with CLM between January 1999 and March 2010, 76 (96%) had 
survived. The three others, who had been diagnosed prenatally, had died within 2 weeks 
after birth. Two of them had a pneumonectomy because of CPAM in the entire lung, 
and required ECMO for 5 and 13 days, respectively. Both died because of therapy-
resistant pulmonary hypertension. The other infant was diagnosed with 
bronchopulmonary sequestration and died of cecum perforation complicated by septic 
shock and intracerebral hemorrhage. 
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Surviving children
n=76
In follow-up at 8 years 
n=61
No follow-up at 8 years 
n=15
 - Diagnosed >8 years:    n=1
 - Refusal:                     n=11
 - Organizational:           n=3
Complete follow-up 
(at 1, 2, 5, 8 years) 
n=43
 - Observation:      n=23 
 - Surgery before FU at 1y:    n=17 
 - Surgery between FU 1-2y:  n=1 
 - Surgery between FU 2-5y:  n=2 
Incomplete follow-up* 
n=18
 - Observation:       n=9 
 - Surgery before FU at 1y:     n=2 
 - Surgery between FU 1-2y:   n=3 
 - Surgery between FU 2-5y:   n=2
 - Surgery between FU 5-8y:   n=2 
Children with CLM born
Jan 1999 - Mar 2010
n=79
Deceased
n=3
 
 
Figure 1 Inclusion flow chart 
CLM: congenital lung malformations, FU: follow-up, y: years.  
* Reasons for incomplete follow-up: organizational (n=10; seen at 1, 5 and 8y: n=1; seen at 
2, 5 and 8y: n=4; seen at 5 and 8y: n=4; seen at 8y: n=1), refusal (n=6; seen at 1, 2 and 8y: 
n=3; seen at 1, 5 and 8y: n=3), diagnosed >1y (n=1, seen at 2, 5 and 8y), diagnosed >2y (n=1, 
seen at 5 and 8y). 
 
Sixty-one (80%) children underwent  follow-up examination at 8 years of age, of whom 
43 (70%) had been seen at all four time points (figure 1). Characteristics of children 
examined at 8 years and those not examined did not differ significantly, except for the 
proportion of children not subjected to CT or histology, which was higher in those not 
examined (supplemental table 1). Supplemental figure 1 provides an overview of the 
number of children per follow-up time point, categorized according to type of 
management (i.e. observation or surgery). 
 
Twenty-nine of the 61 (48%) children had undergone surgery at a median age of 108 
(IQR: 8-828) days. The indications for surgery were respiratory insufficiency (14/29, 
48%), recurrent infections (7/29, 24%), increasing size (3/29, 7%), and miscellaneous 
(5/29, 17%). One child with an extralobar bronchopulmonary sequestration had 
undergone embolization of the aberrant artery at 3 years of age because of cardiac 
insufficiency. This child was included in the surgery group. No features of malignancy 
 
were found in any of the resected specimens. The children in the surgery group had 
less often been diagnosed prenatally; they had a slightly shorter median gestational age 
at birth; and they had more often required mechanical ventilation than those in the 
observation group (table 1). 
 
Table 1 Prenatal, perinatal and postnatal characteristics of children examined at 8 years 
(n=61) 
 n Observation 
group 
n=32; 52% 
n Surgery  
group A 
n=29; 48% 
p 
value 
Maternal age (years)  31 30.7 (29.0-35.1) 22 29.6 (26.9-35.1) 0.43 
Male sex 32 16 (50%) 29 20 (69%) 0.13 
Multiple pregnancy 32 - 29 2 (7%) 0.22 
Prenatal characteristics      
Prenatal diagnosis 32 29 (91%) 29 18 (62%) 0.01 
- Gestational age 
(weeks) at diagnosis 
29 20.4 (19.9-21.7) 15 20.9 (20.1-29.0) 0.15 
Perinatal characteristics     
Cesarean section 32 8 (25%) 23 2 (9%) 0.17 
Gestational age at birth 
(weeks)  
32 39.6 (28.9-41.0) 25 38.7 (36.5-40.1) 0.02 
Preterm birth  32 3 (9%) 29 7 (24%) 0.17 
Birth weight (grams)  32 3503 (2878-3879) 26 3070 (2838-3648) 0.13 
Small for gestational age 32 3 (9%) 22 1 (5%) 0.64 
Apgar score at 5 min  32 9 (9-10) 23 9 (8-10) 0.64 
- Apgar score <7 at 5 
min  
32 2 (6%) 24 2 (8%) 1.00 
Umbilical cord pH 29 7.28 (7.26-7.34) 16 7.30 (7.26-7.36) 0.64 
Postnatal characteristics     
Type of CLM 32  29   
- CPAM  15 (47%)  13 (45%) 0.87 
- Bronchopulmonary 
sequestration 
 5 (16%)  8 (28%) 0.26 
- Congenital lobar 
emphysema 
 4 (13%)  4 (14%) 1.00 
- Bronchogenic cyst  -  2 (7%) 0.22 
- Hybrid or  
inconclusive B 
 4 (13%)  2 (7%) 0.67 
- CLM in regression  3 (9%)  - 0.24 
- Insufficient diagnostics 
(no CT or histology) 
 1 (3%)  - 1.00 
CT imaging available 32 31 (97%) 29 25 (86%) 0.18 
- Age at CT (months) 31 3.0 (0.1-4.5) 25 1.3 (0.1-6.3) 0.84 
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Cesarean section 32 8 (25%) 23 2 (9%) 0.17 
Gestational age at birth 
(weeks)  
32 39.6 (28.9-41.0) 25 38.7 (36.5-40.1) 0.02 
Preterm birth  32 3 (9%) 29 7 (24%) 0.17 
Birth weight (grams)  32 3503 (2878-3879) 26 3070 (2838-3648) 0.13 
Small for gestational age 32 3 (9%) 22 1 (5%) 0.64 
Apgar score at 5 min  32 9 (9-10) 23 9 (8-10) 0.64 
- Apgar score <7 at 5 
min  
32 2 (6%) 24 2 (8%) 1.00 
Umbilical cord pH 29 7.28 (7.26-7.34) 16 7.30 (7.26-7.36) 0.64 
Postnatal characteristics     
Type of CLM 32  29   
- CPAM  15 (47%)  13 (45%) 0.87 
- Bronchopulmonary 
sequestration 
 5 (16%)  8 (28%) 0.26 
- Congenital lobar 
emphysema 
 4 (13%)  4 (14%) 1.00 
- Bronchogenic cyst  -  2 (7%) 0.22 
- Hybrid or  
inconclusive B 
 4 (13%)  2 (7%) 0.67 
- CLM in regression  3 (9%)  - 0.24 
- Insufficient diagnostics 
(no CT or histology) 
 1 (3%)  - 1.00 
CT imaging available 32 31 (97%) 29 25 (86%) 0.18 
- Age at CT (months) 31 3.0 (0.1-4.5) 25 1.3 (0.1-6.3) 0.84 
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Table 1 (continued)      
 n Observation 
group 
n=32; 52% 
n Surgery  
group A 
n=29; 48% 
p 
value 
Localization of CLM 32  29   
- Left upper lobe  5 (16%)  3 (10%) 0.71 
- Left lower lobe  7 (22%)  8 (28%) 0.61 
- Right upper lobe  4 (13%)  - 0.11 
- Right middle lobe  1 (3%)  1 (3%) 1.00 
- Right lower lobe  13 (41%)  8 (28%) 0.28 
- Multilobar  2 (6%)  4 (14%) 0.41 
- Mediastinal  -  3 (10%) 0.10 
- Extralobar  -  2 (7%) 0.22 
Multiple congenital 
anomalies C 
32 6 (19%) 27 5 (17%) 0.88 
Hospitalized ≤28 days after 
birth 
32 32 (100%) 27 24 (89%) 0.09 
- Duration (days) 32 4 (2-8) 23 14 (3-29) 0.003 
- Respiratory support 
during hospitalization 
32  24   
- None  21 (66%)  7 (29%) 0.01 
- Supplemental oxygen 
only 
 8 (25%)  4 (17%) 0.45 
- Mechanical ventilation  3 (9%)  10 (42%) 0.01 
- ECMO  -  3 (13%) 0.07 
- Chronic lung disease 32 - 27 3 (11%) 0.09 
Data presented as median (interquartile range) or n (%). CLM: congenital lung malformation; 
CPAM: congenital pulmonary airway malformation; CT: computed tomography; ECMO: 
extracorporeal membrane oxygenation; n/a: not applicable. A Thoracotomy (n=20); 
thoracoscopy (n=6); laparotomy (n=1); embolization (n=1); unknown (n=1). B CPAM and/or 
congenital lobar emphysema (n=3); CPAM and/or bronchogenic cyst (n=3). C Ventricular 
septal defect (n=2); atrial septal defect (n=2); tetralogy of Fallot (n=1); patent ductus 
arteriosus and duplicated renal collecting system (n=1); laryngeal cyst (n=1); Filamin A 
deficiency (n=1); congenital diaphragmatic hernia (n=1); bladder exstrophy and anal atresia 
and duplicated renal collecting system (n=1); bilateral ovarian cysts (n=1).  
 
 
Spinal and thoracic deformities were assessed in 56 (92%) children at 8 years of age. 
None of them had scoliosis. One child in the observation group had pectus excavatum 
(1/28; 4%) versus three children in the surgery group (3/28; 11%). These three children 
had all undergone thoracotomy.  
  
 
Pulmonary outcomes  
Lung function  
Reliable spirometry tests at 8 years of age were obtained in 57/61 (93%) children. 
Spirometry results per diagnosis are shown in figure 2. Overall, children in the 
observation group (n=31) had median FEV1 SDS (-0.37 (IQR: -0.94 to 0.49)) and FVC 
SDS (0.10 (-0.59 to 0.74)) comparable to reference norms, whereas median FEV1/FVC 
SDS (-0.81 (-1.65 to -0.14)) and FEF25-75% SDS (-1.14 (-1.71 to -0.22)) were significantly 
below 0 (both p<0.001). Four (13%) children scored FEV1 <-1.64 SDS, two (6%) scored 
FVC <-1.64 SDS, and FEV1/FVC and FEF25-75% were <-1.64 SDS in eight (26%) children.  
 
 
 
Figure 2 Scatter plots showing lung functions at 8 years of age in the observation group 
and in the surgery group, per diagnosis 
FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; FEF25-75%: forced 
expiratory flow at 25-75% of FVC; CPAM: congenital pulmonary airway malformation; CLM: 
congenital lung malformation. 
Chapter 9
196
Table 1 (continued)      
 n Observation 
group 
n=32; 52% 
n Surgery  
group A 
n=29; 48% 
p 
value 
Localization of CLM 32  29   
- Left upper lobe  5 (16%)  3 (10%) 0.71 
- Left lower lobe  7 (22%)  8 (28%) 0.61 
- Right upper lobe  4 (13%)  - 0.11 
- Right middle lobe  1 (3%)  1 (3%) 1.00 
- Right lower lobe  13 (41%)  8 (28%) 0.28 
- Multilobar  2 (6%)  4 (14%) 0.41 
- Mediastinal  -  3 (10%) 0.10 
- Extralobar  -  2 (7%) 0.22 
Multiple congenital 
anomalies C 
32 6 (19%) 27 5 (17%) 0.88 
Hospitalized ≤28 days after 
birth 
32 32 (100%) 27 24 (89%) 0.09 
- Duration (days) 32 4 (2-8) 23 14 (3-29) 0.003 
- Respiratory support 
during hospitalization 
32  24   
- None  21 (66%)  7 (29%) 0.01 
- Supplemental oxygen 
only 
 8 (25%)  4 (17%) 0.45 
- Mechanical ventilation  3 (9%)  10 (42%) 0.01 
- ECMO  -  3 (13%) 0.07 
- Chronic lung disease 32 - 27 3 (11%) 0.09 
Data presented as median (interquartile range) or n (%). CLM: congenital lung malformation; 
CPAM: congenital pulmonary airway malformation; CT: computed tomography; ECMO: 
extracorporeal membrane oxygenation; n/a: not applicable. A Thoracotomy (n=20); 
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and duplicated renal collecting system (n=1); bilateral ovarian cysts (n=1).  
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(1/28; 4%) versus three children in the surgery group (3/28; 11%). These three children 
had all undergone thoracotomy.  
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Reliable spirometry tests at 8 years of age were obtained in 57/61 (93%) children. 
Spirometry results per diagnosis are shown in figure 2. Overall, children in the 
observation group (n=31) had median FEV1 SDS (-0.37 (IQR: -0.94 to 0.49)) and FVC 
SDS (0.10 (-0.59 to 0.74)) comparable to reference norms, whereas median FEV1/FVC 
SDS (-0.81 (-1.65 to -0.14)) and FEF25-75% SDS (-1.14 (-1.71 to -0.22)) were significantly 
below 0 (both p<0.001). Four (13%) children scored FEV1 <-1.64 SDS, two (6%) scored 
FVC <-1.64 SDS, and FEV1/FVC and FEF25-75% were <-1.64 SDS in eight (26%) children.  
 
 
 
Figure 2 Scatter plots showing lung functions at 8 years of age in the observation group 
and in the surgery group, per diagnosis 
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In the surgery group (n=26), median FVC SDS was comparable to reference norms (-
0.39 (IQR: -1.16 to 0.68)). The other lung function parameters were significantly below 
0 SDS, with median FEV1  -1.07 (-1.70 to -0.56), FEV1/FVC -1.49 (-2.62 to -0.33) and 
FEF25-75% -1.95 (-2.57 to -0.63) (all p<0.001). Nine (35%) children scored FEV1 <-1.64 
SDS, three (12%) scored FVC <-1.64 SD, FEV1/FVC was <-1.64 SDS in 12 (46%) 
children, and 14 (56%) scored FEF25-75% <-1.64 SDS. Compared with children in the 
observation group, those in the surgery group had lower median FEV1 SDS (p=0.007), 
and a higher proportion scored FEF25-75% <-1.64 SDS (p=0.02); the other parameters 
did not differ significantly. 
 
Bronchodilator reversibility was tested in 38 children. Two of 19 (11%) children in the 
observation group and 2/19 (11%) in the surgery group showed significant reversibility. 
One of these four children had been prescribed inhaled corticosteroids; the others 
were asymptomatic.  
 
Body plethysmography was performed in 41/61 (67%) children. In the observation 
group (n=20), median static lung volumes (SDS) were comparable to reference norms 
(RV 0.15 (IQR: -0.33 to 0.40); TLC 0.13 (-1.12 to 0.58); RV/TLC 0.17 (-0.34 to 0.78)). 
In the surgery group (n=21), median RV (-0.23 (-1.34 to 0.13)) and RV/TLC (-0.20 (-
1.21 to 1.01)) were comparable to reference norms, whereas median TLC was 
significantly below 0 (-0.44 (-1.35 to 0.19), p=0.047). Body plethysmography parameters 
did not differ significantly between both groups. 
 
Diffusion capacity was assessed in 37/61 (61%) children. In both groups, median DLCO 
and DLCO/VA SDS were comparable to reference norms (observation group (n=20): 
0.05 (IQR: -1.03 to 0.54) and 0.07 (-0.50 to 0.54), respectively; surgery group (n=17): 
0.05 (-0.41 to 0.52) and -0.16 (-0.69 to 0.35), respectively). Diffusion capacity did not 
differ significantly between the observation group and the surgery group. 
 
Exercise tolerance 
Exercise tolerance had been assessed in 44/57 (77%) children at 5 years and in 54/61 
(89%) at 8 years of age. Forty-three children were seen at both time points. At 5 years, 
the estimated marginal mean exercise tolerance SDS of children in the observation 
group (n=25; -0.13 (95% CI: -0.56 to 0.30)) did not differ significantly from 0 SDS. Those 
in the surgery group (n=19) scored significantly below 0 SDS (-0.56 (-1.05 to -0.07)). At 
8 years, both groups scored significantly below 0 SDS (observation group (n=29): -0.85 
(-1.30 to -0.41); surgery group (n=25): -1.25 (-1.69 to -0.80)). Eight (28%) children in 
the observation group and 10 (40%) in the surgery group scored <-1 SDS, of whom 
two children in the observation group and three in the surgery group scored <-2 SDS. 
 
 
Overall, the general linear model analysis showed a significant decrease in exercise 
tolerance SDS from 5 to 8 years of age of -0.70 (95% CI: -1.01 to -0.40). Children in 
the surgery group had significantly lower exercise tolerance SDS than those in the 
observation group (mean difference: 0.49 (0.03 to 0.95)). 
 
Occurrence of lower respiratory tract infections 
LRTIs during the past year had been reported for 2/50 (4%) children at 1 year follow-
up, in 4/51 (8%) at 2 years, for 7/57 (12%) at 5 years, and for 3/61 (5%) children at 8 
years. Of 61 children in follow-up, 14 (23%) had suffered at least one LRTI (supplemental 
figure 2). Three of them had an LRTI after surgical resection; four underwent surgical 
resection because of the infection; and seven had been managed by observation despite 
having had an LRTI.  
 
Additional imaging 
In 37 of 61 (61%) children in follow-up at 8 years, additional imaging had been performed 
after the initial diagnostic CT-scan, at a median age of 8.4 years (range: 1.2-15.4 years). 
Additional imaging had been performed mostly because of respiratory symptoms (n=19, 
51%), including coughing, fatigue or deteriorating lung function, or because previous 
imaging had been inconclusive with respect to the type of CLM (n=5, 14%). Eighteen of 
them were managed by watchful waiting (observation group), 18 had undergone surgery 
prior to the imaging, and one child underwent surgical resection after additional imaging.   
 
Of the 37 children who underwent imaging, CT-imaging was performed in 21 (57%) 
children, 14 (38%) children were subjected to X-ray, and two (5%) children underwent 
magnetic resonance imaging. Of the 23 children who had underwent CT or magnetic 
resonance imaging, gas trapping was reported in 10 (43%). 
 
Physical growth 
Physical growth data of all children in follow-up at 8 years are shown in figure 3. 
Estimated marginal mean HFA, DTH and WFH SDS were within reference norms at 1, 
2, 5 and 8 years in both the observation group and the surgery group. Only WFH SDS 
in the surgery group at 2 years (-0.49 (95% CI: -0.95 to -0.03)) was significantly below 
0 SDS. 
 
Overall, the general linear model analysis showed a significant decrease of HFA SDS (-
0.26 (-0.46 to -0.07)) and DTH SDS (-0.26 (-0.46 to -0.06)) between 2 and 5 years, and 
a significant increase of WFH SDS (0.41 (0.10 to 0.71)) between 2 and 8 years. Neither 
the presence of MCA nor the need for surgery affected any physical growth parameter.  
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and a higher proportion scored FEF25-75% <-1.64 SDS (p=0.02); the other parameters 
did not differ significantly. 
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observation group and 2/19 (11%) in the surgery group showed significant reversibility. 
One of these four children had been prescribed inhaled corticosteroids; the others 
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group (n=20), median static lung volumes (SDS) were comparable to reference norms 
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Exercise tolerance 
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(89%) at 8 years of age. Forty-three children were seen at both time points. At 5 years, 
the estimated marginal mean exercise tolerance SDS of children in the observation 
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two children in the observation group and three in the surgery group scored <-2 SDS. 
 
 
Overall, the general linear model analysis showed a significant decrease in exercise 
tolerance SDS from 5 to 8 years of age of -0.70 (95% CI: -1.01 to -0.40). Children in 
the surgery group had significantly lower exercise tolerance SDS than those in the 
observation group (mean difference: 0.49 (0.03 to 0.95)). 
 
Occurrence of lower respiratory tract infections 
LRTIs during the past year had been reported for 2/50 (4%) children at 1 year follow-
up, in 4/51 (8%) at 2 years, for 7/57 (12%) at 5 years, and for 3/61 (5%) children at 8 
years. Of 61 children in follow-up, 14 (23%) had suffered at least one LRTI (supplemental 
figure 2). Three of them had an LRTI after surgical resection; four underwent surgical 
resection because of the infection; and seven had been managed by observation despite 
having had an LRTI.  
 
Additional imaging 
In 37 of 61 (61%) children in follow-up at 8 years, additional imaging had been performed 
after the initial diagnostic CT-scan, at a median age of 8.4 years (range: 1.2-15.4 years). 
Additional imaging had been performed mostly because of respiratory symptoms (n=19, 
51%), including coughing, fatigue or deteriorating lung function, or because previous 
imaging had been inconclusive with respect to the type of CLM (n=5, 14%). Eighteen of 
them were managed by watchful waiting (observation group), 18 had undergone surgery 
prior to the imaging, and one child underwent surgical resection after additional imaging.   
 
Of the 37 children who underwent imaging, CT-imaging was performed in 21 (57%) 
children, 14 (38%) children were subjected to X-ray, and two (5%) children underwent 
magnetic resonance imaging. Of the 23 children who had underwent CT or magnetic 
resonance imaging, gas trapping was reported in 10 (43%). 
 
Physical growth 
Physical growth data of all children in follow-up at 8 years are shown in figure 3. 
Estimated marginal mean HFA, DTH and WFH SDS were within reference norms at 1, 
2, 5 and 8 years in both the observation group and the surgery group. Only WFH SDS 
in the surgery group at 2 years (-0.49 (95% CI: -0.95 to -0.03)) was significantly below 
0 SDS. 
 
Overall, the general linear model analysis showed a significant decrease of HFA SDS (-
0.26 (-0.46 to -0.07)) and DTH SDS (-0.26 (-0.46 to -0.06)) between 2 and 5 years, and 
a significant increase of WFH SDS (0.41 (0.10 to 0.71)) between 2 and 8 years. Neither 
the presence of MCA nor the need for surgery affected any physical growth parameter.  
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Figure 3 Line charts showing physical growth parameters measured at ages 1, 2, 5 and 
8 years 
Symbols represent estimated marginal means with 95% confidence intervals, based on a 
general linear model that includes age, need for surgery (coded as time-dependent 
dichotomous variable), the interaction effect of need for surgery and time point, and the 
presence of multiple congenital anomalies as explanatory variables. 
 
Discussion 
To our knowledge, this is the first study to evaluate lung function, exercise tolerance 
and physical growth in 8-year-old children with either observationally or surgically 
managed CLM. As we hypothesized, most children with asymptomatic CLM had normal 
lung function parameters, exercise tolerance, and physical growth. Those who had 
required surgery had worse lung function and exercise tolerance than healthy children, 
but, in contrast to what we expected, showed normal physical growth. 
 
The optimal management strategy in asymptomatic CLM remains debatable.4 In this 
study, more than half of the children with CLM did not require surgical resection, which 
is consistent with a previous study that advocated a watchful waiting approach.6 When 
only looking at the infants who had been diagnosed prenatally, it appears that 
approximately two-thirds (i.e. 29/47, 62%) could be managed observationally. Children 
in the observation group showed normal physical growth, and most of them had normal 
 
lung function parameters and exercise tolerance at 8 years of age, which supports a 
watchful waiting approach in asymptomatic CLM. About a quarter of children in this 
group did show reduced lung function parameters and/or exercise tolerance, however, 
and clinicians and parents should be aware of this. Several factors could have negatively 
influenced pulmonary outcomes, such as parental smoking and presence of asthma. 
Parents should be carefully counselled and encouraged to stimulate physical activity and 
sport participation of their children.  
 
Approximately half of the children in the surgery group had abnormal lung function 
parameters (except for FVC, which was abnormal in only 12%), and mean exercise 
tolerance fell below -1 SD at 8 years of age. In contrast, a previous study showed that 
over 75% of 21 children who had undergone lobectomy for CLM had normal lung 
function at a median age of 6 years (range 3-16).20 Most of these children, however, had 
been diagnosed prenatally and underwent surgical resection regardless of having 
symptoms. In our study, the majority of these children would have been included in the 
observation group. We, therefore, assume that the pulmonary morbidity we found in 
our surgery group was caused by the severity of the CLM, rather than by the surgery 
itself. In other words, these malformations may not be just isolated or localized defects, 
and weaknesses might occur in adjacent lung sections. In addition, while we included 
children who underwent surgery in the first decade of this century, the 21 children in 
the previous study underwent surgery between 2005 and 2016, when medical 
technologies – including surgical techniques, ventilation methods, and use of ECMO – 
had advanced.  
 
At each follow-up time point, 4-12% of parents reported that their child had suffered 
from an LRTI during the past year. This is higher than the incidence reported in healthy 
European children (i.e. 14.5 per 10 000 children per year).21 Two recent studies 
evaluated data of children with CLM who had been diagnosed prenatally; in both studies, 
9% of children required surgery because of respiratory infections.6, 22 In our study, LRTIs 
in the observation group did not always lead to surgical resection, for example because 
children recovered well from a single LRTI or because no imaging data were available 
to confirm that the LRTI had been located in the same lobe as the CLM. LRTIs have 
also been reported in children with CLM in regression or after surgery. Hence, 
resection does not necessarily eliminate LRTIs; previous research even reported a 
paradoxical increase of pulmonary infections following resection of CLM,7 and a high 
prevalence of recurrent LRTIs (i.e. 19%) in 7-year-olds who had undergone early 
surgery regardless of having symptoms.23  
 
Strengths of our study include the data collection from a longitudinal prospective 
follow-up program, the high proportion (80%) of children that entered this program, 
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the length of follow-up of both observationally and surgically managed children, and the 
standardized assessments during follow-up. Several limitations need to be addressed. 
First, we included children born from 1999 onwards, whereas the 20-week fetal 
anomaly scan was introduced in the Netherlands only in 2007. This has probably led to 
an underestimation of the number of children in the observation group. Second, there 
was selection bias of children in the surgery group: as only symptomatic children 
underwent surgery, it is no surprise that this group showed more morbidity. In some 
children, symptoms even led to the diagnosis of CLM. Third, our study does not answer 
the question whether early surgery in all children with CLM, including asymptomatic 
ones, would have resulted in everyone having a normal lung function and exercise 
tolerance or whether it would have worsened pulmonary outcomes. To find out 
whether surgical treatment could be superior to observation management in children 
with asymptomatic CLM, a randomized controlled trial or case-control study could be 
carried out to evaluate long-term outcomes in asymptomatic children who either do 
or do not undergo surgery. Fourth, LRTIs were parent-reported and we were unable 
to include data on specific pathogens or on the location of the LRTI. To limit recall bias, 
we asked parents to report LRTIs that had occurred during the 12 months preceding 
the follow-up visit; hence, we have no data on LRTIs for ages 2-4 years and 5-7 years. 
Last, the patient samples were too small and the follow-up period was not long enough 
to evaluate the risk of malignancy in CLM, particularly CPAM. 
 
In conclusion, children with CLM may be at risk for reduced lung function and exercise 
tolerance, especially those who required surgery. This study does not give a clear 
answer regarding the optimal management strategy in children with asymptomatic CLM. 
Still, as little pulmonary morbidity was found in these children, this study supports a 
watchful waiting approach in this group. Continued follow-up until adulthood is 
recommended to evaluate the risk of malignancy in both symptomatic and 
asymptomatic CLM. 
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Supplemental material 
 
Supplemental table 1 Characteristics of children examined at 8 years versus those 
who were not examined 
 
n In follow-up at 
8 years 
n=61 
n Not in follow-
up at 8 years 
n=15 
p 
value 
Maternal age (years)  53 30.3 (27.7-35.1) 14 28.9 (26.9-33.9) 0.40 
Male sex 61 36 (59%) 15 9 (60%) 0.95 
Multiple pregnancy 61 2 (3%) 15 1 (7%) 0.49 
Prenatal characteristics     
Prenatal diagnosis 61 47 (77%) 15 12 (80%) 1.00 
- Gestational age 
(weeks) at diagnosis 
43 20.6 (20.0-21.9) 11 20.6 (20.3-21.7) 1.00 
Perinatal characteristics     
Cesarean section 55 10 (18%) 15  1 (7%) 0.44 
- Gestational age at 
birth (weeks)  
57 39.3 (37.4-40.5) 15 38.6 (38.0-40.4) 0.58 
Preterm birth  61 10 (16%) 15 2 (13%) 1.00 
Birth weight (grams)  58 3283 (2855-3821) 15 3170 (2800-3585) 0.42 
Small for gestational age 54 4 (7%) 14 2 (14%) 0.60 
Apgar score at 5 min  55 9 (9-10) 14 9 (8-10) 0.51 
- Apgar score <7 at 5 
min  
56 4 (7%) 14 1 (7%) 1.00 
Umbilical cord pH 45 7.29 (7.26-7.34) 9 7.27 (7.21-7.31) 0.25 
Postnatal characteristics     
Type of CLM 61  15   
- CPAM  28 (46%)  5 (36%) 0.38 
- Bronchopulmonary 
sequestration 
 13 (21%)  2 (14%) 0.72 
- Congenital lobar 
emphysema 
 8 (13%)  1 (7%) 0.68 
- Bronchogenic cyst  2 (3%)  2 (14%) 0.17 
- Hybrid or 
inconclusive A 
 6 (10%)  1 (7%) 1.00 
- CLM in regression  3 (5%)  - 1.00 
- Insufficient diagnostics 
(no CT or histology) 
 1 (2%)  4 (27%) 0.01 
Multiple congenital 
anomalies B 
61 11 (18%) 14 1 (7%) 0.44 
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Supplemental table 1 (continued)    
 n In follow-up at 
8 years 
n=61 
n Not in follow-
up at 8 years 
n=15 
p 
value 
Hospitalized ≤ 28 days 
after birth 
59 56 (95%) 14 14 (100%) 1.00 
Duration (days) 55 5 (2-16) 13 2 (2-5) 0.06 
Respiratory support 
during hospitalization 
56  14   
- None  28 (50%)  11 (79%) 0.05 
- Supplemental oxygen 
only 
 12 (21%)  1 (7%) 0.44 
- Mechanical ventilation  13 (23%)  2 (14%) 0.72 
- ECMO  3 (5%)  - 1.00 
Chronic lung disease 59 3 (5%) 15 2 (13%) 0.27 
Surgical characteristics      
Surgical intervention 61 29 (48%) 14 3 (21%) 0.08 
Indication for surgery 28  3   
- Respiratory 
insufficiency 
 14 (48%)  3 (100%) 0.23 
- Recurrent infections  7 (24%)  - 1.00 
- Increasing size  3 (10%)  - 1.00 
- Volume overload  2 (7%)  - 1.00 
- Unclear  3 (10%)  - 1.00 
Median age at surgery 
(years) C 
29 0.3 (0.0-7.9) 3 0.1 (0.0-0.9) 0.76 
Data presented as median (interquartile range) or n (%), C except for 'median age at surgery', 
which is presented as median (range). CLM: congenital lung malformation; CPAM: congenital 
pulmonary airway malformation; CT: computed tomography. A Hybrid or inconclusive 
diagnosis: CPAM and/or congenital lobar emphysema (n=3), CPAM and/or 
bronchopulmonary sequestration (n=4). B Ventricular septal defect (n=2); atrial septal defect 
(n=2); tetralogy of Fallot (n=1); patent ductus arteriosus and duplicated renal collecting 
system (n=1); laryngeal cyst (n=1); Filamin A deficiency (n=1); congenital diaphragmatic 
hernia (n=1); bladder exstrophy and anal atresia and duplicated renal collecting system 
(n=1); bilateral ovarian cysts (n=1); Coffin Siris syndrome with an atrial septal defect and 
recurrent urolithiasis (n=1). 
 
 
  
 
 
 
Supplemental figure 1 Histogram showing the number of children per follow-up 
time point, categorized according to type of management (observation or surgery) 
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Supplemental figure 2 Lower respiratory tract infections (LRTIs) in the past year, 
reported at ages 1, 2, 5 and 8 years of children who had endured at least one LRTI 
(n=14). 
Numbers 1 to 14 represent different children. CPAM: congenital pulmonary airway 
malformation; CLM: congenital lung malformation. 
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What have we learned?  
 
Aims and main findings 
 
Every day, more than 370 000 newborns enter the world.1 In general, chances of 
surviving and thriving are largely dependent on the place where you are born.2 Being 
diagnosed with a structural congenital anomaly adds some other factors that could 
affect outcome. Even in Western Europe, death due to structural congenital anomalies 
is highly listed in health statistics on infant mortality.3 In surviving children, long-term 
outcome – including physical growth and development – may be affected. This thesis 
focuses on these outcomes for children born with an abdominal wall defect (AWD) or 
a congenital lung malformation (CLM).  
 
In Western Europe, AWD and CLM are usually diagnosed prenatally at the 20-week 
anomaly scan,4, 5 or even as early as in the first trimester.6 This early diagnosis offers 
the opportunity to counsel parents long before the estimated due date, and well before 
the legal upper limit for termination of pregnancy (i.e. 24 weeks’ gestation in the 
Netherlands). A prenatal diagnosis of a congenital anomaly is usually very distressing for 
expecting parents. Early counseling may help reduce feelings of anxiety and stress. They 
can make an informed decision regarding continuation of the pregnancy, and eventually 
prepare themselves for the birth of a child requiring extra care.  
 
In live-born children with an AWD or a CLM, long-term problems are probably not as 
evident as in other congenital anomalies, such as spina bifida or genetic syndromes. 
Most of these children are able to visit the outpatient clinic and to fulfill standardized 
physical and neurodevelopmental assessments. Nonetheless, many of them have 
experienced feeding difficulties, respiratory problems and infections, which put them at 
risk for long-term impairments.  
 
The research presented in this thesis aims to provide caregivers with a general overview 
of what parents who are expecting a child with an AWD or a CLM can expect – from 
the prenatal period up to school age. We asked ourselves two key questions: 
 
 
 
In the following section, our main findings are placed into a broader perspective, and 
recommendations for clinical practice and future research will be discussed. The 
chapter is concluded with a summary on what to tell parents. 
• Can we identify prenatal characteristics that contribute to the prediction of 
postnatal morbidity? 
• What kind of long-term morbidity is seen in these children? 
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Can we identify prenatal characteristics that 
contribute to the prediction of postnatal morbidity? 
 
The 20-week anomaly scan, introduced as standard care in the Netherlands in 2007, 
has led to increased prenatal diagnosis of AWD and CLM.5, 7 Besides prenatal detection, 
we showed that specific ultrasound measures can contribute to the prediction of 
postnatal morbidity in some, but not all of these cases.  
 
In fetuses with gastroschisis, neither two-dimensional (2D) nor three-dimensional (3D) 
ultrasound markers could reliably distinguish between simple and complex gastroschisis 
(chapters 2 and 3). In those with omphalocele, we were able to reliably predict the 
type of postnatal surgery and survival (chapter 5). In fetuses with CLM, we were able 
to predict the need for surgery within 2 years after birth, but not the need for 
respiratory support within 24 hours (chapter 8).  
 
Gastroschisis 
 
The clinical course of infants with gastroschisis largely depends on the presence of 
additional intestinal defects. This is why Molik and colleagues proposed to categorize 
these infants into having either ‘simple’ or ‘complex’ gastroschisis – with the latter 
occurring in approximately 17%.8, 9 This risk categorization has now been widely 
accepted in both research on hospital outcome and in clinical care.  
 
The difference between simple and complex gastroschisis is usually easy to see at 
primary postnatal evaluation, although it can be difficult when the intestines are 
extensively matted together. On prenatal ultrasound, it is – in any case – very difficult 
to distinguish complex from simple gastroschisis. Over the last few decades, numerous 
efforts have been made to predict complex gastroschisis prenatally, using 2D 
ultrasound. In a recent meta-analysis, intra-abdominal bowel dilatation seemed to be 
the most promising predictor of intestinal atresia, but with a low positive predictive 
value of only 22%.10 The studies included in this meta-analysis, however, used different 
thresholds of bowel dilatation, ranging from >6 to >18 mm; some studies did not even 
state a threshold.10 The added value of such a meta-analysis to clinical practice may 
therefore be questionable. This inspired us to evaluate the use of gestational-age 
corrected thresholds for bowel dilatation in the prediction of complex gastroschisis 
(chapter 3). We showed that extra-abdominal bowel dilatation at 30 weeks’ gestation, 
but not at the final ultrasound prior to delivery, was significantly associated with 
complex gastroschisis. Its positive predictive value was low, however; only 40% of 
 
fetuses with extra-abdominal bowel dilatation at 30 weeks’ gestation appeared to have 
complex gastroschisis at birth. 
 
Although the added value of 3D to 2D ultrasound in the fields of obstetrics and prenatal 
medicine was already recognized in the previous century,11 our study was the first to 
evaluate the use of 3D ultrasound in fetal gastroschisis (chapter 2). We hypothesized 
that 3D ultrasound – rather than 2D ultrasound – would be more accurate in measuring 
fetal stomach volume and thus predicting complex gastroschisis. Furthermore, the 
hypothesis arose that stomach-bladder distance, accurately measured using 3D 
ultrasound, may predict complex gastroschisis. This hypothesis was based on a study 
using magnetic resonance imaging (MRI) in 24 fetuses with gastroschisis that described 
extensive stomach-bladder contact in all fetuses with simple gastroschisis, but not in 
those with intestinal stenosis; their abdominal cavity was filled with dilated bowel 
loops.12 Unfortunately, our study showed that neither stomach volume nor stomach-
bladder distance could predict complex gastroschisis. 
 
As intestinal and stomach dilatation throughout gestation have been extensively studied 
without leading to a clear ultrasound predictor for complex gastroschisis,10 we may 
need to think about alternative ways to study complex gastroschisis prenatally. The first 
step should be to study the onset of complex gastroschisis, as this is not well 
understood. Intestinal atresia, perforation or necrosis are most likely the result of 
obstruction at the umbilical ring or a volvulus of the eviscerated intestines,13 which may 
occasionally lead to necrosis of the complete gut with dismal outcome. Parents opting 
for termination of pregnancy or whose pregnancy results in intrauterine death, should 
always be offered autopsy with special attention to intestinal malrotation and volvulus. 
The autopsy findings may provide further insight into the onset and development of 
complex gastroschisis. In continuing pregnancies, MRI throughout gestation may be a 
promising technique to study the onset of complex gastroschisis. The MRI study of 
Brugger and Prayer resulted in very clear images of the development of gastroschisis 
during gestation. The three fetuses with bowel dilatation appeared to have intestinal 
stenosis without atresia.12 It is yet unclear what complex gastroschisis looks like on 
prenatal MRI, and whether this could be distinguished from simple gastroschisis. 
 
Moreover, we must keep in mind that it is in fact not complex gastroschisis that we 
would like to predict, but rather the complexity of the child’s hospital course – which 
eventually influences long-term morbidity, growth, and development. The complexity 
of the child’s hospital course includes chances of complications, the duration of 
parenteral nutrition, and the length of hospital stay. These factors are most likely 
determined by the extent of intestinal damage, which may be related to the exposure 
to amniotic fluid. In light of this, we may have to look further than imaging techniques 
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alone. It would be interesting to identify markers in the amniotic fluid or, less invasive, 
in maternal serum that correlate with the duration of parenteral nutrition and the length 
of hospital stay. 
 
A previous study in 30 fetuses with gastroschisis found a weak correlation between 
lipase concentration in the amniotic fluid and the duration of hemodynamic support.14 
None of the biochemical substances that were assessed (i.e. ferritin, total proteins, and 
digestive compounds) correlated with the duration of parenteral nutrition or the length 
of hospital stay.14 Another marker that may be interesting to look at, is alpha-
fetoprotein (AFP). Historically, before the widespread use of prenatal ultrasound, 
gastroschisis was suspected in case of elevated AFP levels in the amniotic fluid15, 16 or in 
maternal serum.17, 18 AFP is produced by the fetal liver; maternal serum levels of AFP 
increase with increasing gestational age.19 Elevated levels in pregnancies with 
gastroschisis are thought to be caused by direct diffusion through the exposed intestines 
into the amniotic fluid.17 In cases with complex gastroschisis, disturbance of the normal 
passage of amniotic fluid, gastric juice, and/or bile might prevent normal absorption or 
degradation of AFP, leading to even higher levels of maternal serum AFP. Evidence to 
support this hypothesis is lacking.  
 
In addition to AFP, future research on markers in maternal serum could focus on 
specific T-cells. Recently, increased levels of pro-inflammatory CD4+ T-cells that 
originated from the fetal intestine were found in the cord blood of neonates with 
gastroschisis.20 The authors hypothesized that these cells play a role in fetal immune 
activation, caused by exposure of the intestinal serosa to amniotic fluid, or by luminal 
insults resulting in activation of mucosal immune cells.20 It has not been established yet 
whether these measurements correlate with postnatal outcome, and whether these 
cells can already be detected in maternal blood during pregnancy.  
 
Omphalocele 
 
When discussing outcomes in omphalocele, it is important to be aware of the difference 
between fetuses and live-born neonates with omphalocele; or, in other words, the 
difference between the prenatal and postnatal frames of reference. Previous studies on 
live-born neonates reported survival rates of 70-80%,21, 22 which increased to at least 
90% for those with isolated or minor omphalocele.21, 22 These rates seem quite high, 
but ignore the ‘hidden mortality’ of omphalocele during the prenatal period. Our finding 
that only 40% of fetuses with omphalocele were born alive (chapter 6) may still be too 
optimistic; in a more recent Dutch cohort of fetuses with omphalocele diagnosed 
between 2010 and 2013, only 20% was born alive.7  
 
 
This discrepancy may be explained by the difference in the years of inclusion; the routine 
20-week fetal anomaly scan was introduced in the Netherlands only in 2007, and 
ultrasound quality has improved significantly over the years. Although our prenatal 
detection rate of 87% was relatively high, we may have missed additional anomalies, 
possibly leading to a lower rate of parents opting for termination of pregnancy. A 
previous study at our center between 1991 and 2004 showed that over one third of 
fetuses with isolated omphalocele turned out to have additional anomalies after birth.23 
In line with this finding, the rate of fetuses diagnosed with additional anomalies was 56% 
in our study versus 83% in the cohort diagnosed between 2010 and 2013.7 In both 
studies, more than half of the fetuses diagnosed with additional anomalies had a lethal 
prognosis, and 65-70% of parents opted for termination of pregnancy when additional 
anomalies were detected. The termination of pregnancy rate was, therefore, much 
higher in the latter study, which contributed to the lower proportion of live-born 
neonates. The difference between prenatal and postnatal frames of reference may thus 
well become even bigger with advances in prenatal ultrasound; increased detection of 
severe additional anomalies could lead to increased termination of pregnancy rates, 
which would subsequently result in lower rates of prenatal survival, and higher rates of 
survival in live-born neonates. A multidisciplinary approach in parental counseling is very 
important; pediatric surgeons and pediatricians may be more optimistic about survival 
rates than are obstetricians and prenatal specialists.   
 
Besides the presence of additional anomalies, the extent of postnatal morbidity is largely 
determined by the size of the omphalocele, and whether or not the defect can be closed 
primarily (chapter 5). Our findings of the highly predictive value – with sensitivity and 
specificity around 90% – of the prenatal ratio between omphalocele circumference and 
abdominal circumference (OC/AC-ratio) for type of surgical closure, are in line with 
those of a previous study that included only one measurement per patient.24 The finding 
that the OC/AC-ratio appeared not only predictive of type of surgical closure but also 
of 1-year survival is not very surprising, as a higher degree of visceroabdominal 
disproportion is associated with a higher probability of respiratory problems, and 
eventually lower survival.25  
 
Measuring the OC/AC-ratio at three time periods during gestation resulted in different 
cut-offs per time period, as the OC/AC-ratio decreased with increasing gestational age 
(chapter 5). An omphalocele can appear as giant during the first trimester, but relatively 
decrease in size during gestation. Repeated measurements throughout gestation are 
therefore recommended. In addition to the presence of additional anomalies and the 
presence of liver herniation, these cut-offs provide helpful information when counseling 
parents. Parents should be informed that both type of closure and survival can be more 
accurately predicted by measurements in the third trimester.  
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As a constant cut-off throughout gestation would be easier to implement in clinical 
practice, a previous study tried to correct for gestational age by using fetal growth 
parameters that remained relatively constant throughout gestation.26 The ratios in that 
study, however, resulted in lower predictive values for the type of closure than those 
we found. Future research may investigate whether certain algorithms could result in a 
constant cut-off of the OC/AC-ratio throughout gestation, without affecting its 
predictive value.  
 
Another challenge that remains is that of categorization of the size of the omphalocele 
after birth. While the OC/AC-ratio measured in fetuses reflects the extent of 
visceroabdominal disproportion on a continuous scale, live-born neonates are 
categorized into having either a minor or giant omphalocele based on the diameter of 
the defect. This categorization is convenient for clinical and research purposes, but 
there is room for improvement. The most commonly used definition of giant 
omphalocele – a defect of ≥5 cm with liver protruding27 – seems simple, but does not 
sufficiently take into account the extent of visceroabdominal disproportion. For 
example, many clinicians would perceive a defect of 4.8 cm with an entire liver lobe 
protruding seen in a neonate born preterm or small for gestational age as more ‘giant’ 
than a defect of 5 cm with only a slip of the liver entering the sac seen in a term neonate. 
As nowadays over 90% of omphaloceles are diagnosed prenatally,4 we would suggest to 
categorize neonates into having a minor or giant omphalocele according to the final 
OC/AC-ratio prior to delivery. Not only would this provide a more accurate idea of 
the extent of visceroabdominal disproportion, it would also bridge the gap between 
prenatal and postnatal definitions. Based on our findings (chapter 5), we would suggest 
to use a cut-off of 0.63 of the OC/AC-ratio between 30-38 weeks’ gestation; all infants 
without liver herniation at the final ultrasound prior to birth can be regarded as having 
a minor omphalocele.  
 
Congenital lung malformations 
 
In contrast to neonates with AWD, the majority of neonates diagnosed with a CLM do 
not develop symptoms after birth. There may well be a substantial proportion of adults 
who are unaware of having a CLM, as they were born prior to the introduction of the 
20-week fetal anomaly scan, and never developed any symptoms. While the increased 
prenatal detection of CLM nowadays has led to improved care of symptomatic 
neonates, it can also place clinicians and parents in a difficult position as the optimal 
management of asymptomatic CLM is yet to be determined. Parental counseling is 
therefore less straightforward than it is in case of an AWD.  
 
 
Diagnosing the specific type of CLM in a fetus remains difficult (chapter 8). This is 
illustrated by our finding that all cases of congenital lobar emphysema (CLE) had 
presented as a microcystic congenital pulmonary airway malformation (CPAM) on 
prenatal ultrasound. We would not recommend to perform routine fetal MRI, as 
findings on fetal MRI have been found to resemble ultrasound features.28 Instead, we 
propose to describe the lesion prenatally according to its ultrasound appearance (i.e. 
hyperechoic, hypoechoic, or mixed), and to the origin of arterial blood supply (the aorta 
or the pulmonary arteries). Future parents should be informed that the specific type of 
CLM will be determined after postnatal CT-imaging. 
 
There is a persistent belief among clinicians that CLE is very difficult to detect prenatally, 
and that this type of CLM is associated with higher incidence of neonatal respiratory 
distress than other types of CLM.29, 30 This is in contrast to the findings in our study; 
19% of all prenatally detected CLM concerned CLE after birth, and 80% of infants with 
CLE remained asymptomatic and did not need surgical intervention. This increased 
detection rate of asymptomatic CLE may be explained by the introduction of the 20-
week fetal anomaly scan. Clinicians should be aware of our findings when counseling 
parents; infants with CLE do not necessarily have worse outcomes than those with 
other types of CLM.  
 
Our findings of a higher CPAM volume ratio (CVR) in fetuses who after delivery 
required respiratory support within 24 hours or surgery within 2 years (chapter 8), are 
in agreement with those of previous studies.31, 32 Although we were able to reliably 
predict the need for surgery from 24 weeks’ gestation onwards, we were unable to 
predict the need for respiratory support. This was partly due to the fact that even in 
the group who had shown full regression of their CLM on prenatal ultrasound, one 
quarter still required respiratory support within 24 hours after birth – some even 
presented with bilateral pneumothorax. It is unclear how some lesions spontaneously 
shrink or even become invisible during pregnancy. In comparison with our findings, 
previous literature showed that most of these lesions are still visible on postnatal CT-
imaging.33, 34 As we were unable to predict the need for respiratory support, we would 
recommend to have all fetuses with a CLM delivered in a tertiary care center, regardless 
of lesion size and prenatal regression. We hypothesize that the unusual occurrence of 
bilateral pneumothorax may be caused by heterogeneity in the aberrant bronchial tree; 
this may have led to air trapping, which then eventually caused the pneumothorax. This 
hypothesis needs further investigation.  
 
Our cut-offs for predicting the need for surgery may eventually become redundant; if 
future research proves a beneficial effect of early surgery on outcome in asymptomatic 
CLM, all children will be operated on. This will probably take a while, however, and in 
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the meantime our cut-offs provide clinicians and parents with a reliable and valuable 
estimation of the child’s need for surgery.  
 
What kind of long-term morbidity is seen in these 
children? 
In general, the extent of short-term and long-term morbidity in these children is mainly 
determined by the severity of illness, including gastrointestinal and respiratory 
problems, and by the possibilities for adequate sensory stimulation. Sensory stimulation 
can be inadequate in hospitalized children; they are exposed to inevitable, but painful 
medical procedures, high levels of noise and light, and disruption of sleep.35, 36 
Furthermore, hospitalized children do not receive the same interaction and stimulation 
as healthy children generally receive in the home environment; for example, interaction 
and stimulation may be negatively affected by a poor nutritional status and failure to 
thrive, limited freedom of movement, or impaired emotional well-being of either the 
child, its parents, or both.  
We found that most children born with an AWD or a CLM grow normally during 
infancy and childhood, respectively (chapters 3, 6, and 9). During the first two years 
of life, infants born with gastroschisis or omphalocele appeared to be at risk for motor 
function delay (chapter 3 and 6). At school age, parent-reported outcomes of children 
born with gastroschisis or omphalocele were mainly reassuring. Clinicians and parents 
should, however, be aware of the higher risk of cognitive problems (chapter 4 and 7). 
In children born with CLM, we focused on pulmonary outcomes. Most of the children 
with asymptomatic CLM proved to have normal lung function and exercise tolerance. 
Half of those who had required surgery showed abnormal lung function and exercise 
tolerance (chapter 9). 
Gastroschisis 
Our observation that height and weight of children born with gastroschisis are within 
normal range, despite low birth weights (chapter 3), is in line with previous literature.37, 
38 That we did not find any differences in physical growth between simple and complex 
gastroschisis is in contrast to the two studies that took into account the type of 
gastroschisis.38, 39 Apart from these studies, previous literature on physical growth did 
not differentiate between simple and complex gastroschisis, and strong conclusions with 
regards to a potential difference cannot be made yet. A possible explanation for the 
favorable growth of those with complex gastroschisis in our cohort may be the close 
monitoring in our follow-up program, and the intestinal rehabilitation program for those 
with intestinal failure; this finding underlines the importance of adequate follow-up. 
 
Both mental and motor development in infants with gastroschisis have previously been 
reported as favorable, with a low incidence of adverse developmental outcome.37, 39-43 
However, no previous study distinguished between simple and complex gastroschisis. 
Our finding that infants with simple gastroschisis have normal mental and motor 
development – whereas those with complex gastroschisis are at risk of motor function 
delay – may be explained by the higher morbidity in the latter group (chapter 3). 
Previous studies in other groups of patients also showed a relation between the extent 
of morbidity in critically ill children, and neurodevelopmental functioning later in life.44, 
45 Feeding difficulties, complications such as sepsis, painful procedures, and prolonged 
hospital stay may lead to impaired sensory stimulation, emotional deprivation, and 
altered parent-child interaction. These could all interfere with adequate motor function 
development. In addition to early start of pediatric physical therapy, we recommend to 
offer parents not only practical and emotional support, but also teach them how to 
stimulate their child’s development. Several interventions that support parents’ 
presence and involvement in their child’s care during hospitalization have shown to be 
beneficial to parents’ emotional well-being and child development.46-49 Furthermore, the 
implementation of home parenteral nutrition – and thus a reduced length of 
hospitalization – may help improve the child’s motor development. Parents should be 
trained and supported to ensure that they are confident and competent in all aspects 
of their child’s care at home. 
 
In line with previous studies,41, 50, 51 we found that parents of children with gastroschisis 
more often reported cognitive problems in their child at school age; other outcomes 
were similar to those of healthy children (chapter 4). We may have even 
underestimated the prevalence of cognitive problems because of selection bias; the 
response rate was relatively low, particularly in those with a low socioeconomic status. 
Previous research suggests that the cognitive problems in children with gastroschisis 
mainly relate to executive functioning50 or working memory.41, 51 It remains unclear what 
causes cognitive problems in these children, and – more  importantly – what could be 
done to prevent them.  
 
Interestingly, children who had experienced neonatal intestinal failure and children 
whose parents experienced increased vulnerability were more often reported to have 
cognitive problems. An explanation of the latter association could be that parents who 
perceive their child as highly vulnerable may report more problems, despite normal 
outcome at objective assessments. Previous studies also have associated increased 
parent-perceived vulnerability with adverse parent-reported outcome, including 
behavioral problems,52 poorer emotional adjustment,53 and impaired health status.54 
Early parental counseling and support may positively affect the child’s outcome as 
perceived by parents.  
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the meantime our cut-offs provide clinicians and parents with a reliable and valuable 
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regards to a potential difference cannot be made yet. A possible explanation for the 
favorable growth of those with complex gastroschisis in our cohort may be the close 
monitoring in our follow-up program, and the intestinal rehabilitation program for those 
with intestinal failure; this finding underlines the importance of adequate follow-up. 
 
Both mental and motor development in infants with gastroschisis have previously been 
reported as favorable, with a low incidence of adverse developmental outcome.37, 39-43 
However, no previous study distinguished between simple and complex gastroschisis. 
Our finding that infants with simple gastroschisis have normal mental and motor 
development – whereas those with complex gastroschisis are at risk of motor function 
delay – may be explained by the higher morbidity in the latter group (chapter 3). 
Previous studies in other groups of patients also showed a relation between the extent 
of morbidity in critically ill children, and neurodevelopmental functioning later in life.44, 
45 Feeding difficulties, complications such as sepsis, painful procedures, and prolonged 
hospital stay may lead to impaired sensory stimulation, emotional deprivation, and 
altered parent-child interaction. These could all interfere with adequate motor function 
development. In addition to early start of pediatric physical therapy, we recommend to 
offer parents not only practical and emotional support, but also teach them how to 
stimulate their child’s development. Several interventions that support parents’ 
presence and involvement in their child’s care during hospitalization have shown to be 
beneficial to parents’ emotional well-being and child development.46-49 Furthermore, the 
implementation of home parenteral nutrition – and thus a reduced length of 
hospitalization – may help improve the child’s motor development. Parents should be 
trained and supported to ensure that they are confident and competent in all aspects 
of their child’s care at home. 
 
In line with previous studies,41, 50, 51 we found that parents of children with gastroschisis 
more often reported cognitive problems in their child at school age; other outcomes 
were similar to those of healthy children (chapter 4). We may have even 
underestimated the prevalence of cognitive problems because of selection bias; the 
response rate was relatively low, particularly in those with a low socioeconomic status. 
Previous research suggests that the cognitive problems in children with gastroschisis 
mainly relate to executive functioning50 or working memory.41, 51 It remains unclear what 
causes cognitive problems in these children, and – more  importantly – what could be 
done to prevent them.  
 
Interestingly, children who had experienced neonatal intestinal failure and children 
whose parents experienced increased vulnerability were more often reported to have 
cognitive problems. An explanation of the latter association could be that parents who 
perceive their child as highly vulnerable may report more problems, despite normal 
outcome at objective assessments. Previous studies also have associated increased 
parent-perceived vulnerability with adverse parent-reported outcome, including 
behavioral problems,52 poorer emotional adjustment,53 and impaired health status.54 
Early parental counseling and support may positively affect the child’s outcome as 
perceived by parents.  
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In addition, neonatal intestinal failure may have acted as a confounder, by influencing 
both perceived vulnerability and cognitive functioning. If children need medical care for 
a relatively long period, for example because of intestinal failure, parents are usually 
trained to perform certain medical procedures (e.g. dressing changes, care of infusion 
pumps, central line care, colostomy care). Possible distress of either the child, its 
parents or both could negatively affect the attachment style, and may eventually result 
in insecure attachment or even attachment disorders.55, 56 Previous research has linked 
attachment problems or relational trauma to dysregulation of the right brain,57 which 
may impact cognitive functioning. Although very little is known on cognitive functioning 
in children who experienced neonatal intestinal failure, they seem to be at significant 
risk for delayed cognitive development.58 Future research may look into the attachment 
style of these children and their parents, and see whether this style plays a role in the 
child’s cognitive functioning. We recommend to routinely offer psychosocial support to 
all parents who are expecting a child with a congenital anomaly as this may have a 
positive impact on attachment style. Psychosocial support, for example by a nurse 
practitioner or medical social worker, should be part of standard, multidisciplinary care; 
not only after birth, but also during pregnancy in case of a prenatal diagnosis. In addition, 
the follow-up of children with gastroschisis and neonatal intestinal failure should be 
extended to school age, with special attention to cognitive problems and attachment 
style. 
 
Certain remarks must be made. First, we do not know whether the children in our 
group would also have had normal outcome at objective assessments at school age. 
They may well have shown cognitive problems also on a more objective measure; a 
significant proportion attended special education. Second, some factors associated with 
the risk of gastroschisis itself may also negatively affect the child’s cognitive functioning. 
Examples are young maternal age, alcohol and illicit drug use during pregnancy, and low 
socioeconomic status.59, 60 Finally, even if objective assessments show normal outcome, 
parents should be taken seriously if they feel that their child has a problem; it indicates 
that either the child, its parents, or both, need more support. Moreover, objective 
assessments might not always be accurate enough; specific neurodevelopmental 
impairments can be difficult to pick up by a global outcome measure.61  
 
Omphalocele 
 
The relatively high proportions of children with low height and weight we found in 2-
year-olds with omphalocele (chapter 6) are similar to those reported previously among 
children aged 1-10 years.62 Other studies on physical growth did not distinguish 
between gastroschisis and omphalocele.63-65 Considering our finding of normal physical 
growth in infants with gastroschisis, these studies may have overestimated height and 
 
weight. Still, they reported suboptimal growth during infancy.63, 64 As infants with 
omphalocele seem to be at greater risk of failure to thrive than those with gastroschisis, 
we assume that work of breathing may have been an important determinant of poor 
growth; respiratory problems, including pulmonary hypoplasia, are more common in 
infants with omphalocele than in those with gastroschisis.66 The fact that growth seemed 
to be more affected in infants with a giant omphalocele than in those with a minor 
omphalocele supports this assumption. Close monitoring of growth is recommended, 
with early nutritional intervention if necessary. Indirect calorimetry can be helpful to 
determine energy requirements and to avoid underfeeding and overfeeding in critically 
ill children.67 Work of breathing should be supported as much as possible, by 
optimization of respiratory conditions, and with low thresholds for supplemental 
oxygen.  
 
Previous studies on neurodevelopment that did not distinguish between different types 
of non-cardiac structural anomalies reported high prevalences of neurodevelopmental 
problems.68-70 In contrast, the studies that included infants with AWD showed normal 
mental and motor development in infancy.63, 64 As gastroschisis and omphalocele are 
two different entities, however, outcomes should always be evaluated separately, even 
though this negatively affects sample sizes. Similar to our results (chapter 6), the studies 
that included only infants with omphalocele reported motor function delay.51, 71 
Especially infants with a giant omphalocele appear to be at risk of impaired motor 
function, which could be explained by the same factors that may play a role in motor 
function delay in infants with complex gastroschisis. In addition, the ventral hernia and 
altered trunk stability presumably contributed to impaired motor development in 
infancy.  
 
We expect that most children with motor function delay will catch up on it during 
childhood; the right conditions for normal development seem to be present, and a 
previous study reported normal motor function in eight children with a giant 
omphalocele aged 3.5-12 years.72 In line with this finding, our study showed that over 
80% of parents reported normal motor function at school age. Other parent-reported 
outcomes at school age were also mainly reassuring. Follow-up of children with an 
isolated, minor omphalocele can therefore be limited to 2 years of age. As cognitive 
problems were reported more frequently in children with either a giant omphalocele 
or multiple congenital anomalies, we recommend these children are followed until 
reaching school age and beyond. That way, we can offer timely intervention if needed, 
and it may help to point out specific features and possible causes of these problems. 
Remarkably, all three children with Beckwith-Wiedemann Syndrome in our study were 
reported to have cognitive problems (e.g. concentration or language difficulties), 
whereas previous literature reported normal intelligence in these children.73, 74 
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not only after birth, but also during pregnancy in case of a prenatal diagnosis. In addition, 
the follow-up of children with gastroschisis and neonatal intestinal failure should be 
extended to school age, with special attention to cognitive problems and attachment 
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group would also have had normal outcome at objective assessments at school age. 
They may well have shown cognitive problems also on a more objective measure; a 
significant proportion attended special education. Second, some factors associated with 
the risk of gastroschisis itself may also negatively affect the child’s cognitive functioning. 
Examples are young maternal age, alcohol and illicit drug use during pregnancy, and low 
socioeconomic status.59, 60 Finally, even if objective assessments show normal outcome, 
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weight. Still, they reported suboptimal growth during infancy.63, 64 As infants with 
omphalocele seem to be at greater risk of failure to thrive than those with gastroschisis, 
we assume that work of breathing may have been an important determinant of poor 
growth; respiratory problems, including pulmonary hypoplasia, are more common in 
infants with omphalocele than in those with gastroschisis.66 The fact that growth seemed 
to be more affected in infants with a giant omphalocele than in those with a minor 
omphalocele supports this assumption. Close monitoring of growth is recommended, 
with early nutritional intervention if necessary. Indirect calorimetry can be helpful to 
determine energy requirements and to avoid underfeeding and overfeeding in critically 
ill children.67 Work of breathing should be supported as much as possible, by 
optimization of respiratory conditions, and with low thresholds for supplemental 
oxygen.  
 
Previous studies on neurodevelopment that did not distinguish between different types 
of non-cardiac structural anomalies reported high prevalences of neurodevelopmental 
problems.68-70 In contrast, the studies that included infants with AWD showed normal 
mental and motor development in infancy.63, 64 As gastroschisis and omphalocele are 
two different entities, however, outcomes should always be evaluated separately, even 
though this negatively affects sample sizes. Similar to our results (chapter 6), the studies 
that included only infants with omphalocele reported motor function delay.51, 71 
Especially infants with a giant omphalocele appear to be at risk of impaired motor 
function, which could be explained by the same factors that may play a role in motor 
function delay in infants with complex gastroschisis. In addition, the ventral hernia and 
altered trunk stability presumably contributed to impaired motor development in 
infancy.  
 
We expect that most children with motor function delay will catch up on it during 
childhood; the right conditions for normal development seem to be present, and a 
previous study reported normal motor function in eight children with a giant 
omphalocele aged 3.5-12 years.72 In line with this finding, our study showed that over 
80% of parents reported normal motor function at school age. Other parent-reported 
outcomes at school age were also mainly reassuring. Follow-up of children with an 
isolated, minor omphalocele can therefore be limited to 2 years of age. As cognitive 
problems were reported more frequently in children with either a giant omphalocele 
or multiple congenital anomalies, we recommend these children are followed until 
reaching school age and beyond. That way, we can offer timely intervention if needed, 
and it may help to point out specific features and possible causes of these problems. 
Remarkably, all three children with Beckwith-Wiedemann Syndrome in our study were 
reported to have cognitive problems (e.g. concentration or language difficulties), 
whereas previous literature reported normal intelligence in these children.73, 74 
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Unfortunately, our sample size was too small to allow further investigation of this 
finding.  
 
Congenital lung malformations 
 
Our findings of normal physical growth during childhood (chapter 9) are in line with 
those of a previous study in 79 children with CLM who did not undergo surgery.75 We 
showed similar growth in children either operated on or not. In contrast to our findings 
of decreased lung function and exercise tolerance in half of the children in the surgery 
group, a previous study showed normal lung function in over 75% of children who had 
undergone surgery.76 The difference with our study may be explained by selection bias: 
most children included in that study had been diagnosed prenatally, and had undergone 
surgery regardless of having symptoms.76 In our study, the majority of these children 
would have been included in the observation group, of which 75% had normal lung 
function and exercise tolerance. We assume that the impaired lung function and 
exercise tolerance we found in the surgery group is caused by the severity of the CLM, 
rather than by the surgery itself.  
 
As one-quarter of children with asymptomatic CLM showed airflow obstruction and 
decreased exercise tolerance, there seems to be room for improvement. Some 
clinicians prefer early surgery in asymptomatic children, because of the possibility of 
compensatory lung growth, and because surgery is technically easier when the child has 
not yet suffered from lower respiratory tract infections (LRTIs).77, 78 Then again, general 
anesthesia in early life, and possible surgical complications may in fact worsen not only 
the child’s pulmonary outcomes, but also its general neurodevelopment.79 As of yet, we 
know neither whether early surgery in asymptomatic CLM would result in better 
pulmonary outcomes, nor whether this would negatively affect their 
neurodevelopment. 
 
Our finding that children with CLM appeared to be at higher risk of developing LRTIs 
mirrors that of previous studies.80, 81 Currently, it is recommended that all children with 
a CLM who are suspected of having an LRTI should be referred for chest x-ray imaging 
in a low-threshold setting. If recurrent infections are located in the same lobe as the 
CLM, these children usually undergo surgical resection. Although this seems to be a 
logical solution, resection does not necessarily eliminate LRTIs. Previous research even 
reported a paradoxical increase of pulmonary infections after resection of symptomatic 
CLM,75 and a high prevalence of recurrent LRTIs (i.e. 19%) in 7-year-olds who had 
undergone early surgery regardless of having symptoms.82 Surgical resection of the CLM 
because of recurrent LRTIs is therefore questionable, and we do not know whether 
early surgery in asymptomatic CLM would result in a lower prevalence of LRTIs.  
 
The potential risk of malignant transformation is probably the most important reason 
to advocate surgery in children with asymptomatic CLM.77 A recent systematic review 
provided an overview of malignant transformation of CLM. The authors reported 168 
lung tumors associated with CLM, of which 76 involved children, and 92 involved 
adults.83 No limits were set to the birth year of the population, and only four of these 
cases had been diagnosed prenatally. It is very difficult to determine the true risk of 
malignant transformation in asymptomatic CLM, as a large number of these patients 
may be undiagnosed. Some clinicians argue that the risk is not high enough to subject a 
child without any symptoms to major surgery,84 whereas others would say that this 
argument does not hold water as the risk is yet to be determined. Clinicians should at 
least be aware of the potential risk of malignant transformation. Continued monitoring 
until adulthood and beyond may be considered, but this concept needs to be further 
explored. International consensus is needed regarding the frequency and method of 
monitoring, and data should be collected in a standardized way. Advances in molecular 
biology may help in identifying genetic mutations that can reliably distinguish between 
‘normal’ CPAM and malignant tissue.  
 
In summary, there is not enough evidence to draw conclusions regarding the optimal 
management of children with asymptomatic CLM. Compared with healthy children, 
these children seem to be at increased risk for reduced lung function and exercise 
tolerance, for developing LRTIs, and probably even for malignant transformation of their 
CLM. It is not clear whether early surgery in children with asymptomatic CLM would 
improve or deteriorate their outcomes. In addition, the effects of early surgery or 
watchful waiting on parents’ and treating physicians’ psychological wellbeing have not 
been studied yet. Either approach could increase stress and anxiety, for obvious 
reasons. Ideally, a multicenter case-control study or a randomized controlled trial 
should be carried out to provide answers, and to create a risk assessment tool to assist 
clinicians in identifying children who are at risk of adverse outcome. In the meantime, 
we would recommend involving parents in the decision-making process. Parents should 
be counseled on the pros and cons of early surgery versus watchful waiting in 
asymptomatic CLM in a standardized matter. This could, for example, be done by an 
educational video on a webpage or by an app. This also fits well within the family-
centered approach to care.  
 
Limitations 
One of the major limitations of our research concerns the sample sizes. Although our 
sample sizes were relatively large for such rare diseases, they were generally not large 
enough to allow for multivariable regression analyses to find predictors of impaired 
outcome, and we could not distinguish between type of gastroschisis, omphalocele, or 
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reported a paradoxical increase of pulmonary infections after resection of symptomatic 
CLM,75 and a high prevalence of recurrent LRTIs (i.e. 19%) in 7-year-olds who had 
undergone early surgery regardless of having symptoms.82 Surgical resection of the CLM 
because of recurrent LRTIs is therefore questionable, and we do not know whether 
early surgery in asymptomatic CLM would result in a lower prevalence of LRTIs.  
 
The potential risk of malignant transformation is probably the most important reason 
to advocate surgery in children with asymptomatic CLM.77 A recent systematic review 
provided an overview of malignant transformation of CLM. The authors reported 168 
lung tumors associated with CLM, of which 76 involved children, and 92 involved 
adults.83 No limits were set to the birth year of the population, and only four of these 
cases had been diagnosed prenatally. It is very difficult to determine the true risk of 
malignant transformation in asymptomatic CLM, as a large number of these patients 
may be undiagnosed. Some clinicians argue that the risk is not high enough to subject a 
child without any symptoms to major surgery,84 whereas others would say that this 
argument does not hold water as the risk is yet to be determined. Clinicians should at 
least be aware of the potential risk of malignant transformation. Continued monitoring 
until adulthood and beyond may be considered, but this concept needs to be further 
explored. International consensus is needed regarding the frequency and method of 
monitoring, and data should be collected in a standardized way. Advances in molecular 
biology may help in identifying genetic mutations that can reliably distinguish between 
‘normal’ CPAM and malignant tissue.  
 
In summary, there is not enough evidence to draw conclusions regarding the optimal 
management of children with asymptomatic CLM. Compared with healthy children, 
these children seem to be at increased risk for reduced lung function and exercise 
tolerance, for developing LRTIs, and probably even for malignant transformation of their 
CLM. It is not clear whether early surgery in children with asymptomatic CLM would 
improve or deteriorate their outcomes. In addition, the effects of early surgery or 
watchful waiting on parents’ and treating physicians’ psychological wellbeing have not 
been studied yet. Either approach could increase stress and anxiety, for obvious 
reasons. Ideally, a multicenter case-control study or a randomized controlled trial 
should be carried out to provide answers, and to create a risk assessment tool to assist 
clinicians in identifying children who are at risk of adverse outcome. In the meantime, 
we would recommend involving parents in the decision-making process. Parents should 
be counseled on the pros and cons of early surgery versus watchful waiting in 
asymptomatic CLM in a standardized matter. This could, for example, be done by an 
educational video on a webpage or by an app. This also fits well within the family-
centered approach to care.  
 
Limitations 
One of the major limitations of our research concerns the sample sizes. Although our 
sample sizes were relatively large for such rare diseases, they were generally not large 
enough to allow for multivariable regression analyses to find predictors of impaired 
outcome, and we could not distinguish between type of gastroschisis, omphalocele, or 
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CLM in our studies on outcomes at school age. Because these anomalies are rare, this 
issue can only be solved by extending the years of inclusion or by including children 
from multiple centers. Extending the years of inclusion would not be the first choice; a 
very long inclusion period is needed to include a sufficient number of children, whilst 
health care is rapidly changing over time. Multicenter research bypasses this problem, 
but adds the problem of possible heterogeneity in clinical practice. There is thus need 
for standardized treatment protocols and guidelines for follow-up for these rare 
diseases. Development of protocols and guidelines may be facilitated by the European 
Reference Network on inherited and congenital anomalies (ERNICA); subsequent 
execution of large clinical studies would be a promising step towards better 
understanding and treatment options of rare diseases. 
 
Second, selection bias may have influenced our findings. The decision of parents to 
participate in our follow-up program may correlate with social, educational, and health 
circumstances. These circumstances may again correlate with physical growth, 
neurodevelopment, and other outcomes assessed. Moreover, the decision to 
participate in subsequent follow-up could be related to the outcome of previous follow-
up assessments. For example, parents of children with motor function delay at 12 
months of age may be more motivated to visit the outpatient clinic at 24 months, and 
vice versa. The opposite may also be true.  
 
Third, outcomes during infancy do not always adequately predict daily functioning later 
in life.85 Subtle problems may become evident only later in childhood when demands on 
cognitive functioning increase (i.e. children ‘grow into their deficit’).86 Moreover, as 
infants with AWD or CLM normally do not have severe neurologic injury, 
environmental factors may be crucial for their long-term quality of life and school 
functioning. We investigated these long-term outcomes in school-aged children with 
AWD by using parent-reported questionnaires. It should be noted, however, that 
parents’ internal standards may have shifted after having seen their child’s critical state 
after birth. This response shift may lead to overestimation of their child’s abilities, and 
thus to an underestimation of problems.87 It would be interesting to see whether other 
outcome measures, such as elaborate neuropsychological assessments, child-self 
reports or teacher-reports, would lead to different conclusions regarding the outcome 
of these children. But then again, what to do when neuropsychological assessments 
detect problems that do not seem to bother the child or its parents? What should be 
regarded as relevant? In the end, happiness and good quality of life probably matter 
most, more than objective measures of motor function or academic achievements.   
 
 
 
Recommendations for clinical practice 
The research presented in this thesis provides an overview of what parents who are 
expecting a child with an AWD or CLM can expect – from the prenatal period up to 
school age. Our findings underline the necessity of a multidisciplinary, standardized 
approach in parental counseling with long-term follow-up. Psychosocial support, for 
example by a nurse practitioner or medical social worker, should be part of routine 
care – both before and after the delivery. We recommend to strive more towards a 
family-centered approach to care. Parents should be offered not only practical and 
emotional support, but also be taught how to stimulate their child’s development. We 
recommend involving parents in the decision-making process concerning their child’s 
treatment policy, especially in case of asymptomatic CLM. 
 
Based on the insights of this thesis, and in light of the considerations discussed above, 
we present the following specific recommendations for clinical care:  
 
Gastroschisis 
• Parents opting for termination of pregnancy or whose pregnancy results in 
intrauterine death, should always be offered autopsy of the child with special 
attention to intestinal malrotation and volvulus.  
• Follow-up of children with simple gastroschisis without intestinal failure can be 
limited to 2 years of age, considering their favorable outcome. 
• Follow-up of children with neonatal intestinal failure should be extended to school 
age, with special attention to cognitive problems and attachment style. 
 
Omphalocele 
• It is important to be aware of the difference between the prenatal and postnatal 
frames of reference; because of the ‘hidden mortality’ of omphalocele, obstetricians 
and prenatal specialists may be less optimistic about survival rates than pediatric 
surgeons and pediatricians. 
• The OC/AC-ratio and the fetal liver position should be used to predict postnatal 
type of surgery and survival. We recommend repeated measurements of the 
OC/AC-ratio throughout gestation as different cut-offs apply for each time period. 
The OC/AC-ratio at 30-38 weeks’ gestation is most predictive of outcome. 
• Postnatal categorization of minor and giant omphalocele should be based on the 
final OC/AC-ratio prior to birth. We suggest to use a cut-off of 0.63 between 30-
38 weeks’ gestation; all infants without liver herniation at the final ultrasound prior 
to birth can be regarded as having a minor omphalocele. 
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• Physical growth should be monitored closely, with early nutritional intervention if 
necessary. Indirect calorimetry may be helpful to determine energy requirements. 
Thresholds for supplemental oxygen should be low. 
• Follow-up of children with an isolated, minor omphalocele can be limited to 2 years 
of age, as their outcome is usually favorable. 
• Follow-up of children with a giant omphalocele or multiple congenital anomalies 
should be extended to school age, with special attention to cognitive problems. 
 
Congenital lung malformations 
• A prenatal diagnosis of CLM should be descriptive, according to ultrasound 
appearance (i.e. hyperechoic, hypoechoic, or mixed) and the origin of arterial blood 
supply (the aorta or the pulmonary arteries). Future parents should be informed 
that the specific type of CLM will be determined after postnatal CT-imaging. 
• Infants with CLE do not necessarily have worse outcomes than those with other 
types of CLM; clinicians should be aware of this when counseling parents. 
• The CVR from 24 weeks’ onwards should be used to predict the need for surgical 
intervention within 2 years after birth. The CVR is not a reliable predictor of the 
need for respiratory support within 24 hours after birth. 
• All fetuses with a CLM should be delivered at a tertiary care center, regardless of 
lesion size and prenatal regression. 
• Postnatal CT-imaging should be offered to all infants born with CLM. 
• Parents of children with asymptomatic CLM should be involved in the decision-
making process concerning their child’s treatment strategy. They should be 
counseled in a standardized way on the pros and cons of early surgery versus 
watchful waiting, for example by an educational video on a webpage or by an app. 
• Continued follow-up until adulthood and beyond may be considered to evaluate 
the risk of malignancy. This concept needs to be further explored.  
 
Future research directions  
A subject that requires further study, is that of prenatal counseling itself. A systematic 
review in 2016 reported that prenatal counseling reduced parental anxiety.88 This was 
assessed in only three studies, however, and the authors concluded that there is very 
little evidence of the effectiveness of counseling in relation to other psychological 
outcomes.88 Additionally, most of the studies focused on the mothers’ experiences or 
did not mention the parent’s gender. Future research may investigate potential 
differences in needs and experiences between mothers and fathers. In line with this, 
further research should investigate the effect of routine psychosocial support. Previous 
literature has illustrated the overwhelming effect on future parents of a prenatal 
 
diagnosis of a congenital anomaly.88, 89 We hypothesize that routine psychosocial 
support during pregnancy and after the delivery may contribute to better coping, less 
anxiety, and secure attachment between parents and their child. On the long-term, this 
may even lower the chances of behavioral and learning difficulties. We acknowledge 
that these hypotheses are speculative. 
 
Along with the fact that most children born with an AWD or a CLM nowadays survive 
into adulthood, additional important issues emerge. In particular, data on reproductive 
potential are still very limited, despite the existence of evident risk factors that could 
impair fertility or pregnancy outcome. In males born with an AWD, fertility could be 
impaired by prenatal evisceration of the testes, or on account of undescended testes, 
which is relatively often seen in these boys.90, 91 In females born with an AWD, the 
defect itself could impact abdominal capacity. In addition, fertility could be affected by 
postoperative adhesions; the incidence of adhesive small bowel obstruction after 10 
years is estimated as frequent as 37% in gastroschisis, and 15% in omphalocele.92 Normal 
vaginal delivery after an uncomplicated pregnancy has been described in a few women 
previously affected by an AWD,93 but true incidences of infertility and normal pregnancy 
outcome are not known yet. A family history of fertility problems may add to the risk 
of subfertility in patients with omphalocele and Beckwith-Wiedemann Syndrome, of 
whom a significant proportion (i.e. 9-40%) is conceived by assisted reproductive 
technology.94, 95  
 
In adults with a CLM, incidences of fertility problems and pregnancy outcomes have not 
yet been reported. Considering the fact that these patients usually do not need 
abdominal surgery, we expect that fertility will be unaffected. Pregnancy outcome, 
however, might be affected by impaired lung function and reduced exercise tolerance. 
Females with a CLM may have lower reserves to cope with the physiological changes 
during pregnancy, such as increased cardiac output, the significant increase in oxygen 
demand, and the subjective feeling of breathlessness.96 
 
In addition to the general recommendations described above, the results reported in 
this thesis have raised new questions. We have the following specific recommendations 
for future research: 
 
Gastroschisis 
• Future research should aim to gain insight into the timing and development of 
complex gastroschisis, possibly by using autopsy data and/or MRI. In line with this, 
it would be interesting to investigate certain markers of complex gastroschisis in 
the amniotic fluid or, less invasive, in maternal serum that may correlate with the 
duration of parenteral nutrition and hospitalization. 
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differences in needs and experiences between mothers and fathers. In line with this, 
further research should investigate the effect of routine psychosocial support. Previous 
literature has illustrated the overwhelming effect on future parents of a prenatal 
 
diagnosis of a congenital anomaly.88, 89 We hypothesize that routine psychosocial 
support during pregnancy and after the delivery may contribute to better coping, less 
anxiety, and secure attachment between parents and their child. On the long-term, this 
may even lower the chances of behavioral and learning difficulties. We acknowledge 
that these hypotheses are speculative. 
 
Along with the fact that most children born with an AWD or a CLM nowadays survive 
into adulthood, additional important issues emerge. In particular, data on reproductive 
potential are still very limited, despite the existence of evident risk factors that could 
impair fertility or pregnancy outcome. In males born with an AWD, fertility could be 
impaired by prenatal evisceration of the testes, or on account of undescended testes, 
which is relatively often seen in these boys.90, 91 In females born with an AWD, the 
defect itself could impact abdominal capacity. In addition, fertility could be affected by 
postoperative adhesions; the incidence of adhesive small bowel obstruction after 10 
years is estimated as frequent as 37% in gastroschisis, and 15% in omphalocele.92 Normal 
vaginal delivery after an uncomplicated pregnancy has been described in a few women 
previously affected by an AWD,93 but true incidences of infertility and normal pregnancy 
outcome are not known yet. A family history of fertility problems may add to the risk 
of subfertility in patients with omphalocele and Beckwith-Wiedemann Syndrome, of 
whom a significant proportion (i.e. 9-40%) is conceived by assisted reproductive 
technology.94, 95  
 
In adults with a CLM, incidences of fertility problems and pregnancy outcomes have not 
yet been reported. Considering the fact that these patients usually do not need 
abdominal surgery, we expect that fertility will be unaffected. Pregnancy outcome, 
however, might be affected by impaired lung function and reduced exercise tolerance. 
Females with a CLM may have lower reserves to cope with the physiological changes 
during pregnancy, such as increased cardiac output, the significant increase in oxygen 
demand, and the subjective feeling of breathlessness.96 
 
In addition to the general recommendations described above, the results reported in 
this thesis have raised new questions. We have the following specific recommendations 
for future research: 
 
Gastroschisis 
• Future research should aim to gain insight into the timing and development of 
complex gastroschisis, possibly by using autopsy data and/or MRI. In line with this, 
it would be interesting to investigate certain markers of complex gastroschisis in 
the amniotic fluid or, less invasive, in maternal serum that may correlate with the 
duration of parenteral nutrition and hospitalization. 
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• Future research should look into the mechanisms behind the associations between 
parent-reported cognitive problems at school age, and neonatal intestinal failure, 
increased parent-perceived vulnerability, and attachment style.  
 
Omphalocele 
• Future research should investigate whether certain algorithms could result in a 
constant cut-off of the OC/AC-ratio throughout gestation for type of postnatal 
closure, without affecting its predictive value.  
• Future research should look into the mechanism behind parent-reported cognitive 
problems at school age in children with either a giant omphalocele or multiple 
congenital anomalies.  
 
Congenital lung malformations 
• Further research should investigate CLM that seem to disappear prenatally; most 
lesions are still visible on CT-imaging after birth. In line with this, it would be 
interesting to investigate possible mechanisms behind the rather unusual 
occurrence of bilateral pneumothorax in some of these cases. 
• A multicenter case-control study or a randomized controlled trial should be carried 
out to provide answers regarding the optimal management strategy of 
asymptomatic CLM, and to create a risk assessment tool to assist clinicians in 
identifying children who are at risk of adverse outcome. 
• With advances in molecular biology, future research may try to identify genetic 
mutations that can reliably distinguish between ‘normal’ CPAM and malignant 
tissue.   
 
What to tell parents? Take home messages 
Gastroschisis 
• The majority of children with gastroschisis have simple gastroschisis; approximately 
17% has complex gastroschisis. 
• Complex gastroschisis means that gastroschisis is complicated by intestinal atresia, 
volvulus, necrosis and/or perforation. 
• Most children do not have additional structural congenital anomalies; amniocentesis 
is usually not needed.  
• While the difference between simple and complex gastroschisis is usually easy to 
see at primary postnatal evaluation, it is very difficult to distinguish complex from 
simple gastroschisis on prenatal ultrasound. The presence of bowel dilatation does 
not necessarily mean that the child has complex gastroschisis, and absence of bowel 
dilatation does not necessarily mean that the child has simple gastroschisis. 
• Infants with gastroschisis can be delivered vaginally from 37 weeks’ onwards, unless 
obstetric reasons require otherwise. 
• Most live-born infants with gastroschisis survive. 
• Surgery is required shortly after birth, by means of primary closure when possible 
or by placing a silastic silo to allow gradual reduction into the abdominal cavity prior 
to definite closure. 
• Hospital outcome largely depends on the type of gastroschisis; median durations of 
time to full enteral feeding and hospitalization are less than 2 months in infants with 
simple gastroschisis, and close to 6 months in those with complex gastroschisis.  
• Physical growth is within normal range. Neurodevelopment at 2 years of age is 
generally normal in infants with simple gastroschisis; those with complex 
gastroschisis may be at risk for delayed development, with motor function being 
most affected. We expect that most of them will catch up on this during childhood, 
provided that they receive adequate follow-up and timely intervention if needed. 
• Parent-reported outcomes at school age are comparable with those of healthy 
children, except for cognitive problems, which seem to be more prevalent in 
children with gastroschisis.  
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most affected. We expect that most of them will catch up on this during childhood, 
provided that they receive adequate follow-up and timely intervention if needed. 
• Parent-reported outcomes at school age are comparable with those of healthy 
children, except for cognitive problems, which seem to be more prevalent in 
children with gastroschisis.  
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Omphalocele 
• Approximately 75-80% of fetuses with omphalocele present with chromosomal 
abnormalities and/or additional congenital anomalies; amniocentesis is 
recommended. 
• One-third of all fetuses with an omphalocele have a lethal additional anomaly, none 
of these fetuses survive. The survival rate in those with a non-lethal additional 
anomaly is around 20%, depending on the type of anomaly. 
• The survival in fetuses with an isolated omphalocele varies between 32% and 75%, 
depending on the size of the omphalocele, and on whether the liver is herniated or 
not. 
• Most infants with minor omphalocele undergo primary closure within 48 hours 
after birth. Those with giant omphalocele usually require an initial period of 
epithelialization of the omphalocele before definitive surgical closure is performed. 
Closure is usually planned before the age of 1 year.  
• The type of postnatal surgical closure and the chance of 1-year survival can be 
predicted prenatally, using the fetal liver position and the OC/AC-ratio. Predictive 
values increase with increasing gestational age.  
• Infants with omphalocele can be delivered vaginally, unless obstetric reasons 
require otherwise. 
• The 2-year survival rate in live-born infants with a prenatally diagnosed, isolated, 
minor omphalocele, is approximately 80-90%. The survival rate in those with giant 
omphalocele is somewhat lower, mostly because of the risk of respiratory 
problems (e.g. pulmonary hypoplasia, CLD). Approximately 60-70% of these infants 
survive.  
• Hospital outcome largely depends on the type of omphalocele; median durations 
of time to full enteral feeding and hospitalization are approximately 1 week in 
children with a minor omphalocele. Those with a giant omphalocele require around 
3 weeks to reach full enteral feeding, and need to stay in hospital for approximately 
7 weeks.  
• Infants with omphalocele seem to be at risk for failure to thrive. Mental 
development is generally normal at 2 years of age. Those with a giant omphalocele 
are at risk for impaired motor function. We expect that most children with an 
isolated omphalocele will catch up during childhood, provided that they receive 
adequate follow-up and timely intervention if needed. 
• Parent-reported outcomes at school age are comparable with those of healthy 
children. Children with a giant omphalocele or multiple congenital anomalies are 
more often reported to have cognitive problems. 
 
  
 
Congenital lung malformations 
• CLM compromise a group of anomalies that are categorized by the size of the cysts, 
and by the presence or absence of blood supply from the aorta. The prenatal 
appearance of the lesion does not always correspond with that after birth.  
• The prognosis is usually good. Problems during pregnancy, such as hydrops, severe 
mediastinal shift or polyhydramnios, are rare, but when present strongly worsen 
the child’s prognosis. 
• The size of the CLM can either increase, decrease, or remain stable throughout 
pregnancy. Some CLM seem to disappear, but most of these lesions are still visible 
on CT-imaging after birth.  
• Prenatal disappearance of the lesion does not necessarily mean that the child does 
not develop symptoms after birth. 
• It is difficult to prenatally predict the need for respiratory support after birth. In 
most cases, respiratory support directly after birth is not needed. 
• The need for surgery within 2 years after birth can be predicted prenatally, using 
the CVR. 
• Approximately 50% of the children who need respiratory support will need surgical 
intervention before the age of 2 years. Of those who initially do not need 
respiratory support, approximately 15% will eventually need surgery. 
• Most neonates can be discharged home within 1 week after birth. 
• CT-imaging is performed in all infants born with CLM, around the age of 6 months. 
• The optimal management of asymptomatic CLM is still being debated. Some 
clinicians prefer early surgery, whereas others advocate a watchful waiting 
approach.  
• Physical growth is within normal range.  
• Children with a CLM are at risk for reduced lung function and exercise tolerance, 
especially those who require surgery because of symptoms. It is important to 
stimulate physical activity and sport participation. 
• Recurrent LRTIs may occur. We do not know whether surgical resection of the 
CLM will solve this problem. 
• The current literature suggests that the risk of malignant transformation of the 
CLM is small, but not negligible. Therefore, continued follow-up may be considered 
until adulthood and beyond.  
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until adulthood and beyond.  
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Introduction 
Prenatal detection of a congenital anomaly offers the possibility of early parental 
counseling and of optimizing postnatal care. When counseling expectant parents, it is 
important to know how to interpret certain prenatal characteristics, and to be aware 
of the implications of the anomaly in terms of survival, hospital outcome, and long-term 
consequences. 
 
Prenatal detection rates of abdominal wall defects (AWD; i.e. gastroschisis or 
omphalocele) and congenital lung malformations (CLM) are relatively high, but not so 
much is known on the long-term outcome of children born with either of these 
anomalies.  
 
This thesis aims to improve the knowledge on prenatal characteristics and long-term 
outcome of AWD and CLM, with the ultimate aim to optimize parental counselling and 
postnatal follow-up. Most of the presented studies made use of data from the 
longitudinal multidisciplinary follow-up program at the Erasmus MC-Sophia Children’s 
Hospital.  
 
We asked ourselves two general key questions: 
• Can we identify prenatal characteristics that contribute to the prediction of 
postnatal morbidity? 
• What kind of long-term morbidity is seen in these children?  
The research described in this thesis is divided into three parts: gastroschisis, 
omphalocele, and congenital lung malformations. 
Gastroschisis 
 
 
Chapter 2 describes the findings of a longitudinal, prospective cohort study, in which 
we investigated whether prenatal three-dimensional (3D) ultrasound could distinguish 
complex gastroschisis from simple gastroschisis. A previous study using magnetic 
resonance imaging showed stomach-bladder contact in all fetuses with gastroschisis in 
the third trimester, except for those with intestinal stenosis; their abdominal cavity was 
filled with dilated bowel loops. We hypothesized that complex gastroschisis would lead 
to stomach dilatation – which is difficult to measure using two-dimensional ultrasound 
– and to an increased stomach-bladder distance. We assessed the fetal stomach volume 
Can we identify prenatal 2D or 3D ultrasound markers of complex gastroschisis?  
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and stomach-bladder distance throughout gestation. With advancing gestational age, the 
stomach volume increased, and the stomach-bladder distance decreased. The 
developmental changes in stomach volume and stomach bladder distance did not differ 
between fetuses with simple and complex gastroschisis. 
 
In chapter 3 we evaluated the association between gestational-age corrected two-
dimensional (2D) ultrasound markers and complex gastroschisis. We determined the 
presence of either gastric dilatation or bowel dilatation using gestational-age specific 
reference norms, both at 30 weeks’ gestation and at the last ultrasound examination 
prior to delivery. Only extra-abdominal bowel dilatation at 30 weeks’ gestation was 
found to be associated with complex gastroschisis, but its positive predictive value was 
low.  
 
We conclude that neither 2D nor 3D ultrasound measures can reliably distinguish 
complex gastroschisis from simple gastroschisis. 
 
 
 
In chapter 3, we evaluated the physical growth and neurodevelopment of 61 infants 
with either simple or complex gastroschisis at 12 and 24 months of age. At 24 months, 
only 8% scored below Dutch reference norms for weight, and all had normal height. 
Both mental and motor development were normal in over 80% of infants with simple 
gastroschisis, and in half of those with complex gastroschisis – with motor function 
being most affected. 
 
We conclude that most infants with gastroschisis show encouraging physical growth 
and neurodevelopment. Infants with complex gastroschisis may be at increased risk for 
motor function delay; they should be monitored more closely, and offered timely 
pediatric physical therapy. 
 
 
 
Chapter 4 describes daily functioning in 31 children with gastroschisis at school age 
(i.e. 4-17 years). We evaluated parent-reported outcomes using paper questionnaires. 
Parent-perceived vulnerability and motor function were compared with Dutch 
reference data. Data on cognition, health status, quality of life, and behavior were 
How do infants with either simple or complex gastroschisis grow up in terms of 
physical growth, mental development, and motor development? 
 
How do parents rate their child’s motor function, cognition, health status, quality 
of life and behavior at school age? 
 
 
compared with those of healthy controls matched for age, gender, and maternal 
education level. Three-quarters of parents reported that their child had normal motor 
function, and scores on health status, quality of life, and behavior were similar to those 
of matched controls. Cognitive problems were reported in 43% of children with 
gastroschisis (versus 11% of matched controls). Neonatal intestinal failure and increased 
parent-perceived vulnerability were associated with cognitive problems. 
 
We conclude that parent-reported outcomes of children with gastroschisis at school 
age are mainly reassuring. Clinicians and parents should be aware of the higher risk of 
cognitive problems. We recommend multidisciplinary follow-up at school age of 
children with neonatal intestinal failure. 
 
Omphalocele 
 
 
Comparison between the prenatal frame of reference of omphalocele (i.e., survival of 
fetuses) with that after birth (i.e., survival of live born neonates) was studied in chapter 
6. The prenatal frame of reference was considerably worse than that after birth. Fifty 
(40%) of the 126 fetuses diagnosed with omphalocele were live born, and only 35 (28%) 
survived at least 2 years. Additional structural or chromosomal anomalies – mainly 
lethal – were found in more than half of the fetuses, which led to high rates of 
termination of pregnancy and intrauterine death. In contrast, the 2-year survival rate in 
live born neonates was 75%. 
 
We conclude that the prenatal frame of reference differs considerably from that after 
birth; the 2-year survival rate in prenatally diagnosed omphalocele is almost three times 
as low as that in live born neonates. A multidisciplinary approach in parental counselling 
is therefore recommended. 
 
 
 
Chapter 5 describes the predictive value of the ratio between omphalocele 
circumference (OC) and abdominal circumference (AC) for type of surgical closure and 
survival in 63 fetuses with omphalocele. The OC/AC-ratio and liver position were 
determined at three time periods during gestation (11-16, 17-26, and 30-38 weeks). As 
the OC/AC-ratio decreased with increasing gestational age, different cut-offs for 
How does the prenatal frame of reference differ from that after birth? 
Can we prenatally predict the type of surgical closure in fetuses with either 
isolated or non-isolated omphalocele? 
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predicting type of closure were calculated for each time period. Each cut-off had high 
sensitivity and specificity (around 90%). The omphalocele was closed primarily in all 32 
fetuses without liver herniation. Overall, of 37 infants whose defect was closed 
primarily, 36 (97%) survived. 
 
We conclude that the type of surgical closure and survival in fetuses with omphalocele 
can be predicted prenatally, using different cut-offs of the OC/AC-ratio throughout 
gestation combined with the position of the liver.  
 
 
 
We assessed physical growth and neurodevelopment in 42 infants with minor or giant 
omphalocele in chapter 6. At 24 months of age, height was below Dutch reference 
norms in 8% of infants with minor omphalocele, and in 30% of those with giant 
omphalocele. Weight was lower than the norm in 16% of infants with minor 
omphalocele, and in 40% of those with giant omphalocele. Mental development was 
normal in both groups. Motor development was delayed in 21% of infants with minor 
omphalocele, and in 82% of infants with giant omphalocele. 
 
We conclude that infants with omphalocele seem to be at greater risk of failure to 
thrive. They have normal mental development. Infants with giant omphalocele often 
have delayed motor development. We recommend timely referral to pediatric physical 
therapy, and prolonged follow-up in these children.  
 
 
 
Chapter 7 describes daily functioning of 31 children with omphalocele at school age 
(i.e. 4-17 years). We evaluated parent-reported outcomes using paper questionnaires.  
Motor function was compared with Dutch reference data. We compared cognition, 
health status, quality of life, and behavior with those of healthy controls matched for 
age, gender, and maternal education level. Over 80% of parents reported normal motor 
function, and scores on cognition, health status, quality of life, and behavior were similar 
to those of matched controls. Cognitive problems were reported in 26% of children 
with omphalocele (versus 9% of matched controls). Giant omphalocele and multiple 
congenital anomalies were most prominently associated with cognitive problems.  
How do infants with either minor or giant omphalocele grow up in terms of 
physical growth, mental development, and motor development? 
How do parents rate their child’s motor function, cognition, health status, 
quality of life and behavior at school age? 
 
 
We conclude that parent-reported outcomes of children with omphalocele at school 
age are reassuring. Children with isolated, minor omphalocele probably do not need 
extensive long-term follow-up. Those with giant omphalocele or multiple congenital 
anomalies may be at risk for cognitive problems at school age; we recommend long-
term follow-up to ensure that timely intervention can be offered if needed. 
 
Congenital lung malformations 
 
 
In chapter 8, we assessed the concordance between prenatal appearance and postnatal 
type of CLM in 80 fetuses. The CLM were classified according to prenatal ultrasound 
findings into congenital pulmonary airway malformation (CPAM; microcystic, 
macrocystic or mixed), bronchopulmonary sequestration, and hybrid lesion. The 
postnatal diagnosis was made using computed tomography (CT)-imaging and/or 
histology. The most striking finding was that microcystic CPAM on prenatal ultrasound 
appeared to be congenital lobar emphysema in 15 (43%) infants after birth. 
 
We conclude that it is difficult to diagnose the specific type of CLM in a fetus. We 
propose to describe the CLM prenatally according to its ultrasound characteristics (i.e. 
hyperechoic, hypoechoic, or mixed, and with or without arterial blood supply from the 
aorta). The future parents should be informed that the type of CLM will be determined 
after postnatal CT-imaging. 
 
 
 
Chapter 8 describes the predictive value of the CPAM volume ratio (CVR) for the 
need for respiratory support within 24 hours after birth, and for the need for surgical 
intervention within 2 years after birth in 80 fetuses with CLM. The CVR was determined 
at three time periods during gestation (18-24, 24-30, and 30-37 weeks). Overall, 14 
(18%) infants required respiratory support, and 17 (21%) required surgery. The CVR 
from 24 weeks’ onwards proved to be a reliable predictor of the need for surgery 
(sensitivity and specificity around 80%). We could not predict the need for respiratory 
support; the CVR-measurements on prenatal ultrasound in infants who required 
respiratory support had shown large differences, ranging from full regression to a CVR 
>1.6.  
How does the prenatal appearance of CLM correspond with that after birth? 
Can we prenatally predict the need for postnatal respiratory support and/or 
surgical intervention? 
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We conclude that the CVR from 24 weeks’ gestation onwards is a reliable predictor of 
the need for surgery within 2 years after birth. We were unable to predict the need for 
respiratory support within 24 hours after birth; we therefore recommend to have all 
fetuses with a CLM delivered at a tertiary care hospital, regardless of lesion size and 
prenatal regression. 
 
 
 
Chapter 9 describes physical growth, lung function, and exercise tolerance in 61 
children with CLM at the age of 8 years. We evaluated these outcomes both in children 
who had required surgery, as well as in those who were managed by observation. Both 
groups had normal height and weight; the need for surgery did not affect physical 
growth. Most children in the observation group had normal lung function and exercise 
tolerance. About a quarter of children in this group did show reduced lung function 
and/or exercise tolerance, however, and clinicians and parents should be aware of this. 
In the surgery group, approximately half of the children had abnormal lung function, and 
mean exercise tolerance fell below -1 standard deviation.  
 
We conclude that children born with CLM have normal physical growth. They are at 
risk for reduced lung function and exercise tolerance, especially those who require 
surgery. Continued follow-up until adulthood and beyond may be considered to 
evaluate the risk of malignancy. 
 
General discussion 
In chapter 10, we discuss the study results, put them into perspective, and make 
recommendations for clinical practice and future research. In general, our findings 
underline the necessity of a multidisciplinary, standardized approach in parental 
counseling, and long-term follow-up. We recommend to: 
• Strive more towards a family-centered approach to care.  
• Offer parents not only practical and emotional support, but also teach them how 
to stimulate their child’s development.  
• Involve parents in the decision-making process concerning their child’s treatment 
policy. 
 
The chapter is concluded with a summary on what to tell parents who are expecting a 
child with an AWD or a CLM. 
How do these children, either managed observationally or surgically, grow up in 
terms of physical growth, lung function, and exercise tolerance? 
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Introductie  
Ongeveer 3% van alle baby’s in Europa wordt geboren met een anatomische afwijking. 
Sommige van deze afwijkingen kunnen al voor de geboorte worden gezien, tijdens de 
20 weken echo. Voorbeelden van afwijkingen die meestal al voor de geboorte worden 
gezien, zijn een buikwanddefect (gastroschisis of omphalocele) en een aanlegstoornis 
van de long.  
 
Wanneer er een afwijking wordt gezien op de echo, is het belangrijk om de aanstaande 
ouders voor te bereiden op wat ze kunnen verwachten. Wat betekenen bepaalde 
kenmerken op de echo? Wat zijn de overlevingskansen? Hoe ziet de periode van 
ziekenhuisopname eruit? En de periode daarna? Groeit het kind goed en zal hij of zij 
naar een gewone school kunnen? 
 
Er is nog niet zoveel bekend over de langetermijnuitkomsten van kinderen met een 
buikwanddefect of een aanlegstoornis van de long. Het doel van de onderzoeken in dit 
proefschrift was daarom om de kennis over deze afwijkingen te vergroten. Met deze 
kennis kunnen we ouders beter voorbereiden en kan de langetermijnfollow-up worden 
afgestemd op wat deze kinderen nodig hebben. 
 
We stelden onszelf de volgende algemene vragen:  
• Kunnen we voor de geboorte, met behulp van kenmerken op de echo, al 
voorspellen hoe goed of slecht het na de geboorte met het kind zal gaan?  
• Wat zijn de gevolgen van deze afwijkingen op de lange termijn? 
Dit proefschrift is onderverdeeld in drie delen: gastroschisis, omphalocele en 
aanlegstoornis van de long. 
Gastroschisis 
Een kind met gastroschisis heeft een opening in de buikwand, naast de navel. Een deel 
van de darmen is door deze opening naar buiten gekomen. Soms komen ook andere 
organen naar buiten, zoals de maag of de blaas. De meeste baby’s hebben een 
zogenoemde ‘simpele’ gastroschisis. Ongeveer 17% heeft een ‘complexe’ gastroschisis. 
Dat betekent dat de darmen een extra afwijking hebben. Er is bijvoorbeeld een 
darmafsluiting, of er zit een verdraaiing in de darm. Baby’s met complexe gastroschisis 
zijn langer in het ziekenhuis opgenomen dan baby’s met simpele gastroschisis. Dit komt 
omdat het langer duurt voordat hun darmen goed werken; ze hebben vaker 
voedingsproblemen en meer infecties. Het is daarom waardevol om voor de geboorte 
te kunnen voorspellen of er sprake is van een simpele of een complexe gastroschisis. 
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In hoofdstuk 2 hebben we onderzocht of we met driedimensionale (3D) echografie 
tijdens de zwangerschap konden zien welke baby’s complexe gastroschisis hadden. 
Complexe gastroschisis zou kunnen zorgen voor een uitgezette maag, maar met 
tweedimensionale (2D) echografie is dit lastig te meten. Daarnaast liet een eerdere 
studie met magnetic resonance imaging (MRI) zien dat de maag tegen de blaas aan lag bij 
alle baby’s met simpele gastroschisis tijdens de zwangerschap, behalve bij degenen met 
een darmafsluiting. Dit kwam doordat zij uitgezette darmlissen hadden, die 
voorkwamen dat de maag de blaas raakte. We hebben daarom de grootte van de maag 
en de afstand tussen de maag en de blaas gemeten op verschillende momenten in de 
zwangerschap, met behulp van 3D echografie. We zagen dat de grootte van de maag 
tijdens de zwangerschap toenam, terwijl de afstand tussen de maag en de blaas steeds 
kleiner werd. Dit verloop was niet verschillend tussen simpele en complexe 
gastroschisis. 
 
In hoofdstuk 3 is met 2D echografie de mate van uitzetting van de maag en van de 
darmen bepaald bij 30 weken zwangerschap en bij de laatste echo voor de geboorte. 
Bij 30 weken zwangerschap waren de darmen buiten de buik vaker uitgezet bij complexe 
gastroschisis dan bij simpele gastroschisis, maar lang niet alle baby’s met complexe 
gastroschisis hadden uitgezette darmen.  
 
We concluderen dat we geen betrouwbare aanwijzingen tijdens de zwangerschap 
hebben gevonden voor complexe gastroschisis, niet met 2D en ook niet met 3D 
echografie.  
 
 
 
In hoofdstuk 3 hebben we de groei en ontwikkeling beschreven van 61 kinderen met 
simpele of complexe gastroschisis, op de leeftijd van 1 en 2 jaar. Op de leeftijd van 2 
jaar had 8% van de kinderen ondergewicht; er was een normale lengtegroei. Meer dan 
80% van de kinderen met simpele gastroschisis had een normale mentale en motorische 
ontwikkeling. Van de kinderen met complexe gastroschisis had slechts de helft een 
normale ontwikkeling; het motorisch functioneren was het vaakst onder de norm.  
 
Kunnen we met 2D of 3D echografie tijdens de zwangerschap aanwijzingen vinden 
voor de aanwezigheid van complexe gastroschisis?  
Hoe is de groei en ontwikkeling van kinderen met simpele of complexe 
gastroschisis in de eerste twee levensjaren? 
 
 
We concluderen dat de meeste kinderen met gastroschisis goed groeien en zich 
normaal ontwikkelen. Kinderen met complexe gastroschisis hebben mogelijk een 
verhoogd risico op motorische achterstand. Zij moeten goed worden gevolgd en indien 
nodig op tijd worden verwezen voor kinderfysiotherapie. 
 
 
 
Hoofdstuk 4 beschrijft het dagelijks functioneren van 31 kinderen met gastroschisis 
op de schoolleeftijd (4-17 jaar). Ouders hadden hiervoor vragenlijsten ingevuld. We 
vergeleken de mate van kwetsbaarheid zoals ervaren door ouders en het motorisch 
functioneren met Nederlandse referentiewaarden. De gegevens over cognitie, de 
gezondheidsstatus, kwaliteit van leven en gedrag werden vergeleken met die van 
gezonde kinderen van dezelfde leeftijd, hetzelfde geslacht en met hetzelfde 
opleidingsniveau van moeder (controlegroep). Driekwart van de ouders gaf aan dat hun 
kind een normale motorische ontwikkeling had. De scores op het gebied van 
gezondheidsstatus, kwaliteit van leven en gedrag waren vergelijkbaar met die van de 
gezonde kinderen. Meer dan 40% van de ouders van een kind met gastroschisis gaf aan 
dat hun kind cognitieve problemen had (vergeleken met 11% in de controlegroep). De 
kinderen die als baby langdurig infuusvoeding nodig hadden gehad en de kinderen die 
door hun ouders als kwetsbaarder werden gezien, leken vaker cognitieve problemen te 
hebben.  
 
We concluderen dat ouders van een kind met gastroschisis over het algemeen positief 
zijn over het functioneren van hun kind op de schoolleeftijd. Dokters en ouders moeten 
op de hoogte worden gebracht van de mogelijk hogere kans op cognitieve problemen. 
We raden aan om de kinderen met gastroschisis die als baby langdurig infuusvoeding 
nodig hebben gehad op te volgen op de schoolleeftijd.  
 
Omphalocele 
In het begin van de zwangerschap ontwikkelen de darmen zich in de navelstreng. 
Normaal gesproken trekken de darmen zich weer terug in de buik, rond 11 weken 
zwangerschap. Als dit niet gebeurt is er sprake van een omphalocele. Bij een baby met 
een omphalocele komen de darmen – en soms ook andere buikorganen – door de navel 
heen naar buiten. Dit alles wordt bedekt door een dun vlies. Veel ongeboren baby’s 
met een omphalocele hebben daarnaast ook andere afwijkingen, zoals een hartafwijking 
of een chromosoomafwijking. Dit leidt tot vele zwangerschapsafbrekingen en veel 
Hoe beoordelen ouders het motorisch functioneren, het cognitief functioneren, 
de gezondheidsstatus, de kwaliteit van leven en het gedrag van hun kind op de 
schoolleeftijd?  
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sterfte voor de geboorte. Het perspectief voor de geboorte kan daarom verschillen van 
het perspectief na de geboorte. Naast de aanwezigheid van andere afwijkingen maakt 
het veel verschil of de omphalocele groot (‘giant’) of klein (‘minor’) is. Giant 
omphaloceles kunnen niet direct na de geboorte al operatief gesloten worden; vaak 
wordt dit pas gedaan rond de leeftijd van 1 jaar. Baby’s geboren met een giant 
omphalocele hebben vaak minder goed ontwikkelde longen en vaker 
voedingsproblemen dan baby’s met een minor omphalocele.  
 
 
 
In hoofdstuk 6 vergeleken we de overlevingskansen van ongeboren baby’s (het 
perspectief voor de geboorte) met de overlevingskansen van levend geboren baby’s 
(het perspectief na de geboorte). Zoals verwacht, zagen we dat het perspectief voor de 
geboorte veel slechter was dan dat na de geboorte. Van de 126 ongeboren baby’s met 
omphalocele werden er slechts 50 (40%) levend geboren en overleefden er 35 (28%) 
tenminste tot de leeftijd van 2 jaar. Meer dan de helft van de ongeboren baby’s had 
andere afwijkingen, die meestal niet met het leven verenigbaar waren. Veel van de bij 
de studie betrokken ouders besloten daarom de zwangerschap vroegtijdig te beëindigen 
en veel andere baby’s overleden al voor de geboorte. Van alle 69 baby’s die levend 
geboren werden, overleefden er 52 (75%) tenminste tot de leeftijd van 2 jaar.  
 
We concluderen dat het perspectief voor de geboorte sterk verschilt van dat na de 
geboorte. De 2-jaarsoverleving van ongeboren baby’s met een omphalocele is bijna drie 
keer zo laag als dat van levend geboren baby’s. Het verdient aanbeveling dat de ouders 
door meerdere specialisten worden gecounseld: zowel door prenatale specialisten zoals 
gynaecologen en artsen prenatale geneeskunde, als door postnatale specialisten zoals 
kinderartsen en –chirurgen. 
 
 
 
Hoofdstuk 5 beschrijft de voorspellende waarde van de verhouding tussen de omtrek 
van de omphalocele en de buikomtrek (OC/AC-ratio) voor het type operatie en de 
overlevingskansen bij 63 ongeboren baby’s met een omphalocele. De OC/AC-ratio en 
de positie van de lever werden bepaald op drie momenten tijdens de zwangerschap (11-
16, 17-26 en 30-38 weken). Aangezien de OC/AC-ratio daalde gedurende de 
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zwangerschap, berekenden we verschillende afkapwaarden per tijdsperiode voor het 
voorspellen van het type operatie. Elke afkapwaarde bleek een goede voorspeller; de 
sensitiviteit en specificiteit waren rond de 90%. Bij alle 32 baby’s bij wie de lever nog in 
de buik zat kon de omphalocele na de geboorte direct gesloten worden. In totaal kon 
de omphalocele bij 37 baby’s direct na de geboorte gesloten worden; allen op één na 
overleefden.  
 
We concluderen dat we, met behulp van de OC/AC-ratio en de positie van de lever, 
voor de geboorte goed kunnen voorspellen welke omphaloceles direct na de geboorte 
gesloten kunnen worden en wat de overlevingskansen zullen zijn.  
 
 
 
We bekeken de groei en ontwikkeling van 42 kinderen met een minor of giant 
omphalocele in hoofdstuk 6. Op de leeftijd van 2 jaar had 8% van de kinderen met een 
minor omphalocele een achterblijvende lengtegroei en 16% had ondergewicht. Van de 
2-jarigen met een giant omphalocele had 30% een achterblijvende lengtegroei en 40% 
had ondergewicht. Zowel kinderen met een minor als die met een giant omphalocele 
hadden een normale mentale ontwikkeling. De motorische ontwikkeling was vertraagd 
bij 21% van de kinderen met een minor omphalocele en bij 82% van de kinderen met 
een giant omphalocele. 
 
We concluderen dat kinderen met een omphalocele een verhoogd risico hebben op 
achterblijvende groei. De mentale ontwikkeling is normaal. Kinderen met een giant 
omphalocele hebben vaak een vertraagde motorische ontwikkeling, zij moeten goed 
gevolgd worden en op tijd worden verwezen voor kinderfysiotherapie.  
 
 
 
Hoofdstuk 7 beschrijft het dagelijks functioneren van 31 kinderen met een 
omphalocele op de schoolleeftijd (4-17 jaar). Ouders hadden hiervoor vragenlijsten 
ingevuld. We vergeleken de mate van kwetsbaarheid zoals ervaren door ouders en het 
motorisch functioneren met Nederlandse referentiewaarden. De gegevens over 
cognitie, de gezondheidsstatus, kwaliteit van leven en gedrag werden vergeleken met 
die van gezonde kinderen van dezelfde leeftijd, hetzelfde geslacht en met hetzelfde 
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in de eerste twee levensjaren? 
 
Hoe beoordelen ouders de motorische functie, het functioneren op school, de 
gezondheidsstatus, de kwaliteit van leven en het gedrag van hun kind op de 
schoolleeftijd?  
 
Chapter 12
258
sterfte voor de geboorte. Het perspectief voor de geboorte kan daarom verschillen van 
het perspectief na de geboorte. Naast de aanwezigheid van andere afwijkingen maakt 
het veel verschil of de omphalocele groot (‘giant’) of klein (‘minor’) is. Giant 
omphaloceles kunnen niet direct na de geboorte al operatief gesloten worden; vaak 
wordt dit pas gedaan rond de leeftijd van 1 jaar. Baby’s geboren met een giant 
omphalocele hebben vaak minder goed ontwikkelde longen en vaker 
voedingsproblemen dan baby’s met een minor omphalocele.  
 
 
 
In hoofdstuk 6 vergeleken we de overlevingskansen van ongeboren baby’s (het 
perspectief voor de geboorte) met de overlevingskansen van levend geboren baby’s 
(het perspectief na de geboorte). Zoals verwacht, zagen we dat het perspectief voor de 
geboorte veel slechter was dan dat na de geboorte. Van de 126 ongeboren baby’s met 
omphalocele werden er slechts 50 (40%) levend geboren en overleefden er 35 (28%) 
tenminste tot de leeftijd van 2 jaar. Meer dan de helft van de ongeboren baby’s had 
andere afwijkingen, die meestal niet met het leven verenigbaar waren. Veel van de bij 
de studie betrokken ouders besloten daarom de zwangerschap vroegtijdig te beëindigen 
en veel andere baby’s overleden al voor de geboorte. Van alle 69 baby’s die levend 
geboren werden, overleefden er 52 (75%) tenminste tot de leeftijd van 2 jaar.  
 
We concluderen dat het perspectief voor de geboorte sterk verschilt van dat na de 
geboorte. De 2-jaarsoverleving van ongeboren baby’s met een omphalocele is bijna drie 
keer zo laag als dat van levend geboren baby’s. Het verdient aanbeveling dat de ouders 
door meerdere specialisten worden gecounseld: zowel door prenatale specialisten zoals 
gynaecologen en artsen prenatale geneeskunde, als door postnatale specialisten zoals 
kinderartsen en –chirurgen. 
 
 
 
Hoofdstuk 5 beschrijft de voorspellende waarde van de verhouding tussen de omtrek 
van de omphalocele en de buikomtrek (OC/AC-ratio) voor het type operatie en de 
overlevingskansen bij 63 ongeboren baby’s met een omphalocele. De OC/AC-ratio en 
de positie van de lever werden bepaald op drie momenten tijdens de zwangerschap (11-
16, 17-26 en 30-38 weken). Aangezien de OC/AC-ratio daalde gedurende de 
Hoe verschilt het perspectief voor de geboorte van het perspectief na de 
geboorte? 
Kunnen we voor de geboorte voorspellen welk type operatie de baby na de 
geboorte nodig zal hebben?  
 
zwangerschap, berekenden we verschillende afkapwaarden per tijdsperiode voor het 
voorspellen van het type operatie. Elke afkapwaarde bleek een goede voorspeller; de 
sensitiviteit en specificiteit waren rond de 90%. Bij alle 32 baby’s bij wie de lever nog in 
de buik zat kon de omphalocele na de geboorte direct gesloten worden. In totaal kon 
de omphalocele bij 37 baby’s direct na de geboorte gesloten worden; allen op één na 
overleefden.  
 
We concluderen dat we, met behulp van de OC/AC-ratio en de positie van de lever, 
voor de geboorte goed kunnen voorspellen welke omphaloceles direct na de geboorte 
gesloten kunnen worden en wat de overlevingskansen zullen zijn.  
 
 
 
We bekeken de groei en ontwikkeling van 42 kinderen met een minor of giant 
omphalocele in hoofdstuk 6. Op de leeftijd van 2 jaar had 8% van de kinderen met een 
minor omphalocele een achterblijvende lengtegroei en 16% had ondergewicht. Van de 
2-jarigen met een giant omphalocele had 30% een achterblijvende lengtegroei en 40% 
had ondergewicht. Zowel kinderen met een minor als die met een giant omphalocele 
hadden een normale mentale ontwikkeling. De motorische ontwikkeling was vertraagd 
bij 21% van de kinderen met een minor omphalocele en bij 82% van de kinderen met 
een giant omphalocele. 
 
We concluderen dat kinderen met een omphalocele een verhoogd risico hebben op 
achterblijvende groei. De mentale ontwikkeling is normaal. Kinderen met een giant 
omphalocele hebben vaak een vertraagde motorische ontwikkeling, zij moeten goed 
gevolgd worden en op tijd worden verwezen voor kinderfysiotherapie.  
 
 
 
Hoofdstuk 7 beschrijft het dagelijks functioneren van 31 kinderen met een 
omphalocele op de schoolleeftijd (4-17 jaar). Ouders hadden hiervoor vragenlijsten 
ingevuld. We vergeleken de mate van kwetsbaarheid zoals ervaren door ouders en het 
motorisch functioneren met Nederlandse referentiewaarden. De gegevens over 
cognitie, de gezondheidsstatus, kwaliteit van leven en gedrag werden vergeleken met 
die van gezonde kinderen van dezelfde leeftijd, hetzelfde geslacht en met hetzelfde 
Hoe is de groei en ontwikkeling van kinderen met een minor of giant omphalocele 
in de eerste twee levensjaren? 
 
Hoe beoordelen ouders de motorische functie, het functioneren op school, de 
gezondheidsstatus, de kwaliteit van leven en het gedrag van hun kind op de 
schoolleeftijd?  
 
12
Nederlandse samenvatting
259
opleidingsniveau van moeder (controlegroep). Meer dan 80% van de ouders van een 
kind met omphalocele gaf aan dat hun kind een normale motorische ontwikkeling had. 
Scores op het gebied van cognitie, gezondheidsstatus, kwaliteit van leven en gedrag 
waren vergelijkbaar met die van gezonde kinderen. Ruim een kwart van de ouders van 
een kind met omphalocele gaf aan dat hun kind cognitieve problemen had (vergeleken 
met 9% in de controlegroep). Kinderen met een giant omphalocele of meerdere 
aangeboren afwijkingen leken vaker cognitieve problemen te hebben.  
 
We concluderen dat ouders van een kind met omphalocele over het algemeen positief 
zijn over het functioneren van hun kind op de schoolleeftijd. Kinderen met een 
geïsoleerde, minor omphalocele hebben geen langdurige follow-up nodig. Kinderen met 
een giant omphalocele of meerdere aangeboren afwijkingen hebben mogelijk een 
hogere kans op cognitieve problemen. We raden aan om deze groep op te volgen op 
de schoolleeftijd.  
 
Aanlegstoornis van de long 
Een aanlegstoornis van de long is een verzamelterm voor verschillende type 
aandoeningen; de meest bekende en meest voorkomende is een congenitale pulmonale 
luchtwegafwijking (CPAM). Andere aandoeningen zijn een longsekwester, congenitaal 
lobair emfyseem, bronchogene cyste en combinaties van deze afwijkingen. Sinds de 
invoering van de 20-weken echo en verbeterde kwaliteit van de echobeelden, worden 
steeds meer van deze aandoeningen al voor de geboorte ontdekt. Voor de geboorte is 
het lastig te zien om welk type aanlegstoornis het gaat, aangezien er nog geen lucht in 
de longen zit en omdat verschillende typen er hetzelfde uit kunnen zien op de echo. Na 
de geboorte ontwikkelen sommige kinderen klachten, zoals ademhalingsproblemen of 
luchtweginfecties; deze kinderen worden geopereerd. Andere kinderen blijven 
asymptomatisch; deze kinderen worden in het Erasmus MC-Sophia wel gevolgd, maar 
niet geopereerd – in tegenstelling tot sommige andere ziekenhuizen. 
 
 
 
In hoofdstuk 8 hebben we gekeken naar de overeenkomst tussen het beeld van een 
aanlegstoornis van de long voor de geboorte en dat erna. We onderzochten het type 
aanlegstoornis bij 80 ongeboren baby’s. Met echoscopie tijdens de zwangerschap werd 
onderscheid gemaakt tussen CPAM (microcysteus, macrocysteus, of gemengd), 
longsequester, of een gecombineerde vorm. De diagnose na de geboorte werd gemaakt 
met een computed tomography (CT)-scan of met histologisch onderzoek. De meest 
In hoeverre komt het beeld van een aanlegstoornis van de long voor de geboorte 
overeen met dat na de geboorte?  
 
opvallende bevinding was dat een microcysteuze CPAM op de echo in 15 (43%) van de 
gevallen na de geboorte congenitaal lobair emfyseem bleek te zijn.  
 
We concluderen dat het moeilijk is om voor de geboorte al te zien welk type 
aanlegstoornis van de long de baby heeft. We raden daarom aan om alle typen te 
beschrijven aan de hand van het echobeeld (hyperechogeen, hypoechogeen of gemixt; 
met of zonder arteriële bloedvoorziening vanuit de aorta). De ouders moet worden 
verteld dat het type aanlegstoornis van de long pas na de geboorte wordt vastgesteld 
met behulp van een CT-scan. 
 
 
 
Hoofdstuk 8 beschrijft de voorspellende waarde van de CPAM volume ratio (CVR) 
voor de behoefte aan ademhalingsondersteuning binnen 24 uur na de geboorte en de 
noodzaak tot een operatie binnen 2 jaar na de geboorte. We onderzochten 80 
ongeboren baby’s met een aanlegstoornis van de long. De CVR werd bepaald op drie 
momenten tijdens de zwangerschap (18-24, 24-30 en 30-37 weken). In totaal hadden 
14 (18%) baby’s extra zuurstof nodig en werden 17 (21%) baby’s geopereerd. De CVR 
bleek een betrouwbare voorspeller voor de noodzaak tot een operatie (sensitiviteit en 
specificiteit rond 80%) vanaf 24 weken zwangerschap. We konden niet voorspellen 
welke baby’s ademhalingsondersteuning nodig hebben na de geboorte; binnen de groep 
die dit nodig had zagen we grote verschillen in de CVR-metingen. Bij sommigen was de 
afwijking voor de geboorte zelfs helemaal verdwenen.  
 
We concluderen dat de CVR vanaf 24 weken zwangerschap een betrouwbare 
voorspeller is voor de noodzaak tot een operatie. We kunnen niet voorspellen welke 
baby’s na de geboorte ademhalingsondersteuning nodig zullen hebben; we raden 
daarom aan om alle ongeboren baby’s met een CLM in een derdelijns ziekenhuis 
geboren te laten worden, onafhankelijk van de grootte van hun afwijking. 
 
 
Hoofdstuk 9 beschrijft de groei, de longfunctie en het uithoudingsvermogen van 61 
kinderen geboren met een aanlegstoornis van de long, op 8-jarige leeftijd. We bekeken 
deze uitkomsten zowel voor de groep die een operatie nodig had gehad, als voor de 
groep die niet geopereerd was. Beide groepen hadden een normale lengtegroei en een 
Kunnen we voor de geboorte voorspellen welke kinderen na de geboorte zuurstof 
en/of een operatie nodig zullen hebben?  
Hoe is de groei, de longfunctie en het uithoudingsvermogen van kinderen die al 
dan niet geopereerd zijn aan hun aanlegstoornis van de long?  
Chapter 12
260
opleidingsniveau van moeder (controlegroep). Meer dan 80% van de ouders van een 
kind met omphalocele gaf aan dat hun kind een normale motorische ontwikkeling had. 
Scores op het gebied van cognitie, gezondheidsstatus, kwaliteit van leven en gedrag 
waren vergelijkbaar met die van gezonde kinderen. Ruim een kwart van de ouders van 
een kind met omphalocele gaf aan dat hun kind cognitieve problemen had (vergeleken 
met 9% in de controlegroep). Kinderen met een giant omphalocele of meerdere 
aangeboren afwijkingen leken vaker cognitieve problemen te hebben.  
 
We concluderen dat ouders van een kind met omphalocele over het algemeen positief 
zijn over het functioneren van hun kind op de schoolleeftijd. Kinderen met een 
geïsoleerde, minor omphalocele hebben geen langdurige follow-up nodig. Kinderen met 
een giant omphalocele of meerdere aangeboren afwijkingen hebben mogelijk een 
hogere kans op cognitieve problemen. We raden aan om deze groep op te volgen op 
de schoolleeftijd.  
 
Aanlegstoornis van de long 
Een aanlegstoornis van de long is een verzamelterm voor verschillende type 
aandoeningen; de meest bekende en meest voorkomende is een congenitale pulmonale 
luchtwegafwijking (CPAM). Andere aandoeningen zijn een longsekwester, congenitaal 
lobair emfyseem, bronchogene cyste en combinaties van deze afwijkingen. Sinds de 
invoering van de 20-weken echo en verbeterde kwaliteit van de echobeelden, worden 
steeds meer van deze aandoeningen al voor de geboorte ontdekt. Voor de geboorte is 
het lastig te zien om welk type aanlegstoornis het gaat, aangezien er nog geen lucht in 
de longen zit en omdat verschillende typen er hetzelfde uit kunnen zien op de echo. Na 
de geboorte ontwikkelen sommige kinderen klachten, zoals ademhalingsproblemen of 
luchtweginfecties; deze kinderen worden geopereerd. Andere kinderen blijven 
asymptomatisch; deze kinderen worden in het Erasmus MC-Sophia wel gevolgd, maar 
niet geopereerd – in tegenstelling tot sommige andere ziekenhuizen. 
 
 
 
In hoofdstuk 8 hebben we gekeken naar de overeenkomst tussen het beeld van een 
aanlegstoornis van de long voor de geboorte en dat erna. We onderzochten het type 
aanlegstoornis bij 80 ongeboren baby’s. Met echoscopie tijdens de zwangerschap werd 
onderscheid gemaakt tussen CPAM (microcysteus, macrocysteus, of gemengd), 
longsequester, of een gecombineerde vorm. De diagnose na de geboorte werd gemaakt 
met een computed tomography (CT)-scan of met histologisch onderzoek. De meest 
In hoeverre komt het beeld van een aanlegstoornis van de long voor de geboorte 
overeen met dat na de geboorte?  
 
opvallende bevinding was dat een microcysteuze CPAM op de echo in 15 (43%) van de 
gevallen na de geboorte congenitaal lobair emfyseem bleek te zijn.  
 
We concluderen dat het moeilijk is om voor de geboorte al te zien welk type 
aanlegstoornis van de long de baby heeft. We raden daarom aan om alle typen te 
beschrijven aan de hand van het echobeeld (hyperechogeen, hypoechogeen of gemixt; 
met of zonder arteriële bloedvoorziening vanuit de aorta). De ouders moet worden 
verteld dat het type aanlegstoornis van de long pas na de geboorte wordt vastgesteld 
met behulp van een CT-scan. 
 
 
 
Hoofdstuk 8 beschrijft de voorspellende waarde van de CPAM volume ratio (CVR) 
voor de behoefte aan ademhalingsondersteuning binnen 24 uur na de geboorte en de 
noodzaak tot een operatie binnen 2 jaar na de geboorte. We onderzochten 80 
ongeboren baby’s met een aanlegstoornis van de long. De CVR werd bepaald op drie 
momenten tijdens de zwangerschap (18-24, 24-30 en 30-37 weken). In totaal hadden 
14 (18%) baby’s extra zuurstof nodig en werden 17 (21%) baby’s geopereerd. De CVR 
bleek een betrouwbare voorspeller voor de noodzaak tot een operatie (sensitiviteit en 
specificiteit rond 80%) vanaf 24 weken zwangerschap. We konden niet voorspellen 
welke baby’s ademhalingsondersteuning nodig hebben na de geboorte; binnen de groep 
die dit nodig had zagen we grote verschillen in de CVR-metingen. Bij sommigen was de 
afwijking voor de geboorte zelfs helemaal verdwenen.  
 
We concluderen dat de CVR vanaf 24 weken zwangerschap een betrouwbare 
voorspeller is voor de noodzaak tot een operatie. We kunnen niet voorspellen welke 
baby’s na de geboorte ademhalingsondersteuning nodig zullen hebben; we raden 
daarom aan om alle ongeboren baby’s met een CLM in een derdelijns ziekenhuis 
geboren te laten worden, onafhankelijk van de grootte van hun afwijking. 
 
 
Hoofdstuk 9 beschrijft de groei, de longfunctie en het uithoudingsvermogen van 61 
kinderen geboren met een aanlegstoornis van de long, op 8-jarige leeftijd. We bekeken 
deze uitkomsten zowel voor de groep die een operatie nodig had gehad, als voor de 
groep die niet geopereerd was. Beide groepen hadden een normale lengtegroei en een 
Kunnen we voor de geboorte voorspellen welke kinderen na de geboorte zuurstof 
en/of een operatie nodig zullen hebben?  
Hoe is de groei, de longfunctie en het uithoudingsvermogen van kinderen die al 
dan niet geopereerd zijn aan hun aanlegstoornis van de long?  
12
Nederlandse samenvatting
261
normaal gewicht. De meeste kinderen in de niet-geopereerde groep hadden een 
normale longfunctie en een normaal uithoudingsvermogen. Een kwart van deze groep 
had echter een verminderde longfunctie en/of verminderd uithoudingsvermogen. Het 
is daarom belangrijk om hier als dokter of ouder alert op te zijn. In de geopereerde 
groep had ongeveer de helft van de kinderen een verminderde longfunctie. Het 
gemiddelde uithoudingsvermogen in deze groep was minder goed dan dat van gezonde 
Nederlandse kinderen.  
 
We concluderen dat kinderen met een aanlegstoornis van de long goed groeien. Ze 
hebben een verhoogd risico op een verminderde longfunctie en verminderd 
uithoudingsvermogen, met name als ze een operatie nodig hebben gehad. Langdurige 
follow-up tot op de volwassen leeftijd en daarna kan overwogen worden vanwege het 
mogelijke risico op kwaadaardige ontaarding.  
 
Discussie 
In hoofdstuk 10 worden de belangrijkste bevindingen besproken en in perspectief 
geplaatst. Daarnaast geven we aanbevelingen voor de klinische praktijk en voor 
toekomstig onderzoek. Onze bevindingen onderstrepen het belang van een 
multidisciplinaire, gestandaardiseerde aanpak bij het counselen van toekomstige ouders 
en van langetermijnfollow-up. We raden aan om: 
• Meer te streven naar gezinsgerichte zorg. 
• Ouders niet alleen praktische en emotionele steun te bieden, maar hen ook te 
begeleiden in het stimuleren van de ontwikkeling van hun kind.  
• Ouders meer te betrekken bij het beslisproces ten aanzien van het medisch beleid 
van hun kind. 
 
Tot slot geven we een overzicht van wat te vertellen aan ouders in verwachting van een 
kind met een buikwanddefect of een aanlegstoornis van de long.   
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DANKWOORD 
 
Het is af! De afgelopen jaren hebben heel veel mensen mij geholpen bij de 
totstandkoming van dit proefschrift. Graag bedank ik een aantal van hen in het bijzonder. 
 
Allereerst wil ik alle kinderen en hun ouders en verzorgers bedanken voor hun 
bijdrage aan de verschillende onderzoeken en hun deelname aan de chirurgische 
langetermijnfollow-up. Met jullie bijdrage kunnen we aanstaande ouders (en 
zorgverleners) beter voorbereiden op wat zij kunnen verwachten.  
 
Mijn promotor, prof. dr. Tibboel. Beste Dick, u wist me ervan te overtuigen dat 
promoveren voorafgaand aan m'n coschappen echt beter voor me was ('je kunt de rest 
van je leven nog met een pieper in je witte jas lopen'). U kreeg helemaal gelijk. Bedankt 
voor het vertrouwen en voor de kansen die ik heb gekregen. Ik waardeer uw kritische 
blik, snelle reacties, daadkracht en uw enthousiasme voor onderzoek. 
 
Mijn copromotoren, dr. IJsselstijn en dr. Cohen-Overbeek. Lieve Hanneke en Titia, 
in 2013 stond ik opeens bij jullie op de stoep, zonder onderzoekservaring. Jullie hebben 
me als het ware opgevoed als onderzoeker en vormden samen de perfecte combinatie 
van copromotoren. Lieve Hanneke, ik kon ondanks alles altijd op je rekenen en je voelde 
precies aan wanneer ik jouw hulp nodig had. Ik bewonder je organisatietalent en je 
enorme doorzettingsvermogen. Lieve Titia, binnen en buiten dit promotietraject hielp 
je me om uitdagingen aan te gaan. Je lieve en wijze woorden zorgden ervoor dat ik 
steeds weer vol goede moed aan het werk ging. Ik ben jullie dankbaar voor alles wat ik 
van jullie heb geleerd, als onderzoeker en als mens. 
 
Leden van de kleine commissie, prof. dr. de Blaauw, prof. dr. Pajkrt en prof. dr. 
Rings, hartelijk bedankt voor het beoordelen van mijn proefschrift. Daarnaast bedank 
ik de overige leden van de promotiecommissie voor het zitting nemen in de grote 
commissie.  
 
Prof. dr. Wijnen, beste René, officieel geen promotor, maar zo voelde het vaak wel. 
Bedankt voor alle hulp en begeleiding; bij mijn artikelen, tijdens meelopen op OK, 
werkbesprekingen en op de EUPSA congressen. Ik waardeer je betrokkenheid en de 
fijne samenwerking.  
 
Prof. dr. Steegers, mede dankzij u kon ik naar het ISPD congres in Antwerpen en 
naar het ISUOG congres in Singapore. Bedankt!  
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Dankwoord
Alle coauteurs, bedankt voor de fijne samenwerking. Joost en Edu, veel dank voor 
jullie hulp bij de statistiek en voor de vriendelijke mails. Ko, je bent een soort tovenaar 
met woorden. Bedankt voor al je hulp. Marloes, veel dank voor je werk tijdens je 
masteronderzoek, er zijn mooie artikelen uit voortgekomen. Rosan, samen begonnen 
we aan het omphalocele onderzoek, inmiddels alweer jaren geleden. Jij maakte me 
wegwijs in SPSS. Ik ben trots op de artikelen waar we samen aan hebben gewerkt.  
 
Gerbrich, jij maakte me enthousiast over onderzoek doen. Je koppelde me aan 
Hanneke en dat was het begin van mijn carrière als onderzoeker. Dankjewel!  
 
Marja, Jolande en Romy, bedankt voor alle hulp, gezelligheid en betrokkenheid. 
 
Allerbeste kamergenoten van kippenhok SP-2430 en later de compartimenten van SP-
3506, ik heb zoveel van jullie geleerd en met jullie gelachen. Ontzettend bedankt dat 
jullie altijd voor me klaarstonden. Kitty, Marlous, Dorian en Lisette, Hanneke zette 
mij niet voor niets in het kippenhok; bedankt voor het wegwijs maken in de 
onderzoekswereld. Manuel en Bianca, mede-dwarrels, we moeten een patent 
aanvragen op het kwispelkwartier. Misschien kunnen uitvinders Willem en Frank dat 
regelen. Esther, je had vaak aan een half woord genoeg. Die WIDM traditie houden 
we erin. Norani, altijd in voor een croissantje om 10.00uur. Chantal, jouw Harry 
Potter boeken hebben me lange wachttijden doorgeholpen en relaxte avondjes bezorgd. 
Raisa, je wist altijd de juiste dingen te zeggen en te vragen. Henk-Jan, laten we nog 
eens samen pannenkoeken bakken. Renate, zo leuk dat je nu m’n buurvrouw bent. 
Joppe, je komt nooit meer van me af. Michelle en Denise, bedankt voor de 
gezelligheid, veel succes met jullie onderzoek. Stephanie, je bent een heerlijk mens, 
de woensdagen waren significant saaier zonder jou. Shelley, ik heb genoten van je 
humor, samen met jou tussen de struisvogels was fantastisch.  
 
Lieve onderzoekers van het Sophia en van de Prenatale Geneeskunde: alle 
activiteiten, commissies, weekendjes weg, congressen, kopjes koffie, borrels en etentjes 
met jullie hebben voor een onwijs mooie tijd gezorgd. Jennifer, Martine en Tanja, 
bedankt voor de leuke tijd als SOV bestuur. Paulien, Nina, Carsten en Fieke, ik heb 
genoten met jullie in Antwerpen en Singapore, fijn dat jullie altijd de weg terug naar het 
hotel wisten te vinden. Lieve Leontien, je begrijpt me als geen ander. Proost op ons!  
 
Lieve Anne en Carmen, op de allereerste dag van de studie Geneeskunde werden we 
in dezelfde studiegroep ingedeeld. Vanaf dat moment waren we onafscheidelijk en zaten 
we elke dag naast elkaar in college. Nu we elkaar niet meer dagelijks zien volgen de 
datumprikkers elkaar in rap tempo op voor saunadagjes, escaperooms, etentjes, 
 
musicals en concerten. Ik hoop dat dat altijd zo blijft. Bedankt voor jullie humor en 
vriendschap.  
 
Allerbeste toneelvrienden van RISK, ik heb genoten van de wekelijkse 
repetitieavonden, de biertjes in de B, de spelletjes in het park, de repetitieweekenden 
en de voorstellingen die we samen maakten. Toneel spelen was een heerlijke afwisseling 
met het onderzoeksleven.  
 
Lieve Loraine, Angela, Mariëlle en Marinda, we zien elkaar lang niet meer zo vaak 
als toen we nog samen op de basisschool zaten, maar als we elkaar zien is het alsof er 
niets veranderd is. Bedankt voor jullie onvoorwaardelijke vriendschap! 
 
Lieve Bart, je bent een topvent. Toen jij de deur van la casa di P opendeed op mijn 
eerste dag als Rotterdammert wist ik dat het goed zou komen. Bedankt voor je 
betrokkenheid en je lieve berichtjes. 
 
Lieve (schoon)familie, bedankt voor jullie interesse in mijn onderzoek. Paul, een 
gesprek met jou zorgde ervoor dat ik koos voor promoveren voorafgaand aan mijn 
coschappen. Het bleek de goede keuze, bedankt! 
 
Lieve Kim, onze vriendschap werd alleen nog maar mooier toen we allebei gingen 
promoveren. 'Koffie met Kim' werd een heus begrip. Dank dat je me een spiegel 
voorhoudt en dat je er altijd voor me bent – of het nu ’s ochtends vroeg is of midden 
in de nacht. Je bent de perfecte paranimf, ceremoniemeester en bovenal vriendin.  
 
Lieve Tanja, altijd bereid om te helpen. Of het nu gaat om statistiek, motivatie vinden 
voor de sportschool, of het uitzoeken van een bruidstaart. Bedankt voor je luisterende 
oor en het meedenken over eigenlijk alles waar een mens over kan twijfelen. Ik ben 
heel blij dat ik jou er als vriendin bij heb gekregen en dat je m’n paranimf wilt zijn.  
 
Lieve pap en mam, bedankt dat jullie altijd achter me staan als ik mijn dromen achterna 
ga. Jullie kaartjes vielen steeds precies door de brievenbus op de momenten dat ik het 
nodig had. Lieve Vera, je bent het leukste zusje ooit en gelukkig heb jij de creatieve 
genen gekregen. Zonder jouw hulp was dit boekje lang niet zo mooi geworden. 
Dankjewel! 
 
Allerliefste Pascal, ik ben zo gelukkig met jou. Ik kan je niet genoeg bedanken voor 
alles wat je voor me doet. De afgelopen jaren stonden niet alleen in het teken van dit 
promotietraject; ik ben heel trots op ons en kijk uit naar onze toekomst samen.  
Ik hou van je! 
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jullie altijd voor me klaarstonden. Kitty, Marlous, Dorian en Lisette, Hanneke zette 
mij niet voor niets in het kippenhok; bedankt voor het wegwijs maken in de 
onderzoekswereld. Manuel en Bianca, mede-dwarrels, we moeten een patent 
aanvragen op het kwispelkwartier. Misschien kunnen uitvinders Willem en Frank dat 
regelen. Esther, je had vaak aan een half woord genoeg. Die WIDM traditie houden 
we erin. Norani, altijd in voor een croissantje om 10.00uur. Chantal, jouw Harry 
Potter boeken hebben me lange wachttijden doorgeholpen en relaxte avondjes bezorgd. 
Raisa, je wist altijd de juiste dingen te zeggen en te vragen. Henk-Jan, laten we nog 
eens samen pannenkoeken bakken. Renate, zo leuk dat je nu m’n buurvrouw bent. 
Joppe, je komt nooit meer van me af. Michelle en Denise, bedankt voor de 
gezelligheid, veel succes met jullie onderzoek. Stephanie, je bent een heerlijk mens, 
de woensdagen waren significant saaier zonder jou. Shelley, ik heb genoten van je 
humor, samen met jou tussen de struisvogels was fantastisch.  
 
Lieve onderzoekers van het Sophia en van de Prenatale Geneeskunde: alle 
activiteiten, commissies, weekendjes weg, congressen, kopjes koffie, borrels en etentjes 
met jullie hebben voor een onwijs mooie tijd gezorgd. Jennifer, Martine en Tanja, 
bedankt voor de leuke tijd als SOV bestuur. Paulien, Nina, Carsten en Fieke, ik heb 
genoten met jullie in Antwerpen en Singapore, fijn dat jullie altijd de weg terug naar het 
hotel wisten te vinden. Lieve Leontien, je begrijpt me als geen ander. Proost op ons!  
 
Lieve Anne en Carmen, op de allereerste dag van de studie Geneeskunde werden we 
in dezelfde studiegroep ingedeeld. Vanaf dat moment waren we onafscheidelijk en zaten 
we elke dag naast elkaar in college. Nu we elkaar niet meer dagelijks zien volgen de 
datumprikkers elkaar in rap tempo op voor saunadagjes, escaperooms, etentjes, 
 
musicals en concerten. Ik hoop dat dat altijd zo blijft. Bedankt voor jullie humor en 
vriendschap.  
 
Allerbeste toneelvrienden van RISK, ik heb genoten van de wekelijkse 
repetitieavonden, de biertjes in de B, de spelletjes in het park, de repetitieweekenden 
en de voorstellingen die we samen maakten. Toneel spelen was een heerlijke afwisseling 
met het onderzoeksleven.  
 
Lieve Loraine, Angela, Mariëlle en Marinda, we zien elkaar lang niet meer zo vaak 
als toen we nog samen op de basisschool zaten, maar als we elkaar zien is het alsof er 
niets veranderd is. Bedankt voor jullie onvoorwaardelijke vriendschap! 
 
Lieve Bart, je bent een topvent. Toen jij de deur van la casa di P opendeed op mijn 
eerste dag als Rotterdammert wist ik dat het goed zou komen. Bedankt voor je 
betrokkenheid en je lieve berichtjes. 
 
Lieve (schoon)familie, bedankt voor jullie interesse in mijn onderzoek. Paul, een 
gesprek met jou zorgde ervoor dat ik koos voor promoveren voorafgaand aan mijn 
coschappen. Het bleek de goede keuze, bedankt! 
 
Lieve Kim, onze vriendschap werd alleen nog maar mooier toen we allebei gingen 
promoveren. 'Koffie met Kim' werd een heus begrip. Dank dat je me een spiegel 
voorhoudt en dat je er altijd voor me bent – of het nu ’s ochtends vroeg is of midden 
in de nacht. Je bent de perfecte paranimf, ceremoniemeester en bovenal vriendin.  
 
Lieve Tanja, altijd bereid om te helpen. Of het nu gaat om statistiek, motivatie vinden 
voor de sportschool, of het uitzoeken van een bruidstaart. Bedankt voor je luisterende 
oor en het meedenken over eigenlijk alles waar een mens over kan twijfelen. Ik ben 
heel blij dat ik jou er als vriendin bij heb gekregen en dat je m’n paranimf wilt zijn.  
 
Lieve pap en mam, bedankt dat jullie altijd achter me staan als ik mijn dromen achterna 
ga. Jullie kaartjes vielen steeds precies door de brievenbus op de momenten dat ik het 
nodig had. Lieve Vera, je bent het leukste zusje ooit en gelukkig heb jij de creatieve 
genen gekregen. Zonder jouw hulp was dit boekje lang niet zo mooi geworden. 
Dankjewel! 
 
Allerliefste Pascal, ik ben zo gelukkig met jou. Ik kan je niet genoeg bedanken voor 
alles wat je voor me doet. De afgelopen jaren stonden niet alleen in het teken van dit 
promotietraject; ik ben heel trots op ons en kijk uit naar onze toekomst samen.  
Ik hou van je! 
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Dankwoord

